{
               "authors" : "Djoumbou Feunang, Yannick; Iynkkaran, Ithayavani; Assempour,  Nazanin; Wishart (2017)",
               "version" : "1.0",
            "desription" : "BioTransformerDB is a biotransformation database that describes the transformation of small molecules in humans. this is a first partial release, which will be updated very soon.",
            "copyright"  : "BioTransformerDB is offered to the public as a freely acessible database. It is part of BioTransformer, a software tool for the prediction ofsmall molecule metabolism. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (BioTransformer) and the original publication (see citation). We ask that users who download portions of the database, or use the BioTransformer software, cite the BioTransformer reference in any resulting publications.",
             "citation"  : "Djoumbou Feunang, Yannick - Cheminformatics Tools for Enabling Metabolomic, 2017; PhD thesis (University Of Alberta, Canada).",
    "biotransformations" : {
        "BIOTID0001" : {
                             "Name" : "pinoline",
            "Substrate's structure" : "O(C1=C(C=2C3=C(N(C2C(=C1[H])[H])[H])C(N(C(C3([H])[H])([H])[H])[H])([H])[H])[H])C([H])([H])[H]",
                         "InChIKey" : "QYMDEOQLJUUNOF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Yu, A. (2003) Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase; Pharmacogenetics 2003, Vol 13 No 6"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0001",
                     "inchikey" : "HASNCBJLQYTILW-UHFFFAOYSA-N",
                         "name" : "1H,2H,3H,4H,9H�ېpyrido[3,4�ېb]indol�ې6�ېol",
                    "structure" : "OC1=CC=C2NC3=C(CCNC3)C2=C1"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0002" : {
                             "Name" : "(R)-halothane",
            "Substrate's structure" : "C(F)(F)(F)[C@](Cl)(Br)[H]",
                         "InChIKey" : "BCQZXOMGPXTTIC-SFOWXEAESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Spracklin, D.K. et al (1996); Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4; Drug Metab Dispos. 1996 Sep;24(9):976-83.",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0002",
                     "inchikey" : "DTQVDTLACAAQTR-UHFFFAOYSA-N",
                         "name" : "trifluoroacetic acid",
                    "structure" : "OC(=O)C(F)(F)F"
                }
            ],
                    "Reaction Type" : [
                "Dehalogenation"
            ]
        },
        "BIOTID0003" : {
                             "Name" : "(R)-halothane",
            "Substrate's structure" : "C(F)(F)(F)[C@](Cl)(Br)[H]",
                         "InChIKey" : "BCQZXOMGPXTTIC-SFOWXEAESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP3A4; CYP2B6; CYP2C9; CYP2D6",
                       "References" : [
                "Spracklin, D.K. et al (1996); Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4; Drug Metab Dispos. 1996 Sep;24(9):976-83.",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0003",
                     "inchikey" : "HTHNTJCVPNKCPZ-UHFFFAOYSA-N",
                         "name" : "2-chloro-1,1-difluoroethene",
                    "structure" : "FC(F)=CCl"
                }
            ],
                    "Reaction Type" : [
                "Dehalogenation"
            ]
        },
        "BIOTID0004" : {
                             "Name" : "(R)-halothane",
            "Substrate's structure" : "C(F)(F)(F)[C@](Cl)(Br)[H]",
                         "InChIKey" : "BCQZXOMGPXTTIC-SFOWXEAESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP3A4; CYP2B6; CYP2C9; CYP2D6",
                       "References" : [
                "Spracklin, D.K. et al (1996); Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4; Drug Metab Dispos. 1996 Sep;24(9):976-83.",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0004",
                     "inchikey" : "JUKWCHLDFKRDHO-UHFFFAOYSA-N",
                         "name" : "1-chloro-2,2,2-trifluoroethanide",
                    "structure" : "FC(F)(F)[CH-]Cl"
                }
            ],
                    "Reaction Type" : [
                "Dehalogenation"
            ]
        },
        "BIOTID0005" : {
                             "Name" : "(R)-3,4-Methylenedioxymethamphetamine",
            "Substrate's structure" : "C1(=C(C2=C(C(=C1[H])[H])OC(O2)([H])[H])[H])C([C@@](C([H])([H])[H])(N(C([H])([H])[H])[H])[H])([H])[H]",
                         "InChIKey" : "SHXWCVYOXRDMCX-MRVPVSSYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0005",
                     "inchikey" : "NTCPGTZTPGFNOM-SSDOTTSWSA-N",
                         "name" : "N-Methyl-3,4- dihydroxyamphetamine",
                    "structure" : "[H]N(C([H])([H])[H])[C@]([H])(C([H])([H])[H])C([H])([H])C1=C([H])C(O)=C(O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Heterocyclic ring fission"
            ]
        },
        "BIOTID0006" : {
                             "Name" : "(R)-3,4-Methylenedioxymethamphetamine",
            "Substrate's structure" : "C1(=C(C2=C(C(=C1[H])[H])OC(O2)([H])[H])[H])C([C@@](C([H])([H])[H])(N(C([H])([H])[H])[H])[H])([H])[H]",
                         "InChIKey" : "SHXWCVYOXRDMCX-MRVPVSSYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (major); CYP1A2; CYP2B6; CYP3A4",
                       "References" : [
                "Zanger, U.M. and Klein, K. (2013); Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance; Front Genet. 2013; 4: 24.; DOI: 10.3389/fgene.2013.00024",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0006",
                     "inchikey" : "NGBBVGZWCFBOGO-SSDOTTSWSA-N",
                         "name" : "3,4-Methylenedioxymethamphetamine",
                    "structure" : "[H]N[C@]([H])(C([H])([H])[H])C([H])([H])C1=C([H])C2=C(OC([H])([H])O2)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0007" : {
                             "Name" : "Dehydroxyzyleuton",
            "Substrate's structure" : "C1(=C(C2=C(S1)C(=C(C(=C2[H])[H])[H])[H])[H])[C@@](N(C(N([H])[H])=O)[H])(C([H])([H])[H])[H]",
                         "InChIKey" : "CKVDCQYUEYONIA-ZETCQYMHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0007",
                     "inchikey" : "KGUIRZVMBWMQQZ-RWNHWRGESA-N",
                         "name" : "Dehydroxyzyleuton sulfoxide",
                    "structure" : "[H]N([H])C(=O)N([H])[C@]([H])(C1=C([H])C2=C(C([H])=C([H])C([H])=C2[H])S1=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0008" : {
                             "Name" : "Dehydroxyzyleuton",
            "Substrate's structure" : "C1(=C(C2=C(S1)C(=C(C(=C2[H])[H])[H])[H])[H])[C@@](N(C(N([H])[H])=O)[H])(C([H])([H])[H])[H]",
                         "InChIKey" : "CKVDCQYUEYONIA-ZETCQYMHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0008",
                     "inchikey" : "QAVLMIJBDWRSOJ-LURJTMIESA-N",
                         "name" : "(1S)�ې1�ې(6�ېhydroxy�ې1�ېbenzothiophen�ې2�ېyl)ethylurea",
                    "structure" : "[H]N([H])C(=O)N([H])[C@]([H])(C1=C([H])C2=C(S1)C=C(O)C([H])=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0009" : {
                             "Name" : "(-)-etodolac",
            "Substrate's structure" : "O1[C@](C=2N(C=3C(C2C(C1([H])[H])([H])[H])=C(C(=C(C3C(C([H])([H])[H])([H])[H])[H])[H])[H])[H])(C(C([H])([H])[H])([H])[H])C(C(O[H])=O)([H])[H]",
                         "InChIKey" : "NNYBQONXHNTVIJ-QGZVFWFLSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0009",
                     "inchikey" : "GQHWDDBALZVXBU-UHFFFAOYNA-N",
                         "name" : "6-Hydroxyetodolac",
                    "structure" : "CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC(O)=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0010" : {
                             "Name" : "(-)-etodolac",
            "Substrate's structure" : "O1[C@](C=2N(C=3C(C2C(C1([H])[H])([H])[H])=C(C(=C(C3C(C([H])([H])[H])([H])[H])[H])[H])[H])[H])(C(C([H])([H])[H])([H])[H])C(C(O[H])=O)([H])[H]",
                         "InChIKey" : "NNYBQONXHNTVIJ-QGZVFWFLSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0010",
                     "inchikey" : "LOALFJPXZIHKNH-UHFFFAOYNA-N",
                         "name" : "7-Hydroxyetodolac",
                    "structure" : "CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0011" : {
                             "Name" : "(-)-limonene",
            "Substrate's structure" : "[C@@]1(C(C([H])([H])[H])=C([H])[H])(C(C(C(=C(C1([H])[H])[H])C([H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "XMGQYMWWDOXHJM-SNVBAGLBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0011",
                     "inchikey" : "BAVONGHXFVOKBV-UHFFFAOYNA-N",
                         "name" : "Carveol",
                    "structure" : "[H]C([H])=C(C([H])([H])[H])C1([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])(O)C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0012" : {
                             "Name" : "(-)-limonene",
            "Substrate's structure" : "[C@@]1(C(C([H])([H])[H])=C([H])[H])(C(C(C(=C(C1([H])[H])[H])C([H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "XMGQYMWWDOXHJM-SNVBAGLBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0012",
                     "inchikey" : "NDTYTMIUWGWIMO-SNVBAGLBSA-N",
                         "name" : "Perillyl alcohol",
                    "structure" : "[H]C([H])=C(C([H])([H])[H])[C@]1([H])C([H])([H])C([H])=C(C([H])([H])O)C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0013" : {
                             "Name" : "(-)-pseudococaine",
            "Substrate's structure" : "N1(C([H])([H])[H])[C@@]2(C(C([C@]1([C@]([C@@](C2([H])[H])(OC(C=3C(=C(C(=C(C3[H])[H])[H])[H])[H])=O)[H])(C(=O)OC([H])([H])[H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "ZPUCINDJVBIVPJ-LXTVHRRPSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Rendic, S. et al. (1997); Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors; Drug Metabolism reviews 1997, 29, 413-580",
                "Brone, R.F. et al. (1977); Biological Effects of Cocaine Derivatives I: Improved Systhesis and Pharmacological Evaluation of Norcocaine; J. Pharm. Sci. 1977, 66, 119-120."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0013",
                     "inchikey" : "AYDBLCSLKNTEJL-XJFOESAGSA-N",
                         "name" : "Norcocaine",
                    "structure" : "[H]N1[C@]2([H])C([H])([H])C([H])([H])[C@@]1([H])[C@@]([H])(C(=O)OC([H])([H])[H])[C@]([H])(OC(=O)C1=C([H])C([H])=C([H])C([H])=C1[H])C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0014" : {
                             "Name" : "(-)-thalidomide",
            "Substrate's structure" : "O=C1N([C@]2(C(C(C(=O)N(C2=O)[H])([H])[H])([H])[H])[H])C(=O)C3=C(C(=C(C(=C13)[H])[H])[H])[H]",
                         "InChIKey" : "UEJJHQNACJXSKW-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0014",
                     "inchikey" : "HHTOWVWIVBSOKC-IENPIDJESA-N",
                         "name" : "cis, trans-5'-OH-thalidomide",
                    "structure" : "[H]N1C(=O)C([H])(O)C([H])([H])[C@]([H])(N2C(=O)C3=C([H])C([H])=C([H])C([H])=C3C2=O)C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0015" : {
                             "Name" : "(-)-thalidomide",
            "Substrate's structure" : "O=C1N([C@]2(C(C(C(=O)N(C2=O)[H])([H])[H])([H])[H])[H])C(=O)C3=C(C(=C(C(=C13)[H])[H])[H])[H]",
                         "InChIKey" : "UEJJHQNACJXSKW-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0015",
                     "inchikey" : "LJBQRRQTZUJWRC-VIFPVBQESA-N",
                         "name" : "5-OH-thalidomide",
                    "structure" : "[H]N1C(=O)C([H])([H])C([H])([H])[C@]([H])(N2C(=O)C3=C([H])C([H])=C(O)C([H])=C3C2=O)C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0016" : {
                             "Name" : "(-)-thalidomide",
            "Substrate's structure" : "O=C1N([C@]2(C(C(C(=O)N(C2=O)[H])([H])[H])([H])[H])[H])C(=O)C3=C(C(=C(C(=C13)[H])[H])[H])[H]",
                         "InChIKey" : "UEJJHQNACJXSKW-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C19; CYP2E1",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0016",
                     "inchikey" : "MNALUCRLHVMELD-UEJVZZJDSA-N",
                         "name" : "(-)-thalidomide arene oxide",
                    "structure" : "[H]N1C(=O)C([H])([H])C([H])([H])[C@]([H])(N2C(=O)C3=C([H])C4([H])OC4([H])C([H])=C3C2=O)C1=O"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0017" : {
                             "Name" : "(-)-zileuton",
            "Substrate's structure" : "C([C@](N(O[H])C(N([H])[H])=O)(C1=C(C2=C(C(=C(C(=C2S1)[H])[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "MWLSOWXNZPKENC-ZETCQYMHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0017",
                     "inchikey" : "KWEAXQJUQDQMNY-ISJKBYAMSA-N",
                         "name" : "Zileuton sulfoxide",
                    "structure" : "[H]ON(C(=O)N([H])[H])[C@]([H])(C1=C([H])C2=C([H])C([H])=C([H])C([H])=C2S1=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0018" : {
                             "Name" : "(-)-zileuton",
            "Substrate's structure" : "C([C@](N(O[H])C(N([H])[H])=O)(C1=C(C2=C(C(=C(C(=C2S1)[H])[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "MWLSOWXNZPKENC-ZETCQYMHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0018",
                     "inchikey" : "ZQQVPNNYZLDMMO-LURJTMIESA-N",
                         "name" : "Hydroxyzileuton",
                    "structure" : "[H]ON(C(=O)N([H])[H])[C@]([H])(C1=C([H])C2=C([H])C([H])=C(O)C([H])=C2S1)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0019" : {
                             "Name" : "(?)-perhexiline",
            "Substrate's structure" : "C(C(C1(C(C(C(C(C1([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])(C2(C(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])([C@]3(C(C(C(C(N3[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H]",
                         "InChIKey" : "CYXKNKQEMFBLER-GOSISDBHSA-N",
                      "DrugBank ID" : "DBMET00839",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0019",
                     "inchikey" : "DZFRYNPJLZCKSC-BTRQGYIVSA-N",
                         "name" : "cis-hydroxyperhexilline",
                    "structure" : "O[C@H]1CCC(CC1)[C@@H](CC1CCCCN1)C1CCCCC1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0020" : {
                             "Name" : "(?)-perhexiline",
            "Substrate's structure" : "C(C(C1(C(C(C(C(C1([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])(C2(C(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])([C@]3(C(C(C(C(N3[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H]",
                         "InChIKey" : "CYXKNKQEMFBLER-GOSISDBHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0020",
                     "inchikey" : "DZFRYNPJLZCKSC-CRIGQSRLNA-N",
                         "name" : "trans-hydroxyperhexilline",
                    "structure" : "O[C@H]1CC[C@H](CC1)C(CC1CCCCN1)C1CCCCC1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0021" : {
                             "Name" : "(+)-3-carene",
            "Substrate's structure" : "C1(=C(C([C@@]2([C@](C1([H])[H])(C2(C([H])([H])[H])C([H])([H])[H])[H])[H])([H])[H])[H])C([H])([H])[H]",
                         "InChIKey" : "BQOFWKZOCNGFEC-BDAKNGLRSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP2C19; CYP2D6",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0021",
                     "inchikey" : "BLWHTASVUYWISZ-BDAKNGLRSA-N",
                         "name" : "3-Caren-10-ol",
                    "structure" : "[H]C1=C(C([H])([H])O)C([H])([H])[C@@]2([H])[C@@]([H])(C1([H])[H])C2(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0022" : {
                             "Name" : "(+)-3-carene",
            "Substrate's structure" : "C1(=C(C([C@@]2([C@](C1([H])[H])(C2(C([H])([H])[H])C([H])([H])[H])[H])[H])([H])[H])[H])C([H])([H])[H]",
                         "InChIKey" : "BQOFWKZOCNGFEC-BDAKNGLRSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0022",
                     "inchikey" : "AGHSZSJVJPSERC-CCSIGSMKSA-N",
                         "name" : "Carene epoxide",
                    "structure" : "[H]C([H])([H])C12OC1([H])C([H])([H])[C@]1([H])[C@]([H])(C2([H])[H])C1(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0023" : {
                             "Name" : "(+)-bisoprolol",
            "Substrate's structure" : "C1(=C(C(=C(C(=C1[H])[H])C(OC(C(OC(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])([H])[H])([H])[H])[H])[H])OC([C@@](C(N(C(C([H])([H])[H])(C([H])([H])[H])[H])[H])([H])[H])(O[H])[H])([H])[H]",
                         "InChIKey" : "VHYCDWMUTMEGQY-QGZVFWFLSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP3A4",
                       "References" : [
                "Horikiri, Y. (1998); Pharmacokinetics and Metabolism of Bisoprolol Enantiomers in Humans; Journal of Pharmaceutical Sciences; Vol. 87, No. 3"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0023",
                     "inchikey" : "AIGGWEPYIOOYLI-CQSZACIVSA-N",
                         "name" : "(+)-bisoprolol, O-deisopropyl",
                    "structure" : "[H]O[C@@]([H])(C([H])([H])OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])OC([H])([H])C([H])([H])O)C([H])([H])N([H])C([H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0024" : {
                             "Name" : "(+)-fipronil",
            "Substrate's structure" : "ClC1=C(N2N=C(C([S@](=O)C(F)(F)F)=C2N([H])[H])C#N)C(Cl)=C(C(=C1[H])C(F)(F)F)[H]",
                         "InChIKey" : "ZOCSXAVNDGMNBV-SANMLTNESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tang, J. et al. (2004); In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam; Chem Biol Interact. 2004 Apr 15;147(3):319-29"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0024",
                     "inchikey" : "LGHZJDKSVUTELU-UHFFFAOYSA-N",
                         "name" : "f ipronil sulfone",
                    "structure" : "[H]N([H])C1=C(C(=NN1C1=C(Cl)C([H])=C(C([H])=C1Cl)C(F)(F)F)C#N)S(=O)(=O)C(F)(F)F"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0025" : {
                             "Name" : "(+)-halofantrine",
            "Substrate's structure" : "ClC=1C2=C(C([C@](O[H])(C(C(N(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])=C3C(=C2C(=C(Cl)C1[H])[H])C(=C(C(=C3[H])[H])C(F)(F)F)[H])[H]",
                         "InChIKey" : "FOHHNHSLJDZUGQ-RUZDIDTESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Halliday, R.C. et al. An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems. Br J Clin Phar- macol 1995; 40: 369-78."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0025",
                     "inchikey" : "FYHCHSNOXWVJJT-OAQYLSRUSA-N",
                         "name" : "(+)-halofantrine, N-desbutyl",
                    "structure" : "[H]O[C@@]([H])(C1=C2C([H])=C([H])C(=C([H])C2=C2C([H])=C(Cl)C([H])=C(Cl)C2=C1[H])C(F)(F)F)C([H])([H])C([H])([H])NC([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0026" : {
                             "Name" : "(+)-isothujone",
            "Substrate's structure" : "[C@]1([C@]2(C([C@]2(C(C1=O)([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])[H])(C([H])([H])[H])[H]",
                         "InChIKey" : "USMNOWBWPHYOEA-XKSSXDPKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP2B6; CYP2D6; CYP3A4",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0026",
                     "inchikey" : "QCIUNUUHBWFYTD-QNSHHTMESA-N",
                         "name" : "4-hydroxy-isothujone",
                    "structure" : "[H]C([H])([H])C([H])(C([H])([H])[H])[C@@]12C([H])([H])[C@]1([H])[C@@](O)(C(=O)C2([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0027" : {
                             "Name" : "(+)-isothujone",
            "Substrate's structure" : "[C@]1([C@]2(C([C@]2(C(C1=O)([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])[H])(C([H])([H])[H])[H]",
                         "InChIKey" : "USMNOWBWPHYOEA-XKSSXDPKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP2B6; CYP2D6; CYP3A4",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0027",
                     "inchikey" : "BWIMEHVFTVSHCC-NYNCVSEMSA-N",
                         "name" : "7-hydroxy-isothujone",
                    "structure" : "[H]OC(C([H])([H])[H])(C([H])([H])[H])[C@@]12C([H])([H])[C@]1([H])[C@@]([H])(C(=O)C2([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0028" : {
                             "Name" : "(2s,5s)-troglitazone",
            "Substrate's structure" : "C12=C(C(C([C@](O1)(C(OC3=C(C(=C(C(=C3[H])[H])C([C@]4(C(N(C(S4)=O)[H])=O)[H])([H])[H])[H])[H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])C(=C(C(=C2C([H])([H])[H])C([H])([H])[H])O[H])C([H])([H])[H]",
                         "InChIKey" : "GXPHKUHSUJUWKP-CYFREDJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "He, K. et al. (2001); Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reaction; Biochem Pharmacol.; 62(2):191-8",
                "Zanger, U.M. and Schwab, M.; Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation; Pharmacology & Therapeutics 138 (2013) 103���141; PMID:23333322",
                "S��nchez, A. ET AL. (2006); Thiazolidinedione Bioactivation: A Comparison of the Bioactivation Potentials of Troglitazone, Rosiglitazone, and Pioglitazone Using Stable Isotope-Labeled Analogues and Liquid Chromatography Tandem Mass Spectrometry; Current Medicinal Chemistry, 2009 Vol. 16, No. 27"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0028",
                     "inchikey" : "HMEBITABBUPZPK-RDPSFJRHSA-N",
                         "name" : "(2S)�ې3�ې(4�ې{[(2S)�ې6�ېhydroxy�ې2,5,7,8�ېtetramethyl�ې3,4�ېdihydro�ې2H�ې1�ېbenzopyran�ې2�ېyl]methoxy}phenyl)�ې2�ې(hydroxysulfanyl)propanecarbonyl isocyanate",
                    "structure" : "[H]OC1=C(C2=C(O[C@](C([H])([H])[H])(C([H])([H])OC3=C([H])C([H])=C(C([H])=C3[H])C([H])([H])[C@]([H])(SO)C(=O)N=C=O)C([H])([H])C2([H])[H])C(=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Heterocyclic ring fission"
            ]
        },
        "BIOTID0029" : {
                             "Name" : "(2s,5s)-troglitazone",
            "Substrate's structure" : "C12=C(C(C([C@](O1)(C(OC3=C(C(=C(C(=C3[H])[H])C([C@]4(C(N(C(S4)=O)[H])=O)[H])([H])[H])[H])[H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])C(=C(C(=C2C([H])([H])[H])C([H])([H])[H])O[H])C([H])([H])[H]",
                         "InChIKey" : "GXPHKUHSUJUWKP-CYFREDJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "He, K. et al. (2001); Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reaction; Biochem Pharmacol.; 62(2):191-8",
                "Zanger, U.M. and Schwab, M.; Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation; Pharmacology & Therapeutics 138 (2013) 103���141; PMID:23333322",
                "S��nchez, A. ET AL. (2006); Thiazolidinedione Bioactivation: A Comparison of the Bioactivation Potentials of Troglitazone, Rosiglitazone, and Pioglitazone Using Stable Isotope-Labeled Analogues and Liquid Chromatography Tandem Mass Spectrometry; Current Medicinal Chemistry, 2009 Vol. 16, No. 27"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0029",
                     "inchikey" : "XIINUBVMVMENJH-RDPSFJRHSA-N",
                         "name" : "(1S)-1-(formylcarbamoyl)-2-(4-{[(2S)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-yl]methoxy}phenyl)ethane-1-sulfinic acid",
                    "structure" : "[H]OC1=C(C2=C(O[C@](C([H])([H])[H])(C([H])([H])OC3=C([H])C([H])=C(C([H])=C3[H])C([H])([H])[C@@]([H])(C(=O)N([H])C=O)S(O)=O)C([H])([H])C2([H])[H])C(=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Heterocyclic ring fission"
            ]
        },
        "BIOTID0030" : {
                             "Name" : "Saquinavir",
            "Substrate's structure" : "O=C(N(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])[C@]1(N(C([C@@]2([C@](C1([H])[H])(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])([H])[H])C([C@@](O[H])([C@@](N(C(=O)[C@@](N(C(=O)C3=NC=4C(C(=C3[H])[H])=C(C(=C(C4[H])[H])[H])[H])[H])(C(C(=O)N([H])[H])([H])[H])[H])[H])(C(C5=C(C(=C(C(=C5[H])[H])[H])[H])[H])([H])[H])[H])[H])([H])[H])[H]",
                         "InChIKey" : "QWAXKHKRTORLEM-UGJKXSETSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Fitzsimmons, M.E. and Collins, J.M. (1997); Selective Biotransformation of the HIV Protease Inhibitor Saquinavir by Human Small Intestinal Cytochrome P450 3A4: Potential Contribution to High First-Pass Metabolism. Drug Metab. Dispos.; 25; pp. 256���266"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0030",
                     "inchikey" : "SQCJGICLIMLWFB-UGJKXSETSA-N",
                         "name" : "(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-[(1-hydroxy-2-methylpropan-2-yl)carbamoyl]-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[(quinolin-2-yl)formamido]butanediamide",
                    "structure" : "CC(C)(CO)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=CC=C2C=CC=CC2=N1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0031" : {
                             "Name" : "Saquinavir",
            "Substrate's structure" : "O=C(N(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])[C@]1(N(C([C@@]2([C@](C1([H])[H])(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])([H])[H])C([C@@](O[H])([C@@](N(C(=O)[C@@](N(C(=O)C3=NC=4C(C(=C3[H])[H])=C(C(=C(C4[H])[H])[H])[H])[H])(C(C(=O)N([H])[H])([H])[H])[H])[H])(C(C5=C(C(=C(C(=C5[H])[H])[H])[H])[H])([H])[H])[H])[H])([H])[H])[H]",
                         "InChIKey" : "QWAXKHKRTORLEM-UGJKXSETSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Fitzsimmons, M.E. and Collins, J.M. (1997); Selective Biotransformation of the HIV Protease Inhibitor Saquinavir by Human Small Intestinal Cytochrome P450 3A4: Potential Contribution to High First-Pass Metabolism. Drug Metab. Dispos.; 25; pp. 256���266"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0031",
                     "inchikey" : "VEVTYHWFAKZKCL-VICGCSEUSA-N",
                         "name" : "(2S)-N-[(2S,3R)-4-[(3S,4aR,8aS)-3-(tert-butylcarbamoyl)-6-hydroxy-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[(quinolin-2-yl)formamido]butanediamide",
                    "structure" : "CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CC(O)CC[C@@H]2CN1C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=CC=C2C=CC=CC2=N1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0032" : {
                             "Name" : "Saquinavir",
            "Substrate's structure" : "O=C(N(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])[C@]1(N(C([C@@]2([C@](C1([H])[H])(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])([H])[H])C([C@@](O[H])([C@@](N(C(=O)[C@@](N(C(=O)C3=NC=4C(C(=C3[H])[H])=C(C(=C(C4[H])[H])[H])[H])[H])(C(C(=O)N([H])[H])([H])[H])[H])[H])(C(C5=C(C(=C(C(=C5[H])[H])[H])[H])[H])([H])[H])[H])[H])([H])[H])[H]",
                         "InChIKey" : "QWAXKHKRTORLEM-UGJKXSETSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Fitzsimmons, M.E. and Collins, J.M. (1997); Selective Biotransformation of the HIV Protease Inhibitor Saquinavir by Human Small Intestinal Cytochrome P450 3A4: Potential Contribution to High First-Pass Metabolism. Drug Metab. Dispos.; 25; pp. 256���266"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0032",
                     "inchikey" : "YHJGQHOJUFVUIN-XFHLUWSMSA-N",
                         "name" : "(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-7-hydroxy-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[(quinolin-2-yl)formamido]butanediamide",
                    "structure" : "CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCC(O)C[C@@H]2CN1C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=CC=C2C=CC=CC2=N1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0033" : {
                             "Name" : "(r)-(+)-felodipine",
            "Substrate's structure" : "ClC1=C([C@@]2(C(=C(N(C(=C2C(OC([H])([H])[H])=O)C([H])([H])[H])[H])C([H])([H])[H])C(OC(C([H])([H])[H])([H])[H])=O)[H])C(=C(C(=C1Cl)[H])[H])[H]",
                         "InChIKey" : "RZTAMFZIAATZDJ-HNNXBMFYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "62970",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zanger, U.M. and Schwab, M.; Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation; Pharmacology & Therapeutics 138 (2013) 103���141; PMID:23333322"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0033",
                     "inchikey" : "REQRUBNOOIAHMG-UHFFFAOYSA-N",
                         "name" : "Dehydrofelodipine",
                    "structure" : "[H]C1=C([H])C(=C(Cl)C(Cl)=C1[H])C1=C(C(=O)OC([H])([H])C([H])([H])[H])C(=NC(=C1C(=O)OC([H])([H])[H])C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Heteroring dehydrogenation"
            ]
        },
        "BIOTID0034" : {
                             "Name" : "(R)-(-)-Mexiletine",
            "Substrate's structure" : "C([C@@](N([H])[H])(C(OC1=C(C([H])([H])[H])C(=C(C(=C1C([H])([H])[H])[H])[H])[H])([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "VLPIATFUUWWMKC-SNVBAGLBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (minor); CYP2D6 (major)",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Zhou, S.F. and Wang, B. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0034",
                     "inchikey" : "YWOSWRCXWBDSRQ-SECBINFHSA-N",
                         "name" : "(R)-(-)-Mexiletine, p-hydroxyl",
                    "structure" : "[H]N([H])[C@]([H])(C([H])([H])[H])C([H])([H])OC1=C(C([H])=C(O)C([H])=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0035" : {
                             "Name" : "(R)-(-)-Mexiletine",
            "Substrate's structure" : "C([C@@](N([H])[H])(C(OC1=C(C([H])([H])[H])C(=C(C(=C1C([H])([H])[H])[H])[H])[H])([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "VLPIATFUUWWMKC-SNVBAGLBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (minor); CYP2D6 (major)",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Zhou, S.F. and Wang, B. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0035",
                     "inchikey" : "LBHCZYGJQAXJSW-MRVPVSSYSA-N",
                         "name" : "(R)-(-)-Mexiletine, m-hydroxyl",
                    "structure" : "[H]N([H])[C@]([H])(C([H])([H])[H])C([H])([H])OC1=C(C(O)=C([H])C([H])=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0036" : {
                             "Name" : "(R)-(-)-Mexiletine",
            "Substrate's structure" : "C([C@@](N([H])[H])(C(OC1=C(C([H])([H])[H])C(=C(C(=C1C([H])([H])[H])[H])[H])[H])([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "VLPIATFUUWWMKC-SNVBAGLBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (minor); CYP2D6 (major)",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Zhou, S.F. and Wang, B. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0036",
                     "inchikey" : "XMJYSMLLWRQQAE-SECBINFHSA-N",
                         "name" : "(R)-(-)-Mexiletine, 2-OH-hydroxymethyl",
                    "structure" : "[H]N([H])[C@]([H])(C([H])([H])[H])C([H])([H])OC1=C(C([H])=C([H])C([H])=C1C([H])([H])[H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0037" : {
                             "Name" : "(R)-(-)-Mexiletine",
            "Substrate's structure" : "C([C@@](N([H])[H])(C(OC1=C(C([H])([H])[H])C(=C(C(=C1C([H])([H])[H])[H])[H])[H])([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "VLPIATFUUWWMKC-SNVBAGLBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (major); CYP2B6; CYP2E1",
                       "References" : [
                "Abolfathi, Z. et al. (1995); CYP1A2 is the Major Enzyme Involved in the N-Oxidation of Mexiletine (MEX) in Man. Clin. Pharmacol. Ther.; 57; 221 (OIII- A33).",
                "Labbe, L. et al.; (2003). Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine. Xenobi- otica 33:13���25."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0037",
                     "inchikey" : "ABMUWCMGKRQAIK-SNVBAGLBSA-N",
                         "name" : "(R)-(-)-Mexiletine, N-hydroxy",
                    "structure" : "[H]N(O)[C@]([H])(C([H])([H])[H])C([H])([H])OC1=C(C([H])=C([H])C([H])=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0038" : {
                             "Name" : "(r)-azelastine",
            "Substrate's structure" : "C(N1C(C(C([C@](C(C1([H])[H])([H])[H])(N2N=C(C(C3=C(C(=C(Cl)C(=C3[H])[H])[H])[H])([H])[H])C4=C(C(=C(C(=C4C2=O)[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "MBUVEWMHONZEQD-GOSISDBHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2D6; CYP1A2 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0038",
                     "inchikey" : "WRYCMIFVXDQIKN-QGZVFWFLSA-N",
                         "name" : "(r)-azelastine, N-desmethyl",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])C(=O)N(N=C2C([H])([H])C1=C([H])C([H])=C(Cl)C([H])=C1[H])[C@@]1([H])C([H])([H])C([H])([H])NC([H])([H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0039" : {
                             "Name" : "(r)-bupropion",
            "Substrate's structure" : "ClC=1C(=C(C(=O)[C@](N(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])(C([H])([H])[H])[H])C(=C(C1[H])[H])[H])[H]",
                         "InChIKey" : "SNPPWIUOZRMYNY-SECBINFHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP3A4",
                       "References" : [
                "Chen, Y. et al. (2010); The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19, Xenobiotica, 40:8, 536-546, DOI: 10.3109/00498254.2010.492880"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0039",
                     "inchikey" : "AKOAEVOSDHIVFX-SECBINFHSA-N",
                         "name" : "(2R)-1-(3-chlorophenyl)-2-[(1-hydroxy-2-methylpropan-2-yl)amino]propan-1-one",
                    "structure" : "[H]N([C@@]([H])(C(=O)C1=C([H])C(Cl)=C([H])C([H])=C1[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0040" : {
                             "Name" : "(r)-bupropion",
            "Substrate's structure" : "ClC=1C(=C(C(=O)[C@](N(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])(C([H])([H])[H])[H])C(=C(C1[H])[H])[H])[H]",
                         "InChIKey" : "SNPPWIUOZRMYNY-SECBINFHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Chen, Y. et al. (2010); The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19, Xenobiotica, 40:8, 536-546, DOI: 10.3109/00498254.2010.492880"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0040",
                     "inchikey" : "MYCARDPPKMGEQK-LLVKDONJSA-N",
                         "name" : "(2R)-2-(tert-butylamino)-1-(3-chlorophenyl)-3-hydroxypropan-1-one",
                    "structure" : "[H]N([C@@]([H])(C(=O)C1=C([H])C(Cl)=C([H])C([H])=C1[H])C([H])([H])O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0041" : {
                             "Name" : "(r)-bupropion",
            "Substrate's structure" : "ClC=1C(=C(C(=O)[C@](N(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])(C([H])([H])[H])[H])C(=C(C1[H])[H])[H])[H]",
                         "InChIKey" : "SNPPWIUOZRMYNY-SECBINFHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6;CYP2C19; CYP2E1",
                       "References" : [
                "Chen, Y. et al. (2010); The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19, Xenobiotica, 40:8, 536-546, DOI: 10.3109/00498254.2010.492880",
                "Faucette, S.R. et al. (2000); Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity. Drug Metab. Dispos. 2000, 28, 1222 ��� 1230."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0041",
                     "inchikey" : "LSZBTGUSYVNVLH-MRVPVSSYSA-N",
                         "name" : "(2R)-2-(tert-butylamino)-1-(3-chloro-4-hydroxyphenyl)propan-1-one",
                    "structure" : "[H]N([C@@]([H])(C(=O)C1=C([H])C(Cl)=C(O)C([H])=C1[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0042" : {
                             "Name" : "(r)-bupropion",
            "Substrate's structure" : "ClC=1C(=C(C(=O)[C@](N(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])(C([H])([H])[H])[H])C(=C(C1[H])[H])[H])[H]",
                         "InChIKey" : "SNPPWIUOZRMYNY-SECBINFHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6;CYP2C19; CYP2E1",
                       "References" : [
                "Chen, Y. et al. (2010); The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19, Xenobiotica, 40:8, 536-546, DOI: 10.3109/00498254.2010.492880",
                "Faucette, S.R. et al. (2000); Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity. Drug Metab. Dispos. 2000, 28, 1222 ��� 1230."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0042",
                     "inchikey" : "MKUMNNVIQOBJFK-MRVPVSSYSA-N",
                         "name" : "(2R)�ې2�ې(tert�ېbutylamino)�ې1�ې(3�ېchloro�ې5�ېhydroxyphenyl)propan�ې1�ېone",
                    "structure" : "[H]N([C@@]([H])(C(=O)C1=C([H])C(Cl)=C([H])C(O)=C1[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0043" : {
                             "Name" : "(r)-chloroquine",
            "Substrate's structure" : "C(C(N(C(C([H])([H])[H])([H])[H])C(C(C([C@@](C([H])([H])[H])(N(C1=C2C(=C(C(Cl)=C(C2=NC(=C1[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "WHTVZRBIWZFKQO-CQSZACIVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2D6; CYP3A4; CYP3A5",
                       "References" : [
                "Zanger, U.M. and Schwab, M.; Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation; Pharmacology & Therapeutics 138 (2013) 103���141; PMID:23333322",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0043",
                     "inchikey" : "MCYUUUTUAAGOOT-GFCCVEGCSA-N",
                         "name" : "(r)-chloroquine, N-desethyl",
                    "structure" : "[H]N(C1=C2C([H])=C([H])C(Cl)=C([H])C2=NC([H])=C1[H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])NC([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0044" : {
                             "Name" : "(r)-enflurane",
            "Substrate's structure" : "FC(F)(OC(F)(F)[C@@](Cl)(F)[H])[H]",
                         "InChIKey" : "JPGQOUSTVILISH-SFOWXEAESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Kenna, J.G. et Al. (2013); Drug-induced Disease (3rd Edition) (2013), Chapter 23 - Mechanisim, Pathology, and Clinical Presentation of Hepatoxicity of Anesthetic Agents 2013, 403-422 http://dx.doi.org/10.1016/B978-0-12-387817-5.00023-6",
                "Chris, D.D. et al. (1988); Potential Metabolic basis for enflurane hepatitis and the appaarent cross-sensutuzation between enflurane and halothane; Drug Metab Dispos 1988, 16, 135-140"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0044",
                     "inchikey" : "TVUMCYGRGFDDJV-UHFFFAOYSA-N",
                         "name" : "2-(difluoromethoxy)-2,2-difluoroacetyl fluoride",
                    "structure" : "[H]C(F)(F)OC(F)(F)C(F)=O"
                }
            ],
                    "Reaction Type" : [
                "Dehalogenation"
            ]
        },
        "BIOTID0045" : {
                             "Name" : "(r)-ketamine",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[C@]2(C(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])=O)N(C([H])([H])[H])[H])[H])[H])[H])[H])Cl",
                         "InChIKey" : "YQEZLKZALYSWHR-CYBMUJFWSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2B6; CYP3A4 ",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0045",
                     "inchikey" : "BEQZHFIKTBVCAU-GFCCVEGCSA-N",
                         "name" : "Norketamine",
                    "structure" : "[H]N[C@@]1(C(=O)C([H])([H])C([H])([H])C([H])([H])C1([H])[H])C1=C(Cl)C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0046" : {
                             "Name" : "(r)-metoprolol",
            "Substrate's structure" : "O(C([C@](O[H])(C(N(C(C([H])([H])[H])(C([H])([H])[H])[H])[H])([H])[H])[H])([H])[H])C1=C(C(=C(C(C(OC([H])([H])[H])([H])[H])([H])[H])C(=C1[H])[H])[H])[H]",
                         "InChIKey" : "IUBSYMUCCVWXPE-CQSZACIVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0046",
                     "inchikey" : "OFRYBPCSEMMZHR-AFYYWNPRSA-N",
                         "name" : "alpha-Hydroxymetoprolol",
                    "structure" : "[H]O[C@@]([H])(C([H])([H])OC1=C([H])C([H])=C(C([H])=C1[H])C([H])(O)C([H])([H])OC([H])([H])[H])C([H])([H])N([H])C([H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0047" : {
                             "Name" : "(r)-metoprolol",
            "Substrate's structure" : "O(C([C@](O[H])(C(N(C(C([H])([H])[H])(C([H])([H])[H])[H])[H])([H])[H])[H])([H])[H])C1=C(C(=C(C(C(OC([H])([H])[H])([H])[H])([H])[H])C(=C1[H])[H])[H])[H]",
                         "InChIKey" : "IUBSYMUCCVWXPE-CQSZACIVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0047",
                     "inchikey" : "CUKXSBOAIJILRY-CYBMUJFWSA-N",
                         "name" : "O-Demethylmetoprolol",
                    "structure" : "[H]O[C@@]([H])(C([H])([H])OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])O)C([H])([H])N([H])C([H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0048" : {
                             "Name" : "(r)-metoprolol",
            "Substrate's structure" : "O(C([C@](O[H])(C(N(C(C([H])([H])[H])(C([H])([H])[H])[H])[H])([H])[H])[H])([H])[H])C1=C(C(=C(C(C(OC([H])([H])[H])([H])[H])([H])[H])C(=C1[H])[H])[H])[H]",
                         "InChIKey" : "IUBSYMUCCVWXPE-CQSZACIVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0048",
                     "inchikey" : "XJWXVDJGNOHFLR-LLVKDONJSA-N",
                         "name" : "N_DEISOPROPYLATION",
                    "structure" : "[H]NC([H])([H])[C@@]([H])(O[H])C([H])([H])OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])OC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0049" : {
                             "Name" : "(s)-(-)-carvedilol",
            "Substrate's structure" : "C=12C3=C(N(C1C(=C(C(=C2OC([C@](C(N(C(C(OC4=C(C(=C(C(=C4[H])[H])[H])[H])OC([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])(O[H])[H])([H])[H])[H])[H])[H])[H])C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "OGHNVEJMJSYVRP-KRWDZBQOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (major); CYP2E1 (minor); CYP2C9 (minor); CYP3A4 (minor)",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0049",
                     "inchikey" : "ZCJHEORDHXCJNB-KRWDZBQOSA-N",
                         "name" : "4'-OH-carvedilol",
                    "structure" : "[H]O[C@]([H])(C([H])([H])OC1=C([H])C([H])=C([H])C2=C1C1=C(N2[H])C([H])=C([H])C([H])=C1[H])C([H])([H])N([H])C([H])([H])C([H])([H])OC1=C(OC([H])([H])[H])C([H])=C(O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0050" : {
                             "Name" : "(s)-(-)-carvedilol",
            "Substrate's structure" : "C=12C3=C(N(C1C(=C(C(=C2OC([C@](C(N(C(C(OC4=C(C(=C(C(=C4[H])[H])[H])[H])OC([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])(O[H])[H])([H])[H])[H])[H])[H])[H])C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "OGHNVEJMJSYVRP-KRWDZBQOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 (major); CYP2D6 (minor); CYP1A2 (minor); CYP2E1 (minor)",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0050",
                     "inchikey" : "XAUKPPPYYOKVQJ-INIZCTEOSA-N",
                         "name" : "O-Desmethylcarvedilol",
                    "structure" : "[H]O[C@]([H])(C([H])([H])OC1=C([H])C([H])=C([H])C2=C1C1=C(N2[H])C([H])=C([H])C([H])=C1[H])C([H])([H])N([H])C([H])([H])C([H])([H])OC1=C(O)C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0051" : {
                             "Name" : "(s)-(-)-carvedilol",
            "Substrate's structure" : "C=12C3=C(N(C1C(=C(C(=C2OC([C@](C(N(C(C(OC4=C(C(=C(C(=C4[H])[H])[H])[H])OC([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])(O[H])[H])([H])[H])[H])[H])[H])[H])C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "OGHNVEJMJSYVRP-KRWDZBQOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (major); CYP2E1 (minor); CYP2C9 (minor); CYP3A4 (minor)",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0051",
                     "inchikey" : "PVUVZUBTCLBJMT-KRWDZBQOSA-N",
                         "name" : "5'-OH-carvedilol",
                    "structure" : "[H]O[C@]([H])(C([H])([H])OC1=C([H])C([H])=C([H])C2=C1C1=C(N2[H])C([H])=C([H])C([H])=C1[H])C([H])([H])N([H])C([H])([H])C([H])([H])OC1=C(OC([H])([H])[H])C([H])=C([H])C(O)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0052" : {
                             "Name" : "(s)-(-)-carvedilol",
            "Substrate's structure" : "C=12C3=C(N(C1C(=C(C(=C2OC([C@](C(N(C(C(OC4=C(C(=C(C(=C4[H])[H])[H])[H])OC([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])(O[H])[H])([H])[H])[H])[H])[H])[H])C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "OGHNVEJMJSYVRP-KRWDZBQOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (major); CYP3A4 (minor); CYP1A1 (minor)",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0052",
                     "inchikey" : "GPPVNZVFGNMPNR-INIZCTEOSA-N",
                         "name" : "8-OH-carvedilol",
                    "structure" : "[H]O[C@]([H])(C([H])([H])OC1=C([H])C([H])=C([H])C2=C1C1=C(N2[H])C(O)=C([H])C([H])=C1[H])C([H])([H])N([H])C([H])([H])C([H])([H])OC1=C(OC([H])([H])[H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0053" : {
                             "Name" : "(s)-(+)-ibuprofen",
            "Substrate's structure" : "[C@@](C(=O)O[H])(C([H])([H])[H])(C1=C(C(=C(C(=C1[H])[H])C(C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])[H])[H])[H]",
                         "InChIKey" : "HEFNNWSXXWATRW-JTQLQIEISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C8",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0053",
                     "inchikey" : "UJHKVYPPCJBOSG-VIFPVBQESA-N",
                         "name" : "2-Hydroxyibuprofen",
                    "structure" : "[H]OC(=O)[C@]([H])(C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C(O)(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0054" : {
                             "Name" : "(s)-(+)-ibuprofen",
            "Substrate's structure" : "[C@@](C(=O)O[H])(C([H])([H])[H])(C1=C(C(=C(C(=C1[H])[H])C(C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])[H])[H])[H]",
                         "InChIKey" : "HEFNNWSXXWATRW-JTQLQIEISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C8",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0054",
                     "inchikey" : "HFAIHLSDLUYLQA-AXDSSHIGSA-N",
                         "name" : "3-Hydroxyibuprofen",
                    "structure" : "[H]OC(=O)[C@]([H])(C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0055" : {
                             "Name" : "(s)-fluoxetine",
            "Substrate's structure" : "[C@@](C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])(OC2=C(C(=C(C(=C2[H])[H])C(F)(F)F)[H])[H])(C(C(N(C([H])([H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "RTHCYVBBDHJXIQ-INIZCTEOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 (major); CYP2D6; CYP2C19; CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Ring, B.J. et al. (2001); Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine; J Pharmacol Exp Ther. 2001 Jun;297(3):1044-50.",
                "Margolis J.M.; (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes; Drug Metab Dispos. 2000 Oct;28(10):1187-91; PMID: 10997938; Drug Metab Dispos. 2000 Oct;28(10):1187-91."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0055",
                     "inchikey" : "WIQRCHMSJFFONW-HNNXBMFYSA-N",
                         "name" : "(s)-Norfluoxetine",
                    "structure" : "[H]NC([H])([H])C([H])([H])[C@]([H])(OC1=C([H])C([H])=C(C([H])=C1[H])C(F)(F)F)C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0056" : {
                             "Name" : "(s)-fluoxetine",
            "Substrate's structure" : "[C@@](C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])(OC2=C(C(=C(C(=C2[H])[H])C(F)(F)F)[H])[H])(C(C(N(C([H])([H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "RTHCYVBBDHJXIQ-INIZCTEOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Ring, B.J. et al. (2001); Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine; J Pharmacol Exp Ther. 2001 Jun;297(3):1044-50.",
                "Margolis J.M.; (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes; Drug Metab Dispos. 2000 Oct;28(10):1187-91; PMID: 10997938; Drug Metab Dispos. 2000 Oct;28(10):1187-91."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0056",
                     "inchikey" : "BAYGVMXZJBFEMB-UHFFFAOYSA-N",
                         "name" : "p-Trifluoromethyl phenol",
                    "structure" : "[H]C1=C([H])C(=C([H])C([H])=C1O)C(F)(F)F"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0057" : {
                             "Name" : "(s)-fluoxetine",
            "Substrate's structure" : "[C@@](C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])(OC2=C(C(=C(C(=C2[H])[H])C(F)(F)F)[H])[H])(C(C(N(C([H])([H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "RTHCYVBBDHJXIQ-INIZCTEOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Ring, B.J. et al. (2001); Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine; J Pharmacol Exp Ther. 2001 Jun;297(3):1044-50.",
                "Margolis J.M.; (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes; Drug Metab Dispos. 2000 Oct;28(10):1187-91; PMID: 10997938; Drug Metab Dispos. 2000 Oct;28(10):1187-91."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0057",
                     "inchikey" : "CAIKBWLFBLRPJU-UHFFFAOYSA-N",
                         "name" : "3-(methylamino)-1-phenylpropan-1-one",
                    "structure" : "[H]N(C([H])([H])[H])C([H])([H])CC(=O)C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0058" : {
                             "Name" : "(s)-flurbiprofen",
            "Substrate's structure" : "C1(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])=C(C(=C(C(=C1[H])[H])[C@@](C(O[H])=O)(C([H])([H])[H])[H])[H])F",
                         "InChIKey" : "SYTBZMRGLBWNTM-JTQLQIEISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0058",
                     "inchikey" : "GTSMMBJBNJDFRA-VIFPVBQESA-N",
                         "name" : "4-OH-S-flurbiprofen",
                    "structure" : "[H]OC(=O)[C@]([H])(C1=C([H])C(F)=C(C([H])=C1[H])C1=C([H])C([H])=C(O)C([H])=C1[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0059" : {
                             "Name" : "(s)-hexobarbital",
            "Substrate's structure" : "C([C@@]1(C(=O)N(C(=O)N(C1=O)C([H])([H])[H])[H])C2=C(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "UYXAWHWODHRRMR-LBPRGKRZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0059",
                     "inchikey" : "YHCGILGEMWNROZ-MYIOLCAUSA-N",
                         "name" : "3'-OH-(S)-hexobarbital",
                    "structure" : "[H]N1C(=O)N(C(=O)[C@](C1=O)(C1=C([H])C([H])(O)C([H])([H])C([H])([H])C1([H])[H])C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0060" : {
                             "Name" : "(s)-oxybutynin",
            "Substrate's structure" : "O([C@@](C1(C(C(C(C(C1([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])C(OC(C#CC(N(C(C([H])([H])[H])([H])[H])C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])=O)[H]",
                         "InChIKey" : "XIQVNETUBQGFHX-JOCHJYFZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "97700",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Sato, Y. et al. (2012); Conclusive Identification of the Oxybutynin-Hydrolyzing Enzyme in Human Liver; DRUGMETABOLISM ANDDISPOSITION 2012, 40, 902���906",
                "MIZUSHIMA, H. et al. (2007); Stereoselective pharmacokinetics of oxybutynin and\rN-desethyloxybutynin in vitro and in vivo; Xenobiotica, 2007, 37, 59-73",
                "Abramov, Y. et al. (2004); Oxybutynin for treatment of urge urinary incontinence and overactive bladder: an updated review; Expert Opin. Pharmacother., 2004, 5, 2351-2359"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0060",
                     "inchikey" : "YTRNSQPXEDGWMR-CQSZACIVSA-N",
                         "name" : "2-cyclohexyl-2-phenylglycolic acid",
                    "structure" : "OC(=O)[C@](O)(C1CCCCC1)C1=CC=CC=C1"
                },
                {
                     "BTMDB_ID" : "BTMDB0060",
                     "inchikey" : "YTRNSQPXEDGWMR-CQSZACIVSA-N",
                         "name" : "2-cyclohexyl-2-phenylglycolic acid",
                    "structure" : "CCN(CC)CC#CCO"
                }
            ],
                    "Reaction Type" : []
        },
        "BIOTID0061" : {
                             "Name" : "(s)-oxybutynin",
            "Substrate's structure" : "O([C@@](C1(C(C(C(C(C1([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])C(OC(C#CC(N(C(C([H])([H])[H])([H])[H])C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])=O)[H]",
                         "InChIKey" : "XIQVNETUBQGFHX-JOCHJYFZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "133577",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Sato, Y. et al. (2012); Conclusive Identification of the Oxybutynin-Hydrolyzing Enzyme in Human Liver; DRUGMETABOLISM ANDDISPOSITION 2012; 40; 902���906",
                "MIZUSHIMA, H. et al. (2007); Stereoselective pharmacokinetics of oxybutynin and\rN-desethyloxybutynin in vitro and in vivo; Xenobiotica; 2007; 37; 59-73",
                "Abramov, Y. et al. (2004); Oxybutynin for treatment of urge urinary incontinence and overactive bladder: an updated review; Expert Opin. Pharmacother., 2004, 5, 2351-2359"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0061",
                     "inchikey" : "SNIBJKHIKIIGPR-HXUWFJFHSA-N",
                         "name" : "N-desethyloxybutynin",
                    "structure" : "[H]O[C@](C(=O)OC([H])([H])C#CC([H])([H])N([H])C([H])([H])C([H])([H])[H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0062" : {
                             "Name" : "(s)-propafenone",
            "Substrate's structure" : "C=1(C(C(C(C=2C(=C(C(=C(C2OC([C@](C(N(C(C(C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])(O[H])[H])([H])[H])[H])[H])[H])[H])=O)([H])[H])([H])[H])C(=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "JWHAUXFOSRPERK-SFHVURJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0062",
                     "inchikey" : "LUTWDNUXHDYZRA-SFHVURJKSA-N",
                         "name" : "(S)-5-Hydroxypropafenone",
                    "structure" : "[H]O[C@]([H])(C([H])([H])OC1=C(C([H])=C(O)C([H])=C1[H])C(=O)C([H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])N([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0063" : {
                             "Name" : "(s)-propafenone",
            "Substrate's structure" : "C=1(C(C(C(C=2C(=C(C(=C(C2OC([C@](C(N(C(C(C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])(O[H])[H])([H])[H])[H])[H])[H])[H])=O)([H])[H])([H])[H])C(=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "JWHAUXFOSRPERK-SFHVURJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0063",
                     "inchikey" : "HIGKMVIPYOFHBP-HNNXBMFYSA-N",
                         "name" : "(S)-N-Despropylpropafenone",
                    "structure" : "[H]NC([H])([H])[C@]([H])(O[H])C([H])([H])OC1=C(C([H])=C([H])C([H])=C1[H])C(=O)C([H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0064" : {
                             "Name" : "(s)-propafenone",
            "Substrate's structure" : "C=1(C(C(C(C=2C(=C(C(=C(C2OC([C@](C(N(C(C(C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])(O[H])[H])([H])[H])[H])[H])[H])[H])=O)([H])[H])([H])[H])C(=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "JWHAUXFOSRPERK-SFHVURJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (implied)",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0064",
                     "inchikey" : "OKWVLRWZWPULGI-SFHVURJKSA-N",
                         "name" : "(S)-4'-Hydroxypropafenone",
                    "structure" : "[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C(=O)C1=C(OC([H])([H])[C@@]([H])(O[H])C([H])([H])N([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0065" : {
                             "Name" : "(s)-tomoxetine",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])[H])[H])[H])[H])[C@@](OC=2C(=C(C(=C(C2C([H])([H])[H])[H])[H])[H])[H])(C(C(N(C([H])([H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "VHGCDTVCOLNTBX-KRWDZBQOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP2A6; CYP2B6; CYP2C9; CYP2C19; CYP2E1; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0065",
                     "inchikey" : "PPXQPRLGNSJNJM-QGZVFWFLSA-N",
                         "name" : "4-Hydroxy-(s)-tomoxetine",
                    "structure" : "CNCC[C@@H](OC1=CC=C(O)C=C1C)C1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0066" : {
                             "Name" : "(s)-tomoxetine",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])[H])[H])[H])[H])[C@@](OC=2C(=C(C(=C(C2C([H])([H])[H])[H])[H])[H])[H])(C(C(N(C([H])([H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "VHGCDTVCOLNTBX-KRWDZBQOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP2C19 (major)",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Sauer, J-M. et al. (2005); Clinical Pharmacokinetics of Atomoxetine; Clinical Pharmacokinetics; Volume 44, Issue 6, pp 571���590"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0066",
                     "inchikey" : "FYSYNTKLUNOCQR-QGZVFWFLSA-N",
                         "name" : "N-Desmethyl-(s)-tomoxetine",
                    "structure" : "CNCC[C@@H](OC1=CC=CC=C1CO)C1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0067" : {
                             "Name" : "(s)-tomoxetine",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])[H])[H])[H])[H])[C@@](OC=2C(=C(C(=C(C2C([H])([H])[H])[H])[H])[H])[H])(C(C(N(C([H])([H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "VHGCDTVCOLNTBX-KRWDZBQOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP2B6; CYP2C19",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0067",
                     "inchikey" : "JQNRSAPXUBOGPP-QGZVFWFLSA-N",
                         "name" : "2-Hydroxy-(s)-tomoxetine",
                    "structure" : "CC1=CC=CC=C1O[C@H](CCNCO)C1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0068" : {
                             "Name" : "(s)-venlafaxine",
            "Substrate's structure" : "O(C1([C@](C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])(C2=C(C(=C(OC([H])([H])[H])C(=C2[H])[H])[H])[H])[H])C(C(C(C(C1([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "PNVNVHUZROJLTJ-MRXNPFEDSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19 (major); CYP3A4 (minor); CYP2C9 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0068",
                     "inchikey" : "MKAFOJAJJMUXLW-OAHLLOKOSA-N",
                         "name" : "N-Desmethylvenlafaxine",
                    "structure" : "[H]OC1(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H])[C@@]([H])(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0069" : {
                             "Name" : "(s)-venlafaxine",
            "Substrate's structure" : "O(C1([C@](C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])(C2=C(C(=C(OC([H])([H])[H])C(=C2[H])[H])[H])[H])[H])C(C(C(C(C1([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "PNVNVHUZROJLTJ-MRXNPFEDSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0069",
                     "inchikey" : "KYYIDSXMWOZKMP-OAHLLOKOSA-N",
                         "name" : "O-Desmethylvenlafaxine",
                    "structure" : "[H]OC1(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H])[C@@]([H])(C1=C([H])C([H])=C(O)C([H])=C1[H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0070" : {
                             "Name" : "1_4_cineole",
            "Substrate's structure" : "O1C2(C(C(C1(C([H])([H])[H])C(C2([H])[H])([H])[H])([H])[H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[H]",
                         "InChIKey" : "RFFOTVCVTJUTAD-AOOOYVTPSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Miyazawa M. et al. (2002). Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes; Xenobiotica. 31 (10): 713���23. doi:10.1080/00498250110065595. PMID 11695850."
            ],
                         "Products" : [],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0071" : {
                             "Name" : "1_8_cineole",
            "Substrate's structure" : "O1C2(C(C(C(C1(C([H])([H])[H])C([H])([H])[H])(C(C2([H])[H])([H])[H])[H])([H])[H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "WEEGYLXZBRQIMU-WAAGHKOSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Duisken, M. et al. (2005); Metabolism of 1,8-cineole by human cytochrome P450 enzymes: identification of a new hydroxylated metabolite; / Biochimica et Biophysica Acta 1722; 304���31."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0070",
                     "inchikey" : "YVCUGZBVCHODNB-UHFFFAOYNA-N",
                         "name" : "2alpha-hydroxy-1,8-cineole",
                    "structure" : "CC1(C)OC2(C)CCC1CC2O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0072" : {
                             "Name" : "1_8_cineole",
            "Substrate's structure" : "O1C2(C(C(C(C1(C([H])([H])[H])C([H])([H])[H])(C(C2([H])[H])([H])[H])[H])([H])[H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "WEEGYLXZBRQIMU-WAAGHKOSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Duisken, M. et al. (2005); Metabolism of 1,8-cineole by human cytochrome P450 enzymes: identification of a new hydroxylated metabolite; / Biochimica et Biophysica Acta 1722; 304���31."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0071",
                     "inchikey" : "WHIKIYRWRMRQNK-UHFFFAOYNA-N",
                         "name" : "3alpha-hydroxy-1,8-cineole",
                    "structure" : "CC12CCC(C(O)C1)C(C)(C)O2"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0073" : {
                             "Name" : "1-(3-chlorophenyl)piperazine",
            "Substrate's structure" : "C1(N2C(C(N(C(C2([H])[H])([H])[H])[H])([H])[H])([H])[H])=C(C(=C(C(=C1[H])Cl)[H])[H])[H]",
                         "InChIKey" : "VHFVKMTVMIZMIK-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "J. Bolleddula et al.; Drug Metab Rev, 2014; 46(3): 379���419"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0072",
                     "inchikey" : "FXECOYYRPDGOQB-UHFFFAOYSA-N",
                         "name" : "2�ېchloro�ې4�ې(piperazin�ې1�ېyl)phenol",
                    "structure" : "[H]C1=C([H])C(=C([H])C(Cl)=C1O)N1C([H])([H])C([H])([H])NC([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0074" : {
                             "Name" : "1-(4-methoxyphenyl)piperazine",
            "Substrate's structure" : "C(OC=1C(=C(C(=C(C1[H])[H])N2C(C(N(C(C2([H])[H])([H])[H])[H])([H])[H])([H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "MRDGZSKYFPGAKP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "STAACK, R.F. et al. (2004); In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step; xenobiotica, 2004, 34, 179���192"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0073",
                     "inchikey" : "GPEOAEVZTOQXLG-UHFFFAOYSA-N",
                         "name" : "1-(4-hydroxyphenyl)piperazine",
                    "structure" : "[H]N1C([H])([H])C([H])([H])N(C2=C([H])C([H])=C(O)C([H])=C2[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0075" : {
                             "Name" : "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",
            "Substrate's structure" : "C(N1C(C(C(=C(C1([H])[H])[H])C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "PLRACCBDVIHHLZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Bajpai, P. et al. (2013); Metabolism of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine by Mitochondrion-targeted Cytochrome P450 2D6 IMPLICATIONS IN PARKINSON DISEASE; THE JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288, 4436���4451",
                "Coleman, T. et al. (1996); 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease; Journal of Pharmacology and Experimental Therapeutics, 1996, 277, 685-690"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0074",
                     "inchikey" : "FMGYKKMPNATWHP-UHFFFAOYSA-N",
                         "name" : "1-methyl-4-phenylpyridin-1-ium",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C([H])C([H])=[N+](C([H])=C1[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Dehydrogenation"
            ]
        },
        "BIOTID0076" : {
                             "Name" : "1-nitropyrene",
            "Substrate's structure" : "C1=2C3=C4C(=C(C1=C(C(=C(C2C(=C(C3=C(C(=C4[H])[H])[H])[H])[H])[H])[H])[N+]([O-])=O)[H])[H]",
                         "InChIKey" : "ALRLPDGCPYIVHP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0075",
                     "inchikey" : "BOQCPFGCIYLAGN-UHFFFAOYSA-N",
                         "name" : "3-OH-1-nitropyrene",
                    "structure" : "[H]C1=C([H])C2=C3C(C([H])=C([H])C4=C3C(C([H])=C2[H])=C(C([H])=C4O)[N+]([O-])=O)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0077" : {
                             "Name" : "1-nitropyrene",
            "Substrate's structure" : "C1=2C3=C4C(=C(C1=C(C(=C(C2C(=C(C3=C(C(=C4[H])[H])[H])[H])[H])[H])[H])[N+]([O-])=O)[H])[H]",
                         "InChIKey" : "ALRLPDGCPYIVHP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0076",
                     "inchikey" : "HSGLBAJOUBFGPZ-UHFFFAOYNA-N",
                         "name" : "trans-4,5- Dihydrodiol- 1-nitropyrene",
                    "structure" : "[H]C1=C([H])C2=C3C4=C(C([H])=C([H])C(=C4C([H])=C2[H])[N+]([O-])=O)C2([H])OC2([H])C3=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0078" : {
                             "Name" : "1-nitropyrene",
            "Substrate's structure" : "C1=2C3=C4C(=C(C1=C(C(=C(C2C(=C(C3=C(C(=C4[H])[H])[H])[H])[H])[H])[H])[N+]([O-])=O)[H])[H]",
                         "InChIKey" : "ALRLPDGCPYIVHP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP1A2",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0077",
                     "inchikey" : "MAVZUIFIVMZYMX-UHFFFAOYSA-N",
                         "name" : "6-OH-1- nitropyrene",
                    "structure" : "[H]C1=C([H])C2=C3C(C([H])=C([H])C4=C3C(C([H])=C2[H])=C(C([H])=C4[H])[N+]([O-])=O)=C1O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0079" : {
                             "Name" : "1-nitropyrene",
            "Substrate's structure" : "C1=2C3=C4C(=C(C1=C(C(=C(C2C(=C(C3=C(C(=C4[H])[H])[H])[H])[H])[H])[H])[N+]([O-])=O)[H])[H]",
                         "InChIKey" : "ALRLPDGCPYIVHP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0078",
                     "inchikey" : "RHXGKMNLLUKFLG-UHFFFAOYSA-N",
                         "name" : "8-OH-1-nitropyrene",
                    "structure" : "[H]C1=C([H])C2=C3C(C([H])=C([H])C4=C3C1=C([H])C([H])=C4O)=C(C([H])=C2[H])[N+]([O-])=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0080" : {
                             "Name" : "1,2-dichlorobenzene",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])Cl)Cl)[H])[H])[H]",
                         "InChIKey" : "RFFLAFLAYFXFSW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2E1 (major); CYP3A4",
                       "References" : [
                "bogaards, JJP et al. (1995); Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes; Toxicol Appl Pharmacol. 1995 May;132(1):44-52; PMID:7747284",
                "Nedelcheva, V. et al. (1998); Cytochrome P450 catalyzed oxidation of monochlorobenzene, 1,2- and 1,4-dichlorobenzene in rat, mouse, and human liver microsomes; Chemico-Biological Interactions 115 (1998) 53���70"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0079",
                     "inchikey" : "UMPSXRYVXUPCOS-UHFFFAOYSA-N",
                         "name" : "2,3-dichlorophenol",
                    "structure" : "[H]OC1=C([H])C([H])=C([H])C(Cl)=C1Cl"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0081" : {
                             "Name" : "1,2-dichlorobenzene",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])Cl)Cl)[H])[H])[H]",
                         "InChIKey" : "RFFLAFLAYFXFSW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2E1 (major); CYP3A4",
                       "References" : [
                "bogaards, JJP et al. (1995); Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes; Toxicol Appl Pharmacol. 1995 May;132(1):44-52; PMID:7747284",
                "Nedelcheva, V. et al. (1998); Cytochrome P450 catalyzed oxidation of monochlorobenzene, 1,2- and 1,4-dichlorobenzene in rat, mouse, and human liver microsomes; Chemico-Biological Interactions 115 (1998) 53���70"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0080",
                     "inchikey" : "WDNBURPWRNALGP-UHFFFAOYSA-N",
                         "name" : "3,4-dichlorophenol",
                    "structure" : "[H]OC1=C([H])C(Cl)=C(Cl)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0082" : {
                             "Name" : "1,2,4-trichlorobenzene",
            "Substrate's structure" : "ClC=1C(=C(C(=C(C1[H])Cl)Cl)[H])[H]",
                         "InChIKey" : "PBKONEOXTCPAFI-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1 (major)",
                       "References" : [
                "bogaards, JJP et al. (1995); Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes; Toxicol Appl Pharmacol. 1995 May;132(1):44-52; PMID:7747284",
                "Nedelcheva, V. et al. (1998); Cytochrome P450 catalyzed oxidation of monochlorobenzene, 1,2- and 1,4-dichlorobenzene in rat, mouse, and human liver microsomes; Chemico-Biological Interactions 115 (1998) 53���70"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0081",
                     "inchikey" : "WWGQHTJIFOQAOC-UHFFFAOYSA-N",
                         "name" : "2,3,5-trichlorophenol",
                    "structure" : "[H]C1=C(O)C(Cl)=C(Cl)C([H])=C1Cl"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0083" : {
                             "Name" : "1,2,4-trichlorobenzene",
            "Substrate's structure" : "ClC=1C(=C(C(=C(C1[H])Cl)Cl)[H])[H]",
                         "InChIKey" : "PBKONEOXTCPAFI-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major)",
                       "References" : [
                "bogaards, JJP et al. (1995); Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes; Toxicol Appl Pharmacol. 1995 May;132(1):44-52; PMID:7747284",
                "Nedelcheva, V. et al. (1998); Cytochrome P450 catalyzed oxidation of monochlorobenzene, 1,2- and 1,4-dichlorobenzene in rat, mouse, and human liver microsomes; Chemico-Biological Interactions 115 (1998) 53���70"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0082",
                     "inchikey" : "XGCHAIDDPMFRLJ-UHFFFAOYSA-N",
                         "name" : "2,3,6-trichlorophenol",
                    "structure" : "[H]C1=C([H])C(Cl)=C(Cl)C(O)=C1Cl"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0084" : {
                             "Name" : "1,2,4-trichlorobenzene",
            "Substrate's structure" : "ClC=1C(=C(C(=C(C1[H])Cl)Cl)[H])[H]",
                         "InChIKey" : "PBKONEOXTCPAFI-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1 (major); CYP1A1",
                       "References" : [
                "bogaards, JJP et al. (1995); Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes; Toxicol Appl Pharmacol. 1995 May;132(1):44-52; PMID:7747284",
                "Nedelcheva, V. et al. (1998); Cytochrome P450 catalyzed oxidation of monochlorobenzene, 1,2- and 1,4-dichlorobenzene in rat, mouse, and human liver microsomes; Chemico-Biological Interactions 115 (1998) 53���70"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0083",
                     "inchikey" : "LHJGJYXLEPZJPM-UHFFFAOYSA-N",
                         "name" : "2,4,5-trichlorophenol",
                    "structure" : "[H]C1=C(O)C(Cl)=C([H])C(Cl)=C1Cl"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0085" : {
                             "Name" : "2-acetamidofluorene",
            "Substrate's structure" : "N(C=1C(=C2C(=C(C1[H])[H])C=3C(C2([H])[H])=C(C(=C(C3[H])[H])[H])[H])[H])(C(C([H])([H])[H])=O)[H]",
                         "InChIKey" : "CZIHNRWJTSTCEX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "5896",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "McManus, M. E. et al (1990), Metablism of 2-acetylaminofluorene and Benzo(a)pyrene activation of food-derived heterocyclic amine mutagens by human cytochromes P-450; Cancer research, 50 (11); 3367-3376, PMID: 2334931"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0084",
                     "inchikey" : "SOKUIEGXJHVFDV-UHFFFAOYSA-N",
                         "name" : "N-Hydroxy-2-acetamidofluorene",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])C1=C([H])C([H])=C(C([H])=C1C2([H])[H])N(O)C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0086" : {
                             "Name" : "2-naphthylamine",
            "Substrate's structure" : "N(C1=C(C=2C(C(=C1[H])[H])=C(C(=C(C2[H])[H])[H])[H])[H])([H])[H]",
                         "InChIKey" : "JBIJLHTVPXGSAM-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "69176",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Rendic, S., Di Carlo, F. (1997) Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors; Drug Metabolism Reviews, 29:1-2, 413-580; DOI:10.3109/03602539709037591; PMID:9187528"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0085",
                     "inchikey" : "JGXYZXHJZJYHPW-UHFFFAOYSA-N",
                         "name" : "N-Hydroxy-2-naphthalenamine",
                    "structure" : "[H]N(O)C1=C([H])C2=C([H])C([H])=C([H])C([H])=C2C([H])=C1[H] |c:3,6,14,18,t:10|"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0087" : {
                             "Name" : "2-nitropyrene",
            "Substrate's structure" : "C=1(C(=C(C=2C(=C(C=3C(=C(C(=C4C(=C(C1C2C34)[H])[H])[H])[H])[H])[H])[H])[H])[N+](=O)[O-])[H]",
                         "InChIKey" : "MAZCGYFIOOIVHE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0086",
                     "inchikey" : "MFUFBSLEAGDECJ-UHFFFAOYSA-N",
                         "name" : "2-aminopyrene",
                    "structure" : "[H]C1=C([H])C2=C3C(C([H])=C([H])C4=C([H])C(N)=C([H])C(C([H])=C2[H])=C34)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Reduction"
            ]
        },
        "BIOTID0088" : {
                             "Name" : "2-oxoquazepam",
            "Substrate's structure" : "C12=C(C(C3=C(C(=C(C(=C3[H])[H])[H])[H])F)=NC(C(N1C(C(F)(F)F)([H])[H])=O)([H])[H])C(=C(C(=C2[H])[H])Cl)[H]",
                         "InChIKey" : "YFSXBSRGIRSXAD-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9",
                       "References" : [
                "Miura, M and Ohkubo, T (2004); In vitrometabolism of quazepam in human liver and intestine and assessment of drug interactions; Xenobiotica; 34(11-12):1001-11; PMID: 15801544; DOI: 10.1080/02772240400015214"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0087",
                     "inchikey" : "UUODKRKSEPDUBO-UHFFFAOYNA-N",
                         "name" : "3-Hydroxy-2-oxoquazepam",
                    "structure" : "OC1N=C(C2=C(F)C=CC=C2)C2=C(C=CC(Cl)=C2)N(CC(F)(F)F)C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0089" : {
                             "Name" : "2-oxoquazepam",
            "Substrate's structure" : "C12=C(C(C3=C(C(=C(C(=C3[H])[H])[H])[H])F)=NC(C(N1C(C(F)(F)F)([H])[H])=O)([H])[H])C(=C(C(=C2[H])[H])Cl)[H]",
                         "InChIKey" : "YFSXBSRGIRSXAD-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9",
                       "References" : [
                "Miura, M and Ohkubo, T (2004); In vitrometabolism of quazepam in human liver and intestine and assessment of drug interactions; Xenobiotica; 34(11-12):1001-11; PMID: 15801544; DOI: 10.1080/02772240400015214"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0088",
                     "inchikey" : "UVCOILFBWYKHHB-UHFFFAOYSA-N",
                         "name" : "N-Desalkyl-2-oxoquazepam",
                    "structure" : "FC1=C(C=CC=C1)C1=NCC(=O)NC2=C1C=C(Cl)C=C2"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0090" : {
                             "Name" : "2-phenylphenol",
            "Substrate's structure" : "O(C1=C(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])C(=C(C(=C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "LLEMOWNGBBNAJR-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2B6; CYP2D6; CYP2E1; CYP3A4",
                       "References" : [
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0089",
                     "inchikey" : "XCZKKZXWDBOGPA-UHFFFAOYSA-N",
                         "name" : "2,5-dihydroxybiphenyl",
                    "structure" : "[H]OC1=C(C([H])=C(O)C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0091" : {
                             "Name" : "2,2',4,5,5'-pentachlorobiphenyl",
            "Substrate's structure" : "C=1(C=2C(=C(Cl)C(=C(C2Cl)[H])[H])[H])C(=C(Cl)C(Cl)=C(C1Cl)[H])[H]",
                         "InChIKey" : "LAHWLEDBADHJGA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP3A4; CYP2C18",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0090",
                     "inchikey" : "AVHHNFHLLZCWFH-UHFFFAOYSA-N",
                         "name" : "2,2',4',5,5'-pentachloro-[1,1'-biphenyl]-4-ol",
                    "structure" : "[H]C1=C(O)C(Cl)=C([H])C(=C1Cl)C1=C(Cl)C([H])=C(Cl)C(Cl)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0092" : {
                             "Name" : "2,2',4,5,5'-pentachlorobiphenyl",
            "Substrate's structure" : "C=1(C=2C(=C(Cl)C(=C(C2Cl)[H])[H])[H])C(=C(Cl)C(Cl)=C(C1Cl)[H])[H]",
                         "InChIKey" : "LAHWLEDBADHJGA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP3A4; CYP2C18",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0090",
                     "inchikey" : "AVHHNFHLLZCWFH-UHFFFAOYSA-N",
                         "name" : "2,2',4',5,5'-pentachloro-[1,1'-biphenyl]-4-ol",
                    "structure" : "[H]C1=C(O)C(Cl)=C([H])C(=C1Cl)C1=C(Cl)C([H])=C(Cl)C(Cl)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0093" : {
                             "Name" : "3-methylindole",
            "Substrate's structure" : "N1(C(=C(C=2C(=C(C(=C(C12)[H])[H])[H])[H])C([H])([H])[H])[H])[H]",
                         "InChIKey" : "ZFRKQXVRDFCRJG-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2F1",
                       "References" : [
                "Kalgutkar, A.S. et al. (2002); On the Diversity of Oxidative Bioactivation Reactions on Nitrogen-Containing Xenobiotics; Current Drug Metabolism, 3, 379-424; PMID: 12093357"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0091",
                     "inchikey" : "BCNUXXXHEIUHJB-UHFFFAOYSA-O",
                         "name" : "3-methyleneindolenine",
                    "structure" : "[H]C([H])=C1C([H])=[N+]([H])C2=C1C([H])=C([H])C([H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "Dehydrogenation"
            ]
        },
        "BIOTID0094" : {
                             "Name" : "3-methylindole",
            "Substrate's structure" : "N1(C(=C(C=2C(=C(C(=C(C12)[H])[H])[H])[H])C([H])([H])[H])[H])[H]",
                         "InChIKey" : "ZFRKQXVRDFCRJG-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2F1; CYP2A6; CYP3A4; CYP2C8",
                       "References" : [
                "Kalgutkar, A.S. et al. (2002); On the Diversity of Oxidative Bioactivation Reactions on Nitrogen-Containing Xenobiotics; Current Drug Metabolism, 3, 379-424; PMID: 12093357"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0092",
                     "inchikey" : "WHTZCVZCHNDLHB-UHFFFAOYNA-N",
                         "name" : "3-methylindole-2,3-epoxide",
                    "structure" : "[H]N1C2=C(C([H])=C([H])C([H])=C2[H])C2(OC12[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0095" : {
                             "Name" : "4-aminobiphenyl",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])[H])N([H])[H])[H])[H])C=2C(=C(C(=C(C2[H])[H])[H])[H])[H]",
                         "InChIKey" : "DMVOXQPQNTYEKQ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Butler, M.A. et al. (1989); Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines; Proc Natl Acad Sci U S A. 1989 Oct;86(20):7696-700; PMID:2813353; PMCID:PMC298137"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0093",
                     "inchikey" : "MYVLYOJYVMLSFA-UHFFFAOYSA-N",
                         "name" : "4-aminobiphenyl, N-oxide",
                    "structure" : "ONC1=CC=C(C=C1)C1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0096" : {
                             "Name" : "4-Hydroxytamoxifen",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C(O)C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])C([H])=C1[H])\\C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "TXUZVZSFRXZGTL-QPLCGJKRSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0094",
                     "inchikey" : "MHJBZVSGOZTKRH-IZHYLOQSSA-N",
                         "name" : "Endoxifen",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C(O)C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])C([H])([H])NC([H])([H])[H])C([H])=C1[H])\\C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0097" : {
                             "Name" : "4-nitropyrene",
            "Substrate's structure" : "C1=2C3=C4C(=C(C1=C(C(=C(C2C(=C(C3=C(C(=C4[H])[H])[H])[H])[N+]([O-])=O)[H])[H])[H])[H])[H]",
                         "InChIKey" : "UISKIUIWPSPSAV-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0095",
                     "inchikey" : "AYBSKADMMKVOIV-UHFFFAOYSA-N",
                         "name" : "4-aminopyrene",
                    "structure" : "[H]C1=C([H])C2=C3C(=C1[H])C([H])=C(N)C1=C3C(C([H])=C2[H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Reduction"
            ]
        },
        "BIOTID0098" : {
                             "Name" : "58c80",
            "Substrate's structure" : "C=12C(=C(C(=C(C1C(=O)C(O[H])=C(C2=O)[C@]3(C(C([C@@](C(C3([H])[H])([H])[H])(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "NWCVRXADYNRXCT-JOCQHMNTSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0096",
                     "inchikey" : "QSVGNDZSYQMMEG-JOCQHMNTNA-N",
                         "name" : "298C84",
                    "structure" : "[H]OC1=C(C(=O)C2=C(C([H])=C([H])C([H])=C2[H])C1=O)[C@@]1([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])C1([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation",
                "Alkyl hydroxylation"
            ]
        },
        "BIOTID0099" : {
                             "Name" : "7-ethoxyresorufin",
            "Substrate's structure" : "O1C2=C(N=C3C1=C(C(=O)C(=C3[H])[H])[H])C(=C(C(OC(C([H])([H])[H])([H])[H])=C2[H])[H])[H]",
                         "InChIKey" : "CRCWUBLTFGOMDD-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP1A1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0097",
                     "inchikey" : "HSSLDCABUXLXKM-UHFFFAOYSA-N",
                         "name" : "Resorufin",
                    "structure" : "[H]C1=C([H])C2=C(OC3=C([H])C(=O)C([H])=C([H])C3=N2)C([H])=C1O"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0100" : {
                             "Name" : "8-hydroxyefavirenz",
            "Substrate's structure" : "ClC1=CC=2[C@@](OC(=O)NC2C(O)=C1)(C#CC3CC3)C(F)(F)F",
                         "InChIKey" : "OOVOMPCQLMFEDT-ZDUSSCGKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0098",
                     "inchikey" : "WILFXLMJFSKQRP-ZDUSSCGKSA-N",
                         "name" : "8,14-diOH-efavirenz",
                    "structure" : "[H]OC1=C([H])C(Cl)=C([H])C2=C1N([H])C(=O)O[C@]2(C#CC1(O[H])C([H])([H])C1([H])[H])C(F)(F)F"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0101" : {
                             "Name" : "aceclofenac",
            "Substrate's structure" : "C1(=C(C(C(OC(C(O[H])=O)([H])[H])=O)([H])[H])C(=C(C(=C1[H])[H])[H])[H])N(C2=C(C(=C(C(=C2Cl)[H])[H])[H])Cl)[H]",
                         "InChIKey" : "MNIPYSSQXLZQLJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0099",
                     "inchikey" : "BTDFYMBLEDMWOK-UHFFFAOYSA-N",
                         "name" : "4'-OH-aceclofenac",
                    "structure" : "[H]OC(=O)C([H])([H])OC(=O)C([H])([H])C1=C(N([H])C2=C(Cl)C([H])=C(O)C([H])=C2Cl)C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0102" : {
                             "Name" : "aceclofenac",
            "Substrate's structure" : "C1(=C(C(C(OC(C(O[H])=O)([H])[H])=O)([H])[H])C(=C(C(=C1[H])[H])[H])[H])N(C2=C(C(=C(C(=C2Cl)[H])[H])[H])Cl)[H]",
                         "InChIKey" : "MNIPYSSQXLZQLJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0100",
                     "inchikey" : "IUSFDHLZHGPYRJ-UHFFFAOYSA-N",
                         "name" : "5-OH-aceclofenac",
                    "structure" : "[H]OC(=O)C([H])([H])OC(=O)C([H])([H])C1=C(N([H])C2=C(Cl)C([H])=C([H])C([H])=C2Cl)C([H])=C([H])C(O)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0103" : {
                             "Name" : "aceclofenac",
            "Substrate's structure" : "C1(=C(C(C(OC(C(O[H])=O)([H])[H])=O)([H])[H])C(=C(C(=C1[H])[H])[H])[H])N(C2=C(C(=C(C(=C2Cl)[H])[H])[H])Cl)[H]",
                         "InChIKey" : "MNIPYSSQXLZQLJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0101",
                     "inchikey" : "DCOPUUMXTXDBNB-UHFFFAOYSA-N",
                         "name" : "Diclofenac",
                    "structure" : "[H]N(C1=C(C([H])=C([H])C([H])=C1[H])C([H])([H])C(O)=O)C1=C(Cl)C([H])=C([H])C([H])=C1Cl"
                }
            ],
                    "Reaction Type" : []
        },
        "BIOTID0104" : {
                             "Name" : "acetaminophen",
            "Substrate's structure" : "C(C(=O)N(C1=C(C(=C(O[H])C(=C1[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "RZVAJINKPMORJF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2E1; CYP3A4; CYP2A6; CYP2C9; CYP2D6; CYP1A1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0102",
                     "inchikey" : "URNSECGXFRDEDC-UHFFFAOYSA-N",
                         "name" : "N-Acetyl-p-benzoquinone",
                    "structure" : "[H]C1=C([H])C(=NC(=O)C([H])([H])[H])C([H])=C([H])C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic ring oxidation"
            ]
        },
        "BIOTID0105" : {
                             "Name" : "acetaminophen",
            "Substrate's structure" : "C(C(=O)N(C1=C(C(=C(O[H])C(=C1[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "RZVAJINKPMORJF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6 (major); CYP2E1; CYP1A2; CYP2C8; CYP2C9; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0103",
                     "inchikey" : "IPFBMHOMTSBTSU-UHFFFAOYSA-N",
                         "name" : "3-Hydroxyacetaminophen",
                    "structure" : "[H]OC1=C([H])C([H])=C(N([H])C(=O)C([H])([H])[H])C([H])=C1O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0106" : {
                             "Name" : "acetanilide",
            "Substrate's structure" : "O=C(N(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])[H])C([H])([H])[H]",
                         "InChIKey" : "FZERHIULMFGESH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0104",
                     "inchikey" : "RZVAJINKPMORJF-UHFFFAOYSA-N",
                         "name" : "Acetaminophen",
                    "structure" : "[H]N(C(=O)C([H])([H])[H])C1=C([H])C([H])=C(O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0107" : {
                             "Name" : "acetanilide",
            "Substrate's structure" : "O=C(N(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])[H])C([H])([H])[H]",
                         "InChIKey" : "FZERHIULMFGESH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0105",
                     "inchikey" : "GMJUGPZVHVVVCG-UHFFFAOYSA-N",
                         "name" : "N-Hydroxy-N-phenylacetamide",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])N(O)C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0108" : {
                             "Name" : "acrylonitrile",
            "Substrate's structure" : "C(=C(C#N)[H])([H])[H]",
                         "InChIKey" : "NLHHRLWOUZZQLW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Wang, H. et al, (2002) Cytochrome p450 2E1 is essential for acrylonitrile metabolism to cyanide: comparative studies using CYP2E1-null and wild-type mice, DMD: 30:911-917, 2002"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0106",
                     "inchikey" : "RSHIVZARDAPEDE-UHFFFAOYNA-N",
                         "name" : "Cyanoethylene oxide",
                    "structure" : "[H]C1([H])OC1([H])C#N"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0109" : {
                             "Name" : "aflatoxin b1",
            "Substrate's structure" : "C=12C3=C(C(=C(C1C4=C(C(O2)=O)C(C(C4([H])[H])([H])[H])=O)OC([H])([H])[H])[H])O[C@@]5([C@]3(C(=C(O5)[H])[H])[H])[H]",
                         "InChIKey" : "OQIQSTLJSLGHID-WNWIJWBNSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP1A2; CYP3A5; CYP3A4; CYP2A13 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0107",
                     "inchikey" : "KHBXRZGALJGBPA-LMEGTBPZSA-N",
                         "name" : "Aflatoxin B1- exo-8,9-oxide",
                    "structure" : "[H]C1=C(OC([H])([H])[H])C2=C(OC(=O)C3=C2C([H])([H])C([H])([H])C3=O)C2=C1O[C@@]1([H])OC3([H])OC3([H])[C@@]21[H]"
                }
            ],
                    "Reaction Type" : [
                "Eopxidation"
            ]
        },
        "BIOTID0110" : {
                             "Name" : "aflatoxin b1",
            "Substrate's structure" : "C=12C3=C(C(=C(C1C4=C(C(O2)=O)C(C(C4([H])[H])([H])[H])=O)OC([H])([H])[H])[H])O[C@@]5([C@]3(C(=C(O5)[H])[H])[H])[H]",
                         "InChIKey" : "OQIQSTLJSLGHID-WNWIJWBNSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP1A2 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0108",
                     "inchikey" : "MJBWDEQAUQTVKK-IAGOWNOFSA-N",
                         "name" : "Aflatoxin M1",
                    "structure" : "[H]C1=C([H])[C@@]2(O)C3=C(O[C@@]2([H])O1)C([H])=C(OC([H])([H])[H])C1=C3OC(=O)C2=C1C([H])([H])C([H])([H])C2=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0111" : {
                             "Name" : "aflatoxin b1",
            "Substrate's structure" : "C=12C3=C(C(=C(C1C4=C(C(O2)=O)C(C(C4([H])[H])([H])[H])=O)OC([H])([H])[H])[H])O[C@@]5([C@]3(C(=C(O5)[H])[H])[H])[H]",
                         "InChIKey" : "OQIQSTLJSLGHID-WNWIJWBNSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP3A4 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0109",
                     "inchikey" : "GYNOTJLCULOEIM-VYNLQGFGSA-N",
                         "name" : "Aflatoxin Q1",
                    "structure" : "[H]C1=C([H])[C@@]2([H])C3=C(O[C@@]2([H])O1)C([H])=C(OC([H])([H])[H])C1=C3OC(=O)C2=C1C([H])(O)C([H])([H])C2=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation",
                "Alkyl hydroxylation"
            ]
        },
        "BIOTID0112" : {
                             "Name" : "alfentanil",
            "Substrate's structure" : "N1=NN(C(N1C(C(N2C(C(C(C(C2([H])[H])([H])[H])(C(OC([H])([H])[H])([H])[H])N(C(C(C([H])([H])[H])([H])[H])=O)C=3C(=C(C(=C(C3[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])=O)C(C([H])([H])[H])([H])[H]",
                         "InChIKey" : "IDBPHNDTYPBSNI-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0110",
                     "inchikey" : "ZTHRQJQJODGZHV-UHFFFAOYSA-N",
                         "name" : "N-phenylpropionamide",
                    "structure" : "[H]C1=C([H])C([H])=C(NC(=O)C([H])([H])C([H])([H])[H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0113" : {
                             "Name" : "alfentanil",
            "Substrate's structure" : "N1=NN(C(N1C(C(N2C(C(C(C(C2([H])[H])([H])[H])(C(OC([H])([H])[H])([H])[H])N(C(C(C([H])([H])[H])([H])[H])=O)C=3C(=C(C(=C(C3[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])=O)C(C([H])([H])[H])([H])[H]",
                         "InChIKey" : "IDBPHNDTYPBSNI-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0111",
                     "inchikey" : "ULOZGJWEIWAWML-UHFFFAOYSA-N",
                         "name" : "Noralfentanil",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])N(C(=O)C([H])([H])C([H])([H])[H])C1(C([H])([H])OC([H])([H])[H])C([H])([H])C([H])([H])NC([H])([H])C1([H])[H]"
                },
                {
                     "BTMDB_ID" : "BTMDB0111",
                     "inchikey" : "ULOZGJWEIWAWML-UHFFFAOYSA-N",
                         "name" : "Noralfentanil",
                    "structure" : "[H]C(=O)CN1N=NN(CC)C1=O"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0114" : {
                             "Name" : "almotriptan",
            "Substrate's structure" : "C12=C(N(C(=C1C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])[H])[H])C(=C(C(=C2[H])C(S(N3C(C(C(C3([H])[H])([H])[H])([H])[H])([H])[H])(=O)=O)([H])[H])[H])[H]",
                         "InChIKey" : "WKEMJKQOLOHJLZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0112",
                     "inchikey" : "UYQQYVHESFAATL-UHFFFAOYNA-N",
                         "name" : "2-OH-almotriptan",
                    "structure" : "[H]N1C([H])=C(C2=C1C([H])=C([H])C(=C2[H])C([H])([H])S(=O)(=O)N1C([H])([H])C([H])([H])C([H])([H])C1([H])O)C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0115" : {
                             "Name" : "almotriptan",
            "Substrate's structure" : "C12=C(N(C(=C1C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])[H])[H])C(=C(C(=C2[H])C(S(N3C(C(C(C3([H])[H])([H])[H])([H])[H])([H])[H])(=O)=O)([H])[H])[H])[H]",
                         "InChIKey" : "WKEMJKQOLOHJLZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C8; CYP2E1; CYP2D6; CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0113",
                     "inchikey" : "IREINZNGILEJRP-UHFFFAOYSA-N",
                         "name" : "methyl(2-{5-[(pyrrolidine-1-sulfonyl)methyl]-1H-indol-3-yl}ethyl)amine",
                    "structure" : "[H]N1C([H])=C(C2=C1C([H])=C([H])C(=C2[H])C([H])([H])S(=O)(=O)N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H])C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0116" : {
                             "Name" : "alpha-thujone",
            "Substrate's structure" : "[C@@]1([C@]2(C([C@]2(C(C1=O)([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])[H])(C([H])([H])[H])[H]",
                         "InChIKey" : "USMNOWBWPHYOEA-MRTMQBJTSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP2B6; CYP2D6; CYP3A4",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0114",
                     "inchikey" : "QCIUNUUHBWFYTD-JEZHCXPESA-N",
                         "name" : "4-hydroxy-alpha-thujone",
                    "structure" : "[H]C([H])([H])C([H])(C([H])([H])[H])[C@@]12C([H])([H])[C@]1([H])[C@](O)(C(=O)C2([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0117" : {
                             "Name" : "alpha-thujone",
            "Substrate's structure" : "[C@@]1([C@]2(C([C@]2(C(C1=O)([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])[H])(C([H])([H])[H])[H]",
                         "InChIKey" : "USMNOWBWPHYOEA-MRTMQBJTSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "11041106",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP2B6; CYP2D6; CYP3A4",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0115",
                     "inchikey" : "BWIMEHVFTVSHCC-BRDIYROLSA-N",
                         "name" : "7-hydroxy-alpha-thujone",
                    "structure" : "[H]C([H])([H])[C@@]1([H])C(=O)C([H])([H])[C@@]2(C([H])([H])[C@]12[H])C(O)(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0118" : {
                             "Name" : "alprazolam",
            "Substrate's structure" : "C12=C(C(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])=NC(C=4N1C(=NN4)C([H])([H])[H])([H])[H])C(=C(C(=C2[H])[H])Cl)[H]",
                         "InChIKey" : "VREFGVBLTWBCJP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major); CYP2C9 (minor)",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0116",
                     "inchikey" : "CEYGCFLPQFNPST-UHFFFAOYNA-N",
                         "name" : "4-Hydroxyalprazolam",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C1=NC([H])(O)C2=NN=C(N2C2=C1C([H])=C(Cl)C([H])=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0119" : {
                             "Name" : "alprazolam",
            "Substrate's structure" : "C12=C(C(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])=NC(C=4N1C(=NN4)C([H])([H])[H])([H])[H])C(=C(C(=C2[H])[H])Cl)[H]",
                         "InChIKey" : "VREFGVBLTWBCJP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 (minor); CYP2C19 (minor); CYP3A4 (minor)",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0117",
                     "inchikey" : "MTACNNZEKCJJGY-UHFFFAOYNA-N",
                         "name" : "Beta-Hydroxyalprazolam",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C1=NC([H])(O)C2=NN=C(N2C2=C1C([H])=C([H])C([H])=C2[H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0120" : {
                             "Name" : "Ametryn",
            "Substrate's structure" : "[H]N(C1=NC(=NC(SC([H])([H])[H])=N1)N([H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "RQVYBGPQFYCBGX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C19; CYP3A4",
                       "References" : [
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015",
                "Lang, D.H.et al. (1997). Identification of enzymes involved in the metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in human liver microsomes. Chem. Res. Toxicol., Vol. 10, No. 9, (1037-1044"
            ],
                         "Products" : [],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0121" : {
                             "Name" : "Ametryn",
            "Substrate's structure" : "[H]N(C1=NC(=NC(SC([H])([H])[H])=N1)N([H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "RQVYBGPQFYCBGX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C8; CYP2C9; CYP2C19; CYP3A4",
                       "References" : [
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015",
                "Lang, D.H.et al. (1997). Identification of enzymes involved in the metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in human liver microsomes. Chem. Res. Toxicol., Vol. 10, No. 9, (1037-1044"
            ],
                         "Products" : [],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0122" : {
                             "Name" : "aminopyrine",
            "Substrate's structure" : "C=1(C(=C(C(=C(N2C(=O)C(N(C([H])([H])[H])C([H])([H])[H])=C(N2C([H])([H])[H])[H])C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "WOEUPEKLVDSCQN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP2C8; CYP2D6; CYP2C18; CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0118",
                     "inchikey" : "URECXYGMECJQLI-UHFFFAOYSA-N",
                         "name" : "4-(Dimethylamino)-5-methyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one",
                    "structure" : "[H]C1=C(N(C([H])([H])[H])C([H])([H])[H])C(=O)N(N1)C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0123" : {
                             "Name" : "aminopyrine",
            "Substrate's structure" : "C=1(C(=C(C(=C(N2C(=O)C(N(C([H])([H])[H])C([H])([H])[H])=C(N2C([H])([H])[H])[H])C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "WOEUPEKLVDSCQN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A4; CYP2C18; CYP2C19; CYP2C8; CYP2C9; CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0119",
                     "inchikey" : "DAQMTRAJUJQXCT-UHFFFAOYSA-N",
                         "name" : "N-Desmethylaminopyrine",
                    "structure" : "[H]C1=C(NC([H])([H])[H])C(=O)N(N1C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0124" : {
                             "Name" : "amiodarone",
            "Substrate's structure" : "C(C(C(C(C1=C(C(=O)C2=C(C(I)=C(OC(C(N(C(C([H])([H])[H])([H])[H])C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])C(I)=C2[H])[H])C3=C(C(=C(C(=C3O1)[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "IYIKLHRQXLHMJQ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C8; CYP2C9; CYP1A2; CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0120",
                     "inchikey" : "VXOKDLACQICQFA-UHFFFAOYSA-N",
                         "name" : "N-Desethylamiodarone",
                    "structure" : "[H]C1=C([H])C([H])=C2C(OC(=C2C(=O)C2=C([H])C(I)=C(OC([H])([H])C([H])([H])NC([H])([H])C([H])([H])[H])C(I)=C2[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0125" : {
                             "Name" : "amitriptyline",
            "Substrate's structure" : "C(N(C([H])([H])[H])C(C(C(=C1C2=C(C(=C(C(=C2C(C(C3=C(C(=C(C(=C13)[H])[H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "KRMDCWKBEZIMAB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP3A4; CYP2C9; CYP1A2",
                       "References" : [
                "R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0121",
                     "inchikey" : "PHVGLTMQBUFIQQ-UHFFFAOYSA-N",
                         "name" : "Nortriptyline",
                    "structure" : "[H]C(=C1C2=C([H])C([H])=C([H])C([H])=C2C([H])([H])C([H])([H])C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0126" : {
                             "Name" : "amitriptyline",
            "Substrate's structure" : "C(N(C([H])([H])[H])C(C(C(=C1C2=C(C(=C(C(=C2C(C(C3=C(C(=C(C(=C13)[H])[H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "KRMDCWKBEZIMAB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0122",
                     "inchikey" : "GHWBJXOKAFHZAI-ATVHPVEENA-N",
                         "name" : "E-10-OH-amitriptyline",
                    "structure" : "[H]\\C(=C1/C2=C([H])C([H])=C([H])C([H])=C2C([H])([H])C([H])(O)C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0127" : {
                             "Name" : "androstenedione",
            "Substrate's structure" : "C([C@@]12[C@]3([C@@]([C@]4([C@@](C(C3([H])[H])([H])[H])(C([H])([H])[H])C(C(C4([H])[H])([H])[H])=O)[H])(C(C(C1=C(C(C(C2([H])[H])([H])[H])=O)[H])([H])[H])([H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "AEMFNILZOJDQLW-LHHMMCJZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0123",
                     "inchikey" : "WVAMBAWFDOYFOD-HAMDJXSXSA-N",
                         "name" : "6beta-hydroxy-androstenedione",
                    "structure" : "C[C@]12CC[C@@H]3[C@H](CC(O)C4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0128" : {
                             "Name" : "aniline",
            "Substrate's structure" : "C=1(N([H])[H])C(=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "PAYRUJLWNCNPSJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0124",
                     "inchikey" : "PLIKAWJENQZMHA-UHFFFAOYSA-N",
                         "name" : "4-aminophenol",
                    "structure" : "[H]N([H])C1=C([H])C([H])=C(O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0129" : {
                             "Name" : "aniline",
            "Substrate's structure" : "C=1(N([H])[H])C(=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "PAYRUJLWNCNPSJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0125",
                     "inchikey" : "CKRZKMFTZCFYGB-UHFFFAOYSA-N",
                         "name" : "N-Hydroxyaniline",
                    "structure" : "[H]N(O)C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0130" : {
                             "Name" : "antipyrine",
            "Substrate's structure" : "C(N1N(C(=O)C(=C1C([H])([H])[H])[H])C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "VEQOALNAAJBPNY-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C19; CYP2C9; CYP1A2",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0126",
                     "inchikey" : "KZQYIMCESJLPQH-UHFFFAOYSA-N",
                         "name" : "Norantipyrine",
                    "structure" : "[H]C1=C(NN(C1=O)C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0131" : {
                             "Name" : "antipyrine",
            "Substrate's structure" : "C(N1N(C(=O)C(=C1C([H])([H])[H])[H])C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "VEQOALNAAJBPNY-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 ; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0127",
                     "inchikey" : "JBJKAGOWIZGVTR-UHFFFAOYSA-N",
                         "name" : "3-OH-methylantipyrine",
                    "structure" : "[H]C1=C(N(C)N(C1=O)C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0132" : {
                             "Name" : "antipyrine",
            "Substrate's structure" : "C(N1N(C(=O)C(=C1C([H])([H])[H])[H])C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "VEQOALNAAJBPNY-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major); CYP1A2 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0128",
                     "inchikey" : "SKVPTPMWXJSBTF-UHFFFAOYSA-N",
                         "name" : "4-OH-antipyrine",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])N1N(C(=C(O)C1=O)C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0133" : {
                             "Name" : "aprepitant",
            "Substrate's structure" : "C([C@@](O[C@]1(OC(C(N(C(C2=NN(C(=O)N2[H])[H])([H])[H])[C@]1(C3=C(C(=C(F)C(=C3[H])[H])[H])[H])[H])([H])[H])([H])[H])[H])(C4=C(C(=C(C(=C4[H])C(F)(F)F)[H])C(F)(F)F)[H])[H])([H])([H])[H]",
                         "InChIKey" : "ATALOFNDEOCMKK-OITMNORJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5; CYP1A2; CYP2C19",
                       "References" : [
                "Zanger, U.M. and Schwab, M.; Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation; Pharmacology & Therapeutics 138 (2013) 103���141; PMID:23333322"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0129",
                     "inchikey" : "YLAKZWGIZJMOJV-UHFFFAOYSA-N",
                         "name" : "(2R,3S)�ې2�ې[(1R)�ې1�ې[3,5�ېbis(trifluoromethyl)phenyl]ethoxy]�ې3�ې(4�ېfluorophenyl)morpholine",
                    "structure" : "[H]N1N=C(N([H])C1=O)C([H])=O"
                },
                {
                     "BTMDB_ID" : "BTMDB0129",
                     "inchikey" : "YLAKZWGIZJMOJV-UHFFFAOYSA-N",
                         "name" : "(2R,3S)�ې2�ې[(1R)�ې1�ې[3,5�ېbis(trifluoromethyl)phenyl]ethoxy]�ې3�ې(4�ېfluorophenyl)morpholine",
                    "structure" : "[H]N1C([H])([H])C([H])([H])O[C@]([H])(O[C@@]([H])(C2=C([H])C(=C([H])C(=C2[H])C(F)(F)F)C(F)(F)F)C([H])([H])[H])[C@]1([H])C1=C([H])C([H])=C(F)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0134" : {
                             "Name" : "aprepitant",
            "Substrate's structure" : "C([C@@](O[C@]1(OC(C(N(C(C2=NN(C(=O)N2[H])[H])([H])[H])[C@]1(C3=C(C(=C(F)C(=C3[H])[H])[H])[H])[H])([H])[H])([H])[H])[H])(C4=C(C(=C(C(=C4[H])C(F)(F)F)[H])C(F)(F)F)[H])[H])([H])([H])[H]",
                         "InChIKey" : "ATALOFNDEOCMKK-OITMNORJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5; CYP1A2; CYP2C19",
                       "References" : [
                "Zanger, U.M. and Schwab, M.; Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation; Pharmacology & Therapeutics 138 (2013) 103���141; PMID:23333322"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0130",
                     "inchikey" : "MCYCSIKSZLARBD-UHFFFAOYSA-N",
                         "name" : "1�ې[3,5�ېbis(trifluoromethyl)phenyl]ethanone",
                    "structure" : "[H]C1=C(C([H])=C(C([H])=C1C(F)(F)F)C(F)(F)F)C(=O)C([H])([H])[H]"
                },
                {
                     "BTMDB_ID" : "BTMDB0130",
                     "inchikey" : "MCYCSIKSZLARBD-UHFFFAOYSA-N",
                         "name" : "1�ې[3,5�ېbis(trifluoromethyl)phenyl]ethanone",
                    "structure" : "[H]N1N=C(N([H])C1=O)C([H])([H])N1C([H])([H])C([H])([H])O[C@]([H])(O)[C@]1([H])C1=C([H])C([H])=C(F)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0135" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C8; CYP2C9",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0131",
                     "inchikey" : "KGIJOOYOSFUGPC-XTDASVJINA-N",
                         "name" : "5-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])(O)C(\\[H])=C(/[H])\\C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0136" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0132",
                     "inchikey" : "RXLAEFPIBOZBTL-UNXCDKAXNA-N",
                         "name" : "7-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])(O)C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0137" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C8; CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0133",
                     "inchikey" : "ZUOCVLADVGGUGH-OVMCANAPNA-N",
                         "name" : "10-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])(O)C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0138" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C8; CYP2C9; CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0134",
                     "inchikey" : "SAKQICHVWOJSNI-BWWNDVLWNA-N",
                         "name" : "13-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])(O)C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0139" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2A6",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0135",
                     "inchikey" : "NNDIXBJHNLFJJP-DTLRTWKJSA-N",
                         "name" : "20-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0140" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C8; CYP2C9; CYP2C19; CYP2E1",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0136",
                     "inchikey" : "XFUXZHQUWPFWPR-TWVHMNNTNA-N",
                         "name" : "19-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])(O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0141" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2E1",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0137",
                     "inchikey" : "PPCHNRUZQWLEMF-XBOCNYGYNA-N",
                         "name" : "18-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])(O)C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0142" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0138",
                     "inchikey" : "OPPIPPRXLIDJKN-JPURVOHMNA-N",
                         "name" : "17-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])(O)C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0143" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0139",
                     "inchikey" : "JEKNPVYFNMZRJG-UFINWASNNA-N",
                         "name" : "16-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])(O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0144" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2B6 (minor); CYP2D6",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0140",
                     "inchikey" : "JBSCUHKPLGKXKH-ILYOTBPNNA-N",
                         "name" : "14,15-EET",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C1([H])OC1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0145" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2B6 (minor); CYP2D6",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0141",
                     "inchikey" : "DXOYQVHGIODESM-KROJNAHFNA-N",
                         "name" : "11,12-EET",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C1([H])OC1([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0146" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2B6 (minor); CYP2D6",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0142",
                     "inchikey" : "DBWQSCSXHFNTMO-TYAUOURKNA-N",
                         "name" : "8,9-EET",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C1([H])OC1([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0147" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2B6 (minor); CYP2D6",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0143",
                     "inchikey" : "VBQNSZQZRAGRIX-QNEBEIHSNA-N",
                         "name" : "5,6-EET",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C1([H])OC1([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0148" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C8",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0144",
                     "inchikey" : "JSFATNQSLKRBCI-USWFWKISNA-N",
                         "name" : "15-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])/C(/[H])=C(\\[H])C(O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0149" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C9",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0145",
                     "inchikey" : "ZNHVWPKMFKADKW-QGXLQBIUNA-N",
                         "name" : "12-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])=C([H])C([H])(O)C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0150" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C8",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0146",
                     "inchikey" : "GCZRCCHPLVMMJE-QGDGSJJTNA-N",
                         "name" : "11-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])(O)C([H])=C([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0151" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C8; CYP2C9",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0147",
                     "inchikey" : "KATOYYZUTNAWSA-ZMTMACIGNA-N",
                         "name" : "9-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])/C(/[H])=C(/[H])C([H])(O)C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0152" : {
                             "Name" : "arachidonic acid",
            "Substrate's structure" : "O(C(=O)C(C(C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(/C(=C(\\C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])/[H])/[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "YZXBAPSDXZZRGB-DOFZRALJSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C8; CYP2C9",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0148",
                     "inchikey" : "NLUNAYAEIJYXRB-NGVRZBQMNA-N",
                         "name" : "8-HETE",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])(O)C([H])=C([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0153" : {
                             "Name" : "aripiprazole",
            "Substrate's structure" : "ClC1=C(C(=C(C(N2C(C(N(C(C(C(C(OC3=C(C4=C(C(C(C(=O)N4[H])([H])[H])([H])[H])C(=C3[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])C(C2([H])[H])([H])[H])([H])[H])([H])[H])=C1Cl)[H])[H])[H]",
                         "InChIKey" : "CEUORZQYGODEFX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Bauman, N. et al (2008), Comparison of the Bioactivation Potential of the Antidepressant and Hepatotaxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug, DMD 36:1016-1029, 2008"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0149",
                     "inchikey" : "CDONPRYEWWPREK-UHFFFAOYSA-N",
                         "name" : "dehydro-aripiprazole",
                    "structure" : "ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(C=CC(=O)N4)C=C3)CC2)=C1Cl"
                }
            ],
                    "Reaction Type" : [
                "Dehydrogenation"
            ]
        },
        "BIOTID0154" : {
                             "Name" : "aripiprazole",
            "Substrate's structure" : "ClC1=C(C(=C(C(N2C(C(N(C(C(C(C(OC3=C(C4=C(C(C(C(=O)N4[H])([H])[H])([H])[H])C(=C3[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])C(C2([H])[H])([H])[H])([H])[H])([H])[H])=C1Cl)[H])[H])[H]",
                         "InChIKey" : "CEUORZQYGODEFX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Shi, R. et al, (2003), Catalytic mechanism of Cytochrome P450 2D6 for 4-hyroxylation of aripirazole: A QM/MM study; DOI: 10.1002/ejoc.201300427"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0150",
                     "inchikey" : "YZIVLADPQQPFLO-UHFFFAOYSA-N",
                         "name" : "4-Hydroxyaripiprazole",
                    "structure" : "OC1=C(Cl)C(Cl)=C(C=C1)N1CCN(CCCCOC2=CC3=C(CCC(=O)N3)C=C2)CC1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0155" : {
                             "Name" : "aripiprazole",
            "Substrate's structure" : "ClC1=C(C(=C(C(N2C(C(N(C(C(C(C(OC3=C(C4=C(C(C(C(=O)N4[H])([H])[H])([H])[H])C(=C3[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])C(C2([H])[H])([H])[H])([H])[H])([H])[H])=C1Cl)[H])[H])[H]",
                         "InChIKey" : "CEUORZQYGODEFX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Caccia, S. (2007); N-Delakylation of arylpiprazine derivatives: Disposition and metabolism of 1-arylpiperazines formed, Curr Drug Metab 8: 612-622."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0151",
                     "inchikey" : "UDQMXYJSNNCRAS-UHFFFAOYSA-N",
                         "name" : "2,3�ېdichlorophenylpiperazine",
                    "structure" : "[H]C1=C([H])C(N2C([H])([H])C([H])([H])NC([H])([H])C2([H])[H])=C(Cl)C(Cl)=C1[H]"
                },
                {
                     "BTMDB_ID" : "BTMDB0151",
                     "inchikey" : "UDQMXYJSNNCRAS-UHFFFAOYSA-N",
                         "name" : "2,3�ېdichlorophenylpiperazine",
                    "structure" : "[H]N1C(=O)C([H])([H])C([H])([H])C2=C1C([H])=C(OC([H])([H])C([H])([H])C([H])([H])C([H])=O)C([H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0156" : {
                             "Name" : "arverapamil",
            "Substrate's structure" : "C=1(C(=C(C(=C(C(C(N(C(C(C([C@@](C(C([H])([H])[H])(C([H])([H])[H])[H])(C2=C(C(=C(OC([H])([H])[H])C(OC([H])([H])[H])=C2[H])[H])[H])C#N)([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])C1[H])[H])OC([H])([H])[H])OC([H])([H])[H])[H]",
                         "InChIKey" : "UPKQNCPKPOLASS-AREMUKBSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4; CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0152",
                     "inchikey" : "IQVLXQZAOGCLEE-RUZDIDTESA-N",
                         "name" : "(2R)-5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(3-methoxyphenyl)-2-(propan-2-yl)pentanenitrile",
                    "structure" : "[H]N(C([H])([H])C([H])([H])C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])[C@](C#N)(C1=C([H])C([H])=CC(OC([H])([H])[H])=C1[H])C([H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0157" : {
                             "Name" : "arverapamil",
            "Substrate's structure" : "C=1(C(=C(C(=C(C(C(N(C(C(C([C@@](C(C([H])([H])[H])(C([H])([H])[H])[H])(C2=C(C(=C(OC([H])([H])[H])C(OC([H])([H])[H])=C2[H])[H])[H])C#N)([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])C1[H])[H])OC([H])([H])[H])OC([H])([H])[H])[H]",
                         "InChIKey" : "UPKQNCPKPOLASS-AREMUKBSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4; CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0153",
                     "inchikey" : "BQGFPUBUNKYGEY-OAHLLOKOSA-N",
                         "name" : "(2R)-5-amino-2-(3-methoxyphenyl)-2-(propan-2-yl)pentanenitrile",
                    "structure" : "[H]C1=CC(OC([H])([H])[H])=C([H])C(=C1[H])[C@@](C#N)(C([H])([H])C([H])([H])C([H])([H])N)C([H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0158" : {
                             "Name" : "arverapamil",
            "Substrate's structure" : "C=1(C(=C(C(=C(C(C(N(C(C(C([C@@](C(C([H])([H])[H])(C([H])([H])[H])[H])(C2=C(C(=C(OC([H])([H])[H])C(OC([H])([H])[H])=C2[H])[H])[H])C#N)([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])C1[H])[H])OC([H])([H])[H])OC([H])([H])[H])[H]",
                         "InChIKey" : "UPKQNCPKPOLASS-AREMUKBSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4; CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0154",
                     "inchikey" : "RIVVYJWUHXMGSK-UHFFFAOYSA-N",
                         "name" : "2-(3,4-dimethoxyphenyl)acetaldehyde",
                    "structure" : "[H]C(=O)C([H])([H])C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0159" : {
                             "Name" : "astemizole",
            "Substrate's structure" : "C(OC1=C(C(=C(C(C(N2C(C(C(C(C2([H])[H])([H])[H])(N(C3=NC4=C(C(=C(C(=C4N3C(C5=C(C(=C(F)C(=C5[H])[H])[H])[H])([H])[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])C(=C1[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "GXDALQBWZGODGZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP3A4 (minor)",
                       "References" : [
                "Matsumoto, S.and Yamazoe, Y. (2001); Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine; Br J Clin Pharmacol.; 51(2):133-42; PMID:11259984; PMCID:PMC2014443"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0155",
                     "inchikey" : "GJJYAIIDIMCSIM-UHFFFAOYSA-N",
                         "name" : "6-Hydroxyastemizole",
                    "structure" : "[H]N(C1=NC2=C([H])C([H])=C(O)C([H])=C2N1C([H])([H])C1=C([H])C([H])=C(F)C([H])=C1[H])C1([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C2=C([H])C([H])=C(OC([H])([H])[H])C([H])=C2[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0160" : {
                             "Name" : "astemizole",
            "Substrate's structure" : "C(OC1=C(C(=C(C(C(N2C(C(C(C(C2([H])[H])([H])[H])(N(C3=NC4=C(C(=C(C(=C4N3C(C5=C(C(=C(F)C(=C5[H])[H])[H])[H])([H])[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])C(=C1[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "GXDALQBWZGODGZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Matsumoto, S.and Yamazoe, Y. (2001); Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine; Br J Clin Pharmacol.; 51(2):133-42; PMID:11259984; PMCID:PMC2014443"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0156",
                     "inchikey" : "LAGYWHSFHIMTPE-UHFFFAOYSA-N",
                         "name" : "6-desmethylastermizole",
                    "structure" : "[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])C([H])(N([H])C2=NC3=C([H])C([H])=C([H])C([H])=C3N2C([H])([H])C2=C([H])C([H])=C(F)C([H])=C2[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0161" : {
                             "Name" : "astemizole",
            "Substrate's structure" : "C(OC1=C(C(=C(C(C(N2C(C(C(C(C2([H])[H])([H])[H])(N(C3=NC4=C(C(=C(C(=C4N3C(C5=C(C(=C(F)C(=C5[H])[H])[H])[H])([H])[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])C(=C1[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "GXDALQBWZGODGZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (minor)",
                       "References" : [
                "Matsumoto, S.and Yamazoe, Y. (2001); Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine; Br J Clin Pharmacol.; 51(2):133-42; PMID:11259984; PMCID:PMC2014443"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0157",
                     "inchikey" : "SFOVDSLXFUGAIV-UHFFFAOYSA-N",
                         "name" : "norastemizole",
                    "structure" : "[H]N(C1=NC2=C([H])C([H])=C([H])C([H])=C2N1C([H])([H])C1=C([H])C([H])=C(F)C([H])=C1[H])C1([H])C([H])([H])C([H])([H])N([H])C([H])([H])C1([H])[H]"
                },
                {
                     "BTMDB_ID" : "BTMDB0157",
                     "inchikey" : "SFOVDSLXFUGAIV-UHFFFAOYSA-N",
                         "name" : "norastemizole",
                    "structure" : "[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])=O"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0162" : {
                             "Name" : "benzene",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "UHOVQNZJYSORNB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0158",
                     "inchikey" : "ISWSIDIOOBJBQZ-UHFFFAOYSA-N",
                         "name" : "Phenol",
                    "structure" : "[H]C1=C([H])C([H])=C(O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0163" : {
                             "Name" : "bosentan",
            "Substrate's structure" : "C=1(C(=C(N=C(N1)C=2N=C(C(=C(N2)[H])[H])[H])OC(C(O[H])([H])[H])([H])[H])OC=3C(=C(C(=C(C3[H])[H])[H])[H])OC([H])([H])[H])N(S(=O)(=O)C=4C(=C(C(=C(C4[H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])[H])[H]",
                         "InChIKey" : "GJPICJJJRGTNOD-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major); CYP2C9 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0159",
                     "inchikey" : "FAJQMBCLPZWTQJ-UHFFFAOYSA-N",
                         "name" : "4-(2-hydroxy-1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2�۪]bipyrimidinyl-4-yl]-benzenesulfonamide",
                    "structure" : "[H]OC([H])([H])C([H])([H])OC1=C(OC2=C([H])C([H])=C([H])C([H])=C2OC([H])([H])[H])C(=NC(=N1)C1=NC([H])=C([H])C([H])=N1)N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C(CO)(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0164" : {
                             "Name" : "bosentan",
            "Substrate's structure" : "C=1(C(=C(N=C(N1)C=2N=C(C(=C(N2)[H])[H])[H])OC(C(O[H])([H])[H])([H])[H])OC=3C(=C(C(=C(C3[H])[H])[H])[H])OC([H])([H])[H])N(S(=O)(=O)C=4C(=C(C(=C(C4[H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])[H])[H])[H]",
                         "InChIKey" : "GJPICJJJRGTNOD-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major); CYP2C9 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0160",
                     "inchikey" : "STTLKJGYAWXIPP-UHFFFAOYSA-N",
                         "name" : "4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-hydroxyphenoxy)-[2,2�۪]bipyrimidinyl-4-yl]-benzenesulfonamide",
                    "structure" : "[H]OC([H])([H])C([H])([H])OC1=C(OC2=C([H])C([H])=C([H])C([H])=C2O)C(=NC(=N1)C1=NC([H])=C([H])C([H])=N1)N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C(C)(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0165" : {
                             "Name" : "brofaromine",
            "Substrate's structure" : "C12=C(C(=C(C(=C1[H])OC([H])([H])[H])[H])Br)OC(=C2[H])C3(C(C(N(C(C3([H])[H])([H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "WZXHSWVDAYOFPE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0161",
                     "inchikey" : "ROFOHNHESMVUGP-UHFFFAOYSA-N",
                         "name" : "O-desmethyl-brofaromine",
                    "structure" : "[H]OC1=C([H])C2=C(OC(=C2[H])C2([H])C([H])([H])C([H])([H])N([H])C([H])([H])C2([H])[H])C(Br)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0166" : {
                             "Name" : "bropirimine",
            "Substrate's structure" : "C=1(N(C(C(=C(N1)C=2C(=C(C(=C(C2[H])[H])[H])[H])[H])Br)=O)[H])N([H])[H]",
                         "InChIKey" : "CIUUIPMOFZIWIZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Wynalda, M.A. et al. (1998); Human biotransformation of bropirimine. Characterization of the major bropirimine oxidative metabolites formed in vitro; Drug Metab Dispos; 26(10):1048-51; PMID:9763414"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0162",
                     "inchikey" : "CUDNQOMFBZIEEA-UHFFFAOYSA-N",
                         "name" : "m-hydroxybropirimine",
                    "structure" : "OC1=CC(=CC=C1)C1=C(Br)C(O)=NC(=N)N1"
+            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0167" : {
                             "Name" : "bropirimine",
            "Substrate's structure" : "C=1(N(C(C(=C(N1)C=2C(=C(C(=C(C2[H])[H])[H])[H])[H])Br)=O)[H])N([H])[H]",
                         "InChIKey" : "CIUUIPMOFZIWIZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Wynalda, M.A. et al. (1998); Human biotransformation of bropirimine. Characterization of the major bropirimine oxidative metabolites formed in vitro; Drug Metab Dispos; 26(10):1048-51; PMID:9763414"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0163",
                     "inchikey" : "BPQDHWHENINUML-UHFFFAOYSA-N",
                         "name" : "p-hydroxybropirimine",
                    "structure" : "OC1=CC=C(C=C1)C1=C(Br)C(O)=NC(=N)N1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0168" : {
                             "Name" : "caffeine",
            "Substrate's structure" : "C(N1C(=NC2=C1C(=O)N(C([H])([H])[H])C(=O)N2C([H])([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "RYYVLZVUVIJVGH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "4687",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0164",
                     "inchikey" : "QUNWUDVFRNGTCO-UHFFFAOYSA-N",
                         "name" : "Paraxanthine",
                    "structure" : "[H]N1C2=C(N(C([H])=N2)C([H])([H])[H])C(=O)N(C1=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0169" : {
                             "Name" : "caffeine",
            "Substrate's structure" : "C(N1C(=NC2=C1C(=O)N(C([H])([H])[H])C(=O)N2C([H])([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "RYYVLZVUVIJVGH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "5429",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (major); CYP2E1 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0165",
                     "inchikey" : "CGHOLCBXEQQSQJ-UHFFFAOYNA-N",
                         "name" : "Theobromine",
                    "structure" : "[H]C1=NC2=C(N1C([H])([H])[H])C(=O)NC(=O)C2C"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0170" : {
                             "Name" : "caffeine",
            "Substrate's structure" : "C(N1C(=NC2=C1C(=O)N(C([H])([H])[H])C(=O)N2C([H])([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "RYYVLZVUVIJVGH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "2153",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (major); CYP2C8 (minor); CYP2C9 (minor); CYP3A4 (minor); CYP2E1 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0166",
                     "inchikey" : "ZFXYFBGIUFBOJW-UHFFFAOYSA-N",
                         "name" : "Theophylline",
                    "structure" : "[H]C1=NC2=C(N1)C(=O)N(C(=O)N2C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0171" : {
                             "Name" : "caffeine",
            "Substrate's structure" : "C(N1C(=NC2=C1C(=O)N(C([H])([H])[H])C(=O)N2C([H])([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "RYYVLZVUVIJVGH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "79437",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (major); CYP2C8 (minor); CYP2C9 (minor); CYP3A4 (minor); CYP2E1 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0167",
                     "inchikey" : "BYXCFUMGEBZDDI-UHFFFAOYSA-N",
                         "name" : "1,3,7-Trimethyluric acid",
                    "structure" : "[H]C([H])([H])N1C2=C(N(C)C(O)=N2)C(=O)N(C1=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0172" : {
                             "Name" : "carbamazepine",
            "Substrate's structure" : "N(C(=O)N1C2=C(C(=C(C(=C2C(=C(C3=C(C(=C(C(=C13)[H])[H])[H])[H])[H])[H])[H])[H])[H])[H])([H])[H]",
                         "InChIKey" : "FFGPTBGBLSHEPO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP3A4; CYP2C8 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0168",
                     "inchikey" : "ZRWWEEVEIOGMMT-UHFFFAOYNA-N",
                         "name" : "Carbamazepine 10,11-epoxide",
                    "structure" : "[H]N([H])C(=O)N1C2=C([H])C([H])=C([H])C([H])=C2C2OC2C2=C([H])C([H])=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0173" : {
                             "Name" : "carbamazepine",
            "Substrate's structure" : "N(C(=O)N1C2=C(C(=C(C(=C2C(=C(C3=C(C(=C(C(=C13)[H])[H])[H])[H])[H])[H])[H])[H])[H])[H])([H])[H]",
                         "InChIKey" : "FFGPTBGBLSHEPO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP3A4; CYP2C8",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Panesar, S. K., Bandiera, S. M., Abbott, F. S. (1996). Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat. Drug Metab. Dispos. 24:619���627"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0169",
                     "inchikey" : "VPZIYMMSJFWLSP-UHFFFAOYSA-N",
                         "name" : "2-Hydroxycarbamazepine",
                    "structure" : "[H]N([H])C(=O)N1C2=C([H])C([H])=C([H])C([H])=C2C=CC2=C([H])C(O)=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0174" : {
                             "Name" : "carbamazepine",
            "Substrate's structure" : "N(C(=O)N1C2=C(C(=C(C(=C2C(=C(C3=C(C(=C(C(=C13)[H])[H])[H])[H])[H])[H])[H])[H])[H])[H])([H])[H]",
                         "InChIKey" : "FFGPTBGBLSHEPO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP3A4; CYP2C8 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Panesar, S. K., Bandiera, S. M., Abbott, F. S. (1996). Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat. Drug Metab. Dispos. 24:619���628"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0170",
                     "inchikey" : "QQCFBZCATDIWTH-UHFFFAOYSA-N",
                         "name" : "3-Hydroxycarbamazepine",
                    "structure" : "[H]N([H])C(=O)N1C2=C([H])C([H])=C([H])C([H])=C2C=CC2=C([H])C([H])=C(O)C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0175" : {
                             "Name" : "carbamazepine",
            "Substrate's structure" : "N(C(=O)N1C2=C(C(=C(C(=C2C(=C(C3=C(C(=C(C(=C13)[H])[H])[H])[H])[H])[H])[H])[H])[H])[H])([H])[H]",
                         "InChIKey" : "FFGPTBGBLSHEPO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP3A4; CYP2C8 ",
                       "References" : [
                "Panesar, S. K. et al. (1996). Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat. Drug Metab. Dispos. 24:619���628"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0171",
                     "inchikey" : "YKHJWQHRLUVWBR-UHFFFAOYSA-N",
                         "name" : "9-Hydroxycarbamazepine",
                    "structure" : "[H]N([H])C(=O)N1C2=C([H])C([H])=C([H])C([H])=C2C=CC2=C(O)C([H])=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0176" : {
                             "Name" : "Carbofuran",
            "Substrate's structure" : "CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2",
                         "InChIKey" : "DUEPRVBVGDRKAG-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C19; CYP3A4",
                       "References" : [
                "Abass, K. et al. (2010). Metabolism of carbosulfan II. Human interindividual variability in its in vitro hepatic biotransformation and the identification of the cytochrome P450 isoforms involved. Chem. Biol. Interact., Vol. 185, No. 3, (163-173)."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0172",
                     "inchikey" : "RHSUJRQZTQNSLL-UHFFFAOYNA-N",
                         "name" : "e-hydroxy-carbofuran",
                    "structure" : "CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0177" : {
                             "Name" : "celecoxib",
            "Substrate's structure" : "C(C1=C(C(=C(C(=C1[H])[H])C2=C(C(=NN2C3=C(C(=C(C(=C3[H])[H])S(N([H])[H])(=O)=O)[H])[H])C(F)(F)F)[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "RZEKVGVHFLEQIL-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 (major); CYP3A4 (minor); CYP2C19 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Karjalainen, M. (2008), Blackwell Publishing Ltd In vitro Inhibition of CYP1A2 by Model Inhibitors, Anti-Inflammatory Analgesics and Female Sex Steroids: Predictability of in vivo Interactions; Doi: 10.1111/j.1742-7843.2008.00252.x",
                "Werner, U. ( 2003);Celecoxib inhibits metabolism ofcytochrome P450 2D6 substratemetoprolol in humans; (2003), DOI:10.1016/S0009-9236(03)00120-6"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0173",
                     "inchikey" : "ICRSYPPLGADZKA-UHFFFAOYSA-N",
                         "name" : "Hydroxy celecoxib",
                    "structure" : "NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(CO)C=C1)C(F)(F)F"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0178" : {
                             "Name" : "Seratrodast",
            "Substrate's structure" : "[C@@](C=1C(=C(C(=C(C1[H])[H])[H])[H])[H])(C2=C(C(=O)C(=C(C2=O)C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])(C(C(C(C(C(C(O[H])=O)([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "ZBVKEHDGYSLCCC-SFHVURJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP2C9; CYP2C8; CYP3A4; CYP2B6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0174",
                     "inchikey" : "AQWOADAKGYZHIB-KRWDZBQOSA-N",
                         "name" : "5-OH-seratrodast",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C(C(=O)C(=C(C1=O)C([H])([H])[H])C([H])([H])O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0179" : {
                             "Name" : "Seratrodast",
            "Substrate's structure" : "[C@@](C=1C(=C(C(=C(C1[H])[H])[H])[H])[H])(C2=C(C(=O)C(=C(C2=O)C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])(C(C(C(C(C(C(O[H])=O)([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "ZBVKEHDGYSLCCC-SFHVURJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP2C9; CYP2C8",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0175",
                     "inchikey" : "RCTPAQGTCLHAJU-SFHVURJKSA-N",
                         "name" : "4'-OH-seratrodast",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C1=C([H])C([H])=C(O[H])C([H])=C1[H])C1=C(C(=O)C(=C(C1=O)C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0180" : {
                             "Name" : "chlorpromazine",
            "Substrate's structure" : "C(N(C([H])([H])[H])C(C(C(N1C2=C(C(=C(C(=C2SC3=C1C(=C(Cl)C(=C3[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "ZPEIMTDSQAKGNT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0176",
                     "inchikey" : "HICFFJZGXWEIHN-UHFFFAOYSA-N",
                         "name" : "7-Hydroxychlorpromazine",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1Cl)N(C1=C([H])C([H])=C(O)C([H])=C1S2)C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0181" : {
                             "Name" : "chlorpromazine",
            "Substrate's structure" : "C(N(C([H])([H])[H])C(C(C(N1C2=C(C(=C(C(=C2SC3=C1C(=C(Cl)C(=C3[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "ZPEIMTDSQAKGNT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0177",
                     "inchikey" : "QEPPAOXKZOTMPM-UHFFFAOYNA-N",
                         "name" : "Chlorpromazine S-oxide",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N(C1=C(C([H])=C([H])C(Cl)=C1[H])S2=O)C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0182" : {
                             "Name" : "chlorpromazine",
            "Substrate's structure" : "C(N(C([H])([H])[H])C(C(C(N1C2=C(C(=C(C(=C2SC3=C1C(=C(Cl)C(=C3[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "ZPEIMTDSQAKGNT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Zanger, U.M. and Schwab, M.; Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation; Pharmacology & Therapeutics 138 (2013) 103���141; PMID:23333322"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0178",
                     "inchikey" : "YHFXGBOUSIKGMZ-UHFFFAOYSA-N",
                         "name" : "Chlorpromazine, N-desmethyl",
                    "structure" : "[H]C1=C([H])C([H])=C2N(C3=C(SC2=C1[H])C([H])=C([H])C(Cl)=C3[H])C([H])([H])C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0183" : {
                             "Name" : "chlorpropamide",
            "Substrate's structure" : "C1(S(N(C(N(C(C(C([H])([H])[H])([H])[H])([H])[H])[H])=O)[H])(=O)=O)=C(C(=C(C(=C1[H])[H])Cl)[H])[H]",
                         "InChIKey" : "RKWGIWYCVPQPMF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 (major); CYP2C19 (minor); CYP2C8 (minor); CYP1A2 (minor); CYP3A4 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Shon, J. (2004), Chlorpropamide 2 hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism, British Journal of Clinical Pharmacology; DOI:10.1111/j.1365-2125.2005.02364.x"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0179",
                     "inchikey" : "QRXRPQPWKRLTQX-UHFFFAOYSA-N",
                         "name" : "2-OH-chlorpropamide",
                    "structure" : "CCCNC(=O)NS(=O)(=O)C1=C(O)C=C(Cl)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0184" : {
                             "Name" : "chlorpropamide",
            "Substrate's structure" : "C1(S(N(C(N(C(C(C([H])([H])[H])([H])[H])([H])[H])[H])=O)[H])(=O)=O)=C(C(=C(C(=C1[H])[H])Cl)[H])[H]",
                         "InChIKey" : "RKWGIWYCVPQPMF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Shon, J. (2004), Chlorpropamide 2 hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism, British Journal of Clinical Pharmacology; DOI:10.1111/j.1365-2125.2005.02364.x"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0180",
                     "inchikey" : "RXFPYNAVFFDUJE-UHFFFAOYSA-N",
                         "name" : "3-OH-chlorpropamide",
                    "structure" : "CCCNC(=O)NS(=O)(=O)C1=CC(O)=C(Cl)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0185" : {
                             "Name" : "chlorpropamide",
            "Substrate's structure" : "C1(S(N(C(N(C(C(C([H])([H])[H])([H])[H])([H])[H])[H])=O)[H])(=O)=O)=C(C(=C(C(=C1[H])[H])Cl)[H])[H]",
                         "InChIKey" : "RKWGIWYCVPQPMF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Shon, J. (2004), Chlorpropamide 2 hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism, British Journal of Clinical Pharmacology; DOI:10.1111/j.1365-2125.2005.02364.x"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0181",
                     "inchikey" : "AZEPYUPSYWCRBG-UHFFFAOYSA-N",
                         "name" : "p-Chlorobenzene sulfonylurea",
                    "structure" : "NC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0186" : {
                             "Name" : "Chlorpyrifos",
            "Substrate's structure" : "[H]C1=C(Cl)C(OP(=S)(OC([H])([H])C([H])([H])[H])OC([H])([H])C([H])([H])[H])=NC(Cl)=C1Cl",
                         "InChIKey" : "SBPBAQFWLVIOKP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP2B6; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0182",
                     "inchikey" : "WCYYAQFQZQEUEN-UHFFFAOYSA-N",
                         "name" : "3,5,6-Trichloro-2-pyridinol",
                    "structure" : "OC1=NC(Cl)=C(Cl)C=C1Cl"
                }
            ],
                    "Reaction Type" : [
                "Dearylation"
            ]
        },
        "BIOTID0187" : {
                             "Name" : "Chlorpyrifos",
            "Substrate's structure" : "[H]C1=C(Cl)C(OP(=S)(OC([H])([H])C([H])([H])[H])OC([H])([H])C([H])([H])[H])=NC(Cl)=C1Cl",
                         "InChIKey" : "SBPBAQFWLVIOKP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP2B6; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0183",
                     "inchikey" : "UCQFCFPECQILOL-UHFFFAOYSA-N",
                         "name" : "Diethyl phosphorothioate",
                    "structure" : "CCOP(O)(=O)OCC"
                }
            ],
                    "Reaction Type" : [
                "Dearylation"
            ]
        },
        "BIOTID0188" : {
                             "Name" : "Chlorpyrifos",
            "Substrate's structure" : "[H]C1=C(Cl)C(OP(=S)(OC([H])([H])C([H])([H])[H])OC([H])([H])C([H])([H])[H])=NC(Cl)=C1Cl",
                         "InChIKey" : "SBPBAQFWLVIOKP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2B6; CYP2C8; CYP2C9; CYP2C19; CYP2D6; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0184",
                     "inchikey" : "OTMOUPHCTWPNSL-UHFFFAOYSA-N",
                         "name" : "Chlorpyrifos-oxon",
                    "structure" : "CCOP(=O)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl"
                }
            ],
                    "Reaction Type" : [
                "Desulfurization"
            ]
        },
        "BIOTID0189" : {
                             "Name" : "chlorzoxazone",
            "Substrate's structure" : "ClC1=C(C2=C(OC(=O)N2[H])C(=C1[H])[H])[H]",
                         "InChIKey" : "TZFWDZFKRBELIQ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1; CYP1A2; CYP1A1; CYP2A6; CYP2D6; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0185",
                     "inchikey" : "AGLXDWOTVQZHIQ-UHFFFAOYSA-N",
                         "name" : "6-Hydroxychlorzoxazone",
                    "structure" : "[H]N1C(=O)OC2=C1C([H])=C(Cl)C(O)=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0190" : {
                             "Name" : "cinnarizine",
            "Substrate's structure" : "C=1(/C(=C(/C(N2C(C(N(C(C=3C(=C(C(=C(C3[H])[H])[H])[H])[H])(C=4C(=C(C(=C(C4[H])[H])[H])[H])[H])[H])C(C2([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])\\[H])/[H])C(=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "DERZBLKQOCDDDZ-JLHYYAGUSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0186",
                     "inchikey" : "UQMAKWWGLMGUQQ-JXMROGBWNA-N",
                         "name" : "4-{phenyl[4-(3-phenylprop-2-en-1-yl)piperazin-1-yl]methyl}phenol",
                    "structure" : "[H]\\C(=C(\\[H])C([H])([H])N1C([H])([H])C([H])([H])N(C([H])([H])C1([H])[H])C([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C(O)C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0191" : {
                             "Name" : "cinnarizine",
            "Substrate's structure" : "C=1(/C(=C(/C(N2C(C(N(C(C=3C(=C(C(=C(C3[H])[H])[H])[H])[H])(C=4C(=C(C(=C(C4[H])[H])[H])[H])[H])[H])C(C2([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])\\[H])/[H])C(=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "DERZBLKQOCDDDZ-JLHYYAGUSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0187",
                     "inchikey" : "QFWMZESBHJUDQQ-BQYQJAHWSA-N",
                         "name" : "4-{3-[4-(diphenylmethyl)piperazin-1-yl]prop-1-en-1-yl}phenol",
                    "structure" : "[H]\\C(=C(\\[H])C([H])([H])N1C([H])([H])C([H])([H])N(C([H])([H])C1([H])[H])C([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C(O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0192" : {
                             "Name" : "cinnarizine",
            "Substrate's structure" : "C=1(/C(=C(/C(N2C(C(N(C(C=3C(=C(C(=C(C3[H])[H])[H])[H])[H])(C=4C(=C(C(=C(C4[H])[H])[H])[H])[H])[H])C(C2([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])\\[H])/[H])C(=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "DERZBLKQOCDDDZ-JLHYYAGUSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "70048",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP1A2; CYP2A6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0188",
                     "inchikey" : "NWVNXDKZIQLBNM-UHFFFAOYSA-N",
                         "name" : "1-Benzhydrylpiperazine",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(N1C([H])([H])C([H])([H])NC([H])([H])C1([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                },
                {
                     "BTMDB_ID" : "BTMDB0188",
                     "inchikey" : "NWVNXDKZIQLBNM-UHFFFAOYSA-N",
                         "name" : "1-Benzhydrylpiperazine",
                    "structure" : "O=C\\C=C\\C1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0193" : {
                             "Name" : "cinnarizine",
            "Substrate's structure" : "C=1(/C(=C(/C(N2C(C(N(C(C=3C(=C(C(=C(C3[H])[H])[H])[H])[H])(C=4C(=C(C(=C(C4[H])[H])[H])[H])[H])[H])C(C2([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])\\[H])/[H])C(=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "DERZBLKQOCDDDZ-JLHYYAGUSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "3102",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP1A2; CYP2A6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0189",
                     "inchikey" : "RWCCWEUUXYIKHB-UHFFFAOYSA-N",
                         "name" : "Benzophenone",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H]"
                },
                {
                     "BTMDB_ID" : "BTMDB0189",
                     "inchikey" : "RWCCWEUUXYIKHB-UHFFFAOYSA-N",
                         "name" : "Benzophenone",
                    "structure" : "[H]\\C(=C(\\[H])C([H])([H])N1C([H])([H])C([H])([H])NC([H])([H])C1([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Hydrolysis",
                "N-dealkylation"
            ]
        },
        "BIOTID0194" : {
                             "Name" : "cisapride",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])[H])F)[H])[H])OC(C(C(N2C(C([C@@]([C@@](C2([H])[H])(OC([H])([H])[H])[H])(N(C(=O)C=3C(=C(C(=C(C3[H])Cl)N([H])[H])[H])OC([H])([H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "DCSUBABJRXZOMT-RBBKRZOGSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C8; CYP2B6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0190",
                     "inchikey" : "OMLDMGPCWMBPAN-WCQYABFASA-N",
                         "name" : "Norcisapride",
                    "structure" : "[H]N([H])C1=C(Cl)C([H])=C(C(=O)N([H])[C@@]2([H])C([H])([H])C([H])([H])NC([H])([H])[C@@]2([H])OC([H])([H])[H])C(OC([H])([H])[H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0195" : {
                             "Name" : "cisapride",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])[H])F)[H])[H])OC(C(C(N2C(C([C@@]([C@@](C2([H])[H])(OC([H])([H])[H])[H])(N(C(=O)C=3C(=C(C(=C(C3[H])Cl)N([H])[H])[H])OC([H])([H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "DCSUBABJRXZOMT-RBBKRZOGSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C8; CYP2B6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0191",
                     "inchikey" : "JUKZPSFOMPCDJN-UHFFFAOYSA-N",
                         "name" : "3-(4-fluorophenoxy)propanal",
                    "structure" : "[H]C(=O)C([H])([H])C([H])([H])OC1=C([H])C([H])=C(F)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0196" : {
                             "Name" : "cisapride",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])[H])F)[H])[H])OC(C(C(N2C(C([C@@]([C@@](C2([H])[H])(OC([H])([H])[H])[H])(N(C(=O)C=3C(=C(C(=C(C3[H])Cl)N([H])[H])[H])OC([H])([H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "DCSUBABJRXZOMT-RBBKRZOGSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0192",
                     "inchikey" : "JXFYESHHMRUHOT-SIKLNZKXSA-N",
                         "name" : "3-Fluoro-4-hydroxycisapride",
                    "structure" : "[H]N([H])C1=C(Cl)C([H])=C(C(=O)N([H])[C@@]2([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])OC3=C([H])C(F)=C(O)C([H])=C3[H])C([H])([H])[C@@]2([H])OC([H])([H])[H])C(OC([H])([H])[H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0197" : {
                             "Name" : "cisapride",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])[H])F)[H])[H])OC(C(C(N2C(C([C@@]([C@@](C2([H])[H])(OC([H])([H])[H])[H])(N(C(=O)C=3C(=C(C(=C(C3[H])Cl)N([H])[H])[H])OC([H])([H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "DCSUBABJRXZOMT-RBBKRZOGSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0193",
                     "inchikey" : "FNNZAZYOQRBQAC-PGRDOPGGSA-N",
                         "name" : "4-Fluoro-2- hydroxycisapride",
                    "structure" : "[H]N([H])C1=C(Cl)C([H])=C(C(=O)N([H])[C@@]2([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])OC3=C(O)C([H])=C(F)C([H])=C3[H])C([H])([H])[C@@]2([H])OC([H])([H])[H])C(OC([H])([H])[H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0198" : {
                             "Name" : "(+-)-Cisapride",
            "Substrate's structure" : "[H]N([H])C1=C(Cl)C([H])=C(C(=O)N([H])C2([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])OC3=C([H])C([H])=C(F)C([H])=C3[H])C([H])([H])C2([H])OC([H])([H])[H])C(OC([H])([H])[H])=C1[H]",
                         "InChIKey" : "DCSUBABJRXZOMT-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C8; CYP2B6 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0194",
                     "inchikey" : "OMLDMGPCWMBPAN-UHFFFAOYNA-N",
                         "name" : "Norcisapride",
                    "structure" : "[H]N([H])C1=C(Cl)C([H])=C(C(=O)N([H])C2([H])C([H])([H])C([H])([H])N([H])C([H])([H])C2([H])OC([H])([H])[H])C(OC([H])([H])[H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0199" : {
                             "Name" : "(+-)-Cisapride",
            "Substrate's structure" : "[H]N([H])C1=C(Cl)C([H])=C(C(=O)N([H])C2([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])OC3=C([H])C([H])=C(F)C([H])=C3[H])C([H])([H])C2([H])OC([H])([H])[H])C(OC([H])([H])[H])=C1[H]",
                         "InChIKey" : "DCSUBABJRXZOMT-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0195",
                     "inchikey" : "JXFYESHHMRUHOT-UHFFFAOYNA-N",
                         "name" : "3-Fluoro-4-hydroxycisapride",
                    "structure" : "COC1CN(CCCOC2=CC(F)=C(O)C=C2)CCC1NC(=O)C1=CC(Cl)=C(N)C=C1OC"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0200" : {
                             "Name" : "(+-)-Cisapride",
            "Substrate's structure" : "[H]N([H])C1=C(Cl)C([H])=C(C(=O)N([H])C2([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])OC3=C([H])C([H])=C(F)C([H])=C3[H])C([H])([H])C2([H])OC([H])([H])[H])C(OC([H])([H])[H])=C1[H]",
                         "InChIKey" : "DCSUBABJRXZOMT-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0196",
                     "inchikey" : "FNNZAZYOQRBQAC-UHFFFAOYNA-N",
                         "name" : "4-Fluoro-2-hydroxycisapride",
                    "structure" : "COC1CN(CCCOC2=C(O)C=C(F)C=C2)CCC1NC(=O)C1=CC(Cl)=C(N)C=C1OC"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0201" : {
                             "Name" : "clomipramine",
            "Substrate's structure" : "C(N(C([H])([H])[H])C(C(C(N1C2=C(C(=C(C(=C2C(C(C3=C1C(=C(Cl)C(=C3[H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "GDLIGKIOYRNHDA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0197",
                     "inchikey" : "QXZNSJJZRXNDJQ-UHFFFAOYSA-N",
                         "name" : "2-OH-clomipramine",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N(C1=C(C([H])=C(O)C(Cl)=C1[H])C([H])([H])C2([H])[H])C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0202" : {
                             "Name" : "clomipramine",
            "Substrate's structure" : "C(N(C([H])([H])[H])C(C(C(N1C2=C(C(=C(C(=C2C(C(C3=C1C(=C(Cl)C(=C3[H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "GDLIGKIOYRNHDA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0198",
                     "inchikey" : "INPXEQNHQVLPFN-UHFFFAOYSA-N",
                         "name" : "8-OH-clomipramine",
                    "structure" : "[H]C1=C([H])C(O)=C2C(=C1[H])N(C1=C(C([H])=C([H])C(Cl)=C1[H])C([H])([H])C2([H])[H])C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0203" : {
                             "Name" : "clomipramine",
            "Substrate's structure" : "C(N(C([H])([H])[H])C(C(C(N1C2=C(C(=C(C(=C2C(C(C3=C1C(=C(Cl)C(=C3[H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "GDLIGKIOYRNHDA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP3A4; CYP1A2",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0199",
                     "inchikey" : "VPIXQGUBUKFLRF-UHFFFAOYSA-N",
                         "name" : "N-Desmethylclomipramine",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N(C1=C(C([H])=C([H])C(Cl)=C1[H])C([H])([H])C2([H])[H])C([H])([H])C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0204" : {
                             "Name" : "clomipramine",
            "Substrate's structure" : "C(N(C([H])([H])[H])C(C(C(N1C2=C(C(=C(C(=C2C(C(C3=C1C(=C(Cl)C(=C3[H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "GDLIGKIOYRNHDA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0200",
                     "inchikey" : "OVNBDHJPQNLBSY-UHFFFAOYNA-N",
                         "name" : "10-OH-clomipramine",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N(C1=C(C([H])=C([H])C(Cl)=C1[H])C([H])([H])C2([H])O)C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0205" : {
                             "Name" : "clozapine",
            "Substrate's structure" : "C(N1C(C(N(C(C1([H])[H])([H])[H])C2=NC3=C(C(Cl)=C(C(=C3N(C4=C(C(=C(C(=C24)[H])[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "QZUDBNBUXVUHMW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A4; CYP2D6; CYP2C19; CYP2C8; CYP3A5; CYP2C9",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0201",
                     "inchikey" : "JNNOSTQEZICQQP-UHFFFAOYSA-N",
                         "name" : "N-Desmethylclozapine",
                    "structure" : "[H]N1C2=C([H])C([H])=C(Cl)C([H])=C2N=C(N2C([H])([H])C([H])([H])NC([H])([H])C2([H])[H])C2=C([H])C([H])=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0206" : {
                             "Name" : "clozapine",
            "Substrate's structure" : "C(N1C(C(N(C(C1([H])[H])([H])[H])C2=NC3=C(C(Cl)=C(C(=C3N(C4=C(C(=C(C(=C24)[H])[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "QZUDBNBUXVUHMW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP1A2; CYP2C8; CYP2C19; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0202",
                     "inchikey" : "OGUCZBIQSYYWEF-UHFFFAOYSA-N",
                         "name" : "Clozapine-N-oxide",
                    "structure" : "[H]N1C2=C([H])C([H])=C(Cl)C([H])=C2N=C(N2C([H])([H])C([H])([H])[N+]([O-])(C([H])([H])[H])C([H])([H])C2([H])[H])C2=C([H])C([H])=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0207" : {
                             "Name" : "codeine",
            "Substrate's structure" : "[H][C@@]12OC3=C(OC([H])([H])[H])C(=C(C4=C3[C@@]15C(C(N(C([H])([H])[H])[C@]([H])(C4([H])[H])[C@]5([H])C(=C([C@@]2(O[H])[H])[H])[H])([H])[H])([H])[H])[H])[H]",
                         "InChIKey" : "OROGSEYTTFOCAN-DNJOTXNNSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Caraco, Y et al. (1996); Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity; Drug Metab Dispos. 1996 Jul;24(7):761-4"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0203",
                     "inchikey" : "BQJCRHHNABKAKU-KBQPJGBKSA-N",
                         "name" : "morphine",
                    "structure" : "[H]O[C@@]1([H])C([H])=C([H])[C@@]2([H])[C@]3([H])N(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]22C4=C(C([H])=C([H])C(O)=C4O[C@@]12[H])C3([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0208" : {
                             "Name" : "codeine",
            "Substrate's structure" : "[H][C@@]12OC3=C(OC([H])([H])[H])C(=C(C4=C3[C@@]15C(C(N(C([H])([H])[H])[C@]([H])(C4([H])[H])[C@]5([H])C(=C([C@@]2(O[H])[H])[H])[H])([H])[H])([H])[H])[H])[H]",
                         "InChIKey" : "OROGSEYTTFOCAN-DNJOTXNNSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Caraco, Y et al. (1996); Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity; Drug Metab Dispos. 1996 Jul;24(7):761-4"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0204",
                     "inchikey" : "HKOIXWVRNLGFOR-KOFBORESSA-N",
                         "name" : "norcodeine",
                    "structure" : "[H]O[C@@]1([H])C([H])=C([H])[C@@]2([H])[C@]3([H])NC([H])([H])C([H])([H])[C@@]22C4=C(C([H])=C([H])C(OC([H])([H])[H])=C4O[C@@]12[H])C3([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0209" : {
                             "Name" : "cotinine",
            "Substrate's structure" : "C=1(N=C(C([C@]2(N(C([H])([H])[H])C(=O)C(C2([H])[H])([H])[H])[H])=C(C1[H])[H])[H])[H]",
                         "InChIKey" : "UIKROCXWUNQSPJ-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6",
                       "References" : [
                "Oscarson, M; (2001); Genetic Polymorphisms in the Cytochrome P450 2A6 (CYP2A6) Gene: Implications for Interindividual Differences in Nicotine Metabolism; Drug Metabolism and Disposition;  February 2001, 29 (2) 91-95; DMD 29:91���95, 200"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0205",
                     "inchikey" : "XOKCJXZZNAUIQN-IENPIDJESA-N",
                         "name" : "trans-3'-hydroxycotinine",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=N1)[C@@]1([H])N(C(=O)C([H])(O)C1([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0210" : {
                             "Name" : "cotinine",
            "Substrate's structure" : "C=1(N=C(C([C@]2(N(C([H])([H])[H])C(=O)C(C2([H])[H])([H])[H])[H])=C(C1[H])[H])[H])[H]",
                         "InChIKey" : "UIKROCXWUNQSPJ-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6",
                       "References" : [
                "Oscarson, M; (2001); Genetic Polymorphisms in the Cytochrome P450 2A6 (CYP2A6) Gene: Implications for Interindividual Differences in Nicotine Metabolism; Drug Metabolism and Disposition;  February 2001, 29 (2) 91-95; DMD 29:91���95, 200"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0206",
                     "inchikey" : "FXFANIORDKRCCA-QMMMGPOBSA-N",
                         "name" : "Norcotinine",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=N1)[C@@]1([H])NC(=O)C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0211" : {
                             "Name" : "cotinine",
            "Substrate's structure" : "C=1(N=C(C([C@]2(N(C([H])([H])[H])C(=O)C(C2([H])[H])([H])[H])[H])=C(C1[H])[H])[H])[H]",
                         "InChIKey" : "UIKROCXWUNQSPJ-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6",
                       "References" : [
                "Oscarson, M; (2001); Genetic Polymorphisms in the Cytochrome P450 2A6 (CYP2A6) Gene: Implications for Interindividual Differences in Nicotine Metabolism; Drug Metabolism and Disposition;  February 2001, 29 (2) 91-95; DMD 29:91���95, 200"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0207",
                     "inchikey" : "BBNHNZGTKSWIHD-SNVBAGLBSA-N",
                         "name" : "5'-hydroxycotinine",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=N1)[C@@]1(O)N(C)C(=O)C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0212" : {
                             "Name" : "coumarin",
            "Substrate's structure" : "C=12C(=C(C(=C(C1C(=C(C(=O)O2)[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "ZYGHJZDHTFUPRJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP2B6; CYP1A1; CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Ekins, S. and Wrighton, S.A. (1999); The role of CYP2B6 in Human Xenobiotic Metabolism; Drug Metabolism Reviews, 31:3, 719-754, DOI:10.1081/ DMR-100101942; PMID:10461547",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0208",
                     "inchikey" : "ORHBXUUXSCNDEV-UHFFFAOYSA-N",
                         "name" : "7-Hydroxycoumarin",
                    "structure" : "[H]C1=C([H])C2=C(OC1=O)C([H])=C(O)C([H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0213" : {
                             "Name" : "coumarin",
            "Substrate's structure" : "C=12C(=C(C(=C(C1C(=C(C(=O)O2)[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "ZYGHJZDHTFUPRJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Born, S.L. et al. (2002); Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation; Drug Metab Dispos; 30(5):483-7; PMID:11950775; DOI:https://doi.org/10.1124/dmd.30.5.483"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0209",
                     "inchikey" : "MJKVTPMWOKAVMS-UHFFFAOYSA-N",
                         "name" : "3-Hydroxycoumarin",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])C([H])=C(O)C(=O)O2"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0214" : {
                             "Name" : "coumarin",
            "Substrate's structure" : "C=12C(=C(C(=C(C1C(=C(C(=O)O2)[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "ZYGHJZDHTFUPRJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2E1",
                       "References" : [
                "Born, S.L. et al. (2002); Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation; Drug Metab Dispos; 30(5):483-7; PMID:11950775; DOI:https://doi.org/10.1124/dmd.30.5.483"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0210",
                     "inchikey" : "YGDJSRSAEUNWRE-UHFFFAOYNA-N",
                         "name" : "Coumarin 3,4-epoxide",
                    "structure" : "[H]C1=C([H])C2=C(C3OC3C(=O)O2)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0215" : {
                             "Name" : "curcumin",
            "Substrate's structure" : "C=1(C(=C(C(=C(\\C(=C(\\C(C(C(/C(=C(/C=2C(=C(C(=C(C2[H])[H])O[H])OC([H])([H])[H])[H])\\[H])/[H])=O)([H])[H])=O)/[H])\\[H])C1[H])[H])[H])O[H])OC([H])([H])[H]",
                         "InChIKey" : "VFLDPWHFBUODDF-FCXRPNKRSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0211",
                     "inchikey" : "FFRFJIZJLZXEJX-YPCIICBESA-N",
                         "name" : "O-demethyl curcumin",
                    "structure" : "[H]OC1=C([H])C([H])=C(\\C([H])=C(/[H])C(=O)C([H])([H])C(=O)C(\\[H])=C(/[H])C2=C([H])C([H])=C(O[H])C(OC([H])([H])[H])=C2[H])C([H])=C1O"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0216" : {
                             "Name" : "cyclobenzaprine",
            "Substrate's structure" : "C=1(C(=C(C2=C(C1[H])C(C3=C(C(=C2[H])[H])C(=C(C(=C3[H])[H])[H])[H])=C(C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "JURKNVYFZMSNLP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (major); CYP3A4 (major); CYP2D6 (minor)",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0212",
                     "inchikey" : "XECQQDXTQRYYBH-UHFFFAOYSA-N",
                         "name" : "N-Desmethylcyclobenzaprine",
                    "structure" : "[H]C(=C1C2=C(C([H])=C([H])C([H])=C2[H])C([H])=C([H])C2=C1C([H])=C([H])C([H])=C2[H])C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0217" : {
                             "Name" : "dapsone",
            "Substrate's structure" : "N(C=1C(=C(C(=C(C1[H])[H])S(C=2C(=C(C(N([H])[H])=C(C2[H])[H])[H])[H])(=O)=O)[H])[H])([H])[H]",
                         "InChIKey" : "MQJKPEGWNLWLTK-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1; CYP3A4; CYP2C9; CYP2C8",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Winter HR, Wang Y, Unadkat JD (2000); CYP2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone; Drug Metab Dispos. 2000 Aug;28(8):865-8, PMID: 10901692"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0213",
                     "inchikey" : "IYDSJDWESCGRKW-UHFFFAOYSA-N",
                         "name" : "N-Hydroxydapsone",
                    "structure" : "[H]N([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)C1=C([H])C([H])=C(N([H])O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0218" : {
                             "Name" : "debrisoquine",
            "Substrate's structure" : "C12=C(C(C(N(C1([H])[H])C(N([H])[H])=N[H])([H])[H])([H])[H])C(=C(C(=C2[H])[H])[H])[H]",
                         "InChIKey" : "JWPGJSVJDAJRLW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0214",
                     "inchikey" : "AKFURXZANOMQBD-UHFFFAOYNA-N",
                         "name" : "4-Hydroxydebrisoquine",
                    "structure" : "NC(=N)N1CC(O)C2=CC=CC=C2C1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0219" : {
                             "Name" : "desmethylcitalopram",
            "Substrate's structure" : "CNCCCC1(OCC2=CC(=CC=C12)C#N)C1=CC=C(F)C=C1",
                         "InChIKey" : "DYIZNULSIBGJPJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0215",
                     "inchikey" : "RKUKMUWCRLRPEJ-UHFFFAOYNA-N",
                         "name" : "N,N-Didesmethylcitalopram",
                    "structure" : "NCCCC1(OCC2=CC(=CC=C12)C#N)C1=CC=C(F)C=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0220" : {
                             "Name" : "desogestrel",
            "Substrate's structure" : "[C@]12([C@]([C@]3([C@](C(C1([H])[H])=C([H])[H])([C@@]4(C(C(C3([H])[H])([H])[H])=C(C(C(C4([H])[H])([H])[H])([H])[H])[H])[H])[H])[H])(C(C([C@]2(C#C[H])O[H])([H])[H])([H])[H])[H])C(C([H])([H])[H])([H])[H]",
                         "InChIKey" : "RPLCPCMSCLEKRS-BPIQYHPVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0216",
                     "inchikey" : "ZMLDTNLDYRJTAZ-JASYKLOUSA-N",
                         "name" : "3-alpha-OH-desogestrel",
                    "structure" : "[H]O[C@@]1(C#C[H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])[C@]([H])(O)C([H])([H])C([H])([H])[C@]4([H])[C@@]3([H])C(=C([H])[H])C([H])([H])[C@]12C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0221" : {
                             "Name" : "desogestrel",
            "Substrate's structure" : "[C@]12([C@]([C@]3([C@](C(C1([H])[H])=C([H])[H])([C@@]4(C(C(C3([H])[H])([H])[H])=C(C(C(C4([H])[H])([H])[H])([H])[H])[H])[H])[H])[H])(C(C([C@]2(C#C[H])O[H])([H])[H])([H])[H])[H])C(C([H])([H])[H])([H])[H]",
                         "InChIKey" : "RPLCPCMSCLEKRS-BPIQYHPVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0217",
                     "inchikey" : "ZMLDTNLDYRJTAZ-GDLCRWSOSA-N",
                         "name" : "3-beta-OH-desogestrel",
                    "structure" : "[H]O[C@@]1(C#C[H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])[C@@]([H])(O)C([H])([H])C([H])([H])[C@]4([H])[C@@]3([H])C(=C([H])[H])C([H])([H])[C@]12C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0222" : {
                             "Name" : "dexamethasone",
            "Substrate's structure" : "[H][C@@]12C([C@@](C([H])([H])[H])([C@](O[H])(C(=O)C(O[H])([H])[H])[C@@]1(C([H])([H])[H])C([C@](O[H])([C@@]3(F)[C@@]2([H])C(C(C4=C(C(=O)C(=C([C@]34C([H])([H])[H])[H])[H])[H])([H])[H])([H])[H])[H])([H])[H])[H])([H])[H]",
                         "InChIKey" : "UREBDLICKHMUKA-CXSFZGCWSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Daniela, M. (1995); DexamethasoneMetabolismby Human Liverin Vitro.Metabolite Identificationand Inhibitionof 6-Hydroxylation; Department of Pharmacology & Therapeutics, University of Liverpool; 0022-3565/96/2771-0105$"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0218",
                     "inchikey" : "RVBSTEHLLHXILB-GQKYHHCASA-N",
                         "name" : "6-alpha-OH DEXAMETHASONE",
                    "structure" : "[H]OC([H])([H])C(=O)[C@@]1(O[H])[C@]([H])(C([H])([H])[H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])[C@]([H])(O)C4=C([H])C(=O)C([H])=C([H])[C@]4(C([H])([H])[H])[C@@]3(F)[C@@]([H])(O[H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0223" : {
                             "Name" : "dexamethasone",
            "Substrate's structure" : "[H][C@@]12C([C@@](C([H])([H])[H])([C@](O[H])(C(=O)C(O[H])([H])[H])[C@@]1(C([H])([H])[H])C([C@](O[H])([C@@]3(F)[C@@]2([H])C(C(C4=C(C(=O)C(=C([C@]34C([H])([H])[H])[H])[H])[H])([H])[H])([H])[H])[H])([H])[H])[H])([H])[H]",
                         "InChIKey" : "UREBDLICKHMUKA-CXSFZGCWSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Daniela, M. (1995); DexamethasoneMetabolismby Human Liverin Vitro.Metabolite Identificationand Inhibitionof 6-Hydroxylation; Department of Pharmacology & Therapeutics, University of Liverpool; 0022-3565/96/2771-0105$"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0219",
                     "inchikey" : "RVBSTEHLLHXILB-AWKJOQOESA-N",
                         "name" : "6-beta-OH DEXAMETHASONE",
                    "structure" : "[H]OC([H])([H])C(=O)[C@@]1(O[H])[C@]([H])(C([H])([H])[H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])(O)C4=C([H])C(=O)C([H])=C([H])[C@]4(C([H])([H])[H])[C@@]3(F)[C@@]([H])(O[H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0224" : {
                             "Name" : "dextromethorphan",
            "Substrate's structure" : "O(C1=C(C=2[C@]34[C@@]([C@@](N(C(C3([H])[H])([H])[H])C([H])([H])[H])(C(C2C(=C1[H])[H])([H])[H])[H])(C(C(C(C4([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])C([H])([H])[H]",
                         "InChIKey" : "MKXZASYAUGDDCJ-NJAFHUGGSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "5360697",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (major); CYP2C9 (minor); CYP3A4 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Yu, A. et al; (2001); COMPARATIVE CONTRIBUTION TO DEXTROMETHORPHAN METABOLISM BY CYTOCHROME P450 ISOFORMS IN VITRO: CAN DEXTROMETHORPHAN BE USED AS A DUAL PROBE FOR BOTH CYP2D6 AND CYP3A ACTIVITIES?; Drug metabolism and Disposition, 2001 Vol. 29, No. 11"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0220",
                     "inchikey" : "JAQUASYNZVUNQP-PVAVHDDUSA-N",
                         "name" : "Dextrorphan",
                    "structure" : "[H]OC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0225" : {
                             "Name" : "dextromethorphan",
            "Substrate's structure" : "O(C1=C(C=2[C@]34[C@@]([C@@](N(C(C3([H])[H])([H])[H])C([H])([H])[H])(C(C2C(=C1[H])[H])([H])[H])[H])(C(C(C(C4([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])C([H])([H])[H]",
                         "InChIKey" : "MKXZASYAUGDDCJ-NJAFHUGGSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "1671",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major); CYP2D6 (minor); CYP2C9 (minor); CYP2B6 (minor); CYP2C19 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Yu, A. et al; (2001); COMPARATIVE CONTRIBUTION TO DEXTROMETHORPHAN METABOLISM BY CYTOCHROME P450 ISOFORMS IN VITRO: CAN DEXTROMETHORPHAN BE USED AS A DUAL PROBE FOR BOTH CYP2D6 AND CYP3A ACTIVITIES?; Drug metabolism and Disposition, 2001 Vol. 29, No. 11"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0221",
                     "inchikey" : "ILNSWVUXAPSPEH-PVAVHDDUSA-N",
                         "name" : "3-methoxymorphinan",
                    "structure" : "COC1=CC2=C(C[C@@H]3NCC[C@]22CCCC[C@H]32)C=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0226" : {
                             "Name" : "dexverapamil",
            "Substrate's structure" : "O(C=1C(=C([C@](C(C([H])([H])[H])(C([H])([H])[H])[H])(C(C(C(N(C(C(C2=C(C(OC([H])([H])[H])=C(OC([H])([H])[H])C(=C2[H])[H])[H])([H])[H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])([H])[H])C#N)C(=C(C1OC([H])([H])[H])[H])[H])[H])C([H])([H])[H]",
                         "InChIKey" : "SGTNSNPWRIOYBX-HHHXNRCGSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP1A2; CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0222",
                     "inchikey" : "UPKQNCPKPOLASS-AREMUKBSSA-N",
                         "name" : "dexverapamil, N-demethyl",
                    "structure" : "[H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])C([H])([H])NC([H])([H])C([H])([H])C([H])([H])[C@](C#N)(C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1[H])C([H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0227" : {
                             "Name" : "dexverapamil",
            "Substrate's structure" : "O(C=1C(=C([C@](C(C([H])([H])[H])(C([H])([H])[H])[H])(C(C(C(N(C(C(C2=C(C(OC([H])([H])[H])=C(OC([H])([H])[H])C(=C2[H])[H])[H])([H])[H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])([H])[H])C#N)C(=C(C1OC([H])([H])[H])[H])[H])[H])C([H])([H])[H]",
                         "InChIKey" : "SGTNSNPWRIOYBX-HHHXNRCGSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0223",
                     "inchikey" : "WLKVZSXOMGNZLB-AREMUKBSSA-N",
                         "name" : "(2R)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(4-hydroxy-3-methoxyphenyl)-2-(propan-2-yl)pentanenitrile",
                    "structure" : "[H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1O)[C@@](C#N)(C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1[H])C([H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0228" : {
                             "Name" : "dexverapamil",
            "Substrate's structure" : "O(C=1C(=C([C@](C(C([H])([H])[H])(C([H])([H])[H])[H])(C(C(C(N(C(C(C2=C(C(OC([H])([H])[H])=C(OC([H])([H])[H])C(=C2[H])[H])[H])([H])[H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])([H])[H])C#N)C(=C(C1OC([H])([H])[H])[H])[H])[H])C([H])([H])[H]",
                         "InChIKey" : "SGTNSNPWRIOYBX-HHHXNRCGSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4; CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0154",
                     "inchikey" : "RIVVYJWUHXMGSK-UHFFFAOYSA-N",
                         "name" : "2-(3,4-dimethoxyphenyl)acetaldehyde",
                    "structure" : "[H]C(=O)C([H])([H])C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0229" : {
                             "Name" : "dexverapamil",
            "Substrate's structure" : "O(C=1C(=C([C@](C(C([H])([H])[H])(C([H])([H])[H])[H])(C(C(C(N(C(C(C2=C(C(OC([H])([H])[H])=C(OC([H])([H])[H])C(=C2[H])[H])[H])([H])[H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])([H])[H])C#N)C(=C(C1OC([H])([H])[H])[H])[H])[H])C([H])([H])[H]",
                         "InChIKey" : "SGTNSNPWRIOYBX-HHHXNRCGSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4; CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0224",
                     "inchikey" : "WLOBUUJURNEQCL-QGZVFWFLSA-N",
                         "name" : "(R)-D-617",
                    "structure" : "[H]N(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@](C#N)(C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1[H])C([H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0230" : {
                             "Name" : "diazepam",
            "Substrate's structure" : "C(N1C2=C(C(=C(Cl)C(=C2[H])[H])[H])C(=NC(C1=O)([H])[H])C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "AAOVKJBEBIDNHE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP3A4; CYP3A5; CYP2C19; CYP2C8; CYP2C9; CYP2C18",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0225",
                     "inchikey" : "AKPLHCDWDRPJGD-UHFFFAOYSA-N",
                         "name" : "Nordiazepam",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C1=NC([H])([H])C(=O)NC2=C1C([H])=C(Cl)C([H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0231" : {
                             "Name" : "diazepam",
            "Substrate's structure" : "C(N1C2=C(C(=C(Cl)C(=C2[H])[H])[H])C(=NC(C1=O)([H])[H])C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "AAOVKJBEBIDNHE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5; CYP2C19 (minor)",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0226",
                     "inchikey" : "SEQDDYPDSLOBDC-UHFFFAOYNA-N",
                         "name" : "Temazepam",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C1=NC([H])(O)C(=O)N(C2=C1C([H])=C(Cl)C([H])=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0232" : {
                             "Name" : "Diazinon",
            "Substrate's structure" : "CCOP(=S)(OCC)OC1=CC(C)=NC(=N1)C(C)C",
                         "InChIKey" : "FHIVAFMUCKRCQO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Kappers, W.A. et al.; (2001). Diazinon Is Activated by CYP2C19 in Human Liver. Toxicol. Appl. Pharmacol., Vol. 177, No. 1, (68-76)",
                "Buratti, F.M. et al.; Toxicology and Applied Pharmacology 186 (2003) 143���154."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0227",
                     "inchikey" : "AJPIUNPJBFBUKK-UHFFFAOYSA-N",
                         "name" : "Pyrimidinol",
                    "structure" : "CC(C)C1=NC(O)=CC(C)=N1"
                }
            ],
                    "Reaction Type" : [
                "Dearylation"
            ]
        },
        "BIOTID0233" : {
                             "Name" : "Diazinon",
            "Substrate's structure" : "CCOP(=S)(OCC)OC1=CC(C)=NC(=N1)C(C)C",
                         "InChIKey" : "FHIVAFMUCKRCQO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Kappers, W.A. et al.; (2001). Diazinon Is Activated by CYP2C19 in Human Liver. Toxicol. Appl. Pharmacol., Vol. 177, No. 1, (68-76)",
                "Buratti, F.M. et al.; Toxicology and Applied Pharmacology 186 (2003) 143���154."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0228",
                     "inchikey" : "PKUWKAXTAVNIJR-UHFFFAOYSA-N",
                         "name" : "Diethyl thiophosphate",
                    "structure" : "CCOP(O)(=S)OCC"
                }
            ],
                    "Reaction Type" : [
                "Dearylation"
            ]
        },
        "BIOTID0234" : {
                             "Name" : "Diazinon",
            "Substrate's structure" : "CCOP(=S)(OCC)OC1=CC(C)=NC(=N1)C(C)C",
                         "InChIKey" : "FHIVAFMUCKRCQO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C9; CYP2C19; CYP2D6; CYP3A4",
                       "References" : [
                "Kappers, W.A. et al.; (2001). Diazinon Is Activated by CYP2C19 in Human Liver. Toxicol. Appl. Pharmacol., Vol. 177, No. 1, (68-76)",
                "Buratti, F.M. et al.; Toxicology and Applied Pharmacology 186 (2003) 143���154."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0229",
                     "inchikey" : "VBLJFQYCTRKKKF-UHFFFAOYSA-N",
                         "name" : "Diazoxon",
                    "structure" : "CCOP(=O)(OCC)OC1=CC(C)=NC(=N1)C(C)C"
                }
            ],
                    "Reaction Type" : [
                "Desulfurization"
            ]
        },
        "BIOTID0235" : {
                             "Name" : "dibenzylfluorescein",
            "Substrate's structure" : "C1=2C(=C(C(=O)C(=C1OC=3C(C2C=4C(=C(C(=C(C4[H])[H])[H])[H])C(=O)OC(C=5C(=C(C(=C(C5[H])[H])[H])[H])[H])([H])[H])=C(C(=C(C3[H])OC(C=6C(=C(C(=C(C6[H])[H])[H])[H])[H])([H])[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "YZJGKSLPSGPFEV-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C9; CYP2C19; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0230",
                     "inchikey" : "YDIMXOIBAHIGQV-UHFFFAOYSA-N",
                         "name" : "Fluorescein benzyl ester",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])OC(=O)C1=C([H])C([H])=C([H])C([H])=C1C1=C2C([H])=C([H])C(=O)C([H])=C2OC2=C([H])C(O)=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0236" : {
                             "Name" : "dibenzylfluorescein",
            "Substrate's structure" : "C1=2C(=C(C(=O)C(=C1OC=3C(C2C=4C(=C(C(=C(C4[H])[H])[H])[H])C(=O)OC(C=5C(=C(C(=C(C5[H])[H])[H])[H])[H])([H])[H])=C(C(=C(C3[H])OC(C=6C(=C(C(=C(C6[H])[H])[H])[H])[H])([H])[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "YZJGKSLPSGPFEV-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C9; CYP2C19; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0231",
                     "inchikey" : "MZBJPNYKPATCQL-UHFFFAOYSA-N",
                         "name" : "2-[6-(benzyloxy)-3-oxo-3H-xanthen-9-yl]benzoic acid",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])OC1=C([H])C([H])=C2C(OC3=C([H])C(=O)C([H])=C([H])C3=C2C2=C([H])C([H])=C([H])C([H])=C2C(O)=O)=C1[H]"
                }
            ],
                    "Reaction Type" : []
        },
        "BIOTID0237" : {
                             "Name" : "diclofenac",
            "Substrate's structure" : "O(C(=O)C(C1=C(C(=C(C(=C1N(C2=C(Cl)C(=C(C(=C2Cl)[H])[H])[H])[H])[H])[H])[H])[H])([H])[H])[H]",
                         "InChIKey" : "DCOPUUMXTXDBNB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Bort, R. (1999); Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways; Biochem Pharmacol. 1999 Sep 1;58(5):787-96; PMID:10449188"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0232",
                     "inchikey" : "KGVXVPRLBMWZLG-UHFFFAOYSA-N",
                         "name" : "4'-OH-diclofenac",
                    "structure" : "[H]OC(=O)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1N([H])C1=C(Cl)C([H])=C(O)C([H])=C1Cl"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0238" : {
                             "Name" : "diclofenac",
            "Substrate's structure" : "O(C(=O)C(C1=C(C(=C(C(=C1N(C2=C(Cl)C(=C(C(=C2Cl)[H])[H])[H])[H])[H])[H])[H])[H])([H])[H])[H]",
                         "InChIKey" : "DCOPUUMXTXDBNB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP2C8; CYP2C19; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Bort, R. (1999); Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways; Biochem Pharmacol. 1999 Sep 1;58(5):787-96; PMID:10449188"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0233",
                     "inchikey" : "VNQURRWYKFZKJZ-UHFFFAOYSA-N",
                         "name" : "5-OH-diclofenac",
                    "structure" : "[H]OC(=O)C([H])([H])C1=C([H])C(O)=C([H])C([H])=C1N([H])C1=C(Cl)C([H])=C([H])C([H])=C1Cl"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0239" : {
                             "Name" : "diltiazem",
            "Substrate's structure" : "C(OC1=C(C(=C(C(=C1[H])[H])[C@@]2(SC3=C(C(=C(C(=C3N(C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])C(=O)[C@@]2(OC(C([H])([H])[H])=O)[H])[H])[H])[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "HSUGRBWQSSZJOP-RTWAWAEBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major); CYP2C8 (minor); CYP2C9 (minor)",
                       "References" : [
                "Kurokawa, T. et al. (2015); Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as a Rat-Specific Diltiazem Deacetylase; The American Society for Pharmacology and Experimental Therapeutics; 43:1218���1225, August 2015;"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0234",
                     "inchikey" : "YOMLDISQSWWYOT-UXHICEINSA-N",
                         "name" : "N-Demethyldiltiazem",
                    "structure" : "[H]C1=C([H])C([H])=C2N(C(=O)[C@]([H])(OC(=O)C([H])([H])[H])[C@@]([H])(SC2=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0240" : {
                             "Name" : "diltiazem",
            "Substrate's structure" : "C(OC1=C(C(=C(C(=C1[H])[H])[C@@]2(SC3=C(C(=C(C(=C3N(C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])C(=O)[C@@]2(OC(C([H])([H])[H])=O)[H])[H])[H])[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "HSUGRBWQSSZJOP-RTWAWAEBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Kurokawa, T. et al. (2015); Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as a Rat-Specific Diltiazem Deacetylase; The American Society for Pharmacology and Experimental Therapeutics; 43:1218���1225, August 2015;"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0235",
                     "inchikey" : "ALISTFINEQANJP-UXHICEINSA-N",
                         "name" : "O-Demethyldiltiazem",
                    "structure" : "[H]C1=C([H])C([H])=C2N(C(=O)[C@]([H])(OC(=O)C([H])([H])[H])[C@@]([H])(SC2=C1[H])C1=C([H])C([H])=C(O)C([H])=C1[H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0241" : {
                             "Name" : "diphenhydramine",
            "Substrate's structure" : "O(C(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])[H])C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "ZZVUWRFHKOJYTH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP1A2; CYP2C9; CYP2C19; CYP2B6",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0236",
                     "inchikey" : "AGSLYHYWLYGAOU-UHFFFAOYSA-N",
                         "name" : "N-Desmethyldiphenhydramine",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(OC([H])([H])C([H])([H])NC([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0242" : {
                             "Name" : "docetaxel",
            "Substrate's structure" : "O1[C@]2([C@@]([C@@]3([C@@]([C@@](O[H])(C2([H])[H])[H])(C(=O)[C@@](C=4C([C@@]([C@]3(OC(=O)C5=C(C(=C(C(=C5[H])[H])[H])[H])[H])[H])(O[H])C([C@](OC(=O)[C@](O[H])([C@@](N(C(OC(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])=O)[H])(C6=C(C(=C(C(=C6[H])[H])[H])[H])[H])[H])[H])(C4C([H])([H])[H])[H])([H])[H])(C([H])([H])[H])C([H])([H])[H])(O[H])[H])C([H])([H])[H])[H])(OC(=O)C([H])([H])[H])C1([H])[H])[H]",
                         "InChIKey" : "ZDZOTLJHXYCWBA-VCVYQWHSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Rodriguez-Antona, C. et al. (2006); Cytochrome P450 pharmacogenetics and cancer. Nature publishing group. (2006) 25, 1679-1691; DOI: 10.1038/sj.onc.1209377"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0237",
                     "inchikey" : "HABZZLXXUPZIJD-VCVYQWHSSA-N",
                         "name" : "Hydroxy-Docetaxel",
                    "structure" : "CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)C2=CC=CC=C2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)CO)C3=CC=CC=C3)C(C)=C([C@@H](O)C1=O)C2(C)C"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0243" : {
                             "Name" : "doxepin",
            "Substrate's structure" : "[H]/C(/C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])=C/1\\C2=C(C(=C(C(=C2C(OC3=C(C(=C(C(=C13)[H])[H])[H])[H])([H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "ODQWQRRAPPTVAG-BOPFTXTBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Musshoff F. et al. (2010); Pharmacogenetics and forensic toxicology; Forensic Sci Int.; 203, 53-62. doi: doi:10.1016/j.forsciint.2010.07.011"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0238",
                     "inchikey" : "HVKCEFHNSNZIHO-YBEGLDIGSA-N",
                         "name" : "nordoxepin",
                    "structure" : "[H]\\C(=C1\\C2=C([H])C([H])=C([H])C([H])=C2OC([H])([H])C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0244" : {
                             "Name" : "doxepin",
            "Substrate's structure" : "[H]/C(/C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])=C/1\\C2=C(C(=C(C(=C2C(OC3=C(C(=C(C(=C13)[H])[H])[H])[H])([H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "ODQWQRRAPPTVAG-BOPFTXTBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Musshoff F. et al. (2010); Pharmacogenetics and forensic toxicology; Forensic Sci Int.; 203, 53-62. doi: doi:10.1016/j.forsciint.2010.07.011"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0239",
                     "inchikey" : "JCZHLWUPQBSZCM-FRKPEAEDSA-N",
                         "name" : "2-OH-doxepin",
                    "structure" : "[H]\\C(=C1\\C2=C([H])C([H])=C([H])C([H])=C2OC([H])([H])C2=C([H])C([H])=C(O)C([H])=C12)C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0245" : {
                             "Name" : "ebastine",
            "Substrate's structure" : "CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1",
                         "InChIKey" : "VPIRRYIYIPYTGX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Hashizume, T. et al. (2002); Involvement of CYP2J2 and CYP4F12 in the methabolism of Ebastine in Human Intestinal Microsomes. The journal of pharmacology and exprimental therapeutics. 2002, 300 (1) 2980304; DOI: https://doi.org/10.1124/jpet.300.1.298"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0240",
                     "inchikey" : "UAIVWKRILRHHTB-UHFFFAOYSA-N",
                         "name" : "Deslakylebastine",
                    "structure" : "CC(C)(C)C1=CC=C(C=C1)C(=O)CCC=O"
                },
                {
                     "BTMDB_ID" : "BTMDB0240",
                     "inchikey" : "UAIVWKRILRHHTB-UHFFFAOYSA-N",
                         "name" : "Deslakylebastine",
                    "structure" : "C1CC(CCN1)OC(C1=CC=CC=C1)C1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0246" : {
                             "Name" : "ecabapide",
            "Substrate's structure" : "C1(=C(C(=C(C(=C1[H])[H])C(C(N(C(C(N(C2=C(C(=C(C(=C2[H])[H])[H])C(N(C([H])([H])[H])[H])=O)[H])[H])([H])[H])=O)[H])([H])[H])([H])[H])[H])OC([H])([H])[H])OC([H])([H])[H]",
                         "InChIKey" : "JTAGHJPZEDNHHA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Fujimaki, N. et al. (1999); Identi�cation of cytochromes P450 involved in human liver microsomal metabolism of ecabapide, a prokinetic agent; xenobiotica; 29:12, 1273-1282; DOI:10.1080/004982599237930"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0241",
                     "inchikey" : "HHTJYUYIEQTITM-UHFFFAOYSA-N",
                         "name" : "6-hydroxy-ecabapide",
                    "structure" : "CNC(=O)C1=C(O)C=CC(NCC(=O)NCCC2=CC(OC)=C(OC)C=C2)=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0247" : {
                             "Name" : "ecabapide",
            "Substrate's structure" : "C1(=C(C(=C(C(=C1[H])[H])C(C(N(C(C(N(C2=C(C(=C(C(=C2[H])[H])[H])C(N(C([H])([H])[H])[H])=O)[H])[H])([H])[H])=O)[H])([H])[H])([H])[H])[H])OC([H])([H])[H])OC([H])([H])[H]",
                         "InChIKey" : "JTAGHJPZEDNHHA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Fujimaki, N. et al. (1999); Identi�cation of cytochromes P450 involved in human liver microsomal metabolism of ecabapide, a prokinetic agent; xenobiotica; 29:12, 1273-1282; DOI:10.1080/004982599237930"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0242",
                     "inchikey" : "TZEPFEDEUUHBDU-UHFFFAOYSA-N",
                         "name" : "5-amino-2-hydroxy-N-methylbenzamide",
                    "structure" : "CNC(=O)C1=C(O)C=CC(N)=C1"
                },
                {
                     "BTMDB_ID" : "BTMDB0242",
                     "inchikey" : "TZEPFEDEUUHBDU-UHFFFAOYSA-N",
                         "name" : "5-amino-2-hydroxy-N-methylbenzamide",
                    "structure" : "COC1=C(OC)C=C(CCNC(=O)C=O)C=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0248" : {
                             "Name" : "efavirenz",
            "Substrate's structure" : "FC(F)(F)[C@]1(OC(=O)N(C2=C1C(=C(Cl)C(=C2[H])[H])[H])[H])C#CC3(C(C3([H])[H])([H])[H])[H]",
                         "InChIKey" : "XPOQHMRABVBWPR-ZDUSSCGKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP1A2; CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0243",
                     "inchikey" : "OOVOMPCQLMFEDT-ZDUSSCGKSA-N",
                         "name" : "8-OH-efavirenz",
                    "structure" : "[H]N1C(=O)O[C@@](C#CC2([H])C([H])([H])C2([H])[H])(C2=C1C(O)=C([H])C(Cl)=C2[H])C(F)(F)F"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0249" : {
                             "Name" : "eletriptan",
            "Substrate's structure" : "C=12[C@](C([C@@]3(N(C(C(C3([H])[H])([H])[H])([H])[H])C([H])([H])[H])[H])([H])[H])(C(N(C1C(=C(C(=C2[H])C(C(S(C4=C(C(=C(C(=C4[H])[H])[H])[H])[H])(=O)=O)([H])[H])([H])[H])[H])[H])[H])([H])[H])[H]",
                         "InChIKey" : "BBMOMQCRLMEOQE-RTBURBONSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (major); CYP3A4 (major); CYP2C9 (minor); CYP2C19 (minor); CYP1A2 (minor); CYP2C8 (minor)",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0244",
                     "inchikey" : "DZPWTXAGCISGJW-QZTJIDSGSA-N",
                         "name" : "N-Desmethyleletriptan",
                    "structure" : "[H]N1C2=C(C([H])=C(C([H])=C2[H])C([H])([H])C([H])([H])S(=O)(=O)C2=C([H])C([H])=C([H])C([H])=C2[H])[C@]([H])(C([H])([H])[C@]2([H])NC([H])([H])C([H])([H])C2([H])[H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0250" : {
                             "Name" : "eplerenone",
            "Substrate's structure" : "[C@]123[C@](O1)(C([C@]4([C@]([C@@]2([C@@](C(C=5[C@@]3(C(C(C(C5[H])=O)([H])[H])([H])[H])C([H])([H])[H])([H])[H])(C(OC([H])([H])[H])=O)[H])[H])(C(C([C@@]46C(C(C(O6)=O)([H])[H])([H])[H])([H])[H])([H])[H])[H])C([H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "JUKPWJGBANNWMW-VWBFHTRKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "cook, C, S. et al. (2002); INVOLVEMENT OF CYP3A IN THE METABOLISM OF EPLERENONE IN HUMANS AND DOGS: DIFFERENTIAL METABOLISM BY CYP3A4 AND CYP3A5; The American Society for Pharmacology and Experimental Therapeutics; 30:1344���1351, 2002; DOI: 0090-9556/02/3011"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0245",
                     "inchikey" : "DDHQRXOAZNEFKY-YEIJCWOFSA-N",
                         "name" : "6beta-hydroxyeplerenone",
                    "structure" : "COC(=O)[C@@H]1C(O)C2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CCC(=O)O2)[C@H]13"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0251" : {
                             "Name" : "eplerenone",
            "Substrate's structure" : "[C@]123[C@](O1)(C([C@]4([C@]([C@@]2([C@@](C(C=5[C@@]3(C(C(C(C5[H])=O)([H])[H])([H])[H])C([H])([H])[H])([H])[H])(C(OC([H])([H])[H])=O)[H])[H])(C(C([C@@]46C(C(C(O6)=O)([H])[H])([H])[H])([H])[H])([H])[H])[H])C([H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "JUKPWJGBANNWMW-VWBFHTRKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "cook, C, S. et al. (2002); INVOLVEMENT OF CYP3A IN THE METABOLISM OF EPLERENONE IN HUMANS AND DOGS: DIFFERENTIAL METABOLISM BY CYP3A4 AND CYP3A5; The American Society for Pharmacology and Experimental Therapeutics; 30:1344���1351, 2002; DOI: 0090-9556/02/3011"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0246",
                     "inchikey" : "TVCONGKEWSYBKD-NBACNWMZSA-N",
                         "name" : "21-hydroxyeplerenone",
                    "structure" : "COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]22CC(O)C(=O)O2)[C@H]13"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0252" : {
                             "Name" : "erythromycin",
            "Substrate's structure" : "C1([C@@]([C@]([C@]([C@](OC([C@@]([C@]([C@@]([C@]([C@@](C([C@]1(C([H])([H])[H])[H])([H])[H])(O[H])C([H])([H])[H])(O[C@]2([C@@]([C@](C([C@](O2)(C([H])([H])[H])[H])([H])[H])(N(C([H])([H])[H])C([H])([H])[H])[H])(O[H])[H])[H])[H])(C([H])([H])[H])[H])(O[C@@]3(O[C@]([C@@]([C@@](C3([H])[H])(OC([H])([H])[H])C([H])([H])[H])(O[H])[H])(C([H])([H])[H])[H])[H])[H])(C([H])([H])[H])[H])([H])[H])(C(C([H])([H])[H])([H])[H])[H])(C([H])([H])[H])O[H])(O[H])[H])(C([H])([H])[H])[H])([H])[H]",
                         "InChIKey" : "PGRWHWPTHNFQEN-LQDUVHJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2B6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0247",
                     "inchikey" : "SXRMKZCUOASAPB-LXXVJEBNSA-N",
                         "name" : "N-Desmethylerythromycin",
                    "structure" : "[H]O[C@@]1([H])[C@]([H])(O[C@]2([H])[C@@]([H])(C([H])([H])[H])[C@]([H])(O[C@]3([H])O[C@@]([H])(C([H])([H])[H])[C@]([H])(O[H])[C@@](OC([H])([H])[H])(C([H])([H])[H])C3([H])[H])[C@@]([H])(C([H])([H])[H])C([H])([H])O[C@]([H])(C([H])([H])C([H])([H])[H])[C@](O[H])(C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])[H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])([H])[C@]2(O[H])C([H])([H])[H])O[C@]([H])(C([H])([H])[H])C([H])([H])[C@]1([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0253" : {
                             "Name" : "esomeprazole",
            "Substrate's structure" : "[S@](=O)(C(C1=NC(=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H])[H])([H])[H])C=2N(C3=C(N2)C(=C(C(OC([H])([H])[H])=C3[H])[H])[H])[H]",
                         "InChIKey" : "SUBDBMMJDZJVOS-DEOSSOPVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP2C19 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0248",
                     "inchikey" : "CMZHQFXXAAIBKE-VWLOTQADSA-N",
                         "name" : "5-Hydroxyomeprazole",
                    "structure" : "[H]N1C(=NC2=C1C([H])=C(OC([H])([H])[H])C([H])=C2[H])[S@@](=O)C([H])([H])C1=NC([H])=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0254" : {
                             "Name" : "esomeprazole",
            "Substrate's structure" : "[S@](=O)(C(C1=NC(=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H])[H])([H])[H])C=2N(C3=C(N2)C(=C(C(OC([H])([H])[H])=C3[H])[H])[H])[H]",
                         "InChIKey" : "SUBDBMMJDZJVOS-DEOSSOPVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP3A4 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0249",
                     "inchikey" : "IXEQEYRTSRFZEO-UHFFFAOYSA-N",
                         "name" : "Omeprazole sulfone",
                    "structure" : "[H]N1C2=C(N=C1S(=O)(=O)C([H])([H])C1=NC([H])=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H])C([H])=C([H])C(OC([H])([H])[H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0255" : {
                             "Name" : "esomeprazole",
            "Substrate's structure" : "[S@](=O)(C(C1=NC(=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H])[H])([H])[H])C=2N(C3=C(N2)C(=C(C(OC([H])([H])[H])=C3[H])[H])[H])[H]",
                         "InChIKey" : "SUBDBMMJDZJVOS-DEOSSOPVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP2C19 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0250",
                     "inchikey" : "TWXDTVZNDQKCOS-QHCPKHFHSA-N",
                         "name" : "5-O-Desmethylomeprazole",
                    "structure" : "[H]N1C(=NC2=C1C([H])=C(O)C([H])=C2[H])[S@@](=O)C([H])([H])C1=NC([H])=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0256" : {
                             "Name" : "estazolam",
            "Substrate's structure" : "C12=C(C(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])=NC(C=4N1C(=NN4)[H])([H])[H])C(=C(C(=C2[H])[H])Cl)[H]",
                         "InChIKey" : "CDCHDCWJMGXXRH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "M. Miura, K. Otani & T. Ohkubo (2005) Identification of human cytochrome P450 enzymes involved in the formation of 4-hydroxyestazolam from estazolam, Xenobiotica, 35:5, 455-465, DOI: 10.1080/00498250500111612"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0251",
                     "inchikey" : "LJIJJCXFWLORDQ-UHFFFAOYNA-N",
                         "name" : "4-hydroxyestazolam",
                    "structure" : "[H]C1=NN=C2N1C1=C(C([H])=C(Cl)C([H])=C1[H])C(=NC2([H])O)C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0257" : {
                             "Name" : "estradiol",
            "Substrate's structure" : "O[C@@H]1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                         "InChIKey" : "VOXZDWNPVJITMN-NZKIEYOBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP1A2; CYP3A4; CYP1A1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0252",
                     "inchikey" : "DILDHNKDVHLEQB-XSSYPUMDSA-N",
                         "name" : "2-Hydroxyestradiol",
                    "structure" : "C[C@]12CC[C@H]3[C@@H](CCC4=C3C=C(O)C(O)=C4)[C@@H]1CC[C@@H]2O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0258" : {
                             "Name" : "estradiol",
            "Substrate's structure" : "O[C@@H]1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                         "InChIKey" : "VOXZDWNPVJITMN-NZKIEYOBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP1B1 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0253",
                     "inchikey" : "QOZFCKXEVSGWGS-ZHIYBZGJSA-N",
                         "name" : "4-Hydroxyestradiol",
                    "structure" : "C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4O)[C@@H]1CC[C@@H]2O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0259" : {
                             "Name" : "estrone",
            "Substrate's structure" : "O=C1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                         "InChIKey" : "DNXHEGUUPJUMQT-QYFVKBAZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5; CYP3A7; CYP1A2; CYP2B6; CYP2C8; CYP2C9; CYP2C19; CYP2D6",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0254",
                     "inchikey" : "SWINWPBPEKHUOD-JPVZDGGYSA-N",
                         "name" : "2-OH-estrone",
                    "structure" : "C[C@]12CC[C@H]3[C@@H](CCC4=C3C=C(O)C(O)=C4)[C@@H]1CCC2=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0260" : {
                             "Name" : "estrone",
            "Substrate's structure" : "O=C1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                         "InChIKey" : "DNXHEGUUPJUMQT-QYFVKBAZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C9; CYP3A4; CYP3A5; CYP3A7",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0255",
                     "inchikey" : "XQZVQQZZOVBNLU-QDTBLXIISA-N",
                         "name" : "4-OH-estrone",
                    "structure" : "C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4O)[C@@H]1CCC2=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0261" : {
                             "Name" : "estrone",
            "Substrate's structure" : "O=C1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                         "InChIKey" : "DNXHEGUUPJUMQT-QYFVKBAZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP3A4; CYP3A5; CYP3A7",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0256",
                     "inchikey" : "HTORTGVWUGQTHQ-WUAUYOTNSA-N",
                         "name" : "6alpha-OH-estrone",
                    "structure" : "C[C@]12CC[C@H]3[C@@H](C[C@H](O)C4=C3C=CC(O)=C4)[C@@H]1CCC2=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0262" : {
                             "Name" : "estrone",
            "Substrate's structure" : "O=C1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                         "InChIKey" : "DNXHEGUUPJUMQT-QYFVKBAZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5; CYP3A7",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0257",
                     "inchikey" : "HTORTGVWUGQTHQ-UHOVARLQSA-N",
                         "name" : "6beta-estrone",
                    "structure" : "C[C@]12CC[C@H]3[C@@H](C[C@@H](O)C4=C3C=CC(O)=C4)[C@@H]1CCC2=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0263" : {
                             "Name" : "estrone",
            "Substrate's structure" : "O=C1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                         "InChIKey" : "DNXHEGUUPJUMQT-QYFVKBAZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0258",
                     "inchikey" : "MXXBVPDRVYYYJY-JIHIFKDMSA-N",
                         "name" : "7alpha-OH-estrone",
                    "structure" : "C[C@]12CC[C@H]3C([C@@H]1CCC2=O)[C@H](O)CC1=C3C=CC(O)=C1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0264" : {
                             "Name" : "estrone",
            "Substrate's structure" : "O=C1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                         "InChIKey" : "DNXHEGUUPJUMQT-QYFVKBAZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP3A7",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0259",
                     "inchikey" : "FDFNTZDUOBCJMD-OYHJSVMOSA-N",
                         "name" : "15alpha-OH-estrone",
                    "structure" : "C[C@]12CC[C@H]3C(CCC4=C3C=CC(O)=C4)[C@@H]1[C@@H](O)CC2=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0265" : {
                             "Name" : "estrone",
            "Substrate's structure" : "O=C1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                         "InChIKey" : "DNXHEGUUPJUMQT-QYFVKBAZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP2C8; CYP3A4; CYP3A5; CYP3A7",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0260",
                     "inchikey" : "WPOCIZJTELRQMF-DIYRONQZSA-N",
                         "name" : "16alpha-OH-estrone",
                    "structure" : "C[C@]12CC[C@H]3C(CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)C2=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0266" : {
                             "Name" : "estrone",
            "Substrate's structure" : "O=C1[C@@]2([C@H]([C@H]3[C@H](CC2)C4=C(CC3)C=C(O)C=C4)CC1)C",
                         "InChIKey" : "DNXHEGUUPJUMQT-QYFVKBAZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4; CYP3A5",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754430"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0261",
                     "inchikey" : "WPOCIZJTELRQMF-CCIOVHFFSA-N",
                         "name" : "16beta-OH-estrone",
                    "structure" : "C[C@]12CC[C@H]3C(CCC4=C3C=CC(O)=C4)[C@@H]1C[C@H](O)C2=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0267" : {
                             "Name" : "ethanol",
            "Substrate's structure" : "C(C(O[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "LFQSCWFLJHTTHZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0262",
                     "inchikey" : "IKHGUXGNUITLKF-UHFFFAOYSA-N",
                         "name" : "Acetaldehyde",
                    "structure" : "[H]C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0268" : {
                             "Name" : "ethiprole",
            "Substrate's structure" : "N1(C2=C(C=C(C=C2Cl)C(F)(F)F)Cl)C(=C(C(=N1)C#N)S(CC)=O)N",
                         "InChIKey" : "FNELVJVBIYMIMC-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Caboni, P. et al. (2003); Phenylpyrazole Insecticide Photochemistry, Metabolism, and GABAergic Action: Ethiprole Compared with Fipronil; J. Agric. Food Chem. 2003, 51, 7055���7061; DOI: 10.1021/jf030439"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0263",
                     "inchikey" : "SGTQRPFDKIRFIQ-UHFFFAOYSA-N",
                         "name" : "Ethiprole Sulfone",
                    "structure" : "CCS(=O)(=O)C1=C(N)N(N=C1C#N)C1=C(Cl)C=C(C=C1Cl)C(F)(F)F"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0269" : {
                             "Name" : "etoricoxib",
            "Substrate's structure" : "C(C1=NC(=C(C(=C1[H])[H])C2=C(C(=C(Cl)C(=N2)[H])[H])C3=C(C(=C(C(=C3[H])[H])S(C([H])([H])[H])(=O)=O)[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "MNJVRJDLRVPLFE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major); CYP2C9 (minor); CYP2D6 (minor); CYP1A2 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023",
                "Chugh, R. et al. (2007); Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma; Cancer. 2007 Jun 1;109(11):2315-22; PMID:17464949; DOI:10.1002/cncr.22669"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0264",
                     "inchikey" : "SCVWZQQMIZJGJY-UHFFFAOYSA-N",
                         "name" : "6-Hydroxymethyletoricoxib",
                    "structure" : "[H]C1=NC(C2=C([H])N=C(C([H])=C2[H])C([H])([H])O)=C(C([H])=C1Cl)C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0270" : {
                             "Name" : "etoricoxib",
            "Substrate's structure" : "C(C1=NC(=C(C(=C1[H])[H])C2=C(C(=C(Cl)C(=N2)[H])[H])C3=C(C(=C(C(=C3[H])[H])S(C([H])([H])[H])(=O)=O)[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "MNJVRJDLRVPLFE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major); CYP2C9 (minor); CYP2D6 (minor); CYP1A2 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023",
                "Chugh, R. et al. (2007); Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma; Cancer. 2007 Jun 1;109(11):2315-22; PMID:17464949; DOI:10.1002/cncr.22669"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0265",
                     "inchikey" : "KMLFAHIIJSUUPX-UHFFFAOYSA-N",
                         "name" : "Etoricoxib 1'-N'-oxide",
                    "structure" : "[H]C1=NC(C2=C([H])[N+]([O-])=C(C)C([H])=C2[H])=C(C([H])=C1Cl)C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0271" : {
                             "Name" : "fentanyl",
            "Substrate's structure" : "C(C(C(=O)N(C1(C(C(N(C(C(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])([H])[H])([H])[H])C(C1([H])[H])([H])[H])([H])[H])([H])[H])[H])C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "PJMPHNIQZUBGLI-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Feierman, D. et al. (1996); Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes; Drug metabolism and disposition; 0090-9556/96/2409-0932-939$02.OO/O"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0266",
                     "inchikey" : "PMCBDBWCQQBSRJ-UHFFFAOYSA-N",
                         "name" : "Norfentanyl",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])N(C(=O)C([H])([H])C([H])([H])[H])C1([H])C([H])([H])C([H])([H])NC([H])([H])C1([H])[H]"
                },
                {
                     "BTMDB_ID" : "BTMDB0266",
                     "inchikey" : "PMCBDBWCQQBSRJ-UHFFFAOYSA-N",
                         "name" : "Norfentanyl",
                    "structure" : "[H]C1=C([H])C([H])=C(CC=O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0272" : {
                             "Name" : "fk_506",
            "Substrate's structure" : "O1[C@]2([C@@](OC([H])([H])[H])(C([C@]([C@]1(O[H])C(=O)C(=O)N3[C@@](C(C(C(C3([H])[H])([H])[H])([H])[H])([H])[H])(C(O[C@@]([C@@]([C@@](O[H])(C(C(=O)[C@@](C(=C(C([C@@](C([C@@]2(OC([H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])([H])[H])C([H])([H])[H])[H])(C(C(=C([H])[H])[H])([H])[H])[H])([H])[H])[H])(C([H])([H])[H])[H])(\\C(=C(\\[C@]4(C([C@@](OC([H])([H])[H])([C@](O[H])(C(C4([H])[H])([H])[H])[H])[H])([H])[H])[H])/[H])\\C([H])([H])[H])[H])=O)[H])(C([H])([H])[H])[H])([H])[H])[H])[H]",
                         "InChIKey" : "QJJXYPPXXYFBGM-LFZNUXCKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0267",
                     "inchikey" : "OGJRKILIPRVJFS-UIRFILISSA-N",
                         "name" : "13-O-Desmethyltacrolimus",
                    "structure" : "CO[C@@H]1C[C@@H](CC[C@H]1O)\\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@@H](O)C[C@H]2C)[C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0273" : {
                             "Name" : "fk_506",
            "Substrate's structure" : "O1[C@]2([C@@](OC([H])([H])[H])(C([C@]([C@]1(O[H])C(=O)C(=O)N3[C@@](C(C(C(C3([H])[H])([H])[H])([H])[H])([H])[H])(C(O[C@@]([C@@]([C@@](O[H])(C(C(=O)[C@@](C(=C(C([C@@](C([C@@]2(OC([H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])([H])[H])C([H])([H])[H])[H])(C(C(=C([H])[H])[H])([H])[H])[H])([H])[H])[H])(C([H])([H])[H])[H])(\\C(=C(\\[C@]4(C([C@@](OC([H])([H])[H])([C@](O[H])(C(C4([H])[H])([H])[H])[H])[H])([H])[H])[H])/[H])\\C([H])([H])[H])[H])=O)[H])(C([H])([H])[H])[H])([H])[H])[H])[H]",
                         "InChIKey" : "QJJXYPPXXYFBGM-LFZNUXCKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0268",
                     "inchikey" : "ZQRSWRVAAABQEF-DUGRZSFISA-N",
                         "name" : "15-O-Desmethyltacrolimus",
                    "structure" : "CO[C@@H]1C[C@@H](CC[C@H]1O)\\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](O)C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0274" : {
                             "Name" : "flosequinan",
            "Substrate's structure" : "C12=C(N(C=C(C1=O)S(C)=O)C)C=C(C=C2)F",
                         "InChIKey" : "UYGONJYYUKVHDD-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Kashiyama, E. et al, (1997); CYTOCHROME P450 RESPONSIBLE FOR THE STEREOSELECTIVE S-OXIDATION OF FLOSEQUINAN IN HEPATIC MICROSOMES FROM RATS AND HUMANS; The American Society for Pharmacology and Experimental Therapeutics; DOI: 0090-9556/97/2506-07"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0269",
                     "inchikey" : "ZUMVHPMHCIKNFT-UHFFFAOYSA-N",
                         "name" : "flosequinan sulfone",
                    "structure" : "CN1C=C(C(=O)C2=C1C=C(F)C=C2)S(C)(=O)=O"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0275" : {
                             "Name" : "flunarizine",
            "Substrate's structure" : "C=1(/C(=C(/C(N2C(C(N(C(C=3C(=C(C(F)=C(C3[H])[H])[H])[H])(C=4C(=C(C(F)=C(C4[H])[H])[H])[H])[H])C(C2([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])\\[H])/[H])C(=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "SMANXXCATUTDDT-QPJJXVBHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C9",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                ""
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0270",
                     "inchikey" : "TTXIFFYPVGWLSE-UHFFFAOYSA-N",
                         "name" : "1�ې[bis(4�ېfluorophenyl)methyl]piperazine",
                    "structure" : "[H]C1=C([H])C(=C([H])C([H])=C1F)C([H])(N1C([H])([H])C([H])([H])NC([H])([H])C1([H])[H])C1=C([H])C([H])=C(F)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0276" : {
                             "Name" : "flunarizine",
            "Substrate's structure" : "C=1(/C(=C(/C(N2C(C(N(C(C=3C(=C(C(F)=C(C3[H])[H])[H])[H])(C=4C(=C(C(F)=C(C4[H])[H])[H])[H])[H])C(C2([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])\\[H])/[H])C(=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "SMANXXCATUTDDT-QPJJXVBHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                ""
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0271",
                     "inchikey" : "BORXUYRMIOAMIE-OWOJBTEDSA-N",
                         "name" : "p-Hydroxyflunarizine",
                    "structure" : "[H]\\C(=C(\\[H])C([H])([H])N1C([H])([H])C([H])([H])N(C([H])([H])C1([H])[H])C([H])(C1=C([H])C([H])=C(F)C([H])=C1[H])C1=C([H])C([H])=C(F)C([H])=C1[H])C1=C([H])C([H])=C(O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0277" : {
                             "Name" : "flunarizine",
            "Substrate's structure" : "C=1(/C(=C(/C(N2C(C(N(C(C=3C(=C(C(F)=C(C3[H])[H])[H])[H])(C=4C(=C(C(F)=C(C4[H])[H])[H])[H])[H])C(C2([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])\\[H])/[H])C(=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "SMANXXCATUTDDT-QPJJXVBHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP1A1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                ""
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0272",
                     "inchikey" : "LSQARZALBDFYQZ-UHFFFAOYSA-N",
                         "name" : "bis(4�ېfluorophenyl)methanone",
                    "structure" : "[H]C1=C([H])C(=C([H])C([H])=C1F)C(=O)C1=C([H])C([H])=C(F)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0278" : {
                             "Name" : "fluphenazine",
            "Substrate's structure" : "O(C(C(N1C(C(N(C(C(C(N2C3=C(C(=C(C(=C3SC4=C2C(=C(C(=C4[H])[H])C(F)(F)F)[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])C(C1([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "PLDUPXSUYLZYBN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Smith, D.A. et al. (1992); Speculations on the structure-activity relationship (SAR) of cytochrome P450 enzymes, Biochem. Pharmacol  1992, 44, 2089-2098 (1992).",
                "Li, S-F. et al. (2010); Quantitative analysis of fluphenazine hydrochloride in human urine using excitation-emission matrix fluorescence based on oxidation derivatization and combined with second-order calibration methods; Anal. Methods 2010, 2, 1069-1077, DOI:��10.1039/B9AY00299E"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0273",
                     "inchikey" : "UFPPOFUTIWYLNR-UHFFFAOYNA-N",
                         "name" : "10-{3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl}-2-(trifluoromethyl)-10H-5�ȉ��-phenothiazin-5-one",
                    "structure" : "[H]OC([H])([H])C([H])([H])N1C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])N2C3=C([H])C([H])=C([H])C([H])=C3S(=O)C3=C2C([H])=C(C([H])=C3[H])C(F)(F)F)C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0279" : {
                             "Name" : "flutamide",
            "Substrate's structure" : "C(C(C([H])([H])[H])(C(=O)N(C1=C(C(=C(C(=C1[H])[H])[N+]([O-])=O)C(F)(F)F)[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "MKXKFYHWDHIYRV-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP1B1",
                       "References" : [
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0274",
                     "inchikey" : "YPQLFJODEKMJEF-UHFFFAOYSA-N",
                         "name" : "2-OH-flutamide",
                    "structure" : "CC(C)(O)C(=O)NC1=CC=C(C(=C1)C(F)(F)F)[N+]([O-])=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0280" : {
                             "Name" : "fluvastatin",
            "Substrate's structure" : "C=1(C2=C(N(C1/C(=C(/[C@@](C([C@@](C(C(O[H])=O)([H])[H])(O[H])[H])([H])[H])(O[H])[H])\\[H])/[H])C(C([H])([H])[H])(C([H])([H])[H])[H])C(=C(C(=C2[H])[H])[H])[H])C3=C(C(=C(C(=C3[H])[H])F)[H])[H]",
                         "InChIKey" : "FJLGEFLZQAZZCD-JUFISIKESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023",
                "Chugh, R. et al. (2007); Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma; Cancer. 2007 Jun 1;109(11):2315-22; PMID:17464949; DOI:10.1002/cncr.22669"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0275",
                     "inchikey" : "WSYBZSUCJJHTIP-CLFQVBOOSA-N",
                         "name" : "6-OH-fluvastatin",
                    "structure" : "CC(C)N1C(\\C=C\\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=C1C=C(O)C=C2)C1=CC=C(F)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0281" : {
                             "Name" : "fluvastatin",
            "Substrate's structure" : "C=1(C2=C(N(C1/C(=C(/[C@@](C([C@@](C(C(O[H])=O)([H])[H])(O[H])[H])([H])[H])(O[H])[H])\\[H])/[H])C(C([H])([H])[H])(C([H])([H])[H])[H])C(=C(C(=C2[H])[H])[H])[H])C3=C(C(=C(C(=C3[H])[H])F)[H])[H]",
                         "InChIKey" : "FJLGEFLZQAZZCD-JUFISIKESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023",
                "Chugh, R. et al. (2007); Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma; Cancer. 2007 Jun 1;109(11):2315-22; PMID:17464949; DOI:10.1002/cncr.22669"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0276",
                     "inchikey" : "POFAWBXODXSMNI-IGXNXKSNSA-N",
                         "name" : "N-Deisopropyl-fluvastatin",
                    "structure" : "O[C@@H](C[C@@H](O)\\C=C\\C1=C(C2=C(N1)C=CC=C2)C1=CC=C(F)C=C1)CC(O)=O"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0282" : {
                             "Name" : "fluvastatin",
            "Substrate's structure" : "C=1(C2=C(N(C1/C(=C(/[C@@](C([C@@](C(C(O[H])=O)([H])[H])(O[H])[H])([H])[H])(O[H])[H])\\[H])/[H])C(C([H])([H])[H])(C([H])([H])[H])[H])C(=C(C(=C2[H])[H])[H])[H])C3=C(C(=C(C(=C3[H])[H])F)[H])[H]",
                         "InChIKey" : "FJLGEFLZQAZZCD-JUFISIKESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 (major); CYP2C8 (minor); CYP2D6 (minor); CYP3A4 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023",
                "Chugh, R. et al. (2007); Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma; Cancer. 2007 Jun 1;109(11):2315-22; PMID:17464949; DOI:10.1002/cncr.22669"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0277",
                     "inchikey" : "YCXJQQVRCVXLTP-CLFQVBOOSA-N",
                         "name" : "5-OH-fluvastatin",
                    "structure" : "CC(C)N1C(\\C=C\\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=C1C=CC(O)=C2)C1=CC=C(F)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0283" : {
                             "Name" : "fluvoxamine",
            "Substrate's structure" : "C(OC(C(C(C(/C(=N\\OC(C(N([H])[H])([H])[H])([H])[H])/C=1C(=C(C(=C(C1[H])[H])C(F)(F)F)[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "CJOFXWAVKWHTFT-XSFVSMFZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (major); CYP1A2 (minor)",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0278",
                     "inchikey" : "GCSLDHTZSDNYEC-CPNJWEJPSA-N",
                         "name" : "Fluvoxamino alcohol",
                    "structure" : "[H]N([H])C([H])([H])C([H])([H])O\\N=C(\\C1=C([H])C([H])=C(C([H])=C1[H])C(F)(F)F)C([H])([H])C([H])([H])C([H])([H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0284" : {
                             "Name" : "formononetin",
            "Substrate's structure" : "C12=C(C(C(=C(O1)[H])C=3C(=C(C(=C(C3[H])[H])OC([H])([H])[H])[H])[H])=O)C(=C(C(=C2[H])O[H])[H])[H]",
                         "InChIKey" : "HKQYGTCOTHHOMP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0279",
                     "inchikey" : "ZQSIJRDFPHDXIC-UHFFFAOYSA-N",
                         "name" : "Daidzein",
                    "structure" : "[H]OC1=C([H])C2=C(C([H])=C1[H])C(=O)C(=C([H])O2)C1=C([H])C([H])=C(O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0285" : {
                             "Name" : "furafylline",
            "Substrate's structure" : "N1(C(=NC=2N(C(N(C(C12)=O)C([H])([H])[H])=O)C(C=3OC(=C(C3[H])[H])[H])([H])[H])C([H])([H])[H])[H]",
                         "InChIKey" : "KGQZGCIVHYLPBH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Kunze, k.l. et al. (1992); Mechanism-based inhibition of human cytochrome P450 1A2 by furafylline, ISSX Proceedings, 5th North American ZSSX Meeting, Bal Harbour, FL, November 2-6, 1992, 2, 16",
                "Clarke, S.E. et al. (1994); Characterization of the inhibition of P450 1A2 by furafylline, Xenobioticu, 1994, 24, 517-526",
                "Racha, J.K. et al. (1996); Mechanistic studies on the inactivation of human cytochrome P450 1A2 by furafylline, ISSX Proceedings, 7th North American ZSSX Meeting, San Diego, CA, October 20-25, 1996, 10, 229",
                "Kunze. K.L. et al. (1996); Novel aspects of the oxidation of 8-ethyl xanthine analogs of furafylline by human P4501A2, ZSSX Proceedings, 7th North Amencan ZSSX Meeting, San Diego, CA, USA, October 20-25, 1996, 10, 230."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0280",
                     "inchikey" : "FYEQPVVQKHHCMQ-UHFFFAOYSA-N",
                         "name" : "3-[(furan-2-yl)methyl]-8-hydroxy-1-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",
                    "structure" : "[H]OC1=NC2=C(N1[H])C(=O)N(C(=O)N2C([H])([H])C1=C([H])C([H])=C([H])O1)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Alkyl hydroxylation"
            ]
        },
        "BIOTID0286" : {
                             "Name" : "galangin",
            "Substrate's structure" : "C12=C(OC(=C(C1=O)O[H])C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C(=C(C(=C2O[H])[H])O[H])[H]",
                         "InChIKey" : "VCCRNZQBSJXYJD-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 ; CYP2C9",
                       "References" : [
                      "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",  
              ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0281",
                     "inchikey" : "IYRMWMYZSQPJKC-UHFFFAOYSA-N",
                         "name" : "4'-OH-galangin",
                    "structure" : "[H]OC1=C([H])C2=C(C(=O)C(O[H])=C(O2)C2=C([H])C([H])=C(O)C([H])=C2[H])C(O[H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0287" : {
                             "Name" : "galantamine",
            "Substrate's structure" : "[C@]123C4=C(O[C@]1(C([C@](C(=C2[H])[H])(O[H])[H])([H])[H])[H])C(=C(C(=C4C(N(C(C3([H])[H])([H])[H])C([H])([H])[H])([H])[H])[H])[H])OC([H])([H])[H]",
                         "InChIKey" : "ASUTZQLVASHGKV-JDFRZJQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0282",
                     "inchikey" : "OYSGWKOGUVOGFQ-RBOXIYTFSA-N",
                         "name" : "O-Desmethylgalantamine",
                    "structure" : "[H]OC1=C([H])C([H])=C2C3=C1O[C@@]1([H])C([H])([H])[C@@]([H])(O[H])C([H])=C([H])[C@@]31C([H])([H])C([H])([H])N(C([H])([H])[H])C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation",
                "N-dealkylation"
            ]
        },
        "BIOTID0288" : {
                             "Name" : "galantamine",
            "Substrate's structure" : "[C@]123C4=C(O[C@]1(C([C@](C(=C2[H])[H])(O[H])[H])([H])[H])[H])C(=C(C(=C4C(N(C(C3([H])[H])([H])[H])C([H])([H])[H])([H])[H])[H])[H])OC([H])([H])[H]",
                         "InChIKey" : "ASUTZQLVASHGKV-JDFRZJQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0283",
                     "inchikey" : "LROQBKNDGTWXET-FVWDGWMTSA-N",
                         "name" : "Galantamine N-oxide",
                    "structure" : "[H]O[C@@]1([H])C([H])=C([H])[C@@]23C4=C(O[C@@]2([H])C1([H])[H])C(OC([H])([H])[H])=C([H])C([H])=C4C([H])([H])[N+]([O-])(C([H])([H])[H])C([H])([H])C3([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0289" : {
                             "Name" : "genistein",
            "Substrate's structure" : "C1(=C(C(=O)C=2C(=C(C(=C(C2O1)[H])O[H])[H])O[H])C=3C(=C(C(=C(C3[H])[H])O[H])[H])[H])[H]",
                         "InChIKey" : "TZBJGXHYKVUXJN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0284",
                     "inchikey" : "IOYHCQBYQJQBSK-UHFFFAOYSA-N",
                         "name" : "3'-OH-genistein",
                    "structure" : "[H]OC1=C([H])C2=C(C(=O)C(=C([H])O2)C2=C([H])C(O)=C(O[H])C([H])=C2[H])C(O[H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0290" : {
                             "Name" : "granisetron",
            "Substrate's structure" : "C1(=C(C(=C2C(=C1[H])C(=NN2C([H])([H])[H])C(=O)N(C3(C([C@]4(N([C@@](C3([H])[H])(C(C(C4([H])[H])([H])[H])([H])[H])[H])C([H])([H])[H])[H])([H])[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "MFWNKCLOYSRHCJ-BTTYYORXSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1",
                       "References" : [
                          "Bloomer, J.C.; Baldwin, S.J.; Smith, G.J.; Ayrton, A.D.; Clarke, S.E.; Chenery, R.J. Characterisation of the Cytochrome P450 Enzymes Involved in the In Vitro Metabolism of Granisetron. Br. J. Clin. Pharmacol. 1994, 38, 557–567; PMID:7888294; PMCID: PMC1364919"
                        ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0285",
                     "inchikey" : "CGNLROWYSDSBMN-YHWZYXNKSA-N",
                         "name" : "7-Hydroxygranisetron",
                    "structure" : "[H]N(C(=O)C1=NN(C2=C([H])C([H])=C([H])C(O)=C12)C([H])([H])[H])C1([H])C([H])([H])[C@@]2([H])N(C([H])([H])[H])[C@]([H])(C([H])([H])C([H])([H])C2([H])[H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0291" : {
                             "Name" : "granisetron",
            "Substrate's structure" : "C1(=C(C(=C2C(=C1[H])C(=NN2C([H])([H])[H])C(=O)N(C3(C([C@]4(N([C@@](C3([H])[H])(C(C(C4([H])[H])([H])[H])([H])[H])[H])C([H])([H])[H])[H])([H])[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "MFWNKCLOYSRHCJ-BTTYYORXSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major); CYP1A1; CYP2D6; CYP3A5",
                       "References" : [
                          "Bloomer, J.C.; Baldwin, S.J.; Smith, G.J.; Ayrton, A.D.; Clarke, S.E.; Chenery, R.J. Characterisation of the Cytochrome P450 Enzymes Involved in the In Vitro Metabolism of Granisetron. Br. J. Clin. Pharmacol. 1994, 38, 557–567; PMID:7888294; PMCID: PMC1364919"
                      ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0286",
                     "inchikey" : "GHVQAOGYNZNTIA-YHWZYXNKSA-N",
                         "name" : "9'-Desmethylgranisetron",
                    "structure" : "[H]N(C(=O)C1=NNC2=C([H])C([H])=C([H])C([H])=C12)C1([H])C([H])([H])[C@@]2([H])N(C([H])([H])[H])[C@]([H])(C([H])([H])C([H])([H])C2([H])[H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0292" : {
                             "Name" : "guanabenz",
            "Substrate's structure" : "N(=C(N([H])[H])N([H])[H])/N=C(/C=1C(=C(C(=C(C1Cl)[H])[H])[H])Cl)\\[H]",
                         "InChIKey" : "WDZVGELJXXEGPV-YIXHJXPBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                          "Clement, B.; Demesmaeker, M. Formation of Guanoxabenz from Guanabenz in Human Liver: a New Metabolic Marker for CYP1A2. Drug Metab. Dispos. 1997, 25, 1266–1271.; PMID:9351903"
                       ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0287",
                     "inchikey" : "QKIQJNNDIWGVEH-UHFFFAOYSA-N",
                         "name" : "Guanoxabenz",
                    "structure" : "[H]N([H])C(=N\\N=C([H])C1=C(Cl)C([H])=C([H])C([H])=C1Cl)\\N([H])O"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0293" : {
                             "Name" : "haloperidol",
            "Substrate's structure" : "O(C1(C(C(N(C(C(C(C(=O)C2=C(C(=C(F)C(=C2[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])C(C1([H])[H])([H])[H])([H])[H])([H])[H])C3=C(C(=C(Cl)C(=C3[H])[H])[H])[H])[H]",
                         "InChIKey" : "LNEPOXFFQSENCJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2D6",
                       "References" : [
                          "Fang, J.; Baker, G.B.; Coutts, R.T.; Silverstone, P. Enzymatic Studies on the Metabolism of Haloperidol: Invovement of CYP3A4 and 2D6. ISSX Proceedings, 7th North American ISSX Meeting, San Diego, CA, USA, Oct 20 – 25, 1996; International Society for the Study of Xenobiotics: Bethesda, MD, 1996; Vol. 10, 357;"
                          "Usuki, E.; Van Der Schyf, C.J.; Castagnoli, N., Jr Metabolism of Haloperidol and Tetrahydropyridine Dehydration Product HPTP. Drug Metab. Rev. 1998, 30, 809–826.",
                          "Takeshita, M.; Miura, M.; Ohkubo, T.; Sugawara, K. Asymmetric Redox Reactions in Human Liver Stereoselective Oxidation of Optically Active Dihydrohaloperidols, Dihydrobromoperidols and Stereospecific Reduction of Haloperidol and Bromoperidol. Enantiomer 2000, 5, 189–195"

                       ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0288",
                     "inchikey" : "WUYWHIAAQYQKPP-UHFFFAOYSA-N",
                         "name" : "p-Fluorobenzoylpropionic acid and 4-(4-chlorophenyl)-4-hydroxypiperidine",
                    "structure" : "[H]C1=C([H])C(=C([H])C([H])=C1F)C(=O)C([H])([H])C([H])([H])C(O)=O AND [H]OC1(C2=C([H])C([H])=C(Cl)C([H])=C2[H])C([H])([H])C([H])([H])NC([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0294" : {
                             "Name" : "haloperidol",
            "Substrate's structure" : "O(C1(C(C(N(C(C(C(C(=O)C2=C(C(=C(F)C(=C2[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])C(C1([H])[H])([H])[H])([H])[H])([H])[H])C3=C(C(=C(Cl)C(=C3[H])[H])[H])[H])[H]",
                         "InChIKey" : "LNEPOXFFQSENCJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                          "Fang, J.; Baker, G.B.; Coutts, R.T.; Silverstone, P. Enzymatic Studies on the Metabolism of Haloperidol: Invovement of CYP3A4 and 2D6. ISSX Proceedings, 7th North American ISSX Meeting, San Diego, CA, USA, Oct 20 – 25, 1996; International Society for the Study of Xenobiotics: Bethesda, MD, 1996; Vol. 10, 357;"
                          "Usuki, E.; Van Der Schyf, C.J.; Castagnoli, N., Jr Metabolism of Haloperidol and Tetrahydropyridine Dehydration Product HPTP. Drug Metab. Rev. 1998, 30, 809–826.",
                          "Takeshita, M.; Miura, M.; Ohkubo, T.; Sugawara, K. Asymmetric Redox Reactions in Human Liver Stereoselective Oxidation of Optically Active Dihydrohaloperidols, Dihydrobromoperidols and Stereospecific Reduction of Haloperidol and Bromoperidol. Enantiomer 2000, 5, 189–195"
                      ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0289",
                     "inchikey" : "KAPIKUHBALFONG-UHFFFAOYSA-N",
                         "name" : "Haloperidol pyridinium",
                    "structure" : "[H]C1=C([H])C(=C([H])C([H])=C1F)C(=O)C([H])([H])C([H])([H])C([H])([H])[N+]1=C([H])C([H])=C(C([H])=C1[H])C1=C([H])C([H])=C(Cl)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Heteroring dehydrogenation"
            ]
        },
        "BIOTID0295" : {
                             "Name" : "harmaline",
            "Substrate's structure" : "C=12C3=C(N(C1C(=NC(C2([H])[H])([H])[H])C([H])([H])[H])[H])C(=C(C(=C3[H])[H])OC([H])([H])[H])[H]",
                         "InChIKey" : "RERZNCLIYCABFS-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (major); CYP1A2 (minor)",
                       "References" : [
                          "Yu, A. M., Idle, J. R., Krausz, K. W., Kupfer, A., Gonzalez, F. J. 2003d. Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic β-carboline alkaloids har- maline and harmine. J Pharmacol Exp Ther 305:315–322.; PMID:12649384"
                      ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0290",
                     "inchikey" : "RHVPEFQDYMMNSY-UHFFFAOYSA-N",
                         "name" : "Harmalol",
                    "structure" : "[H]N1C2=C(C([H])=C([H])C(O)=C2[H])C2=C1C(=NC([H])([H])C2([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0296" : {
                             "Name" : "harmine",
            "Substrate's structure" : "C=12C3=C(N(C1C(=NC(=C2[H])[H])C([H])([H])[H])[H])C(=C(C(=C3[H])[H])OC([H])([H])[H])[H]",
                         "InChIKey" : "BXNJHAXVSOCGBA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (major); CYP2C9 (minor); CYP2C19 (minor); CYP1A2 (minor)",
                       "References" : [
                          "Wang and Zhou (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0291",
                     "inchikey" : "AVGHDEIZJIEIFK-UHFFFAOYSA-N",
                         "name" : "Harmol",
                    "structure" : "[H]N1C2=C(C([H])=C(O)C(OC([H])([H])[H])=C2[H])C2=C1C(=NC([H])=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0297" : {
                             "Name" : "harmine",
            "Substrate's structure" : "C=12C3=C(N(C1C(=NC(=C2[H])[H])C([H])([H])[H])[H])C(=C(C(=C3[H])[H])OC([H])([H])[H])[H]",
                         "InChIKey" : "BXNJHAXVSOCGBA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                          "Wang and Zhou (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
                       ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0292",
                     "inchikey" : "SATMZMMKDDTOSQ-UHFFFAOYSA-N",
                         "name" : "6-OH-harmaline",
                    "structure" : "[H]N1C2=C(C([H])=C([H])C(O)=C2[H])C2=C1C(=NC([H])=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0298" : {
                             "Name" : "hexane",
            "Substrate's structure" : "C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "VLKZOEOYAKHREP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP2E1",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0293",
                     "inchikey" : "QNVRIHYSUZMSGM-UHFFFAOYNA-N",
                         "name" : "Hexanol",
                    "structure" : "[H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0299" : {
                             "Name" : "imatinib",
            "Substrate's structure" : "O=C(N(C1=C(C(N(C=2N=C(C=3C(=C(C(=NC3[H])[H])[H])[H])C(=C(N2)[H])[H])[H])=C(C(=C1[H])[H])C([H])([H])[H])[H])[H])C4=C(C(=C(C(N5C(C(N(C(C5([H])[H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])([H])[H])C(=C4[H])[H])[H])[H]",
                         "InChIKey" : "KTUFNOKKBVMGRW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major); CYP2C8",
                       "References" : [
                          "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675; PMID:19515014"
                        ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0294",
                     "inchikey" : "BQQYXPHRXIZMDM-UHFFFAOYSA-N",
                         "name" : "N-desmethylimatinib",
                    "structure" : "[H]N(C(=O)C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])N1C([H])([H])C([H])([H])NC([H])([H])C1([H])[H])C1=C([H])C(N([H])C2=NC([H])=C([H])C(=N2)C2=C([H])N=C([H])C([H])=C2[H])=C(C([H])=C1[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0300" : {
                             "Name" : "imipramine",
            "Substrate's structure" : "C(N(C([H])([H])[H])C(C(C(N1C2=C(C(=C(C(=C2C(C(C3=C(C(=C(C(=C13)[H])[H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "BCGWQEUPMDMJNV-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP2C19 (major); CYP2D6 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0295",
                     "inchikey" : "ROTCPJFWLNDKHU-UHFFFAOYSA-N",
                         "name" : "2-Hydroxyimipramine",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N(C1=C([H])C([H])=C(O)C([H])=C1C([H])([H])C2([H])[H])C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0301" : {
                             "Name" : "imipramine",
            "Substrate's structure" : "C(N(C([H])([H])[H])C(C(C(N1C2=C(C(=C(C(=C2C(C(C3=C(C(=C(C(=C13)[H])[H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "BCGWQEUPMDMJNV-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP2C19; CYP2C18; CYP2D6; CYP1A2 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0296",
                     "inchikey" : "HCYAFALTSJYZDH-UHFFFAOYSA-N",
                         "name" : "Desimipramine",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N(C1=C([H])C([H])=C([H])C([H])=C1C([H])([H])C2([H])[H])C([H])([H])C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0302" : {
                             "Name" : "indiplon",
            "Substrate's structure" : "C=1(C(=C(SC1C(C=2C(=NN3C2N=C(C(=C3C=4C(=C(N(C([H])([H])[H])C(C([H])([H])[H])=O)C(=C(C4[H])[H])[H])[H])[H])[H])[H])=O)[H])[H])[H]",
                         "InChIKey" : "CBIAWPMZSFFRGN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0297",
                     "inchikey" : "KZQWYRRAKXJLDE-UHFFFAOYSA-N",
                         "name" : "N-Desmethylindiplon",
                    "structure" : "[H]C1=C([H])C([H])=C(S1)C(=O)C1=C2N=C([H])C([H])=C(N2N=C1[H])C1=C([H])C([H])=C([H])C(NC(=O)C([H])([H])[H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0303" : {
                             "Name" : "indomethacin",
            "Substrate's structure" : "C(OC1=C(C2=C(C(=C1[H])[H])N(C(=O)C3=C(C(=C(Cl)C(=C3[H])[H])[H])[H])C(C([H])([H])[H])=C2C(C(O[H])=O)([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "CGIGDMFJXJATDK-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "159665",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 (major); CYP2C19 (minor); CYP2D6 (minor); CYP1A2 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0298",
                     "inchikey" : "KMLNWQPYFBIALN-UHFFFAOYSA-N",
                         "name" : "O-Desmethylindomethacin",
                    "structure" : "[H]OC(=O)C([H])([H])C1=C(N(C(=O)C2=C([H])C([H])=C(Cl)C([H])=C2[H])C2=C1C([H])=C(O)C([H])=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0304" : {
                             "Name" : "irbesartan",
            "Substrate's structure" : "C(C(C(C(C1=NC2(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])C(=O)N1C(C3=C(C(=C(C(=C3[H])[H])C4=C(C(=C(C(=C4C5=NN(N=N5)[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "YOSHYTLCDANDAN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0299",
                     "inchikey" : "YASLDPAAWWZGIP-UHFFFAOYNA-N",
                         "name" : "2-(3-hydroxybutyl)-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one",
                    "structure" : "[H]N1N=NC(=N1)C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])N1C(=O)C2(N=C1C([H])([H])C([H])([H])C([H])(O)C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0305" : {
                             "Name" : "irbesartan",
            "Substrate's structure" : "C(C(C(C(C1=NC2(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])C(=O)N1C(C3=C(C(=C(C(=C3[H])[H])C4=C(C(=C(C(=C4C5=NN(N=N5)[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "YOSHYTLCDANDAN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0300",
                     "inchikey" : "SGLAKMDXJPVHBY-UHFFFAOYNA-N",
                         "name" : "M7",
                    "structure" : "[H]N1N=NC(=N1)C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])N1C(=O)C2(N=C1C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])(O)C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0306" : {
                             "Name" : "irbesartan",
            "Substrate's structure" : "C(C(C(C(C1=NC2(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])C(=O)N1C(C3=C(C(=C(C(=C3[H])[H])C4=C(C(=C(C(=C4C5=NN(N=N5)[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "YOSHYTLCDANDAN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0300",
                     "inchikey" : "SGLAKMDXJPVHBY-UHFFFAOYNA-N",
                         "name" : "M5",
                    "structure" : "[H]N1N=NC(=N1)C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])N1C(=O)C2(N=C1C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])(O)C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0307" : {
                             "Name" : "irinotecan",
            "Substrate's structure" : "C(C(C1=C2C(N3C(=C(C4=C(C(OC(=O)[C@]4(O[H])C(C([H])([H])[H])([H])[H])([H])[H])C3=O)[H])C2=NC5=C1C(=C(OC(=O)N6C(C(C(C(C6([H])[H])([H])[H])(N7C(C(C(C(C7([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])C(=C5[H])[H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "UWKQSNNFCGGAFS-XIFFEERXSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Rouits, E. et al (2008); Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients; British Journal of Cancer 99, 1239 ��� 1245"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0301",
                     "inchikey" : "BSVVZICJFYZDJJ-XIFFEERXSA-N",
                         "name" : "7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin",
                    "structure" : "CCC1=C2C=C(OC(=O)N3CCC(CC3)NCCCCC(O)=O)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O"
                }
            ],
                    "Reaction Type" : [
                "Heterocyclic ring fission"
            ]
        },
        "BIOTID0308" : {
                             "Name" : "kaempferide",
            "Substrate's structure" : "O=C1C2=C(OC(=C1O[H])C3=C(C(=C(C(=C3[H])[H])OC([H])([H])[H])[H])[H])C(=C(C(=C2O[H])[H])O[H])[H]",
                         "InChIKey" : "SQFSKOYWJBQGKQ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 ; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0281",
                     "inchikey" : "IYRMWMYZSQPJKC-UHFFFAOYSA-N",
                         "name" : "4'-OH-galangin",
                    "structure" : "[H]OC1=C([H])C2=C(C(=O)C(O[H])=C(O2)C2=C([H])C([H])=C(O)C([H])=C2[H])C(O[H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0309" : {
                             "Name" : "ketobemidone",
            "Substrate's structure" : "C1(C2=C(C(=C(C(=C2[H])[H])[H])O[H])[H])(C(C(N(C(C1([H])[H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])C(C(C([H])([H])[H])([H])[H])=O",
                         "InChIKey" : "ALFGKMXHOUSVAD-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0302",
                     "inchikey" : "BJTDPLRIKDSWIS-UHFFFAOYSA-N",
                         "name" : "Norketobemidone",
                    "structure" : "[H]OC1=C([H])C([H])=C([H])C(=C1[H])C1(C(=O)C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])NC([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0310" : {
                             "Name" : "l-cyclophosphamide",
            "Substrate's structure" : "[P@]1(N(C(C(C(O1)([H])[H])([H])[H])([H])[H])[H])(N(C(C(Cl)([H])[H])([H])[H])C(C(Cl)([H])[H])([H])[H])=O",
                         "InChIKey" : "CMSMOCZEIVJLDB-CQSZACIVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Whirl-Carrillo, M. et al. (2012); Pharmacogenomics knowledge for personalized medicine; Clin Pharmacol Ther. 2012 Oct;92(4):414-7. doi: 10.1038/clpt.2012.96; PMID:22992668; PMCID:PMC3660037"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0303",
                     "inchikey" : "DZKGMGPLDJOVCX-LLVKDONJSA-N",
                         "name" : "Dechloroethyl cyclophosphamide",
                    "structure" : "[H]N(C([H])([H])C([H])([H])Cl)[P@]1(=O)OC([H])([H])C([H])([H])C([H])([H])N1[H]"
                },
                {
                     "BTMDB_ID" : "BTMDB0303",
                     "inchikey" : "DZKGMGPLDJOVCX-LLVKDONJSA-N",
                         "name" : "Dechloroethyl cyclophosphamide",
                    "structure" : "[H]C(=O)C([H])([H])Cl"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0311" : {
                             "Name" : "l-ifosfamide",
            "Substrate's structure" : "ClC(C(N([P@@]1(=O)OC(C(C(N1C(C(Cl)([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "HOMGKSMUEGBAAB-CQSZACIVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP3A4; CYP3A5",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023",
                "Chugh, R. et al. (2007); Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma; Cancer. 2007 Jun 1;109(11):2315-22; PMID:17464949; DOI:10.1002/cncr.22669"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0304",
                     "inchikey" : "DZKGMGPLDJOVCX-NSHDSACASA-N",
                         "name" : "3-Dechloroethylifosfamide",
                    "structure" : "[H]N(C([H])([H])C([H])([H])Cl)[P@@]1(=O)OC([H])([H])C([H])([H])C([H])([H])N1[H]"
                },
                {
                     "BTMDB_ID" : "BTMDB0304",
                     "inchikey" : "DZKGMGPLDJOVCX-NSHDSACASA-N",
                         "name" : "3-Dechloroethylifosfamide",
                    "structure" : "[H]C(=O)C([H])([H])Cl"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0312" : {
                             "Name" : "l-ifosfamide",
            "Substrate's structure" : "ClC(C(N([P@@]1(=O)OC(C(C(N1C(C(Cl)([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "HOMGKSMUEGBAAB-CQSZACIVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP3A4; CYP3A5",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023",
                "Chugh, R. et al. (2007); Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma; Cancer. 2007 Jun 1;109(11):2315-22; PMID:17464949; DOI:10.1002/cncr.22669"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0305",
                     "inchikey" : "ROGLJLJCDSTWBN-LLVKDONJSA-N",
                         "name" : "2-Dechloroethylifosfamide",
                    "structure" : "[H]N([H])[P@@]1(=O)OC([H])([H])C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])Cl"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0313" : {
                             "Name" : "l-ifosfamide",
            "Substrate's structure" : "ClC(C(N([P@@]1(=O)OC(C(C(N1C(C(Cl)([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "HOMGKSMUEGBAAB-CQSZACIVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6 (major); CYP3A4 (major); CYP2A6 (minor); CYP2C8 (minor); CYP2C9 (minor); CYP2C19 (minor); CYP3A5 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023",
                "Chugh, R. et al. (2007); Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma; Cancer. 2007 Jun 1;109(11):2315-22; PMID:17464949; DOI:10.1002/cncr.22669"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0306",
                     "inchikey" : "JHUJMHKRHQPBRG-LGTFYCNTSA-N",
                         "name" : "4-Hydroxyifosfamide",
                    "structure" : "[H]OC1([H])N(C([H])([H])C([H])([H])Cl)[P@](=O)(OC([H])([H])C1([H])[H])N([H])C([H])([H])C([H])([H])Cl"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0314" : {
                             "Name" : "l-trofosfamide",
            "Substrate's structure" : "N(C(C(Cl)([H])[H])([H])[H])(C(C(Cl)([H])[H])([H])[H])[P@@]1(=O)N(C(C(Cl)([H])[H])([H])[H])C(C(C(O1)([H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "UMKFEPPTGMDVMI-QGZVFWFLSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2B6; CYP2A6; CYP2C9",
                       "References" : [
                "Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0307",
                     "inchikey" : "RAXABQCFPAWRSY-AHMWTOSDSA-N",
                         "name" : "l-ifosfamide",
                    "structure" : "[H]C([H])(Cl)C([H])([H])N(C([H])([H])C([H])([H])Cl)[P@]1(=O)OC([H])([H])C([H])([H])C([H])(O)N1C([H])([H])C([H])([H])Cl"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0315" : {
                             "Name" : "l-trofosfamide",
            "Substrate's structure" : "N(C(C(Cl)([H])[H])([H])[H])(C(C(Cl)([H])[H])([H])[H])[P@@]1(=O)N(C(C(Cl)([H])[H])([H])[H])C(C(C(O1)([H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "UMKFEPPTGMDVMI-QGZVFWFLSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2B6",
                       "References" : [
                "Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023",
                "May-Manke, A. et al. (1999); Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N -dechloroethylation of trofosfamide; Cancer Chemother Pharmacol. 1999;44(4):327-34; PMID:10447581; DOI:10.1007/s002800050985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0308",
                     "inchikey" : "UMKFEPPTGMDVMI-QGZVFWFLSA-N",
                         "name" : "Ifosfamide",
                    "structure" : "[H]C([H])(Cl)C([H])([H])N(C([H])([H])C([H])([H])Cl)[P@]1(=O)OC([H])([H])C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])Cl"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0316" : {
                             "Name" : "l-trofosfamide",
            "Substrate's structure" : "N(C(C(Cl)([H])[H])([H])[H])(C(C(Cl)([H])[H])([H])[H])[P@@]1(=O)N(C(C(Cl)([H])[H])([H])[H])C(C(C(O1)([H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "UMKFEPPTGMDVMI-QGZVFWFLSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2B6",
                       "References" : [
                "Zhang, J. et al. (2005); Metabolism and transport of oxazaphosphorines and the clinical implications; Drug Metab Rev. 2005;37(4):611-703; PMID:16393888; DOI:10.1080/03602530500364023",
                "May-Manke, A. et al. (1999); Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N -dechloroethylation of trofosfamide; Cancer Chemother Pharmacol. 1999;44(4):327-34; PMID:10447581; DOI:10.1007/s002800050985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0309",
                     "inchikey" : "CMSMOCZEIVJLDB-CQSZACIVSA-N",
                         "name" : "l-cyclophosphamide",
                    "structure" : "[H]N1C([H])([H])C([H])([H])C([H])([H])O[P@@]1(=O)N(C([H])([H])C([H])([H])Cl)C([H])([H])C([H])([H])Cl"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0317" : {
                             "Name" : "laquinimod",
            "Substrate's structure" : "C12=C(N(C(C(=C1O[H])C(N(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C(C([H])([H])[H])([H])[H])=O)=O)C([H])([H])[H])C(=C(C(=C2Cl)[H])[H])[H]",
                         "InChIKey" : "GKWPCEFFIHSJOE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tuvesson,H. et al.(2005); CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THEMETABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR; DRUG METABOLISM AND DISPOSITION, 2005, 33, 866-872"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0310",
                     "inchikey" : "HBMNTNTZJMZXKP-UHFFFAOYSA-N",
                         "name" : "5-chloro-N-ethyl-4-hydroxy-N-(4-hydroxyphenyl)-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamide",
                    "structure" : "[H]OC1=C(C(=O)N(C2=C([H])C([H])=C(O)C([H])=C2[H])C([H])([H])C([H])([H])[H])C(=O)N(C2=C1C(Cl)=C([H])C([H])=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0318" : {
                             "Name" : "laquinimod",
            "Substrate's structure" : "C12=C(N(C(C(=C1O[H])C(N(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C(C([H])([H])[H])([H])[H])=O)=O)C([H])([H])[H])C(=C(C(=C2Cl)[H])[H])[H]",
                         "InChIKey" : "GKWPCEFFIHSJOE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tuvesson,H. et al.(2005); CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THEMETABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR; DRUG METABOLISM AND DISPOSITION, 2005, 33, 866-872"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0311",
                     "inchikey" : "BZKCTVZVKAXVFH-UHFFFAOYSA-N",
                         "name" : "5-chloro-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                    "structure" : "[H]OC1=C(C(=O)NC2=C([H])C([H])=C([H])C([H])=C2[H])C(=O)N(C2=C1C(Cl)=C([H])C([H])=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0319" : {
                             "Name" : "laquinimod",
            "Substrate's structure" : "C12=C(N(C(C(=C1O[H])C(N(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C(C([H])([H])[H])([H])[H])=O)=O)C([H])([H])[H])C(=C(C(=C2Cl)[H])[H])[H]",
                         "InChIKey" : "GKWPCEFFIHSJOE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tuvesson,H. et al.(2005); CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THEMETABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR; DRUG METABOLISM AND DISPOSITION, 2005, 33, 866-872"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0312",
                     "inchikey" : "PRSDPSUTNKQSOJ-UHFFFAOYSA-N",
                         "name" : "5-chloro-N-ethyl-4-hydroxy-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                    "structure" : "[H]OC1=C(C(=O)N(C2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])C([H])([H])[H])C(=O)N([H])C2=C1C(Cl)=C([H])C([H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0320" : {
                             "Name" : "laquinimod",
            "Substrate's structure" : "C12=C(N(C(C(=C1O[H])C(N(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C(C([H])([H])[H])([H])[H])=O)=O)C([H])([H])[H])C(=C(C(=C2Cl)[H])[H])[H]",
                         "InChIKey" : "GKWPCEFFIHSJOE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tuvesson,H. et al.(2005); CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THEMETABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR; DRUG METABOLISM AND DISPOSITION, 2005, 33, 866-872"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0313",
                     "inchikey" : "KBIYOPLLPLGYEU-UHFFFAOYSA-N",
                         "name" : "5-chloro-N-ethyl-4,8-dihydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                    "structure" : "[H]OC1=C(C(=O)N(C2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])C([H])([H])[H])C(=O)N(C2=C1C(Cl)=C([H])C([H])=C2O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0321" : {
                             "Name" : "laquinimod",
            "Substrate's structure" : "C12=C(N(C(C(=C1O[H])C(N(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C(C([H])([H])[H])([H])[H])=O)=O)C([H])([H])[H])C(=C(C(=C2Cl)[H])[H])[H]",
                         "InChIKey" : "GKWPCEFFIHSJOE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tuvesson,H. et al.(2005); CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THEMETABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR; DRUG METABOLISM AND DISPOSITION, 2005, 33, 866-872"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0314",
                     "inchikey" : "JQKWEWTUEMBDKZ-UHFFFAOYSA-N",
                         "name" : "5-chloro-N-ethyl-4,7-dihydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                    "structure" : "[H]OC1=C(C(=O)N(C2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])C([H])([H])[H])C(=O)N(C2=C1C(Cl)=C([H])C(O)=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0322" : {
                             "Name" : "laquinimod",
            "Substrate's structure" : "C12=C(N(C(C(=C1O[H])C(N(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C(C([H])([H])[H])([H])[H])=O)=O)C([H])([H])[H])C(=C(C(=C2Cl)[H])[H])[H]",
                         "InChIKey" : "GKWPCEFFIHSJOE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tuvesson,H. et al.(2005); CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THEMETABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR; DRUG METABOLISM AND DISPOSITION, 2005, 33, 866-872"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0315",
                     "inchikey" : "IYYNHKJIMIURLE-UHFFFAOYSA-N",
                         "name" : "5-chloro-N-ethyl-4,6-dihydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                    "structure" : "[H]OC1=C(C(=O)N(C2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])C([H])([H])[H])C(=O)N(C2=C1C(Cl)=C(O)C([H])=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0323" : {
                             "Name" : "lauric acid",
            "Substrate's structure" : "C(C(C(C(C(C(C(C(C(C(C(C(=O)O[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "POULHZVOKOAJMA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1 (major); CYP2C8 (minor); CYP2B6 (minor)",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0316",
                     "inchikey" : "ZDHCZVWCTKTBRY-UHFFFAOYSA-N",
                         "name" : "12-Hydroxylauric acid",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0324" : {
                             "Name" : "licofelone",
            "Substrate's structure" : "C(C1(C([H])([H])[H])C(N2C(C(C(O[H])=O)([H])[H])=C(C(=C2C1([H])[H])C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C4=C(C(=C(Cl)C(=C4[H])[H])[H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "UAWXGRJVZSAUSZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C8; CYP2C19; CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0317",
                     "inchikey" : "OCECVTMNVSFNIW-UHFFFAOYSA-N",
                         "name" : "licofelone M4",
                    "structure" : "CC1(C)CN2C(CC(O)=O)=C(C(=C2C1)C1=CC=C(O)C=C1)C1=CC=C(Cl)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0325" : {
                             "Name" : "licofelone",
            "Substrate's structure" : "C(C1(C([H])([H])[H])C(N2C(C(C(O[H])=O)([H])[H])=C(C(=C2C1([H])[H])C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C4=C(C(=C(Cl)C(=C4[H])[H])[H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "UAWXGRJVZSAUSZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0318",
                     "inchikey" : "QUCLYFKWRYCDCG-UHFFFAOYSA-N",
                         "name" : "licofelone M2",
                    "structure" : "CC1(C)CN2C(CC(O)=O)=C(C(=C2C1)C1=CC=CC=C1)C1=CC=C(Cl)C(O)=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0326" : {
                             "Name" : "lidocaine",
            "Substrate's structure" : "C(C(N(C(C([H])([H])[H])([H])[H])C(C(=O)N(C1=C(C([H])([H])[H])C(=C(C(=C1C([H])([H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "NNJVILVZKWQKPM-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A4; CYP3A5; CYP2C8; CYP2C18; CYP2B6; CYP2A6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Ekins, S. and Wrighton, S.A. (1999); The role of CYP2B6 in Human Xenobiotic Metabolism; Drug Metabolism Reviews, 31:3, 719-754, DOI:10.1081/ DMR-100101942; PMID:10461547",
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0319",
                     "inchikey" : "WRMRXPASUROZGT-UHFFFAOYSA-N",
                         "name" : "Monoethylglycinexylidide",
                    "structure" : "[H]N(C(=O)C([H])([H])NC([H])([H])C([H])([H])[H])C1=C(C([H])=C([H])C([H])=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0327" : {
                             "Name" : "lidocaine",
            "Substrate's structure" : "C(C(N(C(C([H])([H])[H])([H])[H])C(C(=O)N(C1=C(C([H])([H])[H])C(=C(C(=C1C([H])([H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "NNJVILVZKWQKPM-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Ekins, S. and Wrighton, S.A. (1999); The role of CYP2B6 in Human Xenobiotic Metabolism; Drug Metabolism Reviews, 31:3, 719-754, DOI:10.1081/ DMR-100101942; PMID:10461547",
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015",
                "Thomas, J., Meffin, P. (1972). Aromatic hydroxylation of lidocaine and mepivacaine in rats and humans. J. Med. Chem. 15:1046���1049."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0320",
                     "inchikey" : "PMGUCIDDSCRAMY-UHFFFAOYSA-N",
                         "name" : "3-Hydroxylidocaine",
                    "structure" : "[H]N(C(=O)C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])C1=C(C([H])=C([H])C(O)=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0328" : {
                             "Name" : "linomide",
            "Substrate's structure" : "C12=C(N(C(C(=C1O[H])C(N(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C([H])([H])[H])=O)=O)C([H])([H])[H])C(=C(C(=C2[H])[H])[H])[H]",
                         "InChIKey" : "SGOOQMRIPALTEL-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tuvesson, H. et al.(2005); CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THEMETABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR; DRUG METABOLISM AND DISPOSITION, 2005, 33, 866-827"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0321",
                     "inchikey" : "AHXNUHLQDWODQB-UHFFFAOYSA-N",
                         "name" : "4,8-dihydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                    "structure" : "[H]OC1=C(C(=O)N(C2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])[H])C(=O)N(C2=C1C([H])=C([H])C([H])=C2O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0329" : {
                             "Name" : "linomide",
            "Substrate's structure" : "C12=C(N(C(C(=C1O[H])C(N(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C([H])([H])[H])=O)=O)C([H])([H])[H])C(=C(C(=C2[H])[H])[H])[H]",
                         "InChIKey" : "SGOOQMRIPALTEL-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tuvesson,H. et al.(2000) Identification of cytochrome P4503A as the major subfamily responsible for the metabolismof roquinimex in man, Xenobiotica, 30:9, 905-914, DOI: 10.1080/004982500433327"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0322",
                     "inchikey" : "NPWHYPYXYXHWLK-UHFFFAOYSA-N",
                         "name" : "4,7-dihydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                    "structure" : "[H]OC1=C(C(=O)N(C2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])[H])C(=O)N(C2=C1C([H])=C([H])C(O)=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0330" : {
                             "Name" : "linomide",
            "Substrate's structure" : "C12=C(N(C(C(=C1O[H])C(N(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C([H])([H])[H])=O)=O)C([H])([H])[H])C(=C(C(=C2[H])[H])[H])[H]",
                         "InChIKey" : "SGOOQMRIPALTEL-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tuvesson,H. et al.(2000) Identification of cytochrome P4503A as the major subfamily responsible for the metabolismof roquinimex in man, Xenobiotica, 30:9, 905-914, DOI: 10.1080/004982500433327"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0323",
                     "inchikey" : "TXDLBIHXLIOKOO-UHFFFAOYSA-N",
                         "name" : "4,6-dihydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                    "structure" : "[H]OC1=C(C(=O)N(C2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])[H])C(=O)N(C2=C1C([H])=C(O)C([H])=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0331" : {
                             "Name" : "linomide",
            "Substrate's structure" : "C12=C(N(C(C(=C1O[H])C(N(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C([H])([H])[H])=O)=O)C([H])([H])[H])C(=C(C(=C2[H])[H])[H])[H]",
                         "InChIKey" : "SGOOQMRIPALTEL-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tuvesson,H. et al.(2000) Identification of cytochrome P4503A as the major subfamily responsible for the metabolismof roquinimex in man, Xenobiotica, 30:9, 905-914, DOI: 10.1080/004982500433327"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0324",
                     "inchikey" : "ZZCUZAQEHJPLGL-UHFFFAOYSA-N",
                         "name" : "4-hydroxy-N-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                    "structure" : "[H]OC1=C(C(=O)N(C2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])[H])C(=O)NC2=C1C([H])=C([H])C([H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0332" : {
                             "Name" : "linomide",
            "Substrate's structure" : "C12=C(N(C(C(=C1O[H])C(N(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C([H])([H])[H])=O)=O)C([H])([H])[H])C(=C(C(=C2[H])[H])[H])[H]",
                         "InChIKey" : "SGOOQMRIPALTEL-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tuvesson,H. et al.(2000) Identification of cytochrome P4503A as the major subfamily responsible for the metabolismof roquinimex in man, Xenobiotica, 30:9, 905-914, DOI: 10.1080/004982500433327"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0325",
                     "inchikey" : "SCIYKTDXFNBCIV-UHFFFAOYSA-N",
                         "name" : "4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",
                    "structure" : "[H]OC1=C(C(=O)NC2=C([H])C([H])=C([H])C([H])=C2[H])C(=O)N(C)C2=C1C([H])=C([H])C([H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0333" : {
                             "Name" : "linomide",
            "Substrate's structure" : "C12=C(N(C(C(=C1O[H])C(N(C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])C([H])([H])[H])=O)=O)C([H])([H])[H])C(=C(C(=C2[H])[H])[H])[H]",
                         "InChIKey" : "SGOOQMRIPALTEL-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Tuvesson,H. et al.(2000) Identification of cytochrome P4503A as the major subfamily responsible for the metabolism of roquinimex in man, Xenobiotica, 30:9, 905-914, DOI: 10.1080/004982500433327"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0326",
                     "inchikey" : "JWKWHXCWAUZAOS-UHFFFAOYSA-N",
                         "name" : "4-hydroxy-N-(4-hydroxyphenyl)-N,1-dimethyl-2-oxo-1,2-dihydroquinoline-3-carboxamide",
                    "structure" : "[H]OC1=C(C(=O)N(C)C2=C([H])C([H])=C(O)C([H])=C2[H])C(=O)N(C)C2=C1C([H])=C([H])C([H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0334" : {
                             "Name" : "lisofylline",
            "Substrate's structure" : "C12=C(N(C(N(C1=O)C(C(C(C([C@@](C([H])([H])[H])(O[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])=O)C([H])([H])[H])N=C(N2C([H])([H])[H])[H]",
                         "InChIKey" : "NSMXQKNUPPXBRG-SECBINFHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2A6",
                       "References" : [
                "Shin, H.S. et al. (1998); CYP3A4-mediated Oxidation of Lisofylline to Lisofylline 4,5-diol in Human Liver Microsomes, Journal of Pharmaceutical Sciences, 1998, 87, 390-393"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0327",
                     "inchikey" : "ZJBOLBRXIQZJSF-VEDVMXKPSA-N",
                         "name" : "lisofylline 4,5-diol",
                    "structure" : "[H]O[C@]([H])(C([H])([H])[H])C([H])(O[H])C([H])([H])C([H])([H])C([H])([H])N1C(=O)N(C2=C(N(C([H])=N2)C([H])([H])[H])C1=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0335" : {
                             "Name" : "lisofylline",
            "Substrate's structure" : "C12=C(N(C(N(C1=O)C(C(C(C([C@@](C([H])([H])[H])(O[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])=O)C([H])([H])[H])N=C(N2C([H])([H])[H])[H]",
                         "InChIKey" : "NSMXQKNUPPXBRG-SECBINFHSA-N",
                      "DrugBank ID" : "DB00806",
                       "PubChem ID" : "4740",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Lee, S.H. et al. (1997); Cytochrome P450 Isozymes Involved in Lisofylline Metabolism to Pentoxifylline in Human Liver Microsomes, Drug Metabolism and Disposition, 1997, 25, 1354-1358",
                "Lillibridge. et al. (1996); Metabolism of Lisofylline and Pentoxifylline in Human Liver Microsomes and Cytosol, Drug Metabolism and Disposition, 1996, 24, 1174-1179",
                "Shin, H.S. et al. (1998); CYP3A4-mediated Oxidation of Lisofylline to Lisofylline 4,5-diol in Human Liver Microsomes, Journal of Pharmaceutical Sciences, 1998, 87, 390-393"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0328",
                     "inchikey" : "BYPFEZZEUUWMEJ-UHFFFAOYSA-N",
                         "name" : "pentoxifylline",
                    "structure" : "[H]C1=NC2=C(N1C([H])([H])[H])C(=O)N(C(=O)N2C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0336" : {
                             "Name" : "loperamide",
            "Substrate's structure" : "C(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])(C(C(N3C(C(C(C(C3([H])[H])([H])[H])(C4=C(C(=C(C(=C4[H])[H])Cl)[H])[H])O[H])([H])[H])([H])[H])([H])[H])([H])[H])C(N(C([H])([H])[H])C([H])([H])[H])=O",
                         "InChIKey" : "RDOIQAHITMMDAJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2D6; CYP2C8; CYP2B6",
                       "References" : [
                "Kalgutkar, A.S. et al. (2004); IDENTIFICATION OF AN N-METHYL-4-PHENYLPYRIDINIUM-LIKE METABOLITE OF THE ANTIDIARRHEAL AGENT LOPERAMIDE IN HUMAN LIVER MICROSOMES: UNDER LYING REASON(S) FOR THE LACK OF NEUROTOXICITY DESPITE THE BIOACTIVATION EVENT,  DRUG METABOLISM  AND DISPOSITION, 2004, 32, 943���952",
                "Yue, L. et al. (2016); Identification of novel small-molecule inhibitors targeting menin���MLL interaction, repurposing the antidiarrheal loperamide, Organic & Biomolecular Chemistry, 2016, 14, 8503-8519",
                "Niemi, M. et al. (2006); Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide, Eur J Clin Pharmacol 2006, 62: 463\r���472, DOI: 10.1007/s00228-006-0133-z",
                "Kim, K-A. et al. (2004); Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes,  Eur J Clin Pharmacol, 2004, 60, 575���581, DOI 10.1007/s00228-004-0815-3"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0329",
                     "inchikey" : "ZMOPTLXEYOVARP-UHFFFAOYSA-N",
                         "name" : "N-Desmethyloperamide",
                    "structure" : "[H]N(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0337" : {
                             "Name" : "lornoxicam",
            "Substrate's structure" : "S1(C2=C(C(=C(N1C([H])([H])[H])C(N(C3=NC(=C(C(=C3[H])[H])[H])[H])[H])=O)O[H])SC(=C2[H])Cl)(=O)=O",
                         "InChIKey" : "WLHQHAUOOXYABV-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 ",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0330",
                     "inchikey" : "NQOMZUZLRFQVLR-UHFFFAOYSA-N",
                         "name" : "5'-Hydroxylornoxicam",
                    "structure" : "CN1C(C(=O)NC2=NC=C(O)C=C2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0338" : {
                             "Name" : "losartan",
            "Substrate's structure" : "C(C(C(C(C1=NC(Cl)=C(C(O[H])([H])[H])N1C(C2=C(C(=C(C(=C2[H])[H])C3=C(C(=C(C(=C3C4=NN(N=N4)[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "PSIFNNKUMBGKDQ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Ekins, S. and Wrighton, S.A. (1999); The role of CYP2B6 in Human Xenobiotic Metabolism; Drug Metabolism Reviews, 31:3, 719-754, DOI:10.1081/ DMR-100101942; PMID:10461547",
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0331",
                     "inchikey" : "ZEUXAIYYDDCIRX-UHFFFAOYSA-N",
                         "name" : "E-3174",
                    "structure" : "[H]OC(=O)C1=C(Cl)N=C(N1C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1C1=NN([H])N=N1)C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0339" : {
                             "Name" : "lovastatin",
            "Substrate's structure" : "[H][C@]12[C@](C([C@@](C([H])([H])[H])(C(=C1C(=C([C@](C([H])([H])[H])([C@@]2(C(C([C@@]3(C([C@@](O[H])(C(C(=O)O3)([H])[H])[H])([H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])[H])[H])([H])[H])(OC(=O)[C@@](C([H])([H])[H])(C(C([H])([H])[H])([H])[H])[H])[H]",
                         "InChIKey" : "PCZOHLXUXFIOCF-BXMDZJJMSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Jacobsen, W. et al. (1999); Comparison of Cytochrome P-450-Dependent Metabolism and Drug Interactions of the 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Lovastatin and Pravastatin in the Liver; DRUG METABOLISM  AND DISPOSITION, 1999, 27, 173���179",
                "Wang, R.W. et al. (1991); Biotransformation of lovastatin: IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes; Archives of Biochemistry and Biophysics, 1991, 290, 355-361",
                "Caron, G. et al. (2007); Predicting the Oxidative Metabolism of Statins: An Application\rof the MetaSite Algorithm; Pharmaceutical Research, 2007, 24, 480-501"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0332",
                     "inchikey" : "FUCXPWLYQFERRA-QOPMPQMQSA-N",
                         "name" : "6'beta-Hydroxylovastatin",
                    "structure" : "[H]O[C@@]1([H])C([H])([H])C(=O)O[C@]([H])(C([H])([H])C([H])([H])[C@@]2([H])[C@]([H])(C([H])=C([H])C3=C([H])[C@](O)(C([H])([H])[H])C([H])([H])[C@]([H])(OC(=O)[C@@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[H])[C@]23[H])C([H])([H])[H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0340" : {
                             "Name" : "lovastatin",
            "Substrate's structure" : "[H][C@]12[C@](C([C@@](C([H])([H])[H])(C(=C1C(=C([C@](C([H])([H])[H])([C@@]2(C(C([C@@]3(C([C@@](O[H])(C(C(=O)O3)([H])[H])[H])([H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])[H])[H])([H])[H])(OC(=O)[C@@](C([H])([H])[H])(C(C([H])([H])[H])([H])[H])[H])[H]",
                         "InChIKey" : "PCZOHLXUXFIOCF-BXMDZJJMSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Jacobsen, W. et al. (1999); Comparison of Cytochrome P-450-Dependent Metabolism and Drug Interactions of the 3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Lovastatin and Pravastatin in the Liver; DRUG METABOLISM  AND DISPOSITION, 1999, 27, 173���179",
                "Wang, R.W. et al. (1991); Biotransformation of lovastatin: IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes; Archives of Biochemistry and Biophysics, 1991, 290, 355-361",
                "Caron, G. et al. (2007); Predicting the Oxidative Metabolism of Statins: An Application\rof the MetaSite Algorithm; Pharmaceutical Research, 2007, 24, 480-501"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0333",
                     "inchikey" : "BFOCOHWMHIGTLP-PCXYPTFZSA-N",
                         "name" : "3-Hydroxylovastatin",
                    "structure" : "CC[C@H](O)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0341" : {
                             "Name" : "m-xylene",
            "Substrate's structure" : "C=1(C(=C(C(C([H])([H])[H])=C(C1C([H])([H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "IVSZLXZYQVIEFR-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Tassaneeyakul, W. et al. (1996); Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene, The Journal of Pharmacology and Experimental Therapeutics January 1996,  276, 101-108"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0334",
                     "inchikey" : "KUFFULVDNCHOFZ-UHFFFAOYSA-N",
                         "name" : "2,4-Dimethylphenol",
                    "structure" : "[H]OC1=C(C([H])=C(C([H])=C1[H])C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0342" : {
                             "Name" : "m-xylene",
            "Substrate's structure" : "C=1(C(=C(C(C([H])([H])[H])=C(C1C([H])([H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "IVSZLXZYQVIEFR-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Tassaneeyakul, W. et al. (1996); Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene, The Journal of Pharmacology and Experimental Therapeutics January 1996,  276, 101-108"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0335",
                     "inchikey" : "JJCKHVUTVOPLBV-UHFFFAOYSA-N",
                         "name" : "3-Methylbenzylalcohol",
                    "structure" : "[H]OC([H])([H])C1=C([H])C(=C([H])C([H])=C1[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0343" : {
                             "Name" : "maprotiline",
            "Substrate's structure" : "N(C(C(C(C12C(C(C(C=3C1=C(C(=C(C3[H])[H])[H])[H])(C=4C2=C(C(=C(C4[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])(C([H])([H])[H])[H]",
                         "InChIKey" : "QSLMDECMDJKHMQ-GSXCWMCISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP1A2",
                       "References" : [
                "Regioselective Metabolism of Toluene and o-, m- and p-Xylene1"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0336",
                     "inchikey" : "IFHUOEQJTQWFGJ-UHFFFAOYSA-N",
                         "name" : "desmethylmaprotiline",
                    "structure" : "[H]NC([H])([H])C([H])([H])C([H])([H])C12C3=C([H])C([H])=C([H])C([H])=C3C([H])(C3=C([H])C([H])=C([H])C([H])=C13)C([H])([H])C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0344" : {
                             "Name" : "maprotiline",
            "Substrate's structure" : "N(C(C(C(C12C(C(C(C=3C1=C(C(=C(C3[H])[H])[H])[H])(C=4C2=C(C(=C(C4[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])(C([H])([H])[H])[H]",
                         "InChIKey" : "QSLMDECMDJKHMQ-GSXCWMCISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0337",
                     "inchikey" : "XEIQDMGVTYYHBG-UHFFFAOYNA-N",
                         "name" : "3-OH-maprotiline",
                    "structure" : "[H]N(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C12C3=C([H])C([H])=C([H])C([H])=C3C([H])(C3=C([H])C([H])=C(O)C([H])=C13)C([H])([H])C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0345" : {
                             "Name" : "maprotiline",
            "Substrate's structure" : "N(C(C(C(C12C(C(C(C=3C1=C(C(=C(C3[H])[H])[H])[H])(C=4C2=C(C(=C(C4[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])(C([H])([H])[H])[H]",
                         "InChIKey" : "QSLMDECMDJKHMQ-GSXCWMCISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0338",
                     "inchikey" : "RGTALAKWLKCOBO-UHFFFAOYNA-N",
                         "name" : "2-OH-maprotiline",
                    "structure" : "[H]N(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C12C3=C([H])C([H])=C([H])C([H])=C3C([H])(C3=C([H])C(O)=C([H])C([H])=C13)C([H])([H])C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0346" : {
                             "Name" : "mefenamic acid",
            "Substrate's structure" : "C(C1=C(C([H])([H])[H])C(N(C2=C(C(=C(C(=C2C(O[H])=O)[H])[H])[H])[H])[H])=C(C(=C1[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "HYYBABOKPJLUIN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 ",
                       "References" : [
                "Hug, F. (2007); Molecular Modelling Analysis of the Metabolism of Mefenamic Acid. Journal of Pharmacology and Toxicology, 2: 72-79; DOI: 10.3923/jpt.2007.72.79"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0339",
                     "inchikey" : "QBONJEHEDCBRMZ-UHFFFAOYSA-N",
                         "name" : "3-hydroxymethyl mefenamic aci",
                    "structure" : "[H]OC(=O)C1=C([H])C([H])=C([H])C([H])=C1N([H])C1=C([H])C([H])=C([H])C(=C1C([H])([H])[H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0347" : {
                             "Name" : "meiqx",
            "Substrate's structure" : "N=1C(=C(N=C2C3=C(C(=C(C12)[H])[H])N(C(=N3)N([H])[H])C([H])([H])[H])C([H])([H])[H])[H]",
                         "InChIKey" : "DVCCCQNKIYNAKB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Fujita, K. et al. (2002). Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats. PMID: 12079509"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0340",
                     "inchikey" : "FVNCCTJGBOTWTM-UHFFFAOYSA-N",
                         "name" : "N-OH-MeIQX",
                    "structure" : "[H]N(O)C1=NC2=C(C([H])=C([H])C3=NC([H])=C(N=C23)C([H])([H])[H])N1C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0348" : {
                             "Name" : "meiqx",
            "Substrate's structure" : "N=1C(=C(N=C2C3=C(C(=C(C12)[H])[H])N(C(=N3)N([H])[H])C([H])([H])[H])C([H])([H])[H])[H]",
                         "InChIKey" : "DVCCCQNKIYNAKB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Fujita, K. et al. (2002). Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats. PMID: 12079509"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0341",
                     "inchikey" : "NKWBDQYTYVRHRD-UHFFFAOYSA-N",
                         "name" : "IQx-8-COOH",
                    "structure" : "[H]N([H])C1=NC2=C(C([H])=C([H])C3=NC([H])=C(N=C23)C(O)=O)N1C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic oxidation"
            ]
        },
        "BIOTID0349" : {
                             "Name" : "melatonin",
            "Substrate's structure" : "C(OC1=C(C2=C(N(C(=C2C(C(N(C(C([H])([H])[H])=O)[H])([H])[H])([H])[H])[H])[H])C(=C1[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "DRLFMBDRBRZALE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C19 (minor); CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Kazumi, Y.Y. et al. (2011); Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order; Drug Metabolism Reviews; 43:4; 409-439; DOI:10.3109/03602532.2011.624103; PMID:22017508"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0342",
                     "inchikey" : "OMYMRCXOJJZYKE-UHFFFAOYSA-N",
                         "name" : "6-Hydroxymelatonin",
                    "structure" : "[H]N(C(=O)C([H])([H])[H])C([H])([H])C([H])([H])C1=C([H])N([H])C2=C1C([H])=C(OC([H])([H])[H])C(O)=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0350" : {
                             "Name" : "melatonin",
            "Substrate's structure" : "C(OC1=C(C2=C(N(C(=C2C(C(N(C(C([H])([H])[H])=O)[H])([H])[H])([H])[H])[H])[H])C(=C1[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "DRLFMBDRBRZALE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19 (major); CYP1A2; CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Kazumi, Y.Y. et al. (2011); Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order; Drug Metabolism Reviews; 43:4; 409-439; DOI:10.3109/03602532.2011.624103; PMID:22017508"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0343",
                     "inchikey" : "MVAWJSIDNICKHF-UHFFFAOYSA-N",
                         "name" : "N-Acetyl-5-hydroxytryptamine",
                    "structure" : "[H]N(C(=O)C([H])([H])[H])C([H])([H])C([H])([H])C1=C([H])N([H])C2=C1C([H])=C(O)C([H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0351" : {
                             "Name" : "midazolam",
            "Substrate's structure" : "C(C1=NC(=C2C(N=C(C3=C(C(=C(C(=C3F)[H])[H])[H])[H])C4=C(C(=C(C(Cl)=C4[H])[H])[H])N12)([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "DDLIGBOFAVUZHB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5; CYP3A7; CYP2B6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Khan, K. K. et al. (2002); Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: An evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation; Mol. Pharmacol. 61:495���506",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0344",
                     "inchikey" : "QHSMEGADRFZVNE-UHFFFAOYSA-N",
                         "name" : "1'-Hydroxymidazolam",
                    "structure" : "[H]C1=C2N(C(=N1)C([H])([H])O)C1=C(C([H])=C(Cl)C([H])=C1[H])C(=NC2([H])[H])C1=C([H])C([H])=C([H])C([H])=C1F"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0352" : {
                             "Name" : "midazolam",
            "Substrate's structure" : "C(C1=NC(=C2C(N=C(C3=C(C(=C(C(=C3F)[H])[H])[H])[H])C4=C(C(=C(C(Cl)=C4[H])[H])[H])N12)([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "DDLIGBOFAVUZHB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5; CYP3A7",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Khan, K. K. et al. (2002); Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: An evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation; Mol. Pharmacol. 61:495���506",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0345",
                     "inchikey" : "ZYISITHKPKHPKG-UHFFFAOYNA-N",
                         "name" : "4-Hydroxymidazolam",
                    "structure" : "[H]C1=C2N(C(=N1)C([H])([H])[H])C1=C(C([H])=C(Cl)C([H])=C1[H])C(=NC2([H])O)C1=C([H])C([H])=C([H])C([H])=C1F"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0353" : {
                             "Name" : "mifepristone",
            "Substrate's structure" : "[H][C@@]12C(C([C@@](O[H])(C#CC([H])([H])[H])[C@@]1(C([H])([H])[H])C([C@](C3=C(C(=C(C(=C3[H])[H])N(C([H])([H])[H])C([H])([H])[H])[H])[H])(C4=C5C(C(C(=O)C(=C5C(C([C@@]24[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "VKHAHZOOUSRJNA-GCNJZUOMSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Khan, K. K. et al. (2002); Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: An evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation; Mol. Pharmacol. 61:495���506",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996016"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0346",
                     "inchikey" : "IBLXOBHABOVXDY-WKWWZUSTSA-N",
                         "name" : "Monodemethylated mifepristone",
                    "structure" : "[H]O[C@@]1(C#CC([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])[C@@]3([H])C(=C4C(=C([H])C(=O)C([H])([H])C4([H])[H])C([H])([H])C3([H])[H])[C@@]([H])(C3=C([H])C([H])=C(NC([H])([H])[H])C([H])=C3[H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0354" : {
                             "Name" : "mifepristone",
            "Substrate's structure" : "[H][C@@]12C(C([C@@](O[H])(C#CC([H])([H])[H])[C@@]1(C([H])([H])[H])C([C@](C3=C(C(=C(C(=C3[H])[H])N(C([H])([H])[H])C([H])([H])[H])[H])[H])(C4=C5C(C(C(=O)C(=C5C(C([C@@]24[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "VKHAHZOOUSRJNA-GCNJZUOMSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Khan, K. K. et al. (2002); Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: An evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation; Mol. Pharmacol. 61:495���506",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996018"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0347",
                     "inchikey" : "ULLTWLWXPJPTQG-GCNJZUOMSA-N",
                         "name" : "17alpha-hydroxymifepristone",
                    "structure" : "[H]O[C@@]1(C#CC([H])([H])O)C([H])([H])C([H])([H])[C@@]2([H])[C@@]3([H])C(=C4C(=C([H])C(=O)C([H])([H])C4([H])[H])C([H])([H])C3([H])[H])[C@@]([H])(C3=C([H])C([H])=C(C([H])=C3[H])N(C([H])([H])[H])C([H])([H])[H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0355" : {
                             "Name" : "minaprine",
            "Substrate's structure" : "C1(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])=C(C(=C(N=N1)N(C(C(N3C(C(OC(C3([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])C([H])([H])[H])[H]",
                         "InChIKey" : "LDMWSLGGVTVJPG-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0348",
                     "inchikey" : "ADRHYFBXMFKHDO-UHFFFAOYSA-N",
                         "name" : "4-Hydroxyminaprine",
                    "structure" : "[H]N(C1=C(C([H])=C(N=N1)C1=C([H])C([H])=C(O)C([H])=C1[H])C([H])([H])[H])C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0356" : {
                             "Name" : "montelukast",
            "Substrate's structure" : "O(C(=O)C(C1(C(C1([H])[H])([H])[H])C(S[C@](C(C(C2=C(C(=C(C(=C2C(O[H])(C([H])([H])[H])C([H])([H])[H])[H])[H])[H])[H])([H])[H])([H])[H])(C3=C(C(=C(C(/C(=C(/C4=NC5=C(C(=C(C(Cl)=C5[H])[H])[H])C(=C4[H])[H])\\[H])/[H])=C3[H])[H])[H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "UCHDWCPVSPXUMX-TZIWLTJVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2A6",
                       "References" : [
                "R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0349",
                     "inchikey" : "QFTNWCBEAVHLQA-XNHCCDLUSA-N",
                         "name" : "montelukast sulfoxide",
                    "structure" : "[H]OC(=O)C([H])([H])C1(C([H])([H])S(=O)[C@@]([H])(C2=C([H])C([H])=C([H])C(\\C([H])=C(/[H])C3=NC4=C(C([H])=C([H])C(Cl)=C4[H])C([H])=C3[H])=C2[H])C([H])([H])C([H])([H])C2=C([H])C([H])=C([H])C([H])=C2C(O[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0357" : {
                             "Name" : "montelukast",
            "Substrate's structure" : "O(C(=O)C(C1(C(C1([H])[H])([H])[H])C(S[C@](C(C(C2=C(C(=C(C(=C2C(O[H])(C([H])([H])[H])C([H])([H])[H])[H])[H])[H])[H])([H])[H])([H])[H])(C3=C(C(=C(C(/C(=C(/C4=NC5=C(C(=C(C(Cl)=C5[H])[H])[H])C(=C4[H])[H])\\[H])/[H])=C3[H])[H])[H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "UCHDWCPVSPXUMX-TZIWLTJVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0350",
                     "inchikey" : "CHRNGXJVKOMERP-FPUIOERCSA-N",
                         "name" : "21-Hydroxymontelukast",
                    "structure" : "[H]OC(=O)C([H])([H])C1(C([H])([H])S[C@@]([H])(C2=C([H])C([H])=C([H])C(\\C([H])=C(/[H])C3=NC4=C(C([H])=C([H])C(Cl)=C4[H])C([H])=C3[H])=C2[H])C([H])([H])[C@@]([H])(O[H])C2=C([H])C([H])=C([H])C([H])=C2C(O[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0358" : {
                             "Name" : "montelukast",
            "Substrate's structure" : "O(C(=O)C(C1(C(C1([H])[H])([H])[H])C(S[C@](C(C(C2=C(C(=C(C(=C2C(O[H])(C([H])([H])[H])C([H])([H])[H])[H])[H])[H])[H])([H])[H])([H])[H])(C3=C(C(=C(C(/C(=C(/C4=NC5=C(C(=C(C(Cl)=C5[H])[H])[H])C(=C4[H])[H])\\[H])/[H])=C3[H])[H])[H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "UCHDWCPVSPXUMX-TZIWLTJVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3677"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0351",
                     "inchikey" : "CHRNGXJVKOMERP-SIOAQITRSA-N",
                         "name" : "[1�ې({[(1R,3S)�ې1�ې{3�ې[(E)�ې2�ې(7�ېchloroquinolin�ې2�ېyl)ethenyl]phenyl}�ې3�ېhydroxy�ې3�ې[2�ې(2�ېhydroxypropan�ې2�ېyl)phenyl]propyl]sulfanyl}methyl)cyclopropyl]aceticacid",
                    "structure" : "[H]OC(=O)C([H])([H])C1(C([H])([H])S[C@@]([H])(C2=C([H])C([H])=C([H])C(\\C([H])=C(/[H])C3=NC4=C(C([H])=C([H])C(Cl)=C4[H])C([H])=C3[H])=C2[H])C([H])([H])[C@]([H])(O[H])C2=C([H])C([H])=C([H])C([H])=C2C(O[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0359" : {
                             "Name" : "montelukast",
            "Substrate's structure" : "O(C(=O)C(C1(C(C1([H])[H])([H])[H])C(S[C@](C(C(C2=C(C(=C(C(=C2C(O[H])(C([H])([H])[H])C([H])([H])[H])[H])[H])[H])[H])([H])[H])([H])[H])(C3=C(C(=C(C(/C(=C(/C4=NC5=C(C(=C(C(Cl)=C5[H])[H])[H])C(=C4[H])[H])\\[H])/[H])=C3[H])[H])[H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "UCHDWCPVSPXUMX-TZIWLTJVSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "R1) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3678"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0352",
                     "inchikey" : "UFQIEVSCRCMNLW-SHISVWIYSA-N",
                         "name" : "[1�ې({[(1R)�ې1�ې{3�ې[(E)�ې2�ې(7�ېchloroquinolin�ې2�ېyl)ethenyl]phenyl}�ې3�ې[2�ې(1,2�ېdihydroxypropan�ې2�ېyl)phenyl]propyl]sulfanyl}methyl)cyclopropyl]aceticacid",
                    "structure" : "[H]OC(=O)C([H])([H])C1(C([H])([H])S[C@@]([H])(C2=C([H])C([H])=C([H])C(\\C([H])=C(/[H])C3=NC4=C(C([H])=C([H])C(Cl)=C4[H])C([H])=C3[H])=C2[H])C([H])([H])C([H])([H])C2=C([H])C([H])=C([H])C([H])=C2C(O[H])(C([H])([H])[H])C([H])([H])O[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0360" : {
                             "Name" : "n-methylformamide",
            "Substrate's structure" : "C(N(C(=O)[H])[H])([H])([H])[H]",
                         "InChIKey" : "ATHHXGZTWNVVOU-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "J. Bolleddula et al.; Drug Metab Rev, 2014; 46(3): 379���419"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0353",
                     "inchikey" : "HAMGRBXTJNITHG-UHFFFAOYSA-N",
                         "name" : "Methyl Isocyanate",
                    "structure" : "[H]C([H])([H])N=C=O"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0361" : {
                             "Name" : "nabumetone",
            "Substrate's structure" : "C12=C(C(=C(C(=C1[H])[H])OC([H])([H])[H])[H])C(=C(C(=C2[H])C(C(C(C([H])([H])[H])=O)([H])[H])([H])[H])[H])[H]",
                         "InChIKey" : "BLXXJMDCKKHMKV-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Montellano, P. R. O (2013); Cytochrome P450-activated prodrugs; Future Med Chem., 5(2): 213���228. doi:10.4155/fmc.12.197."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0354",
                     "inchikey" : "HLOFWGGVFLUZMZ-UHFFFAOYNA-N",
                         "name" : "4�ېhydroxy�ې4�ې(6�ېmethoxynaphthalen�ې2�ېyl)butan�ې2�ېone",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C([H])C(=C2[H])C([H])(O)C([H])([H])C(=O)C([H])([H])[H])C([H])=C1OC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0362" : {
                             "Name" : "naproxen",
            "Substrate's structure" : "C12=C(C(=C(C(=C1[H])[H])OC([H])([H])[H])[H])C(=C(C(=C2[H])[C@@](C(O[H])=O)(C([H])([H])[H])[H])[H])[H]",
                         "InChIKey" : "CMWTZPSULFXXJA-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP2C9 (major); CYP1A2 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0355",
                     "inchikey" : "XWJUDDGELKXYNO-QMMMGPOBSA-N",
                         "name" : "Desmethylnaproxen",
                    "structure" : "[H]OC(=O)[C@]([H])(C1=C([H])C2=C(C([H])=C1[H])C([H])=C(O)C([H])=C2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0363" : {
                             "Name" : "nefazodone",
            "Substrate's structure" : "C(C(C1=NN(C(C(C(N2C(C(N(C(C2([H])[H])([H])[H])C3=C(C(Cl)=C(C(=C3[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])C(=O)N1C(C(OC4=C(C(=C(C(=C4[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "VRBKIVRKKCLPHA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "J. Bolleddula et al.; Drug Metab Rev, 2014; 46(3): 379���419"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0356",
                     "inchikey" : "VHFVKMTVMIZMIK-UHFFFAOYSA-N",
                         "name" : "1-(3-chlorophenyl)piperazine",
                    "structure" : "[H]C1=C([H])C(=C([H])C(Cl)=C1[H])N1C([H])([H])C([H])([H])NC([H])([H])C1([H])[H]"
                },
                {
                     "BTMDB_ID" : "BTMDB0356",
                     "inchikey" : "VHFVKMTVMIZMIK-UHFFFAOYSA-N",
                         "name" : "1-(3-chlorophenyl)piperazine",
                    "structure" : "[H]C(=O)C([H])([H])C([H])([H])N1N=C(N(C1=O)C([H])([H])C([H])([H])OC1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0364" : {
                             "Name" : "nevirapine",
            "Substrate's structure" : "C(C1=C2N(C(=O)C3=C(N=C(C(=C3[H])[H])[H])N(C4(C(C4([H])[H])([H])[H])[H])C2=NC(=C1[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "NQDJXKOVJZTUJA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0357",
                     "inchikey" : "LFZSOJABLBVGRJ-UHFFFAOYSA-N",
                         "name" : "2-OH-nevirapine",
                    "structure" : "[H]N1C2=C(C([H])=C(O)N=C2N(C2=C(C([H])=C([H])C([H])=N2)C1=O)C1([H])C([H])([H])C1([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0365" : {
                             "Name" : "nevirapine",
            "Substrate's structure" : "C(C1=C2N(C(=O)C3=C(N=C(C(=C3[H])[H])[H])N(C4(C(C4([H])[H])([H])[H])[H])C2=NC(=C1[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "NQDJXKOVJZTUJA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (major); CYP2B6 (minor); CYP3A4 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0358",
                     "inchikey" : "DZPVEPLRIKDBFC-UHFFFAOYSA-N",
                         "name" : "8-OH-nevirapine",
                    "structure" : "[H]N1C2=C(C([H])=C([H])N=C2N(C2=C(C([H])=C(O)C([H])=N2)C1=O)C1([H])C([H])([H])C1([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0366" : {
                             "Name" : "nevirapine",
            "Substrate's structure" : "C(C1=C2N(C(=O)C3=C(N=C(C(=C3[H])[H])[H])N(C4(C(C4([H])[H])([H])[H])[H])C2=NC(=C1[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "NQDJXKOVJZTUJA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0359",
                     "inchikey" : "DANIONWINZEYME-UHFFFAOYSA-N",
                         "name" : "3-OH-nevirapine",
                    "structure" : "[H]N1C2=C(C(O)=C([H])N=C2N(C2=C(C([H])=C([H])C([H])=N2)C1=O)C1([H])C([H])([H])C1([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0367" : {
                             "Name" : "nevirapine",
            "Substrate's structure" : "C(C1=C2N(C(=O)C3=C(N=C(C(=C3[H])[H])[H])N(C4(C(C4([H])[H])([H])[H])[H])C2=NC(=C1[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "NQDJXKOVJZTUJA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major); CYP2D6 (minor); CYP2C9 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0360",
                     "inchikey" : "YCSZLSPYGSAXJE-UHFFFAOYSA-N",
                         "name" : "12-OH-nevirapine",
                    "structure" : "[H]N1C2=C(C([H])=C([H])N=C2N(C2=C(C([H])=C([H])C([H])=N2)C1=O)C1([H])C([H])([H])C1([H])[H])C([H])([H])CO"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0368" : {
                             "Name" : "nicotine",
            "Substrate's structure" : "C(N1C(C(C([C@]1(C2=C(N=C(C(=C2[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "SNICXCGAKADSCV-JTQLQIEISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6 (major); CYP2B6; CYP2A13",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0361",
                     "inchikey" : "GTQXYYYOJZZJHL-JTQLQIEISA-N",
                         "name" : "(S)-Nicotine ��1��_,5��_-iminium ion",
                    "structure" : "[H]C1=[N+](C([H])([H])[H])[C@]([H])(C2=C([H])N=C([H])C([H])=C2[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Heteroring dehydrogenation"
            ]
        },
        "BIOTID0369" : {
                             "Name" : "nicotine",
            "Substrate's structure" : "C(N1C(C(C([C@]1(C2=C(N=C(C(=C2[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "SNICXCGAKADSCV-JTQLQIEISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0362",
                     "inchikey" : "BOQRPPFUUSHFGW-SNVBAGLBSA-N",
                         "name" : "2��_-Hydroxynicotine",
                    "structure" : "[H]C1=NC([H])=C(C([H])=C1[H])[C@@]1(O)N(C([H])([H])[H])C([H])([H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0370" : {
                             "Name" : "nicotine",
            "Substrate's structure" : "C(N1C(C(C([C@]1(C2=C(N=C(C(=C2[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "SNICXCGAKADSCV-JTQLQIEISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP2B6; CYP2A13",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0363",
                     "inchikey" : "MYKUKUCHPMASKF-VIFPVBQESA-N",
                         "name" : "Nornicotine",
                    "structure" : "[H]C1=NC([H])=C(C([H])=C1[H])[C@@]1([H])NC([H])([H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0371" : {
                             "Name" : "nifedipine",
            "Substrate's structure" : "C(OC(=O)C1=C(C([H])([H])[H])N(C(C([H])([H])[H])=C(C1(C2=C(C(=C(C(=C2[N+]([O-])=O)[H])[H])[H])[H])[H])C(=O)OC([H])([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "HYIMSNHJOBLJNT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0364",
                     "inchikey" : "UMQHJQGNGLQJPF-UHFFFAOYSA-N",
                         "name" : "Oxidized nifedipine",
                    "structure" : "[H]C1=C([H])C([H])=C(C(=C1[H])C1=C(C(=O)OC([H])([H])[H])C(=NC(=C1C(=O)OC([H])([H])[H])C([H])([H])[H])C([H])([H])[H])[N+]([O-])=O"
                }
            ],
                    "Reaction Type" : [
                "Heteroring dehydrogenation"
            ]
        },
        "BIOTID0372" : {
                             "Name" : "nortriptyline",
            "Substrate's structure" : "C(N(C(C(C(=C1C2=C(C(=C(C(=C2C(C(C3=C(C(=C(C(=C13)[H])[H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "PHVGLTMQBUFIQQ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0365",
                     "inchikey" : "VAGXZGJKNUNLHK-WJDWOHSUNA-N",
                         "name" : "E-10-OH-nortriptyline",
                    "structure" : "[H]\\C(=C1/C2=C([H])C([H])=C([H])C([H])=C2C([H])([H])C([H])(O)C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0373" : {
                             "Name" : "nortriptyline",
            "Substrate's structure" : "C(N(C(C(C(=C1C2=C(C(=C(C(=C2C(C(C3=C(C(=C(C(=C13)[H])[H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "PHVGLTMQBUFIQQ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Musshoff F. et al. (2010); Pharmacogenetics and forensic toxicology; Forensic Sci Int.; 203, 53-62. doi: doi:10.1016/j.forsciint.2010.07.011"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0366",
                     "inchikey" : "PTQFRALDEONNOA-UHFFFAOYSA-N",
                         "name" : "demethylnortriptyline",
                    "structure" : "[H]NC([H])([H])C([H])([H])C([H])=C1C2=C([H])C([H])=C([H])C([H])=C2C([H])([H])C([H])([H])C2=C([H])C([H])=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0374" : {
                             "Name" : "pentoxyresorufin",
            "Substrate's structure" : "O1C2=C(N=C3C1=C(C(=O)C(=C3[H])[H])[H])C(=C(C(OC(C(C(C(C([H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])=C2[H])[H])[H]",
                         "InChIKey" : "ZPSOKQFFOYYPKC-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP1B1",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0097",
                     "inchikey" : "HSSLDCABUXLXKM-UHFFFAOYSA-N",
                         "name" : "Resorufin",
                    "structure" : "[H]C1=C([H])C2=C(OC3=C([H])C(=O)C([H])=C([H])C3=N2)C([H])=C1O"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0375" : {
                             "Name" : "perphenazine",
            "Substrate's structure" : "O(C(C(N1C(C(N(C(C(C(N2C3=C(C(=C(C(=C3SC4=C2C(=C(Cl)C(=C4[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])C(C1([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "RGCVKNLCSQQDEP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP1A2; CYP3A4; CYP2C9; CYP2C19; CYP2D6 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0367",
                     "inchikey" : "ZWIQAXTYRCAVFE-UHFFFAOYSA-N",
                         "name" : "N-Dealkylated perphenazine",
                    "structure" : "[H]C1=C([H])C([H])=C2N(C3=C(SC2=C1[H])C([H])=C([H])C(Cl)=C3[H])C([H])([H])C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])NC([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0376" : {
                             "Name" : "perphenazine",
            "Substrate's structure" : "O(C(C(N1C(C(N(C(C(C(N2C3=C(C(=C(C(=C3SC4=C2C(=C(Cl)C(=C4[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])C(C1([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "RGCVKNLCSQQDEP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0368",
                     "inchikey" : "WXJXTMQMAOYROI-UHFFFAOYNA-N",
                         "name" : "Perphenazine sulfoxide",
                    "structure" : "[H]OC([H])([H])C([H])([H])N1C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])N2C3=C([H])C([H])=C([H])C([H])=C3S(=O)C3=C2C([H])=C(Cl)C([H])=C3[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0377" : {
                             "Name" : "phenacetin",
            "Substrate's structure" : "O(C1=C(C(=C(N(C(=O)C([H])([H])[H])[H])C(=C1[H])[H])[H])[H])C(C([H])([H])[H])([H])[H]",
                         "InChIKey" : "CPJSUEIXXCENMM-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2E1; CYP2D6; CYP2C19; CYP2C9; CYP2A6",
                       "References" : [
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Venkatakrishnan, K. et al. (1998); Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity; J Pharm Sci. 1998 Dec;87(12):1502-7; PMID:10189256"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0104",
                     "inchikey" : "RZVAJINKPMORJF-UHFFFAOYSA-N",
                         "name" : "Acetaminophen",
                    "structure" : "CC(=O)NC1=CC=C(O)C=C1"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0378" : {
                             "Name" : "phenacetin",
            "Substrate's structure" : "O(C1=C(C(=C(N(C(=O)C([H])([H])[H])[H])C(=C1[H])[H])[H])[H])C(C([H])([H])[H])([H])[H]",
                         "InChIKey" : "CPJSUEIXXCENMM-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2",
                       "References" : [
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Venkatakrishnan, K. et al. (1998); Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity; J Pharm Sci. 1998 Dec;87(12):1502-7; PMID:10189256"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0369",
                     "inchikey" : "GPMYDZBSYQUDJZ-UHFFFAOYSA-N",
                         "name" : "N-OH-phenacetin",
                    "structure" : "[H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])C([H])([H])[H])N(O)C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0379" : {
                             "Name" : "phenol",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1O[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "ISWSIDIOOBJBQZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0370",
                     "inchikey" : "QIGBRXMKCJKVMJ-UHFFFAOYSA-N",
                         "name" : "Hydroquinone",
                    "structure" : "[H]OC1=C([H])C([H])=C(O[H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0380" : {
                             "Name" : "phenytoin",
            "Substrate's structure" : "O=C1N(C(=O)C(N1[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "CXOFVDLJLONNDW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3679"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0371",
                     "inchikey" : "FSPRLRPJSPWQNC-UHFFFAOYNA-N",
                         "name" : "3'-HPPH",
                    "structure" : "[H]N1C(=O)N([H])C(C1=O)(C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C([H])C(O)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0381" : {
                             "Name" : "phenytoin",
            "Substrate's structure" : "O=C1N(C(=O)C(N1[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "CXOFVDLJLONNDW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 (major); CYP2C19 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3679"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0372",
                     "inchikey" : "XEEDURHPFVXALT-UHFFFAOYNA-N",
                         "name" : "4'-HPPH",
                    "structure" : "[H]N1C(=O)N([H])C(C1=O)(C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C(O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0382" : {
                             "Name" : "phenytoin",
            "Substrate's structure" : "O=C1N(C(=O)C(N1[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "CXOFVDLJLONNDW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3679"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0373",
                     "inchikey" : "FEEKFEKCXIDMIS-UHFFFAOYNA-N",
                         "name" : "5�ې(3,4�ېdihydroxycyclohexa�ې1,5�ېdien�ې1�ېyl)�ې5�ېphenylimidazolidine�ې2,4�ېdione",
                    "structure" : "[H]N1C(=O)N([H])C(C1=O)(C1=C([H])C(O)C(O)C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "C-oxidation"
            ]
        },
        "BIOTID0383" : {
                             "Name" : "piroxicam",
            "Substrate's structure" : "C(N1C(C(=O)N(C2=NC(=C(C(=C2[H])[H])[H])[H])[H])=C(O[H])C3=C(C(=C(C(=C3[H])[H])[H])[H])S1(=O)=O)([H])([H])[H]",
                         "InChIKey" : "QYSPLQLAKJAUJT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0374",
                     "inchikey" : "CCKOORANQAQKKV-UHFFFAOYSA-N",
                         "name" : "5'-Hydroxypiroxicam",
                    "structure" : "CN1C(C(=O)NC2=NC=C(O)C=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0384" : {
                             "Name" : "progesterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](C(C([H])([H])[H])=O)([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "RJKFOVLPORLFTN-LEKSSAKUSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0375",
                     "inchikey" : "BOZZHCVRWNSXMR-QOJGXCKPSA-N",
                         "name" : "2beta-OH-progesterone",
                    "structure" : "[H]C1=C2C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])(C(=O)C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])[C@]([H])(O)C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0385" : {
                             "Name" : "progesterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](C(C([H])([H])[H])=O)([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "RJKFOVLPORLFTN-LEKSSAKUSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A4; CYP4B1",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0376",
                     "inchikey" : "PWCLWZOSAFOXFL-CXICGXRGSA-N",
                         "name" : "6beta-OH-progesterone",
                    "structure" : "[H]C1=C2[C@]([H])(O)C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])(C(=O)C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C([H])([H])C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0386" : {
                             "Name" : "progesterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](C(C([H])([H])[H])=O)([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "RJKFOVLPORLFTN-LEKSSAKUSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP1A1; CYP2D6; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3679"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0377",
                     "inchikey" : "LOVNYFVWYTXDRE-MQWPULPWSA-N",
                         "name" : "16beta-OH-progesterone",
                    "structure" : "[H]C1=C2C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])[C@]([H])(O)[C@]([H])(C(=O)C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C([H])([H])C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0387" : {
                             "Name" : "progesterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](C(C([H])([H])[H])=O)([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "RJKFOVLPORLFTN-LEKSSAKUSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D4; CYP2D6; CYP2C19 ",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3680"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0378",
                     "inchikey" : "DBPWSSGDRRHUNT-CEGNMAFCSA-N",
                         "name" : "17beta-OH-progesterone",
                    "structure" : "[H]C1=C2C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@](O)(C(=O)C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C([H])([H])C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0388" : {
                             "Name" : "progesterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](C(C([H])([H])[H])=O)([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "RJKFOVLPORLFTN-LEKSSAKUSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3681"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0379",
                     "inchikey" : "ZESRJSPZRDMNHY-YFWFAHHUSA-N",
                         "name" : "21-OH-progesterone",
                    "structure" : "[H]C1=C2C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@]([H])(C(=O)C([H])([H])O)[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C([H])([H])C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0389" : {
                             "Name" : "promazine",
            "Substrate's structure" : "N1(C2=C(SC3=C1C(=C(C(=C3[H])[H])[H])[H])C(=C(C(=C2[H])[H])[H])[H])C(C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "ZGUGWUXLJSTTMA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (major); CYP3A4 (major); CYP2A6 (minor); CYP2B6 (minor; CYP2D6 (minor); CYP2E1 (minor)",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0380",
                     "inchikey" : "KSHDHDWHIWBNHA-UHFFFAOYSA-N",
                         "name" : "Promazine 5-sulfoxide",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])S(=O)C1=C(C([H])=C([H])C([H])=C1[H])N2C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0390" : {
                             "Name" : "promazine",
            "Substrate's structure" : "N1(C2=C(SC3=C1C(=C(C(=C3[H])[H])[H])[H])C(=C(C(=C2[H])[H])[H])[H])C(C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "ZGUGWUXLJSTTMA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (major); CYP2C9 (minor); CYP2C19 (major); CYP2A6 (minor); CYP2B6 (minor); CYP2D6 (minor); CYP2E1 (minor)",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0381",
                     "inchikey" : "WOCOVPRTRIBGFZ-UHFFFAOYSA-N",
                         "name" : "N-Desmethyl promazine",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])N(C1=C(S2)C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0391" : {
                             "Name" : "propofol",
            "Substrate's structure" : "C(C(C([H])([H])[H])(C1=C(C(=C(C(C(C([H])([H])[H])(C([H])([H])[H])[H])=C1O[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "OLBCVFGFOZPWHH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "3014064",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6 (major); CYP2C9 (major); CYP1A2 (minor); CYP2A6 (minor); CYP2C8 (minor); CYP2C19 (minor); CYP2D6 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0382",
                     "inchikey" : "UFWIJKBKROBWTG-UHFFFAOYSA-N",
                         "name" : "4-OH-propofol",
                    "structure" : "CC(C)C1=CC(O)=CC(C(C)C)=C1O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0392" : {
                             "Name" : "quazepam",
            "Substrate's structure" : "C12=C(C(C3=C(C(=C(C(=C3[H])[H])[H])[H])F)=NC(C(N1C(C(F)(F)F)([H])[H])=S)([H])[H])C(=C(C(=C2[H])[H])Cl)[H]",
                         "InChIKey" : "IKMPWMZBZSAONZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "93250",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Miura, M and Ohkubo, T (2004); In vitrometabolism of quazepam in human liver and intestine and assessment of drug interactions; Xenobiotica; 34(11-12):1001-11; PMID: 15801544; DOI: 10.1080/02772240400015214"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0383",
                     "inchikey" : "YFSXBSRGIRSXAD-UHFFFAOYSA-N",
                         "name" : "2-Oxoquazepam",
                    "structure" : "FC1=C(C=CC=C1)C1=NCC(=O)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2"
                }
            ],
                    "Reaction Type" : [
                "Hydrolysis"
            ]
        },
        "BIOTID0393" : {
                             "Name" : "quazepam",
            "Substrate's structure" : "C12=C(C(C3=C(C(=C(C(=C3[H])[H])[H])[H])F)=NC(C(N1C(C(F)(F)F)([H])[H])=S)([H])[H])C(=C(C(=C2[H])[H])Cl)[H]",
                         "InChIKey" : "IKMPWMZBZSAONZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "93250",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Miura, M and Ohkubo, T (2004); In vitrometabolism of quazepam in human liver and intestine and assessment of drug interactions; Xenobiotica; 34(11-12):1001-11; PMID: 15801544; DOI: 10.1080/02772240400015214"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0383",
                     "inchikey" : "YFSXBSRGIRSXAD-UHFFFAOYSA-N",
                         "name" : "2-Oxoquazepam",
                    "structure" : "FC1=C(C=CC=C1)C1=NCC(=O)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2"
                }
            ],
                    "Reaction Type" : [
                "Hydrolysis"
            ]
        },
        "BIOTID0394" : {
                             "Name" : "quazepam",
            "Substrate's structure" : "C12=C(C(C3=C(C(=C(C(=C3[H])[H])[H])[H])F)=NC(C(N1C(C(F)(F)F)([H])[H])=S)([H])[H])C(=C(C(=C2[H])[H])Cl)[H]",
                         "InChIKey" : "IKMPWMZBZSAONZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "93250",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Miura, M and Ohkubo, T (2004); In vitrometabolism of quazepam in human liver and intestine and assessment of drug interactions; Xenobiotica; 34(11-12):1001-11; PMID: 15801544; DOI: 10.1080/02772240400015214"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0383",
                     "inchikey" : "YFSXBSRGIRSXAD-UHFFFAOYSA-N",
                         "name" : "2-Oxoquazepam",
                    "structure" : "FC1=C(C=CC=C1)C1=NCC(=O)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2"
                }
            ],
                    "Reaction Type" : [
                "Hydrolysis"
            ]
        },
        "BIOTID0395" : {
                             "Name" : "quinidine",
            "Substrate's structure" : "[H][C@@]12C(C(N(C([C@@]1(C(=C([H])[H])[H])[H])([H])[H])[C@]([H])(C2([H])[H])[C@@](O[H])(C3=C4C(=C(OC([H])([H])[H])C(=C(C4=NC(=C3[H])[H])[H])[H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "LOUPRKONTZGTKE-LHHVKLHASA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0384",
                     "inchikey" : "BSRUJCFCZKMFMB-LGWHJFRWSA-N",
                         "name" : "3-Hydroxyquinidine",
                    "structure" : "[H]O[C@@]([H])(C1=C2C([H])=C(OC([H])([H])[H])C([H])=C([H])C2=NC([H])=C1[H])[C@]1([H])N2C([H])([H])C([H])([H])[C@@]([H])(C1([H])[H])[C@@](O)(C([H])=C([H])[H])C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0396" : {
                             "Name" : "quinidine",
            "Substrate's structure" : "[H][C@@]12C(C(N(C([C@@]1(C(=C([H])[H])[H])[H])([H])[H])[C@]([H])(C2([H])[H])[C@@](O[H])(C3=C4C(=C(OC([H])([H])[H])C(=C(C4=NC(=C3[H])[H])[H])[H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "LOUPRKONTZGTKE-LHHVKLHASA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9; CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0385",
                     "inchikey" : "WVDIZKMXQMCCAA-IKJOXUIJSA-N",
                         "name" : "Quinidine-N-oxide",
                    "structure" : "[H]O[C@@]([H])(C1=C2C([H])=C(OC([H])([H])[H])C([H])=C([H])C2=NC([H])=C1[H])[C@@]1([H])C([H])([H])[C@]2([H])C([H])([H])C([H])([H])[N+]1([O-])C([H])([H])[C@]2([H])C([H])=C([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0397" : {
                             "Name" : "(R)-mianserin",
            "Substrate's structure" : "C1(=C(C(=C(C2=C1C(C3=C(C(=C(C(=C3[H])[H])[H])[H])[C@]4(N2C(C(N(C4([H])[H])C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "UEQUQVLFIPOEMF-SFHVURJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP1A2; CYP3A4; CYP2B6",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Rendic, S., Di Carlo, F. (1997) Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors; Drug Metabolism Reviews, 29:1-2, 413-580; DOI:10.3109/03602539709037591; PMID:9187528"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0386",
                     "inchikey" : "ZBILSSSEXRZGKS-KRWDZBQOSA-N",
                         "name" : "(R)-mianserin, N-Desmethyl",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])C([H])([H])C1=C(C([H])=C([H])C([H])=C1[H])[C@@]1([H])N2C([H])([H])C([H])([H])NC1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0398" : {
                             "Name" : "(R)-mianserin",
            "Substrate's structure" : "C1(=C(C(=C(C2=C1C(C3=C(C(=C(C(=C3[H])[H])[H])[H])[C@]4(N2C(C(N(C4([H])[H])C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "UEQUQVLFIPOEMF-SFHVURJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Rendic, S., Di Carlo, F. (1997) Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors; Drug Metabolism Reviews, 29:1-2, 413-580; DOI:10.3109/03602539709037591; PMID:9187528"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0387",
                     "inchikey" : "IXAPYQICIDTITB-SFHVURJKSA-N",
                         "name" : "(R)-mianserin, 8-hydroxy",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])[C@@]1([H])N(C3=C(C([H])=C([H])C(O)=C3[H])C2([H])[H])C([H])([H])C([H])([H])N(C([H])([H])[H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0399" : {
                             "Name" : "(R)-mianserin",
            "Substrate's structure" : "C1(=C(C(=C(C2=C1C(C3=C(C(=C(C(=C3[H])[H])[H])[H])[C@]4(N2C(C(N(C4([H])[H])C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "UEQUQVLFIPOEMF-SFHVURJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423",
                "Rendic, S., Di Carlo, F. (1997) Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors; Drug Metabolism Reviews, 29:1-2, 413-580; DOI:10.3109/03602539709037591; PMID:9187528"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0388",
                     "inchikey" : "VVDXWJOYXVNLLQ-LROBGIAVSA-N",
                         "name" : "(R)-mianserin, N-oxide",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])C([H])([H])C1=C(C([H])=C([H])C([H])=C1[H])[C@@]1([H])N2C([H])([H])C([H])([H])[N+]([O-])(C([H])([H])[H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0400" : {
                             "Name" : "ranitidine",
            "Substrate's structure" : "C(N(/C(/N(C(C(SC(C1=C(C(=C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])O1)[H])[H])([H])[H])([H])[H])([H])[H])[H])=C(\\[N+]([O-])=O)/[H])[H])([H])([H])[H]",
                         "InChIKey" : "VMXUWOKSQNHOCA-UKTHLTGXSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP1A2; CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0389",
                     "inchikey" : "WZLBVRXZNDXPPW-XYOKQWHBSA-N",
                         "name" : "Desmethylranitidine",
                    "structure" : "[H]N(\\C(N([H])C([H])([H])C([H])([H])SC([H])([H])C1=C([H])C([H])=C(O1)C([H])([H])NC([H])([H])[H])=C(\\[H])[N+]([O-])=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0401" : {
                             "Name" : "reduced_dolasetron",
            "Substrate's structure" : "C=1(C(=C2C(=C(C1[H])[H])N(C(=C2C(OC3(C([C@@]4(N5[C@](C3([H])[H])(C(C([C@@](C5([H])[H])(O[H])[H])(C4([H])[H])[H])([H])[H])[H])[H])([H])[H])[H])=O)[H])[H])[H])[H]",
                         "InChIKey" : "MLWGAEVSWJXOQJ-XYLOAFBBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0390",
                     "inchikey" : "HISIYQCTEKKZGZ-KXFXSALQSA-N",
                         "name" : "Dolasetron N-oxide",
                    "structure" : "[H]O[C@]1([H])C([H])([H])[N+]2([O-])[C@@]3([H])C([H])([H])C([H])(OC(=O)C4=C([H])N([H])C5=C([H])C([H])=C([H])C([H])=C45)C([H])([H])[C@]2([H])C([H])([H])C1([H])C3([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0402" : {
                             "Name" : "reduced_dolasetron",
            "Substrate's structure" : "C=1(C(=C2C(=C(C1[H])[H])N(C(=C2C(OC3(C([C@@]4(N5[C@](C3([H])[H])(C(C([C@@](C5([H])[H])(O[H])[H])(C4([H])[H])[H])([H])[H])[H])[H])([H])[H])[H])=O)[H])[H])[H])[H]",
                         "InChIKey" : "MLWGAEVSWJXOQJ-XYLOAFBBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (major); CYP3A4; CYP2C9",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0391",
                     "inchikey" : "ZMHGUJOFLCUYPP-HGBKZWNCSA-N",
                         "name" : "6-Hydroxydolasetron",
                    "structure" : "[H]O[C@]1([H])C([H])([H])N2[C@@]3([H])C([H])([H])C([H])(OC(=O)C4=C([H])N([H])C5=C([H])C(O)=C([H])C([H])=C45)C([H])([H])[C@]2([H])C([H])([H])C1([H])C3([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0403" : {
                             "Name" : "reduced_dolasetron",
            "Substrate's structure" : "C=1(C(=C2C(=C(C1[H])[H])N(C(=C2C(OC3(C([C@@]4(N5[C@](C3([H])[H])(C(C([C@@](C5([H])[H])(O[H])[H])(C4([H])[H])[H])([H])[H])[H])[H])([H])[H])[H])=O)[H])[H])[H])[H]",
                         "InChIKey" : "MLWGAEVSWJXOQJ-XYLOAFBBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP2C9",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0392",
                     "inchikey" : "GQVSIRWNARNIIA-HGBKZWNCSA-N",
                         "name" : "5-Hydroxydolasetron",
                    "structure" : "[H]O[C@]1([H])C([H])([H])N2[C@@]3([H])C([H])([H])C([H])(OC(=O)C4=C([H])N([H])C5=C([H])C([H])=C(O)C([H])=C45)C([H])([H])[C@]2([H])C([H])([H])C1([H])C3([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0404" : {
                             "Name" : "reduced_dolasetron",
            "Substrate's structure" : "C=1(C(=C2C(=C(C1[H])[H])N(C(=C2C(OC3(C([C@@]4(N5[C@](C3([H])[H])(C(C([C@@](C5([H])[H])(O[H])[H])(C4([H])[H])[H])([H])[H])[H])[H])([H])[H])[H])=O)[H])[H])[H])[H]",
                         "InChIKey" : "MLWGAEVSWJXOQJ-XYLOAFBBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP2C9",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0393",
                     "inchikey" : "OBVOORYFKGUOIG-MJRCBCLYSA-N",
                         "name" : "7-Hydroxydolasetron",
                    "structure" : "[H]O[C@]1([H])C([H])([H])N2[C@@]3([H])C([H])([H])C([H])(OC(=O)C4=C([H])N([H])C5=C(O)C([H])=C([H])C([H])=C45)C([H])([H])[C@]2([H])C([H])([H])C1([H])C3([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0405" : {
                             "Name" : "retinal",
            "Substrate's structure" : "C1(/C(=C(/C(=C(/C(=C(/C(=C(/C(=O)[H])\\[H])/C([H])([H])[H])\\[H])/[H])\\[H])/C([H])([H])[H])\\[H])/[H])=C(C(C(C(C1(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "NCYCYZXNIZJOKI-OVSJKPMPSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP1A2; CYP1B1",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0394",
                     "inchikey" : "SHGAZHPCJJPHSC-YCNIQYBTSA-N",
                         "name" : "all-trans retinoic acid",
                    "structure" : "[H]/C(=C(/[H])\\C(=C(/[H])C(O)=O)\\C([H])([H])[H])/C(/[H])=C(/C(/[H])=C(\\[H])C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])\\C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "C-oxidation"
            ]
        },
        "BIOTID0406" : {
                             "Name" : "retinol",
            "Substrate's structure" : "C/C(=C\\CO)/C=C/C=C(\\C)/C=C/C1=C(C)CCCC1(C)C",
                         "InChIKey" : "FPIPGXGPPPQFEQ-OVSJKPMPSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP3A4; CYP1B1",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0395",
                     "inchikey" : "NCYCYZXNIZJOKI-OVSJKPMPSA-N",
                         "name" : "All-trans-retinal",
                    "structure" : "C\\C(\\C=C\\C=C(/C)\\C=C\\C1=C(C)CCCC1(C)C)=C/C=O"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0407" : {
                             "Name" : "riluzole",
            "Substrate's structure" : "S1C2=C(N=C1N([H])[H])C(=C(C(OC(F)(F)F)=C2[H])[H])[H]",
                         "InChIKey" : "FTALBRSUTCGOEG-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0396",
                     "inchikey" : "GXFFABIWILZVMT-UHFFFAOYSA-N",
                         "name" : "4-OH-riluzole",
                    "structure" : "[H]N([H])C1=NC2=C(S1)C([H])=C(OC(F)(F)F)C([H])=C2O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0408" : {
                             "Name" : "riluzole",
            "Substrate's structure" : "S1C2=C(N=C1N([H])[H])C(=C(C(OC(F)(F)F)=C2[H])[H])[H]",
                         "InChIKey" : "FTALBRSUTCGOEG-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0397",
                     "inchikey" : "ABPVPMBDUVEIQV-UHFFFAOYSA-N",
                         "name" : "5-OH-riluzole",
                    "structure" : "[H]N([H])C1=NC2=C(S1)C([H])=C(OC(F)(F)F)C(O)=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0409" : {
                             "Name" : "riluzole",
            "Substrate's structure" : "S1C2=C(N=C1N([H])[H])C(=C(C(OC(F)(F)F)=C2[H])[H])[H]",
                         "InChIKey" : "FTALBRSUTCGOEG-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP1A1",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0398",
                     "inchikey" : "ASRHRBKKDHQFAF-UHFFFAOYSA-N",
                         "name" : "7-OH-riluzole",
                    "structure" : "[H]N([H])C1=NC2=C(S1)C(O)=C(OC(F)(F)F)C([H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0410" : {
                             "Name" : "riluzole",
            "Substrate's structure" : "S1C2=C(N=C1N([H])[H])C(=C(C(OC(F)(F)F)=C2[H])[H])[H]",
                         "InChIKey" : "FTALBRSUTCGOEG-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0399",
                     "inchikey" : "MFGRTKLVQQZZIE-UHFFFAOYSA-N",
                         "name" : "N-OH-riluzole",
                    "structure" : "[H]N(O)C1=NC2=C(S1)C([H])=C(OC(F)(F)F)C([H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0411" : {
                             "Name" : "ropivacaine",
            "Substrate's structure" : "N(C=1C(=C(C(=C(C1C([H])([H])[H])[H])[H])[H])C([H])([H])[H])(C(=O)[C@]2(N(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])C(C(C([H])([H])[H])([H])[H])([H])[H])[H])[H]",
                         "InChIKey" : "ZKMNUMMKYBVTFN-HNNXBMFYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0400",
                     "inchikey" : "IXOVDWXTIIYVOJ-AWEZNQCLSA-N",
                         "name" : "3-OH-ropivacaine",
                    "structure" : "[H]N(C(=O)[C@@]1([H])N(C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H])C1=C(C([H])=C([H])C(O)=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0412" : {
                             "Name" : "ropivacaine",
            "Substrate's structure" : "N(C=1C(=C(C(=C(C1C([H])([H])[H])[H])[H])[H])C([H])([H])[H])(C(=O)[C@]2(N(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])C(C(C([H])([H])[H])([H])[H])([H])[H])[H])[H]",
                         "InChIKey" : "ZKMNUMMKYBVTFN-HNNXBMFYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0401",
                     "inchikey" : "SILRCGDPZGQJOQ-LBPRGKRZSA-N",
                         "name" : "PPX",
                    "structure" : "[H]N(C(=O)[C@@]1([H])NC([H])([H])C([H])([H])C([H])([H])C1([H])[H])C1=C(C([H])=C([H])C([H])=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0413" : {
                             "Name" : "s-methyl diethylthiocarbamate",
            "Substrate's structure" : "N(C(C([H])([H])[H])([H])[H])(C(C([H])([H])[H])([H])[H])C(=O)SC([H])([H])[H]",
                         "InChIKey" : "AQTFQQHFHGBCPG-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2A6; CYP2C9; CYP1A2; CYP2B6; CYP2E1; CYP2D6",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0402",
                     "inchikey" : "FQSRGOGWCPXJIN-UHFFFAOYNA-N",
                         "name" : "MeDTC sulfoxide",
                    "structure" : "[H]C([H])([H])S(=O)C(=O)N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0414" : {
                             "Name" : "selegiline",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])[H])C([C@](N(C([H])([H])[H])C(C#C[H])([H])[H])(C([H])([H])[H])[H])([H])[H])[H])[H])[H]",
                         "InChIKey" : "MEZLKOACVSPNER-GFCCVEGCSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6 (major); CYP2C19; CYP2D6; CYP1A2; CYP2C9; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0403",
                     "inchikey" : "UUFAJPMQSFXDFR-LLVKDONJSA-N",
                         "name" : "Desmethylselegiline",
                    "structure" : "[H]C#CC([H])([H])N[C@]([H])(C([H])([H])[H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0415" : {
                             "Name" : "selegiline",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])[H])C([C@](N(C([H])([H])[H])C(C#C[H])([H])[H])(C([H])([H])[H])[H])([H])[H])[H])[H])[H]",
                         "InChIKey" : "MEZLKOACVSPNER-GFCCVEGCSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP2C19; CYP2D6; CYP1A2; CYP2C9; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0404",
                     "inchikey" : "MYWUZJCMWCOHBA-SECBINFHSA-N",
                         "name" : "Methamphetamine",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[C@]([H])(NC([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0416" : {
                             "Name" : "sildenafil",
            "Substrate's structure" : "C(C(C(C1=NN(C([H])([H])[H])C2=C1N(C(=NC2=O)C3=C(OC(C([H])([H])[H])([H])[H])C(=C(C(=C3[H])S(=O)(=O)N4C(C(N(C([H])([H])[H])C(C4([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "BNRNXUUZRGQAQC-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9; CYP2C19; CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0405",
                     "inchikey" : "VACAHCFUDUBDNR-UHFFFAOYSA-N",
                         "name" : "N-Desmethyl sildenafil",
                    "structure" : "[H]N1C2=C(N(N=C2C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])[H])C(=O)N=C1C1=C(OC([H])([H])C([H])([H])[H])C([H])=C([H])C(=C1[H])S(=O)=O"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0417" : {
                             "Name" : "simvastatin",
            "Substrate's structure" : "[H][C@]12[C@](C([C@@](C([H])([H])[H])(C(=C1C(=C([C@](C([H])([H])[H])([C@@]2(C(C([C@@]3(C([C@@](O[H])(C(C(=O)O3)([H])[H])[H])([H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])[H])[H])([H])[H])(OC(=O)C(C([H])([H])[H])(C([H])([H])[H])C(C([H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "RYMZZMVNJRMUDD-HGQWONQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0406",
                     "inchikey" : "WJKSTNFUSXHVRJ-ZEUMIXTGSA-N",
                         "name" : "6'-�_-Hydroxysimvastatin",
                    "structure" : "[H]O[C@@]1([H])C([H])([H])C(=O)O[C@]([H])(C([H])([H])C([H])([H])[C@@]2([H])[C@]([H])(C([H])=C([H])C3=C([H])[C@](O)(C([H])([H])[H])C([H])([H])[C@]([H])(OC(=O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])[H])[C@]23[H])C([H])([H])[H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0418" : {
                             "Name" : "simvastatin",
            "Substrate's structure" : "[H][C@]12[C@](C([C@@](C([H])([H])[H])(C(=C1C(=C([C@](C([H])([H])[H])([C@@]2(C(C([C@@]3(C([C@@](O[H])(C(C(=O)O3)([H])[H])[H])([H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])[H])[H])([H])[H])(OC(=O)C(C([H])([H])[H])(C([H])([H])[H])C(C([H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "RYMZZMVNJRMUDD-HGQWONQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0407",
                     "inchikey" : "MRCKOKWQDZYFLT-IHHACARCSA-N",
                         "name" : "3', 5'-Dihydrodiol",
                    "structure" : "[H]O[C@@]1([H])C([H])([H])C(=O)O[C@]([H])(C([H])([H])C([H])([H])[C@@]2([H])[C@]([H])(C(O)C([H])=C3C(O)[C@]([H])(C([H])([H])[H])C([H])([H])[C@]([H])(OC(=O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])[H])[C@]23[H])C([H])([H])[H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0419" : {
                             "Name" : "simvastatin",
            "Substrate's structure" : "[H][C@]12[C@](C([C@@](C([H])([H])[H])(C(=C1C(=C([C@](C([H])([H])[H])([C@@]2(C(C([C@@]3(C([C@@](O[H])(C(C(=O)O3)([H])[H])[H])([H])[H])[H])([H])[H])([H])[H])[H])[H])[H])[H])[H])[H])([H])[H])(OC(=O)C(C([H])([H])[H])(C([H])([H])[H])C(C([H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "RYMZZMVNJRMUDD-HGQWONQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0408",
                     "inchikey" : "WDTQWJUBUXHODX-BGYTUHEHSA-N",
                         "name" : "6'-exomethylene",
                    "structure" : "[H]O[C@@]1([H])C([H])([H])C(=O)O[C@]([H])(C([H])([H])C([H])([H])[C@@]2([H])[C@]([H])(C([H])=C([H])C3=C([H])C(=C([H])[H])C([H])([H])[C@]([H])(OC(=O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])[H])[C@]23[H])C([H])([H])[H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Dehydrogenation"
            ]
        },
        "BIOTID0420" : {
                             "Name" : "sirolimus",
            "Substrate's structure" : "N12C(C([C@@]3(O[C@](C([C@@](C(=C(C(=C(C(=C([C@](C([C@](C([C@@]([C@@](C(=C([C@](C(C([C@](OC([C@@]1(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])[H])=O)([C@@](C([C@]4(C([C@]([C@@](C(C4([H])[H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])([H])[H])=O)(C([H])([H])[H])[H])[H])C([H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])=O)(C([H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])[H])[H])[H])[H])C([H])([H])[H])(OC([H])([H])[H])[H])([H])[H])(C(C([C@]3(C([H])([H])[H])[H])([H])[H])([H])[H])[H])O[H])=O)=O",
                         "InChIKey" : "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0409",
                     "inchikey" : "RGRYVHKBWYXMGM-KXYVTGLFSA-N",
                         "name" : "39-O-Desmethylsirolimus",
                    "structure" : "[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]2([H])OC(=O)[C@@]3([H])N(C(=O)C(=O)[C@]4(O[H])O[C@@]([H])(C([H])([H])C([H])([H])[C@@]4([H])C([H])([H])[H])C([H])([H])[C@]([H])(OC([H])([H])[H])C(=C([H])C([H])=C([H])C([H])=C([H])[C@@]([H])(C([H])([H])[H])C([H])([H])[C@]([H])(C(=O)[C@]([H])(OC([H])([H])[H])[C@]([H])(O[H])C(=C([H])[C@]([H])(C(=O)C2([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])C([H])([H])[C@@]1([H])O"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0421" : {
                             "Name" : "sirolimus",
            "Substrate's structure" : "N12C(C([C@@]3(O[C@](C([C@@](C(=C(C(=C(C(=C([C@](C([C@](C([C@@]([C@@](C(=C([C@](C(C([C@](OC([C@@]1(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])[H])=O)([C@@](C([C@]4(C([C@]([C@@](C(C4([H])[H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])([H])[H])=O)(C([H])([H])[H])[H])[H])C([H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])=O)(C([H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])[H])[H])[H])[H])C([H])([H])[H])(OC([H])([H])[H])[H])([H])[H])(C(C([C@]3(C([H])([H])[H])[H])([H])[H])([H])[H])[H])O[H])=O)=O",
                         "InChIKey" : "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0410",
                     "inchikey" : "ZHYGVVKSAGDVDY-AVLJHKTDSA-N",
                         "name" : "16-O-Desmethylsirolimus",
                    "structure" : "[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]2([H])OC(=O)[C@@]3([H])N(C(=O)C(=O)[C@]4(O[H])O[C@@]([H])(C([H])([H])C([H])([H])[C@@]4([H])C([H])([H])[H])C([H])([H])[C@]([H])(O)C(=C([H])C([H])=C([H])C([H])=C([H])[C@@]([H])(C([H])([H])[H])C([H])([H])[C@]([H])(C(=O)[C@]([H])(OC([H])([H])[H])[C@]([H])(O[H])C(=C([H])[C@]([H])(C(=O)C2([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])C([H])([H])[C@@]1([H])OC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0422" : {
                             "Name" : "sirolimus",
            "Substrate's structure" : "N12C(C([C@@]3(O[C@](C([C@@](C(=C(C(=C(C(=C([C@](C([C@](C([C@@]([C@@](C(=C([C@](C(C([C@](OC([C@@]1(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])[H])=O)([C@@](C([C@]4(C([C@]([C@@](C(C4([H])[H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])([H])[H])=O)(C([H])([H])[H])[H])[H])C([H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])=O)(C([H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])[H])[H])[H])[H])C([H])([H])[H])(OC([H])([H])[H])[H])([H])[H])(C(C([C@]3(C([H])([H])[H])[H])([H])[H])([H])[H])[H])O[H])=O)=O",
                         "InChIKey" : "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0411",
                     "inchikey" : "IPSCPJKWFFXCSS-CRHVAVOSSA-N",
                         "name" : "12-OH-sirolimus",
                    "structure" : "[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]2([H])OC(=O)[C@@]3([H])N(C(=O)C(=O)[C@]4(O[H])O[C@@]([H])(C([H])([H])C([H])(O)[C@@]4([H])C([H])([H])[H])C([H])([H])[C@]([H])(OC([H])([H])[H])C(=C([H])C([H])=C([H])C([H])=C([H])[C@@]([H])(C([H])([H])[H])C([H])([H])[C@]([H])(C(=O)[C@]([H])(OC([H])([H])[H])[C@]([H])(O[H])C(=C([H])[C@]([H])(C(=O)C2([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])C([H])([H])[C@@]1([H])OC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0423" : {
                             "Name" : "sirolimus",
            "Substrate's structure" : "N12C(C([C@@]3(O[C@](C([C@@](C(=C(C(=C(C(=C([C@](C([C@](C([C@@]([C@@](C(=C([C@](C(C([C@](OC([C@@]1(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])[H])=O)([C@@](C([C@]4(C([C@]([C@@](C(C4([H])[H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])([H])[H])=O)(C([H])([H])[H])[H])[H])C([H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])=O)(C([H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])[H])[H])[H])[H])C([H])([H])[H])(OC([H])([H])[H])[H])([H])[H])(C(C([C@]3(C([H])([H])[H])[H])([H])[H])([H])[H])[H])O[H])=O)=O",
                         "InChIKey" : "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259988"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0412",
                     "inchikey" : "VNPBYTOPCULMPL-HOWKTRJGSA-N",
                         "name" : "11-OH-sirolimus",
                    "structure" : "[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]2([H])OC(=O)[C@@]3([H])N(C(=O)C(=O)[C@]4(O[H])O[C@@]([H])(C([H])([H])C([H])([H])[C@@]4(O)C([H])([H])[H])C([H])([H])[C@]([H])(OC([H])([H])[H])C(=C([H])C([H])=C([H])C([H])=C([H])[C@@]([H])(C([H])([H])[H])C([H])([H])[C@]([H])(C(=O)[C@]([H])(OC([H])([H])[H])[C@]([H])(O[H])C(=C([H])[C@]([H])(C(=O)C2([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])C([H])([H])[C@@]1([H])OC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0424" : {
                             "Name" : "sirolimus",
            "Substrate's structure" : "N12C(C([C@@]3(O[C@](C([C@@](C(=C(C(=C(C(=C([C@](C([C@](C([C@@]([C@@](C(=C([C@](C(C([C@](OC([C@@]1(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])[H])=O)([C@@](C([C@]4(C([C@]([C@@](C(C4([H])[H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])([H])[H])=O)(C([H])([H])[H])[H])[H])C([H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])=O)(C([H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])[H])[H])[H])[H])C([H])([H])[H])(OC([H])([H])[H])[H])([H])[H])(C(C([C@]3(C([H])([H])[H])[H])([H])[H])([H])[H])[H])O[H])=O)=O",
                         "InChIKey" : "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259989"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0413",
                     "inchikey" : "JMPXWMAQDNEFCU-KKSZJLDLSA-N",
                         "name" : "25-OH-sirolimus",
                    "structure" : "[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]2([H])OC(=O)[C@@]3([H])N(C(=O)C(=O)[C@]4(O[H])O[C@@]([H])(C([H])([H])C([H])([H])[C@@]4([H])C([H])([H])[H])C([H])([H])[C@]([H])(OC([H])([H])[H])C(=C([H])C([H])=C([H])C([H])=C([H])[C@@]([H])(C([H])([H])[H])C([H])([H])[C@](O)(C(=O)[C@]([H])(OC([H])([H])[H])[C@]([H])(O[H])C(=C([H])[C@]([H])(C(=O)C2([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])C([H])([H])[C@@]1([H])OC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0425" : {
                             "Name" : "sirolimus",
            "Substrate's structure" : "N12C(C([C@@]3(O[C@](C([C@@](C(=C(C(=C(C(=C([C@](C([C@](C([C@@]([C@@](C(=C([C@](C(C([C@](OC([C@@]1(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])[H])=O)([C@@](C([C@]4(C([C@]([C@@](C(C4([H])[H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])([H])[H])=O)(C([H])([H])[H])[H])[H])C([H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])=O)(C([H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])[H])[H])[H])[H])C([H])([H])[H])(OC([H])([H])[H])[H])([H])[H])(C(C([C@]3(C([H])([H])[H])[H])([H])[H])([H])[H])[H])O[H])=O)=O",
                         "InChIKey" : "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259990"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0414",
                     "inchikey" : "HEOYJBLRGSZZKU-PZAKLEERSA-N",
                         "name" : "24-OH-sirolimus",
                    "structure" : "[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]2([H])OC(=O)[C@@]3([H])N(C(=O)C(=O)[C@]4(O[H])O[C@@]([H])(C([H])([H])C([H])([H])[C@@]4([H])C([H])([H])[H])C([H])([H])[C@]([H])(OC([H])([H])[H])C(=C([H])C([H])=C([H])C([H])=C([H])[C@@]([H])(C([H])([H])[H])C([H])(O)[C@]([H])(C(=O)[C@]([H])(OC([H])([H])[H])[C@]([H])(O[H])C(=C([H])[C@]([H])(C(=O)C2([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])C([H])([H])[C@@]1([H])OC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0426" : {
                             "Name" : "sirolimus",
            "Substrate's structure" : "N12C(C([C@@]3(O[C@](C([C@@](C(=C(C(=C(C(=C([C@](C([C@](C([C@@]([C@@](C(=C([C@](C(C([C@](OC([C@@]1(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])[H])=O)([C@@](C([C@]4(C([C@]([C@@](C(C4([H])[H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])([H])[H])=O)(C([H])([H])[H])[H])[H])C([H])([H])[H])(O[H])[H])(OC([H])([H])[H])[H])=O)(C([H])([H])[H])[H])([H])[H])(C([H])([H])[H])[H])[H])[H])[H])[H])[H])C([H])([H])[H])(OC([H])([H])[H])[H])([H])[H])(C(C([C@]3(C([H])([H])[H])[H])([H])[H])([H])[H])[H])O[H])=O)=O",
                         "InChIKey" : "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259991"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0415",
                     "inchikey" : "OEGQYPSSHFUXKW-CRTUHNFWSA-N",
                         "name" : "46-OH-sirolimus",
                    "structure" : "[H]O[C@]1([H])C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]2([H])OC(=O)[C@@]3([H])N(C(=O)C(=O)[C@]4(O[H])O[C@@]([H])(C([H])([H])C([H])([H])[C@@]4([H])C([H])([H])[H])C([H])([H])[C@]([H])(OC([H])([H])[H])C(=C([H])C([H])=C([H])C([H])=C([H])[C@@]([H])(C([H])([H])[H])C([H])([H])[C@]([H])(C(=O)[C@]([H])(OC([H])([H])[H])[C@]([H])(O[H])C(=C([H])[C@]([H])(C(=O)C2([H])[H])C([H])([H])[H])C([H])([H])[H])C([H])([H])O)C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])C([H])([H])[C@@]1([H])OC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0427" : {
                             "Name" : "styrene",
            "Substrate's structure" : "C=1(C(C(=C([H])[H])[H])=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "PPBRXRYQALVLMV-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259993"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0416",
                     "inchikey" : "AWMVMTVKBNGEAK-UHFFFAOYNA-N",
                         "name" : "Styrene 7,8-oxide",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C1([H])OC1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0428" : {
                             "Name" : "Styrene",
            "Substrate's structure" : "[H]C([H])=C([H])C1=C([H])C([H])=C([H])C([H])=C1[H]",
                         "InChIKey" : "PPBRXRYQALVLMV-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0416",
                     "inchikey" : "AWMVMTVKBNGEAK-UHFFFAOYNA-N",
                         "name" : "Styrene 7,8-oxide",
                    "structure" : "C1OC1C1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0429" : {
                             "Name" : "sulfamethoxazole",
            "Substrate's structure" : "C(C1=C(C(N(S(=O)(=O)C2=C(C(=C(N([H])[H])C(=C2[H])[H])[H])[H])[H])=NO1)[H])([H])([H])[H]",
                         "InChIKey" : "JLKIGFTWXXRPMT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0417",
                     "inchikey" : "MJAMPGKHIZXVFJ-UHFFFAOYSA-N",
                         "name" : "Sulfamethoxazole N4-hydroxylamine",
                    "structure" : "[H]N(O)C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C1=NOC(=C1[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0430" : {
                             "Name" : "tacrine",
            "Substrate's structure" : "N1=C2C(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])=C(N([H])[H])C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "YLJREFDVOIBQDA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259993"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0418",
                     "inchikey" : "HLVVITIHAZBPKB-UHFFFAOYNA-N",
                         "name" : "N4-hydroxylamine",
                    "structure" : "[H]N([H])C1=C2C(=NC3=C1C([H])=C([H])C([H])=C3[H])C([H])([H])C([H])([H])C([H])([H])C2([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0431" : {
                             "Name" : "tacrine",
            "Substrate's structure" : "N1=C2C(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])=C(N([H])[H])C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "YLJREFDVOIBQDA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259993"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0419",
                     "inchikey" : "BISIFJGUTDFVFR-UHFFFAOYNA-N",
                         "name" : "4- Hydroxytacrine",
                    "structure" : "[H]N([H])C1=C2C(=NC3=C1C([H])=C([H])C([H])=C3[H])C([H])(O)C([H])([H])C([H])([H])C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0432" : {
                             "Name" : "tacrine",
            "Substrate's structure" : "N1=C2C(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])=C(N([H])[H])C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "YLJREFDVOIBQDA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259993"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0420",
                     "inchikey" : "PYCYYSWVRAEADT-UHFFFAOYNA-N",
                         "name" : "2-Hydroxytacrine",
                    "structure" : "[H]N([H])C1=C2C(=NC3=C1C([H])=C([H])C([H])=C3[H])C([H])([H])C([H])([H])C([H])(O)C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0433" : {
                             "Name" : "tacrine",
            "Substrate's structure" : "N1=C2C(C(C(C(C2([H])[H])([H])[H])([H])[H])([H])[H])=C(N([H])[H])C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "YLJREFDVOIBQDA-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259993"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0421",
                     "inchikey" : "XEUVIAIVRAPEEH-UHFFFAOYSA-N",
                         "name" : "7-Hydroxytacrine",
                    "structure" : "[H]N([H])C1=C2C(=NC3=C1C([H])=C([H])C([H])=C3O)C([H])([H])C([H])([H])C([H])([H])C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0434" : {
                             "Name" : "tamoxifen",
            "Substrate's structure" : "C(C(/C(=C(\\C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])/C2=C(C(=C(OC(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])C(=C2[H])[H])[H])[H])/C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "NKANXQFJJICGDU-QPLCGJKRSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP1A2; CYP1A1; CYP3A4; CYP1B1 (at a high concentration (250�_M)); CYP2C9 (at a high concentration (250�_M)); CYP2C19 (at a high concentration (250�_M)); CYP3A5 (at a high concentration (250�_M)); CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0422",
                     "inchikey" : "NYDCDZSEEAUOHN-IZHYLOQSSA-N",
                         "name" : "N-Desmethyltamoxifen",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])([H])[H])\\C1=C([H])C([H])=C(OC([H])([H])C([H])([H])NC([H])([H])[H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0435" : {
                             "Name" : "tamoxifen",
            "Substrate's structure" : "C(C(/C(=C(\\C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])/C2=C(C(=C(OC(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])C(=C2[H])[H])[H])[H])/C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "NKANXQFJJICGDU-QPLCGJKRSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (major); CYP2B6; CYP2C9; CYP3A4 (at a high concentration (250�_M)); CYP1A1 (at a high concentration (250�_M)); CYP1A2 (at a high concentration (250�_M)); CYP3A5 (at a high concentration (250�_M))",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0423",
                     "inchikey" : "TXUZVZSFRXZGTL-QPLCGJKRSA-N",
                         "name" : "4-Hydroxytamoxifen",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C(O)C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])C([H])=C1[H])\\C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0436" : {
                             "Name" : "tamoxifen",
            "Substrate's structure" : "C(C(/C(=C(\\C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])/C2=C(C(=C(OC(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])C(=C2[H])[H])[H])[H])/C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "NKANXQFJJICGDU-QPLCGJKRSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP2B6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0424",
                     "inchikey" : "DODQJNMQWMSYGS-QPLCGJKRSA-N",
                         "name" : "4'-Hydroxytamoxifen",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C(O)C([H])=C1[H])C([H])([H])C([H])([H])[H])\\C1=C([H])C([H])=C(OC([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0437" : {
                             "Name" : "tamoxifen",
            "Substrate's structure" : "C(C(/C(=C(\\C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])/C2=C(C(=C(OC(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])C(=C2[H])[H])[H])[H])/C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "NKANXQFJJICGDU-QPLCGJKRSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2D6; CYP2B6 (give smaller amounts of �-hydroxylation); CYP2C9  (give smaller amounts of �-hydroxylation); CYP2C19 (give smaller amounts of �-hydroxylation); CYP3A5 (give smaller amounts of �-hydroxylation)",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0425",
                     "inchikey" : "BPHFBQJMFWCHGH-QPLCGJKRNA-N",
                         "name" : "alpha-Hydroxytamoxifen",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])(O)C([H])([H])[H])\\C1=C([H])C([H])=C(OC([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0438" : {
                             "Name" : "tamoxifen",
            "Substrate's structure" : "C(C(/C(=C(\\C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])/C2=C(C(=C(OC(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])C(=C2[H])[H])[H])[H])/C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "NKANXQFJJICGDU-QPLCGJKRSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5; CYP2B6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0426",
                     "inchikey" : "ZQZFYGIXNQKOAV-OCEACIFDSA-N",
                         "name" : "3-Hydroxytamoxifen",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(/C1=C([H])C([H])=C(OC([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])C([H])=C1[H])C1=C([H])C(O)=C([H])C([H])=C1[H])\\C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0439" : {
                             "Name" : "taxol",
            "Substrate's structure" : "[C@@]12([C@]3([C@](OC3([H])[H])(C([C@@]([C@]1(C([C@@](C=4C([C@]([C@]2(OC(C5=C(C(=C(C(=C5[H])[H])[H])[H])[H])=O)[H])(C([C@@](C4C([H])([H])[H])(OC(=O)[C@@]([C@](C6=C(C(=C(C(=C6[H])[H])[H])[H])[H])(N(C(C7=C(C(=C(C(=C7[H])[H])[H])[H])[H])=O)[H])[H])(O[H])[H])[H])([H])[H])O[H])(C([H])([H])[H])C([H])([H])[H])(OC(C([H])([H])[H])=O)[H])=O)C([H])([H])[H])(O[H])[H])([H])[H])[H])OC(C([H])([H])[H])=O)[H]",
                         "InChIKey" : "RCINICONZNJXQF-YUKVPPSFSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP2C8",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0427",
                     "inchikey" : "NDCWHEDPSFRTDA-ZYWDROJESA-N",
                         "name" : "6�-Hydroxypaclitaxel",
                    "structure" : "[H]O[C@@]([H])(C(=O)O[C@]1([H])C(=C2[C@@]([H])(OC(=O)C([H])([H])[H])C(=O)[C@]3(C([H])([H])[H])[C@@]([H])(O[H])[C@]([H])(O)[C@@]4([H])OC([H])([H])[C@@]4(OC(=O)C([H])([H])[H])[C@]3([H])[C@]([H])(OC(=O)C3=C([H])C([H])=C([H])C([H])=C3[H])[C@](O[H])(C1([H])[H])C2(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])[C@@]([H])(N([H])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0440" : {
                             "Name" : "taxol",
            "Substrate's structure" : "[C@@]12([C@]3([C@](OC3([H])[H])(C([C@@]([C@]1(C([C@@](C=4C([C@]([C@]2(OC(C5=C(C(=C(C(=C5[H])[H])[H])[H])[H])=O)[H])(C([C@@](C4C([H])([H])[H])(OC(=O)[C@@]([C@](C6=C(C(=C(C(=C6[H])[H])[H])[H])[H])(N(C(C7=C(C(=C(C(=C7[H])[H])[H])[H])[H])=O)[H])[H])(O[H])[H])[H])([H])[H])O[H])(C([H])([H])[H])C([H])([H])[H])(OC(C([H])([H])[H])=O)[H])=O)C([H])([H])[H])(O[H])[H])([H])[H])[H])OC(C([H])([H])[H])=O)[H]",
                         "InChIKey" : "RCINICONZNJXQF-YUKVPPSFSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP3A4 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996016"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0428",
                     "inchikey" : "XKSMHFPSILYEIA-YUKVPPSFSA-N",
                         "name" : "3��_-pHydroxypaclitaxel",
                    "structure" : "[H]O[C@@]([H])(C(=O)O[C@]1([H])C(=C2[C@@]([H])(OC(=O)C([H])([H])[H])C(=O)[C@]3(C([H])([H])[H])[C@@]([H])(O[H])C([H])([H])[C@@]4([H])OC([H])([H])[C@@]4(OC(=O)C([H])([H])[H])[C@]3([H])[C@]([H])(OC(=O)C3=C([H])C([H])=C([H])C([H])=C3[H])[C@](O[H])(C1([H])[H])C2(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H])[C@@]([H])(N([H])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C(O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0441" : {
                             "Name" : "teniposide",
            "Substrate's structure" : "[H][C@]12C(OC(=O)[C@]1([H])[C@](C3=C(C(OC([H])([H])[H])=C(O[H])C(OC([H])([H])[H])=C3[H])[H])(C4=C(C5=C(OC(O5)([H])[H])C(=C4[C@]2(O[C@@]6(O[C@]7([H])C(O[C@](O[C@@]7([H])[C@](O[H])([C@]6(O[H])[H])[H])(C8=C(C(=C(S8)[H])[H])[H])[H])([H])[H])[H])[H])[H])[H])[H])([H])[H]",
                         "InChIKey" : "NRUKOCRGYNPUPR-QBPJDGROSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP3A4; CYP3A5 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0429",
                     "inchikey" : "HFNGFXBXLSRAKX-KHIFWGIGSA-N",
                         "name" : "Teniposide catechol",
                    "structure" : "[H]OC1=C(OC([H])([H])[H])C([H])=C(C([H])=C1O)[C@]1([H])C2=C([H])C3=C(OC([H])([H])O3)C([H])=C2[C@@]([H])(O[C@]2([H])O[C@]3([H])C([H])([H])O[C@]([H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]2([H])O[H])C2=C([H])C([H])=C([H])S2)[C@@]2([H])C([H])([H])OC(=O)[C@]12[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0442" : {
                             "Name" : "tenoxicam",
            "Substrate's structure" : "S1(=O)(=O)N(/C(/C(=O)C=2SC(=C(C12)[H])[H])=C(/O[H])\\N(C3=NC(=C(C(=C3[H])[H])[H])[H])[H])C([H])([H])[H]",
                         "InChIKey" : "WZWYJBNHTWCXIM-JLHYYAGUSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "54692969",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0430",
                     "inchikey" : "INPPRTDYEGRTIU-JLHYYAGUSA-N",
                         "name" : "5'-Hydroxytenoxicam",
                    "structure" : "[H]O\\C(N([H])C1=NC([H])=C(O)C([H])=C1[H])=C1\\N(C([H])([H])[H])S(=O)(=O)C2=C(SC([H])=C2[H])C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0443" : {
                             "Name" : "terbinafine",
            "Substrate's structure" : "C(N(C(/C(=C(/C#CC(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])\\[H])/[H])([H])[H])C(C1=C(C(=C(C2=C(C(=C(C(=C12)[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "DOMXUEMWDBAQBQ-WEVVVXLNSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C9; CYP1A2",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0431",
                     "inchikey" : "IZJZLXQHMWUCIC-XBXARRHUSA-N",
                         "name" : "N-Desmethylterbinafine",
                    "structure" : "[H]\\C(C#CC(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])=C(\\[H])C([H])([H])NC([H])([H])C1=C([H])C([H])=C([H])C2=C([H])C([H])=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0444" : {
                             "Name" : "terbinafine",
            "Substrate's structure" : "C(N(C(/C(=C(/C#CC(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])\\[H])/[H])([H])[H])C(C1=C(C(=C(C2=C(C(=C(C(=C12)[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "DOMXUEMWDBAQBQ-WEVVVXLNSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C8; CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0432",
                     "inchikey" : "GPEJUKJZTGFNKY-XBXARRHUSA-N",
                         "name" : "Hydroxyterbinafine",
                    "structure" : "[H]\\C(C#CC(C([H])([H])[H])(C([H])([H])[H])C([H])([H])O)=C(\\[H])C([H])([H])N(C([H])([H])[H])C([H])([H])C1=C([H])C([H])=C([H])C2=C([H])C([H])=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0445" : {
                             "Name" : "terbinafine",
            "Substrate's structure" : "C(N(C(/C(=C(/C#CC(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])\\[H])/[H])([H])[H])C(C1=C(C(=C(C2=C(C(=C(C(=C12)[H])[H])[H])[H])[H])[H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "DOMXUEMWDBAQBQ-WEVVVXLNSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3677"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0433",
                     "inchikey" : "SQAINHDHICKHLX-UHFFFAOYSA-N",
                         "name" : "1-Naphtaldehyde",
                    "structure" : "[H]C(=O)C1=C([H])C([H])=C([H])C2=C([H])C([H])=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0446" : {
                             "Name" : "testosterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](O[H])([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "MUMGGOZAMZWBJJ-DYKIIFRCSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5;  CYP2C9; CYP1A1; CYP1B1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0434",
                     "inchikey" : "XSEGWEUVSZRCBC-ZVBLRVHNSA-N",
                         "name" : "6�_Hydroxytestosterone",
                    "structure" : "[H]O[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])[C@@]([H])(O)C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0447" : {
                             "Name" : "testosterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](O[H])([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "MUMGGOZAMZWBJJ-DYKIIFRCSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP3A4 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0435",
                     "inchikey" : "ZOIPFFUVGMVQGE-DTQPDNRZSA-N",
                         "name" : "2�-Hydroxytestosterone",
                    "structure" : "[H]O[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)[C@]([H])(O)C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0448" : {
                             "Name" : "testosterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](O[H])([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "MUMGGOZAMZWBJJ-DYKIIFRCSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP3A4 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0436",
                     "inchikey" : "ZOIPFFUVGMVQGE-LXKHFVGGSA-N",
                         "name" : "2�_-Hydroxytestosterone",
                    "structure" : "[H]O[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)[C@@]([H])(O)C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0449" : {
                             "Name" : "testosterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](O[H])([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "MUMGGOZAMZWBJJ-DYKIIFRCSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0437",
                     "inchikey" : "KYGUQDTWUBBBSD-MJVYMRHDSA-N",
                         "name" : "15�-Hydroxytestosterone",
                    "structure" : "[H]O[C@@]1([H])C([H])([H])[C@]([H])(O)[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0450" : {
                             "Name" : "testosterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](O[H])([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "MUMGGOZAMZWBJJ-DYKIIFRCSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0438",
                     "inchikey" : "KYGUQDTWUBBBSD-XJBBOAPUSA-N",
                         "name" : "15�_-Hydroxytestosterone",
                    "structure" : "[H]O[C@@]1([H])C([H])([H])[C@@]([H])(O)[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0451" : {
                             "Name" : "testosterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](O[H])([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "MUMGGOZAMZWBJJ-DYKIIFRCSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2B6 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0439",
                     "inchikey" : "YMCWOAZGWMZGQT-FPNLOETNSA-N",
                         "name" : "16�-Hydroxytestosterone",
                    "structure" : "[H]O[C@@]1([H])[C@]([H])(O)C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0452" : {
                             "Name" : "testosterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](O[H])([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "MUMGGOZAMZWBJJ-DYKIIFRCSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2B6 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259988"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0440",
                     "inchikey" : "YMCWOAZGWMZGQT-KYQPOWKGSA-N",
                         "name" : "16�_-Hydroxytestosterone",
                    "structure" : "[H]O[C@@]1([H])[C@@]([H])(O)C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C([H])C(=O)C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0453" : {
                             "Name" : "testosterone",
            "Substrate's structure" : "[H][C@@]12C(C([C@](O[H])([C@@]1(C([H])([H])[H])C(C([C@@]3([H])[C@@]2([H])C(C(C4=C(C(=O)C(C([C@]34C([H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])([H])[H])([H])[H]",
                         "InChIKey" : "MUMGGOZAMZWBJJ-DYKIIFRCSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP2C9 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259989"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0441",
                     "inchikey" : "AEMFNILZOJDQLW-QAGGRKNESA-N",
                         "name" : "Androstenedione",
                    "structure" : "[H]C1=C2C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])C(=O)[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C([H])([H])C1=O"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0454" : {
                             "Name" : "theophylline",
            "Substrate's structure" : "O=C1N(C(=O)N(C=2N=C(N(C21)[H])[H])C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "ZFXYFBGIUFBOJW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP1A2; CYP1A1 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0442",
                     "inchikey" : "OTSBKHHWSQYEHK-UHFFFAOYSA-N",
                         "name" : "1,3-Dimethyluric acid",
                    "structure" : "[H]N1C(O)=NC2=C1C(=O)N(C(=O)N2C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0455" : {
                             "Name" : "theophylline",
            "Substrate's structure" : "O=C1N(C(=O)N(C=2N=C(N(C21)[H])[H])C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "ZFXYFBGIUFBOJW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0443",
                     "inchikey" : "MVOYJPOZRLFTCP-UHFFFAOYSA-N",
                         "name" : "1-Methylxanthine",
                    "structure" : "[H]N1C([H])=NC2=C1C(=O)N(C(=O)N2[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0456" : {
                             "Name" : "theophylline",
            "Substrate's structure" : "O=C1N(C(=O)N(C=2N=C(N(C21)[H])[H])C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "ZFXYFBGIUFBOJW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0444",
                     "inchikey" : "GMSNIKWWOQHZGF-UHFFFAOYSA-N",
                         "name" : "3-Methylxanthine",
                    "structure" : "[H]N1C([H])=NC2=C1C(=O)N([H])C(=O)N2C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0457" : {
                             "Name" : "thiabendazole",
            "Substrate's structure" : "N1(C2=C(C(=C(C(=C2N=C1C3=C(SC(=N3)[H])[H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "WJCNZQLZVWNLKY-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0445",
                     "inchikey" : "VNENJHUOPQAPAT-UHFFFAOYSA-N",
                         "name" : "5-hydroxythiabendazole",
                    "structure" : "[H]N1C(=NC2=C([H])C([H])=C(O)C([H])=C12)C1=C([H])SC([H])=N1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0458" : {
                             "Name" : "ticlopidine",
            "Substrate's structure" : "ClC1=C(C(=C(C(=C1C(N2C(C(C3=C(C2([H])[H])C(=C(S3)[H])[H])([H])[H])([H])[H])([H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "PHWBOXQYWZNQIN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0446",
                     "inchikey" : "RLTCLQFOWWSHJX-UHFFFAOYSA-N",
                         "name" : "Thienodihydropyridinium",
                    "structure" : "[H]C1=C([H])C2=C(S1)C([H])([H])C([H])([H])[N+](=C2[H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1Cl"
                }
            ],
                    "Reaction Type" : [
                "Heteroring dehydrogenation"
            ]
        },
        "BIOTID0459" : {
                             "Name" : "ticlopidine",
            "Substrate's structure" : "ClC1=C(C(=C(C(=C1C(N2C(C(C3=C(C2([H])[H])C(=C(S3)[H])[H])([H])[H])([H])[H])([H])[H])[H])[H])[H])[H]",
                         "InChIKey" : "PHWBOXQYWZNQIN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0447",
                     "inchikey" : "SSVDYGNPKZJQKO-UHFFFAOYNA-N",
                         "name" : "Ticlopidine S-oxide",
                    "structure" : "[H]C1=C([H])S(=O)C2=C1C([H])([H])N(C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1Cl)C([H])([H])C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0460" : {
                             "Name" : "ticrynafen",
            "Substrate's structure" : "C1(=C(C(=C(OC(C(=O)O[H])([H])[H])C(=C1[H])[H])Cl)Cl)C(C=2SC(=C(C2[H])[H])[H])=O",
                         "InChIKey" : "AGHANLSBXUWXTB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C9 (major)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0448",
                     "inchikey" : "QEVMJPARVMJGMC-UHFFFAOYNA-N",
                         "name" : "Tienilic acid-s-oxide",
                    "structure" : "[H]OC(=O)C([H])([H])OC1=C(Cl)C(Cl)=C(C([H])=C1[H])C(=O)C1=C([H])C([H])=C([H])S1=O"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0461" : {
                             "Name" : "ticrynafen",
            "Substrate's structure" : "C1(=C(C(=C(OC(C(=O)O[H])([H])[H])C(=C1[H])[H])Cl)Cl)C(C=2SC(=C(C2[H])[H])[H])=O",
                         "InChIKey" : "AGHANLSBXUWXTB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C9 (major); CYP2C18; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0449",
                     "inchikey" : "RJEINYXLECHKSU-UHFFFAOYNA-N",
                         "name" : "Thiophene-4,5-epoxide",
                    "structure" : "[H]OC(=O)C([H])([H])OC1=C(Cl)C(Cl)=C(C([H])=C1[H])C(=O)C1=C([H])C2([H])OC2([H])S1"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0462" : {
                             "Name" : "tolbutamide",
            "Substrate's structure" : "C(C(C(C(N(C(=O)N(S(=O)(=O)C1=C(C(=C(C([H])([H])[H])C(=C1[H])[H])[H])[H])[H])[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "JLRGJRBPOGGCBT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0450",
                     "inchikey" : "SJRHYONYKZIRPM-UHFFFAOYSA-N",
                         "name" : "4-Hydroxytolbutamide",
                    "structure" : "[H]N(C(=O)N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0463" : {
                             "Name" : "tolterodine",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])C([H])([H])[H])[H])[H])O[H])[C@@](C=2C(=C(C(=C(C2[H])[H])[H])[H])[H])(C(C(N(C(C([H])([H])[H])(C([H])([H])[H])[H])C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "OOGJQPCLVADCPB-HXUWFJFHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (major); CYP2C9 (minor); CYP2C19 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0451",
                     "inchikey" : "CPLYUIYTJCFQJD-QGZVFWFLSA-N",
                         "name" : "N-Dealkylated tolterodine",
                    "structure" : "[H]OC1=C([H])C([H])=C(C([H])=C1[C@@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])([H])NC([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0464" : {
                             "Name" : "tolterodine",
            "Substrate's structure" : "C=1(C(=C(C(=C(C1[H])C([H])([H])[H])[H])[H])O[H])[C@@](C=2C(=C(C(=C(C2[H])[H])[H])[H])[H])(C(C(N(C(C([H])([H])[H])(C([H])([H])[H])[H])C(C([H])([H])[H])(C([H])([H])[H])[H])([H])[H])([H])[H])[H]",
                         "InChIKey" : "OOGJQPCLVADCPB-HXUWFJFHSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0452",
                     "inchikey" : "DUXZAXCGJSBGDW-HXUWFJFHSA-N",
                         "name" : "5-Hydroxymethyl tolterodine",
                    "structure" : "[H]OC1=C([H])C([H])=C(CO)C([H])=C1[C@@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])([H])N(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0465" : {
                             "Name" : "toluene",
            "Substrate's structure" : "C=1(C(C([H])([H])[H])=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "YXFVVABEGXRONW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1 (at low concentrations); CYP2B6 (at hight concentrations); CYP2C8; CYP1A2; CYP1A1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0453",
                     "inchikey" : "WVDDGKGOMKODPV-UHFFFAOYSA-N",
                         "name" : "Benzyl alcohol",
                    "structure" : "OCC1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0466" : {
                             "Name" : "toluene",
            "Substrate's structure" : "C=1(C(C([H])([H])[H])=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "YXFVVABEGXRONW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0454",
                     "inchikey" : "QWVGKYWNOKOFNN-UHFFFAOYSA-N",
                         "name" : "o-Cresol",
                    "structure" : "CC1=C(O)C=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0467" : {
                             "Name" : "toluene",
            "Substrate's structure" : "C=1(C(C([H])([H])[H])=C(C(=C(C1[H])[H])[H])[H])[H]",
                         "InChIKey" : "YXFVVABEGXRONW-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0455",
                     "inchikey" : "IWDCLRJOBJJRNH-UHFFFAOYSA-N",
                         "name" : "p-Cresol",
                    "structure" : "CC1=CC=C(O)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0468" : {
                             "Name" : "torasemide",
            "Substrate's structure" : "C(C(C([H])([H])[H])(N(C(=O)N(S(=O)(=O)C1=C(N(C2=C(C(=C(C(C([H])([H])[H])=C2[H])[H])[H])[H])[H])C(=C(N=C1[H])[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "NGBFQHCMQULJNZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0456",
                     "inchikey" : "WCYVLAMJCQZUCR-UHFFFAOYSA-N",
                         "name" : "N-[(4-{[3-(hydroxymethyl)phenyl]imino}-1,4-dihydropyridin-3-yl)sulfonyl]propane-2-carbamimidic acid",
                    "structure" : "[H]N(C1=C([H])C([H])=C([H])C(CO)=C1[H])C1=C(C([H])=NC([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])C([H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0469" : {
                             "Name" : "toremifene",
            "Substrate's structure" : "C(C(/C(=C(\\C=1C(=C(C(=C(C1[H])[H])[H])[H])[H])/C=2C(=C(C(OC(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])=C(C2[H])[H])[H])[H])/C=3C(=C(C(=C(C3[H])[H])[H])[H])[H])([H])[H])(Cl)([H])[H]",
                         "InChIKey" : "XFCLJVABOIYOMF-QPLCGJKRSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP3A4 (major)",
                       "References" : [
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0457",
                     "inchikey" : "WKJKBQYEFAFHCY-IZHYLOQSSA-N",
                         "name" : "N-desmethyltoremifene",
                    "structure" : "CNCCOC1=CC=C(C=C1)C(=C(\\CCCl)C1=CC=CC=C1)\\C1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0470" : {
                             "Name" : "trazodone",
            "Substrate's structure" : "C=1(C(=C(N2C(C1[H])=NN(C2=O)C(C(C(N3C(C(N(C(C3([H])[H])([H])[H])C=4C(=C(C(=C(C4[H])[H])[H])Cl)[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])[H]",
                         "InChIKey" : "PHLBKPHSAVXXEF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0356",
                     "inchikey" : "VHFVKMTVMIZMIK-UHFFFAOYSA-N",
                         "name" : "m-CPP",
                    "structure" : "[H]C1=C([H])C(Cl)=C([H])C(=C1[H])N1C([H])([H])C([H])([H])NC([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0471" : {
                             "Name" : "trazodone",
            "Substrate's structure" : "C=1(C(=C(N2C(C1[H])=NN(C2=O)C(C(C(N3C(C(N(C(C3([H])[H])([H])[H])C=4C(=C(C(=C(C4[H])[H])[H])Cl)[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])[H]",
                         "InChIKey" : "PHLBKPHSAVXXEF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0458",
                     "inchikey" : "FNUZSRSXQFIOPL-UHFFFAOYSA-N",
                         "name" : "p-Hydroxytrazodone",
                    "structure" : "[H]C1=C([H])N2C(=NN(C2=O)C([H])([H])C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])N(C3=C([H])C([H])=C(O)C(Cl)=C3[H])C([H])([H])C2([H])[H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0472" : {
                             "Name" : "trazodone",
            "Substrate's structure" : "C=1(C(=C(N2C(C1[H])=NN(C2=O)C(C(C(N3C(C(N(C(C3([H])[H])([H])[H])C=4C(=C(C(=C(C4[H])[H])[H])Cl)[H])([H])[H])([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])[H]",
                         "InChIKey" : "PHLBKPHSAVXXEF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0459",
                     "inchikey" : "QFERKVDPWYTEPE-UHFFFAOYNA-N",
                         "name" : "Trazodone epoxide",
                    "structure" : "[H]C1=C([H])C(Cl)=C([H])C(=C1[H])N1C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])N2N=C3N(C([H])=C([H])C4([H])OC34[H])C2=O)C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0473" : {
                             "Name" : "triamterene",
            "Substrate's structure" : "N(C1=NC(N([H])[H])=C2N=C(C(N([H])[H])=NC2=N1)C3=C(C(=C(C(=C3[H])[H])[H])[H])[H])([H])[H]",
                         "InChIKey" : "FNYLWPVRPXGIIP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0460",
                     "inchikey" : "QNJVMSASTUDLGC-UHFFFAOYSA-N",
                         "name" : "4'-OH-triamterene",
                    "structure" : "[H]N([H])C1=NC(N([H])[H])=C2N=C(C(=NC2=N1)N([H])[H])C1=C([H])C([H])=C(O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0474" : {
                             "Name" : "valdecoxib",
            "Substrate's structure" : "C(C1=C(C(=NO1)C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])C3=C(C(=C(C(=C3[H])[H])S(N([H])[H])(=O)=O)[H])[H])([H])([H])[H]",
                         "InChIKey" : "LNPDTQAFDNKSHK-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0461",
                     "inchikey" : "UJSFKTUZOASIPA-UHFFFAOYSA-N",
                         "name" : "4�ې[5�ې(hydroxymethyl)�ې3�ېphenyl�ې1,2�ېoxazol�ې4�ېyl]benzene�ې1�ېsulfonamide",
                    "structure" : "[H]N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C1=C(ON=C1C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0475" : {
                             "Name" : "valdecoxib",
            "Substrate's structure" : "C(C1=C(C(=NO1)C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])C3=C(C(=C(C(=C3[H])[H])S(N([H])[H])(=O)=O)[H])[H])([H])([H])[H]",
                         "InChIKey" : "LNPDTQAFDNKSHK-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0462",
                     "inchikey" : "IAVWHASLRCBDDK-UHFFFAOYSA-N",
                         "name" : "4�ې[3�ې(3�ېhydroxyphenyl)�ې5�ېmethyl�ې1,2�ېoxazol�ې4�ېyl]benzene�ې1�ېsulfonamide",
                    "structure" : "[H]N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C1=C(ON=C1C1=C([H])C([H])=C([H])C(O)=C1[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0476" : {
                             "Name" : "valproic acid",
            "Substrate's structure" : "C(C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])(C(O[H])=O)[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "NIJJYAXOARWZEE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2B6; CYP2A6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0463",
                     "inchikey" : "OASKNPCLIHUTTL-UHFFFAOYNA-N",
                         "name" : "4-Hydroxyvalproate",
                    "structure" : "[H]OC(=O)C([H])(C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])(O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0477" : {
                             "Name" : "valproic acid",
            "Substrate's structure" : "C(C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])(C(O[H])=O)[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "NIJJYAXOARWZEE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2B6; CYP2A6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0464",
                     "inchikey" : "ZIWBCJXKYKOLJK-UHFFFAOYNA-N",
                         "name" : "5-Hydroxyvalproate",
                    "structure" : "[H]OC(=O)C([H])(C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0478" : {
                             "Name" : "valproic acid",
            "Substrate's structure" : "C(C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])(C(O[H])=O)[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "NIJJYAXOARWZEE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2B6; CYP2A6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0465",
                     "inchikey" : "LLPFTSMZBSRZDV-UHFFFAOYNA-N",
                         "name" : "3-Hydroxyvalproate",
                    "structure" : "[H]OC(=O)C([H])(C([H])([H])C([H])([H])C([H])([H])[H])C([H])(O)C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0479" : {
                             "Name" : "valproic acid",
            "Substrate's structure" : "C(C(C(C(C(C(C([H])([H])[H])([H])[H])([H])[H])(C(O[H])=O)[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "NIJJYAXOARWZEE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0466",
                     "inchikey" : "UMYDNZXEHYSVFY-UHFFFAOYNA-N",
                         "name" : "4-ene-valproate",
                    "structure" : "[H]OC(=O)C([H])(C([H])([H])C([H])=C([H])[H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Dehydrogenation"
            ]
        },
        "BIOTID0480" : {
                             "Name" : "valsartan",
            "Substrate's structure" : "C(C(C(C(C(=O)N(C(C1=C(C(=C(C(=C1[H])[H])C2=C(C(=C(C(=C2C3=NN(N=N3)[H])[H])[H])[H])[H])[H])[H])([H])[H])[C@@](C(C([H])([H])[H])(C([H])([H])[H])[H])(C(O[H])=O)[H])([H])[H])([H])[H])([H])[H])([H])([H])[H]",
                         "InChIKey" : "ACWBQPMHZXGDFX-QFIPXVFZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0467",
                     "inchikey" : "ICSQZMPILLPFKC-XLDIYJRPSA-N",
                         "name" : "4-OH-valsartan",
                    "structure" : "[H]OC(=O)[C@@]([H])(N(C(=O)C([H])([H])C([H])([H])C([H])(O)C([H])([H])[H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1C1=NN([H])N=N1)C([H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0481" : {
                             "Name" : "vicriviroc",
            "Substrate's structure" : "COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)C1=C(C)N=CN=C1C)C1=CC=C(C=C1)C(F)(F)F",
                         "InChIKey" : "CNPVJJQCETWNEU-CYFREDJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0468",
                     "inchikey" : "JBIGWLFHMIEHKP-ZDUSSCGKSA-N",
                         "name" : "N-Desalkylvicriviroc",
                    "structure" : "C[C@H]1CN(CCN1)C1(C)CCN(CC1)C(=O)C1=C(C)N=CN=C1C"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0482" : {
                             "Name" : "vicriviroc",
            "Substrate's structure" : "COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)C1=C(C)N=CN=C1C)C1=CC=C(C=C1)C(F)(F)F",
                         "InChIKey" : "CNPVJJQCETWNEU-CYFREDJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4; CYP3A5",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3678"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0469",
                     "inchikey" : "KKISTQPVRGXETN-MBSDFSHPSA-N",
                         "name" : "O-Desmethylvicriviroc",
                    "structure" : "C[C@H]1CN(CCN1[C@@H](CO)C1=CC=C(C=C1)C(F)(F)F)C1(C)CCN(CC1)C(=O)C1=C(C)N=CN=C1C"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0483" : {
                             "Name" : "vicriviroc",
            "Substrate's structure" : "COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)C1=C(C)N=CN=C1C)C1=CC=C(C=C1)C(F)(F)F",
                         "InChIKey" : "CNPVJJQCETWNEU-CYFREDJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3680"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0470",
                     "inchikey" : "FJGWJMSLTFKZKY-CYFREDJKSA-N",
                         "name" : "Vicriviroc N-oxide",
                    "structure" : "COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)C1=C(C)[N+]([O-])=CN=C1C)C1=CC=C(C=C1)C(F)(F)F"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0484" : {
                             "Name" : "voriconazole",
            "Substrate's structure" : "C([C@@](C1=NC(=NC(=C1F)[H])[H])([C@](O[H])(C(N2C(=NC(=N2)[H])[H])([H])[H])C3=C(F)C(=C(F)C(=C3[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "BCEHBSKCWLPMDN-MGPLVRAMSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0471",
                     "inchikey" : "BGPPSFHHAYWTMX-LRDDRELGSA-N",
                         "name" : "Hydroxymethyl Voriconazole",
                    "structure" : "[H]O[C@](C1=C(F)C([H])=C(F)C([H])=C1[H])(C([H])([H])N1N=C([H])N=C1[H])[C@]([H])(C1=NC([H])=NC([H])=C1F)C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0485" : {
                             "Name" : "voriconazole",
            "Substrate's structure" : "C([C@@](C1=NC(=NC(=C1F)[H])[H])([C@](O[H])(C(N2C(=NC(=N2)[H])[H])([H])[H])C3=C(F)C(=C(F)C(=C3[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "BCEHBSKCWLPMDN-MGPLVRAMSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 (major); CYP2C19 (major); CYP3A4 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0472",
                     "inchikey" : "KPLFPLUCFPRUHU-MGPLVRAMSA-N",
                         "name" : "Voriconazole N-Oxide",
                    "structure" : "[H]O[C@](C1=C(F)C([H])=C(F)C([H])=C1[H])(C([H])([H])N1N=C([H])N=C1[H])[C@]([H])(C1=NC([H])=[N+]([O-])C([H])=C1F)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0486" : {
                             "Name" : "warfarin-r",
            "Substrate's structure" : "O1C(O[H])=C([C@](C(C(=O)C([H])([H])[H])([H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])[H])C(=O)C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "QTXVAVXCBMYBJW-OAHLLOKOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0473",
                     "inchikey" : "KLDFTXZRAPVGLB-LDCVWXEPSA-N",
                         "name" : "10-Hydroxywarfarin",
                    "structure" : "[H]OC1=C(C(=O)C2=C(O1)C([H])=C([H])C([H])=C2[H])[C@@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])(O)C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0487" : {
                             "Name" : "warfarin-r",
            "Substrate's structure" : "O1C(O[H])=C([C@](C(C(=O)C([H])([H])[H])([H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])[H])C(=O)C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "QTXVAVXCBMYBJW-OAHLLOKOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP1A1; CYP2C19",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0474",
                     "inchikey" : "JFCOGWFGPAUYNK-CQSZACIVSA-N",
                         "name" : "6-Hydroxywarfarin",
                    "structure" : "[H]OC1=C(C(=O)C2=C(O1)C([H])=C([H])C(O)=C2[H])[C@@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0488" : {
                             "Name" : "warfarin-r",
            "Substrate's structure" : "O1C(O[H])=C([C@](C(C(=O)C([H])([H])[H])([H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])[H])C(=O)C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "QTXVAVXCBMYBJW-OAHLLOKOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP1A1; CYP2C19",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0475",
                     "inchikey" : "RCTGERXIFCOAHF-CQSZACIVSA-N",
                         "name" : "8-Hydroxywarfarin",
                    "structure" : "[H]OC1=C(C(=O)C2=C(O1)C(O)=C([H])C([H])=C2[H])[C@@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0489" : {
                             "Name" : "warfarin-r",
            "Substrate's structure" : "O1C(O[H])=C([C@](C(C(=O)C([H])([H])[H])([H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])[H])C(=O)C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "QTXVAVXCBMYBJW-OAHLLOKOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP1A1; CYP2C8",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0476",
                     "inchikey" : "BQSUFDMOXLLKQK-OAHLLOKOSA-N",
                         "name" : "#NAME?",
                    "structure" : "[H]OC1=C(C(=O)C2=C(O1)C([H])=C(O)C([H])=C2[H])[C@@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0490" : {
                             "Name" : "warfarin-r",
            "Substrate's structure" : "O1C(O[H])=C([C@](C(C(=O)C([H])([H])[H])([H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])[H])C(=O)C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "QTXVAVXCBMYBJW-OAHLLOKOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C18",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0477",
                     "inchikey" : "UNTPHJKCRGFOFJ-OAHLLOKOSA-N",
                         "name" : "4'- Hydroxywarfarin",
                    "structure" : "[H]OC1=C(C(=O)C2=C(O1)C([H])=C([H])C([H])=C2[H])[C@@]([H])(C1=C([H])C([H])=C(O)C([H])=C1[H])C([H])([H])C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0491" : {
                             "Name" : "warfarin-s",
            "Substrate's structure" : "O1C(O[H])=C([C@@](C(C(=O)C([H])([H])[H])([H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])[H])C(=O)C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "QTXVAVXCBMYBJW-HNNXBMFYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0478",
                     "inchikey" : "BQSUFDMOXLLKQK-HNNXBMFYSA-N",
                         "name" : "7-Hydroxywarfarin",
                    "structure" : "[H]OC1=C(C(=O)C2=C(O1)C([H])=C(O)C([H])=C2[H])[C@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0492" : {
                             "Name" : "warfarin-s",
            "Substrate's structure" : "O1C(O[H])=C([C@@](C(C(=O)C([H])([H])[H])([H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])[H])C(=O)C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "QTXVAVXCBMYBJW-HNNXBMFYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0479",
                     "inchikey" : "UNTPHJKCRGFOFJ-HNNXBMFYSA-N",
                         "name" : "4'-Hydroxywarfarin",
                    "structure" : "[H]OC1=C(C(=O)C2=C(O1)C([H])=C([H])C([H])=C2[H])[C@]([H])(C1=C([H])C([H])=C(O)C([H])=C1[H])C([H])([H])C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0493" : {
                             "Name" : "warfarin-s",
            "Substrate's structure" : "O1C(O[H])=C([C@@](C(C(=O)C([H])([H])[H])([H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])[H])C(=O)C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "QTXVAVXCBMYBJW-HNNXBMFYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C8; CYP2C18; CYP2C19; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0480",
                     "inchikey" : "JFCOGWFGPAUYNK-AWEZNQCLSA-N",
                         "name" : "6-Hydroxylation",
                    "structure" : "[H]OC1=C(C(=O)C2=C(O1)C([H])=C([H])C(O)=C2[H])[C@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0494" : {
                             "Name" : "warfarin-s",
            "Substrate's structure" : "O1C(O[H])=C([C@@](C(C(=O)C([H])([H])[H])([H])[H])(C2=C(C(=C(C(=C2[H])[H])[H])[H])[H])[H])C(=O)C3=C1C(=C(C(=C3[H])[H])[H])[H]",
                         "InChIKey" : "QTXVAVXCBMYBJW-HNNXBMFYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0481",
                     "inchikey" : "KLDFTXZRAPVGLB-MYJWUSKBSA-N",
                         "name" : "10-Hydroxylation",
                    "structure" : "[H]OC1=C(C(=O)C2=C(O1)C([H])=C([H])C([H])=C2[H])[C@]([H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])(O)C(=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0495" : {
                             "Name" : "7-Ethoxy-4-trifluoromethylcoumarin",
            "Substrate's structure" : "CCOC1=CC=C2C(OC(=O)C=C2C(F)(F)F)=C1",
                         "InChIKey" : "OLHOIERZAZMHGK-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP1A2; CYP2B6; CYP2E1; CYP2C9; CYP2C19",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0482",
                     "inchikey" : "CCKWMCUOHJAVOL-UHFFFAOYSA-N",
                         "name" : "7-Hydroxy-4-trifluoromethylcourmarin",
                    "structure" : "[H]C1=C(O)C([H])=C2OC(=O)C([H])=C(C2=C1[H])C(F)(F)F"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0496" : {
                             "Name" : "7-Benzyloxyresorufin",
            "Substrate's structure" : "C1=CC=C(C=C1)COC2=CC=C3C(=C2)OC4=CC(=O)C=CC4=N3",
                         "InChIKey" : "XNZRYTITWLGTJS-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP1B1",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0097",
                     "inchikey" : "HSSLDCABUXLXKM-UHFFFAOYSA-N",
                         "name" : "Resorufin",
                    "structure" : "[H]OC1=C([H])C([H])=C2N=C3C([H])=C([H])C(=O)C([H])=C3OC2=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0497" : {
                             "Name" : "Methyl N,N-diethyldithiocarbamate",
            "Substrate's structure" : "CCN(CC)C(=S)SC",
                         "InChIKey" : "JYRXPFCUABYLPD-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2A6; CYP2B6; CYP2E1; CYP3A4; CYP3A5",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0483",
                     "inchikey" : "RSPAUUVFJFPEHQ-UHFFFAOYSA-N",
                         "name" : "MeDDC sulfine",
                    "structure" : "[H]C([H])([H])SC(=S=O)N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0498" : {
                             "Name" : "DMXAA",
            "Substrate's structure" : "CC1=CC=C2C(=O)C3=CC=CC(CC(O)=O)=C3OC2=C1C",
                         "InChIKey" : "XGOYIMQSIKSOBS-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0484",
                     "inchikey" : "JEPCGWROBIUIMK-UHFFFAOYSA-N",
                         "name" : "6-Hydroxy-MXAA",
                    "structure" : "CC1=C2OC3=C(CC(O)=O)C=CC=C3C(=O)C2=CC=C1CO"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0499" : {
                             "Name" : "Nitrosodiethylamine",
            "Substrate's structure" : "CCN(CC)N=O",
                         "InChIKey" : "WBNQDOYYEUMPFS-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP2B6; CYP2E1",
                       "References" : [
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015",
                "Ekins, S. and Wrighton, S.A. (1999); The role of CYP2B6 in Human Xenobiotic Metabolism; Drug Metabolism Reviews, 31:3, 719-754, DOI:10.1081/ DMR-100101942; PMID:10461547"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0485",
                     "inchikey" : "SCSKXSBERKMMJG-UHFFFAOYSA-N",
                         "name" : "N-Nitrosomonoethylamine",
                    "structure" : "[H]N(CC)N=O"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0500" : {
                             "Name" : "N-Nitrosodimethylamine",
            "Substrate's structure" : "CN(C)N=O",
                         "InChIKey" : "UMFJAHHVKNCGLG-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1; CYP2A6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0486",
                     "inchikey" : "CDKXZKUBCGJTDG-UHFFFAOYSA-N",
                         "name" : "N-Nitroso-N-methyl-N-hydroxymethylamine",
                    "structure" : "CN(CO)N=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0501" : {
                             "Name" : "N-Nitrosodimethylamine",
            "Substrate's structure" : "CN(C)N=O",
                         "InChIKey" : "UMFJAHHVKNCGLG-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2E1",
                       "References" : [
                "Kelley, R.W. et al. (2006); Heteromeric Complex Formation between CYP2E1 and CYP1A2: Evidence for the involvement of electrostatic interactions; Biochemistry. 2006 December 26; 45(51): 15807���15816.; doi:10.1021/bi061803n; PMCID:PMC1994092"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0487",
                     "inchikey" : "CIJBKNZDKBKMFU-UHFFFAOYSA-N",
                         "name" : "N-Nitrosomethylamine",
                    "structure" : "CNN=O"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0502" : {
                             "Name" : "NNK",
            "Substrate's structure" : "CN(CCCC(=O)C1=CC=CN=C1)N=O",
                         "InChIKey" : "FLAQQSHRLBFIEZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP1B1; CYP2A6; CYP2B6; CYP2D6; CYP2E1",
                       "References" : [
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0503" : {
                             "Name" : "DEET",
            "Substrate's structure" : "O=C(C1=CC(=CC=C1)C)N(CC)CC",
                         "InChIKey" : "MMOXZBCLCQITDF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2B6; CYP2D6; CYP2E1",
                       "References" : [
                "Usmani, K.A. et al (2002); In vitro human metabolism and interactions of repellent N,N-diethyl-m-toluamide; Drug. Metab. Dispos.;30(3):289-94.; PMID11854147"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0488",
                     "inchikey" : "FRZJZRVZZNTMAW-UHFFFAOYSA-N",
                         "name" : "N,N-diethyl-m-hydroxymethylbenzamide",
                    "structure" : "CCN(CC)C(=O)C1=CC(CO)=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0504" : {
                             "Name" : "DEET",
            "Substrate's structure" : "O=C(C1=CC(=CC=C1)C)N(CC)CC",
                         "InChIKey" : "MMOXZBCLCQITDF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP2C19; CYP3A4; CYP3A5",
                       "References" : [
                "Usmani, K.A. et al (2002); In vitro human metabolism and interactions of repellent N,N-diethyl-m-toluamide; Drug. Metab. Dispos.;30(3):289-94.; PMID11854147"
            ],
                         "Products" : [],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0505" : {
                             "Name" : "DEET",
            "Substrate's structure" : "[H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C(=O)N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "MMOXZBCLCQITDF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP2B6; CYP2D6; CYP2E1",
                       "References" : [
                "Usmani, K.A.; (2002). In vitro human metabolism and interactions of repellent N,N-diethyl-m- toluamide. Drug Metab. Dispos., Vol. 30, No. 3, (289-294)."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0489",
                     "inchikey" : "MMOXZBCLCQITDF-UHFFFAOYSA-N",
                         "name" : "N,N-diethyl-m-hydroxymethylbenzamide",
                    "structure" : "[H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C(=O)N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0506" : {
                             "Name" : "DEET",
            "Substrate's structure" : "[H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C(=O)N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "MMOXZBCLCQITDF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP3A4",
                       "References" : [
                "Usmani, K.A.; (2002). In vitro human metabolism and interactions of repellent N,N-diethyl-m- toluamide. Drug Metab. Dispos., Vol. 30, No. 3, (289-294)."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0490",
                     "inchikey" : "FPINATACRXASTP-UHFFFAOYSA-N",
                         "name" : "N-ethyl-m-toluamide",
                    "structure" : "[H]N(C(=O)C1=C([H])C(=C([H])C([H])=C1[H])C([H])([H])[H])C([H])([H])C([H])([H])[H]"
                },
                {
                     "BTMDB_ID" : "BTMDB0490",
                     "inchikey" : "FPINATACRXASTP-UHFFFAOYSA-N",
                         "name" : "N-ethyl-m-toluamide",
                    "structure" : "[H]C([H])([H])C=O"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0507" : {
                             "Name" : "dibenzo(a,h)anthracene",
            "Substrate's structure" : "C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5=CC=CC=C54)C=C32",
                         "InChIKey" : "LHRCREOYAASXPZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0491",
                     "inchikey" : "KRMRQHCFOIRUMJ-UHFFFAOYNA-N",
                         "name" : "dibenzo(a,h)anthracene 1,2-epoxide",
                    "structure" : "O1C2C=CC3=C(C12)C1=C(C=C3)C=C2C(C=CC3=C2C=CC=C3)=C1"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0508" : {
                             "Name" : "dibenzo(a,h)anthracene",
            "Substrate's structure" : "C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5=CC=CC=C54)C=C32",
                         "InChIKey" : "LHRCREOYAASXPZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (major); CYP2B6 (minor); CYP2C9 (major)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675",
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0492",
                     "inchikey" : "JXNLSXIURKVPSX-UHFFFAOYNA-N",
                         "name" : "dibenzo(a,h)anthracene 3,4-epoxide",
                    "structure" : "C1CC2=C(C=C1)C=CC1=CC3=C(C=CC4=C3C=CC3OC43)C=C21"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0509" : {
                             "Name" : "p-Methoxyacetanilide",
            "Substrate's structure" : "COC1=CC=C(NC(C)=O)C=C1",
                         "InChIKey" : "XVAIDCNLVLTVFM-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Yun, C.H. et al (2001); Oxidations of p-alkoxyacylanilides catalyzed by human cytochrome P450 1A2: structure-activity relationships and simulation of rate constants of individual steps in catalysis.; Biochemistry 2001, 40, 4521-4530; PMID:11284709."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0104",
                     "inchikey" : "RZVAJINKPMORJF-UHFFFAOYSA-N",
                         "name" : "p-Methoxyacetanilide, O-demethyl-",
                    "structure" : "[H]OC1=CC=C(NC(C)=O)C=C1"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0510" : {
                             "Name" : "Proguanil",
            "Substrate's structure" : "CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1",
                         "InChIKey" : "SSOLNOMRVKKSON-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C19; CYP2D6; CYP3A4; CYP2C9 (minor)",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Diaz, D.S. et al. (2008); Role of Specific Cytochrome P450 Isoforms in the Conversion of Phenoxypropoxybiguanide Analogs in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines; Drug Metabolism and Disposition February 2008, 36 (2) 380-385; DOI: https://doi.org/10.1124/dmd.106.013920",
                "Birkett, D.J. et al. (1994); In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase; Br J Clin Pharmacol.; 37(5):413-20."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0493",
                     "inchikey" : "QMNFFXRFOJIOKZ-UHFFFAOYSA-N",
                         "name" : "Cycloguanil",
                    "structure" : "CC1(C)N=C(N)N=C(N)N1C1=CC=C(Cl)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Heteroring formation"
            ]
        },
        "BIOTID0511" : {
                             "Name" : "Proguanil",
            "Substrate's structure" : "CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1",
                         "InChIKey" : "SSOLNOMRVKKSON-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Diaz, D.S. et al. (2008); Role of Specific Cytochrome P450 Isoforms in the Conversion of Phenoxypropoxybiguanide Analogs in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines; Drug Metabolism and Disposition February 2008, 36 (2) 380-385; DOI: https://doi.org/10.1124/dmd.106.013920",
                "Birkett, D.J. et al. (1994); In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase; Br J Clin Pharmacol.; 37(5):413-20."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0494",
                     "inchikey" : "HTYFFCPFVMJTKM-UHFFFAOYSA-N",
                         "name" : "4-Chlorophenylbiguanide",
                    "structure" : "NC(=N)NC(=N)NC1=CC=C(Cl)C=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0512" : {
                             "Name" : "Verapamil",
            "Substrate's structure" : "COC1=CC=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC=C(OC)C(OC)=C2)C=C1OC",
                         "InChIKey" : "SGTNSNPWRIOYBX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP1A2; CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0495",
                     "inchikey" : "UPKQNCPKPOLASS-UHFFFAOYNA-N",
                         "name" : "Norverapamil",
                    "structure" : "COC1=CC=C(CCNCCCC(C#N)(C(C)C)C2=CC=C(OC)C(OC)=C2)C=C1OC"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0513" : {
                             "Name" : "Verapamil",
            "Substrate's structure" : "COC1=CC=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC=C(OC)C(OC)=C2)C=C1OC",
                         "InChIKey" : "SGTNSNPWRIOYBX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C18",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0496",
                     "inchikey" : "CAAKRPRWCVWYAO-UHFFFAOYNA-N",
                         "name" : "D-702",
                    "structure" : "COC1=CC(CCN(C)CCCC(C#N)(C(C)C)C2=CC=C(OC)C(OC)=C2)=CC=C1O"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0514" : {
                             "Name" : "Verapamil",
            "Substrate's structure" : "COC1=CC=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC=C(OC)C(OC)=C2)C=C1OC",
                         "InChIKey" : "SGTNSNPWRIOYBX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0497",
                     "inchikey" : "WLKVZSXOMGNZLB-UHFFFAOYNA-N",
                         "name" : "M9 (D-703)",
                    "structure" : "COC1=CC(=CC=C1O)C(CCCN(C)CCC1=CC=C(OC)C(OC)=C1)(C#N)C(C)C"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0515" : {
                             "Name" : "Verapamil",
            "Substrate's structure" : "COC1=CC=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC=C(OC)C(OC)=C2)C=C1OC",
                         "InChIKey" : "SGTNSNPWRIOYBX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4; CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0498",
                     "inchikey" : "WLOBUUJURNEQCL-UHFFFAOYNA-N",
                         "name" : "D-617",
                    "structure" : "[H]N(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1"
                },
                {
                     "BTMDB_ID" : "BTMDB0498",
                     "inchikey" : "WLOBUUJURNEQCL-UHFFFAOYNA-N",
                         "name" : "D-617",
                    "structure" : "COC1=CC=C(CC=O)C=C1OC"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0516" : {
                             "Name" : "Bufuralol",
            "Substrate's structure" : "CCC1=C2OC(=CC2=CC=C1)C(O)CNC(C)(C)C",
                         "InChIKey" : "SSEBTPPFLLCUMN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Yamazaki, H. et al. (1994); Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes; Molecular Pharmacology September 1994, 46 (3) 568-577"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0499",
                     "inchikey" : "VWEQAYFMBKZBLK-UHFFFAOYNA-N",
                         "name" : "4-Hydroxybufuralol",
                    "structure" : "CCC1=C2OC(=CC2=C(O)C=C1)C(O)CNC(C)(C)C"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0517" : {
                             "Name" : "Bufuralol",
            "Substrate's structure" : "CCC1=C2OC(=CC2=CC=C1)C(O)CNC(C)(C)C",
                         "InChIKey" : "SSEBTPPFLLCUMN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Yamazaki, H. et al. (1994); Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes; Molecular Pharmacology September 1994, 46 (3) 568-577"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0500",
                     "inchikey" : "JSCCUEPMAIGYSD-UHFFFAOYNA-N",
                         "name" : "6-Hydroxubufuralol",
                    "structure" : "CCC1=C2OC(=CC2=CC=C1O)C(O)CNC(C)(C)C"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0518" : {
                             "Name" : "Bufuralol",
            "Substrate's structure" : "CCC1=C2OC(=CC2=CC=C1)C(O)CNC(C)(C)C",
                         "InChIKey" : "SSEBTPPFLLCUMN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0501",
                     "inchikey" : "FVNDVONSLMNGES-UHFFFAOYNA-N",
                         "name" : "1'2'-Ethenylbufuralol",
                    "structure" : "CC(C)(C)NCC(O)C1=CC2=CC=CC(C=C)=C2O1"
                }
            ],
                    "Reaction Type" : [
                "Dehydrogenation"
            ]
        },
        "BIOTID0519" : {
                             "Name" : "Halothane ",
            "Substrate's structure" : "FC(F)(F)C(Cl)Br",
                         "InChIKey" : "BCQZXOMGPXTTIC-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1; CYP2A6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0502",
                     "inchikey" : "PNQBEPDZQUOCNY-UHFFFAOYSA-N",
                         "name" : "Trifluoroacetyl chloride",
                    "structure" : "FC(F)(F)C(Cl)=O"
                }
            ],
                    "Reaction Type" : [
                "Dehalogenation"
            ]
        },
        "BIOTID0520" : {
                             "Name" : "Halothane ",
            "Substrate's structure" : "FC(F)(F)C(Cl)Br",
                         "InChIKey" : "BCQZXOMGPXTTIC-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0503",
                     "inchikey" : "CYXIKYKBLDZZNW-UHFFFAOYSA-N",
                         "name" : "chlorotrifluoroethane",
                    "structure" : "[H]C([H])(Cl)C(F)(F)F"
                }
            ],
                    "Reaction Type" : [
                "Dehalogenation"
            ]
        },
        "BIOTID0521" : {
                             "Name" : "Halothane ",
            "Substrate's structure" : "FC(F)(F)C(Cl)Br",
                         "InChIKey" : "BCQZXOMGPXTTIC-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0003",
                     "inchikey" : "HTHNTJCVPNKCPZ-UHFFFAOYSA-N",
                         "name" : "chlorodifluoroethene",
                    "structure" : "[H]C(Cl)=C(F)F"
                }
            ],
                    "Reaction Type" : [
                "Dehalogenation"
            ]
        },
        "BIOTID0522" : {
                             "Name" : "delta-9-Tetrahydrocannabinol",
            "Substrate's structure" : "CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)O",
                         "InChIKey" : "CYQFCXCEBYINGO-IAGOWNOFSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0504",
                     "inchikey" : "YCBKSSAWEUDACY-IAGOWNOFSA-N",
                         "name" : "11-OH-delata-Tetrahydrocannabinol",
                    "structure" : "CCCCCC1=CC(O)=C2[C@@H]3C=C(CO)CC[C@H]3C(C)(C)OC2=C1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0523" : {
                             "Name" : "delta-9-Tetrahydrocannabinol",
            "Substrate's structure" : "CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)O",
                         "InChIKey" : "CYQFCXCEBYINGO-IAGOWNOFSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0505",
                     "inchikey" : "DJCKLUPKZRLTPE-RQFJBDDASA-N",
                         "name" : "7-OH-delta-9-Tetrahydrocannabinol",
                    "structure" : "CCCCCC1=CC(O)=C2[C@@H]3C=C(C)C[C@H](O)C3C(C)(C)OC2=C1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0524" : {
                             "Name" : "delta-9-Tetrahydrocannabinol",
            "Substrate's structure" : "CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)O",
                         "InChIKey" : "CYQFCXCEBYINGO-IAGOWNOFSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0506",
                     "inchikey" : "DJCKLUPKZRLTPE-VPWXQRGCSA-N",
                         "name" : "7alpha-OH-delta-9-Tetrahydrocannabinol",
                    "structure" : "[H][C@@]12C=C(C)C[C@@H](O)[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0525" : {
                             "Name" : "delta-9-Tetrahydrocannabinol",
            "Substrate's structure" : "CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)O",
                         "InChIKey" : "CYQFCXCEBYINGO-IAGOWNOFSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0507",
                     "inchikey" : "INKUWBOHCFHXTJ-YNPPLXCJSA-N",
                         "name" : "8-OH-delta-9-Tetrahydrocannabinol",
                    "structure" : "[H][C@@]12C=C(C)C(O)C[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0526" : {
                             "Name" : "delta-9-Tetrahydrocannabinol",
            "Substrate's structure" : "CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)O",
                         "InChIKey" : "CYQFCXCEBYINGO-IAGOWNOFSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0508",
                     "inchikey" : "INKUWBOHCFHXTJ-PWZMFNOBSA-N",
                         "name" : "8alpha-OH-delta-9-Tetrahydrocannabinol",
                    "structure" : "CCCCCC1=CC(O)=C2[C@@H]3C=C(C)[C@H](O)CC3C(C)(C)OC2=C1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0527" : {
                             "Name" : "Erlotinib",
            "Substrate's structure" : "COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1",
                         "InChIKey" : "AAKJLRGGTJKAMG-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5; CYP1A1; CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0509",
                     "inchikey" : "MTLKTHNRZJKPRP-UHFFFAOYSA-N",
                         "name" : "2�ې({4�ې[(3�ېethynylphenyl)amino]�ې6�ې(2�ېmethoxyethoxy)quinazolin�ې7�ېyl}oxy)ethan�ې1�ېol",
                    "structure" : "COCCOC1=C(OCCO)C=C2N=CN=C(NC3=CC(=CC=C3)C#C)C2=C1"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0528" : {
                             "Name" : "zafirlukast",
            "Substrate's structure" : "C(OC1=C(C(C2=C(N(C([H])([H])[H])C3=C2C(=C(N(C(=O)OC4(C(C(C(C4([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])C(=C3[H])[H])[H])[H])([H])[H])C(=C(C(=C1[H])C(=O)N(S(=O)(=O)C5=C(C(=C(C(=C5C([H])([H])[H])[H])[H])[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "YEEZWCHGZNKEEK-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0510",
                     "inchikey" : "HZAQOSFFIGVMDH-UHFFFAOYSA-N",
                         "name" : "cyclopentyl N�ې[1�ې(hydroxymethyl)�ې3�ې({2�ېmethoxy�ې4�ې[(2�ېmethylbenzenesulfonyl)carbamoyl]phenyl}methyl)indol�ې5�ېyl]carbamate",
                    "structure" : "[H]N(C(=O)OC1([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H])C1=C([H])C2=C(C([H])=C1[H])N(C([H])=C2C([H])([H])C1=C(OC([H])([H])[H])C([H])=C(C([H])=C1[H])C(=O)N([H])S(=O)(=O)C1=C([H])C([H])=C([H])C([H])=C1C([H])([H])[H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0529" : {
                             "Name" : "zafirlukast",
            "Substrate's structure" : "C(OC1=C(C(C2=C(N(C([H])([H])[H])C3=C2C(=C(N(C(=O)OC4(C(C(C(C4([H])[H])([H])[H])([H])[H])([H])[H])[H])[H])C(=C3[H])[H])[H])[H])([H])[H])C(=C(C(=C1[H])C(=O)N(S(=O)(=O)C5=C(C(=C(C(=C5C([H])([H])[H])[H])[H])[H])[H])[H])[H])[H])([H])([H])[H]",
                         "InChIKey" : "YEEZWCHGZNKEEK-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0511",
                     "inchikey" : "OPQKYGDYABHOST-UHFFFAOYNA-N",
                         "name" : "3�ېhydroxycyclopentyl N�ې[3�ې({2�ېmethoxy�ې4�ې[(2�ېmethylbenzenesulfonyl)carbamoyl]phenyl}methyl)�ې1�ېmethylindol�ې5�ېyl]carbamate",
                    "structure" : "[H]N(C(=O)OC1([H])C([H])([H])C([H])([H])C([H])(O)C1([H])[H])C1=C([H])C2=C(C([H])=C1[H])N(C([H])=C2C([H])([H])C1=C(OC([H])([H])[H])C([H])=C(C([H])=C1[H])C(=O)N([H])S(=O)(=O)C1=C([H])C([H])=C([H])C([H])=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0530" : {
                             "Name" : "zolmitriptan",
            "Substrate's structure" : "O1C([C@@](N(C1=O)[H])(C(C=2C(=C3C(C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])=C(N(C3=C(C2[H])[H])[H])[H])[H])([H])[H])[H])([H])[H]",
                         "InChIKey" : "ULSDMUVEXKOYBU-ZDUSSCGKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0512",
                     "inchikey" : "QGGCHSMZXKNGCK-LBPRGKRZSA-N",
                         "name" : "N-Desmethylzolmitriptan",
                    "structure" : "[H]N1C([H])=C(C2=C([H])C(=C([H])C([H])=C12)C([H])([H])[C@]1([H])N([H])C(=O)OC1([H])[H])C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0531" : {
                             "Name" : "zolmitriptan",
            "Substrate's structure" : "O1C([C@@](N(C1=O)[H])(C(C=2C(=C3C(C(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])=C(N(C3=C(C2[H])[H])[H])[H])[H])([H])[H])[H])([H])[H]",
                         "InChIKey" : "ULSDMUVEXKOYBU-ZDUSSCGKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0513",
                     "inchikey" : "GZYCQRZFJIZOKU-ZDUSSCGKSA-N",
                         "name" : "Zolmitriptan N-oxide",
                    "structure" : "[H]N1C([H])=C(C2=C([H])C(=C([H])C([H])=C12)C([H])([H])[C@]1([H])N([H])C(=O)OC1([H])[H])C([H])([H])C([H])([H])[N+]([O-])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0532" : {
                             "Name" : "zolpidem",
            "Substrate's structure" : "C1(=C(C2=C(C(=C(C(=C2[H])[H])C([H])([H])[H])[H])[H])N=C3N1C(=C(C(=C3[H])[H])C([H])([H])[H])[H])C(C(N(C([H])([H])[H])C([H])([H])[H])=O)([H])[H]",
                         "InChIKey" : "ZAFYATHCZYHLPB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4(major); CYP1A2 (minor); CYP2D6 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0514",
                     "inchikey" : "ZAFYATHCZYHLPB-UHFFFAOYSA-N",
                         "name" : "methoxyzolpidem",
                    "structure" : "C1(=C(C2=C(C(=C(C(=C2[H])[H])C([H])([H])[H])[H])[H])N=C3N1C(=C(C(=C3[H])[H])C([H])([H])[H])[H])C(C(N(C([H])([H])[H])C([H])([H])[H])=O)([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0533" : {
                             "Name" : "zolpidem",
            "Substrate's structure" : "C1(=C(C2=C(C(=C(C(=C2[H])[H])C([H])([H])[H])[H])[H])N=C3N1C(=C(C(=C3[H])[H])C([H])([H])[H])[H])C(C(N(C([H])([H])[H])C([H])([H])[H])=O)([H])[H]",
                         "InChIKey" : "ZAFYATHCZYHLPB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4(major); CYP1A2 (minor); CYP2D6 (minor); CYP2C9 (minor); CYP2C19 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0515",
                     "inchikey" : "OQTVDLUCOCICRN-UHFFFAOYSA-N",
                         "name" : "methoxyzolpidem",
                    "structure" : "[H]C1=C([H])C(=C([H])C([H])=C1CO)C1=C(N2C([H])=C(C(O)=C([H])C2=N1)C([H])([H])[H])C([H])([H])C(=O)N(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0534" : {
                             "Name" : "zotepine",
            "Substrate's structure" : "C12=C(SC3=C(C(=C1OC(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])[H])C(=C(C(=C3[H])[H])[H])[H])C(=C(C(=C2[H])Cl)[H])[H]",
                         "InChIKey" : "HDOZVRUNCMBHFH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP3A4; CYP3A5; CYP2B6; CYP2C19",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0516",
                     "inchikey" : "OVVBIIBBRZVPAL-UHFFFAOYSA-N",
                         "name" : "Norzotepine",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])C([H])=C(OC([H])([H])C([H])([H])NC([H])([H])[H])C1=C(S2)C([H])=C([H])C(Cl)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0535" : {
                             "Name" : "zotepine",
            "Substrate's structure" : "C12=C(SC3=C(C(=C1OC(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])[H])C(=C(C(=C3[H])[H])[H])[H])C(=C(C(=C2[H])Cl)[H])[H]",
                         "InChIKey" : "HDOZVRUNCMBHFH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0517",
                     "inchikey" : "IZIOJMRQCYPVQW-UHFFFAOYSA-N",
                         "name" : "Zotepine N-oxide",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])C([H])=C(OC([H])([H])C([H])([H])[N+]([O-])(C([H])([H])[H])C([H])([H])[H])C1=C(S2)C([H])=C([H])C(Cl)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0536" : {
                             "Name" : "zotepine",
            "Substrate's structure" : "C12=C(SC3=C(C(=C1OC(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])[H])C(=C(C(=C3[H])[H])[H])[H])C(=C(C(=C2[H])Cl)[H])[H]",
                         "InChIKey" : "HDOZVRUNCMBHFH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0518",
                     "inchikey" : "MCQGRTOFLHWZAG-UHFFFAOYSA-N",
                         "name" : "2-OH-zotepine",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1O)C([H])=C(OC([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])C1=C(S2)C([H])=C([H])C(Cl)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0537" : {
                             "Name" : "zotepine",
            "Substrate's structure" : "C12=C(SC3=C(C(=C1OC(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])[H])C(=C(C(=C3[H])[H])[H])[H])C(=C(C(=C2[H])Cl)[H])[H]",
                         "InChIKey" : "HDOZVRUNCMBHFH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP3A4; CYP2D6; CYP2C19",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0519",
                     "inchikey" : "MOEFMTBUTHFFHY-UHFFFAOYSA-N",
                         "name" : "3-OH-zotepine",
                    "structure" : "[H]C1=C([H])C2=C(SC3=C(C([H])=C(Cl)C([H])=C3[H])C(OC([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])=C2[H])C([H])=C1O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0538" : {
                             "Name" : "zotepine",
            "Substrate's structure" : "C12=C(SC3=C(C(=C1OC(C(N(C([H])([H])[H])C([H])([H])[H])([H])[H])([H])[H])[H])C(=C(C(=C3[H])[H])[H])[H])C(=C(C(=C2[H])Cl)[H])[H]",
                         "InChIKey" : "HDOZVRUNCMBHFH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2B6; CYP3A4; CYP3A5",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0520",
                     "inchikey" : "GPQLECKPRFIPAC-UHFFFAOYNA-N",
                         "name" : "Zotepine -oxide",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])S(=O)C1=C(C([H])=C(Cl)C([H])=C1[H])C(OC([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0539" : {
                             "Name" : "Benzo[a]pyrene",
            "Substrate's structure" : "C1=CC=C2C(=C1)C=C3C=CC4=CC=CC5=CC=C2C3=C45",
                         "InChIKey" : "FMMWHPNWAFZXNH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP1B1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0521",
                     "inchikey" : "OLLMQFHYRYHKTD-UHFFFAOYNA-N",
                         "name" : "Benzo[a]pyrene-7,8-epoxide",
                    "structure" : "[H]C1=C([H])C2=C([H])C([H])=C3C4=C(C([H])=C5C([H])=C([H])C(=C1[H])C2=C35)C1([H])OC1([H])C([H])=C4[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0540" : {
                             "Name" : "Benzo[a]pyrene",
            "Substrate's structure" : "C1=CC=C2C(=C1)C=C3C=CC4=CC=CC5=CC=C2C3=C45",
                         "InChIKey" : "FMMWHPNWAFZXNH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C8; CYP2C9;CYP2C19; CYP1A1; CYP1B1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0522",
                     "inchikey" : "HIWUMYIKMBIYMX-UHFFFAOYNA-N",
                         "name" : "3-Hydroxybenzo[a]pyrene",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])C1=C3C(C([H])=C([H])C4=C3C(C([H])=C1[H])=C([H])C1([H])OC41[H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0541" : {
                             "Name" : "Benzo[a]pyrene",
            "Substrate's structure" : "C1=CC=C2C(=C1)C=C3C=CC4=CC=CC5=CC=C2C3=C45",
                         "InChIKey" : "FMMWHPNWAFZXNH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1B1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0523",
                     "inchikey" : "GOEJUYABKOTLJA-UHFFFAOYNA-N",
                         "name" : "9-Hydroxybenzo[a]pyrene",
                    "structure" : "[H]C1=C([H])C2=C([H])C([H])=C3C4=C2C(C([H])=C([H])C4=C([H])C2=C3C3([H])OC3([H])C([H])=C2[H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0542" : {
                             "Name" : "Benzo[a]pyrene",
            "Substrate's structure" : "C1=CC=C2C(=C1)C=C3C=CC4=CC=CC5=CC=C2C3=C45",
                         "InChIKey" : "FMMWHPNWAFZXNH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0524",
                     "inchikey" : "SFZMXWGXHHIMNU-UHFFFAOYNA-N",
                         "name" : "1-Hydroxybenzo[a]pyrene",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])C1=C3C(C([H])=C([H])C4=C([H])C5([H])OC5([H])C(C([H])=C1[H])=C34)=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0543" : {
                             "Name" : "Benzo[a]pyrene",
            "Substrate's structure" : "C1=CC=C2C(=C1)C=C3C=CC4=CC=CC5=CC=C2C3=C45",
                         "InChIKey" : "FMMWHPNWAFZXNH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1B1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0525",
                     "inchikey" : "XGZQLNASOQVQTD-UHFFFAOYNA-N",
                         "name" : "Benzo[a]pyrene-4,5-epoxide",
                    "structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])C1=C3C(=C2[H])C2([H])OC2([H])C2=C([H])C([H])=C([H])C(C([H])=C1[H])=C32"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0544" : {
                             "Name" : "Retinoic acid, all-trans",
            "Substrate's structure" : "C1(=C(CCCC1(C)C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C",
                         "InChIKey" : "SHGAZHPCJJPHSC-YCNIQYBTSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A7; CYP2C8 (major); CYP3A4; CYP2C9 (minor); CYP2B6; CYP3A5; CYP2A6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0526",
                     "inchikey" : "KGUMXGDKXYTTEY-FRCNGJHJNA-N",
                         "name" : "4-Hydroxyretinoic acid",
                    "structure" : "C\\C(\\C=C\\C1=C(C)C(O)CCC1(C)C)=C/C=C/C(/C)=C/C(O)=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0545" : {
                             "Name" : "Retinoic acid, all-trans",
            "Substrate's structure" : "C1(=C(CCCC1(C)C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C",
                         "InChIKey" : "SHGAZHPCJJPHSC-YCNIQYBTSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP4A11; CYP3A7; CYP1A1; CYP2C8; CYP2C9; CYP2C18; CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0527",
                     "inchikey" : "XSJOIRFEYHJNAW-FCKHSPHMSA-N",
                         "name" : "18-Hydroxyretinoic acid",
                    "structure" : "C\\C(\\C=C\\C1=C(CO)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0546" : {
                             "Name" : "Retinoic acid, all-trans",
            "Substrate's structure" : "C1(=C(CCCC1(C)C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C",
                         "InChIKey" : "SHGAZHPCJJPHSC-YCNIQYBTSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C9; CYP1A1; CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0528",
                     "inchikey" : "KEEHJLBAOLGBJZ-WEDZBJJJNA-N",
                         "name" : "5,6-Epoxy-retinoic acid",
                    "structure" : "C\\C(\\C=C\\C12OC1(C)CCCC2(C)C)=C/C=C/C(/C)=C/C(O)=O"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0547" : {
                             "Name" : "Nelfinavir",
            "Substrate's structure" : "CC1=C(O)C=CC=C1C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C",
                         "InChIKey" : "QAGYKUNXZHXKMR-HKWSIXNMSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0529",
                     "inchikey" : "SLEPDNKZXLVSOH-HKWSIXNMSA-N",
                         "name" : "Nelfinavir hydroxyl-t- butylamide",
                    "structure" : "CC1=C(O)C=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)CO"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0548" : {
                             "Name" : "Nelfinavir",
            "Substrate's structure" : "CC1=C(O)C=CC=C1C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C",
                         "InChIKey" : "QAGYKUNXZHXKMR-HKWSIXNMSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0530",
                     "inchikey" : "QTSSATVFYFFGRH-HPHCTBIGSA-N",
                         "name" : "3,4-Dihydroxynelfinavir",
                    "structure" : "CC1=C(O)C(O)=CC=C1C(=O)N[C@@H](CSC1=CC=CC=C1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0549" : {
                             "Name" : "Metamphetamine",
            "Substrate's structure" : "CN[C@@H](C)CC1=CC=CC=C1",
                         "InChIKey" : "MYWUZJCMWCOHBA-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0531",
                     "inchikey" : "SBUQZKJEOOQSBV-QMMMGPOBSA-N",
                         "name" : "4-Hydroxymethamphetamine",
                    "structure" : "CN[C@@H](C)CC1=CC=C(O)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0550" : {
                             "Name" : "Metamphetamine",
            "Substrate's structure" : "CN[C@@H](C)CC1=CC=CC=C1",
                         "InChIKey" : "MYWUZJCMWCOHBA-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0532",
                     "inchikey" : "KWTSXDURSIMDCE-QMMMGPOBSA-N",
                         "name" : "Amphetamine",
                    "structure" : "C[C@H](N)CC1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0551" : {
                             "Name" : "Methylene chloride",
            "Substrate's structure" : "ClCCl",
                         "InChIKey" : "YMWUJEATGCHHMB-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0533",
                     "inchikey" : "GJYVZUKSNFSLCL-UHFFFAOYSA-N",
                         "name" : "Dichloromethanol",
                    "structure" : "OC(Cl)Cl"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0552" : {
                             "Name" : "Phenobarbital",
            "Substrate's structure" : "CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2",
                         "InChIKey" : "DDBREPKUVSBGFI-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19; CYP2E1",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Lee, A.M. et al. (2006); Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism; Eur J Pharmacol. 2006 Dec 15;552(1-3):151-8; PMID:17049344; DOI:10.1016/j.ejphar.2006.09.006"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0534",
                     "inchikey" : "IEPXMKJNWPXDBP-UHFFFAOYSA-N",
                         "name" : "p-Hydroxyphenobarbital",
                    "structure" : "CCC1(C(=O)NC(=O)NC1=O)C1=CC=C(O)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0553" : {
                             "Name" : "Glyburide",
            "Substrate's structure" : "[H]N(C(=O)C1=C(OC([H])([H])[H])C([H])=C([H])C(Cl)=C1[H])C([H])([H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "ZNNLBTZKUZBEKO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0535",
                     "inchikey" : "PASKIAZVROHUGZ-PMACEKPBSA-N",
                         "name" : "2-trans-hydroxycyclohexyl glyburide",
                    "structure" : "[H]N(C(=O)C1=C(OC([H])([H])[H])C([H])=C([H])C(Cl)=C1[H])C([H])([H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])[C@@]1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@]1([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0554" : {
                             "Name" : "Glyburide",
            "Substrate's structure" : "[H]N(C(=O)C1=C(OC([H])([H])[H])C([H])=C([H])C(Cl)=C1[H])C([H])([H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "ZNNLBTZKUZBEKO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0536",
                     "inchikey" : "IUWSGCQEWOOQDN-HDICACEKNA-N",
                         "name" : "4-cis-hydroxycyclohexyl glyburide",
                    "structure" : "[H]N(C(=O)C1=C(OC([H])([H])[H])C([H])=C([H])C(Cl)=C1[H])C([H])([H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])[C@]1([H])C([H])([H])C([H])([H])[C@]([H])(O)C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0555" : {
                             "Name" : "Glyburide",
            "Substrate's structure" : "[H]N(C(=O)C1=C(OC([H])([H])[H])C([H])=C([H])C(Cl)=C1[H])C([H])([H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "ZNNLBTZKUZBEKO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0537",
                     "inchikey" : "IUWSGCQEWOOQDN-IYARVYRRNA-N",
                         "name" : "4-trans-hydroxycyclohexyl glyburide",
                    "structure" : "[H]N(C(=O)C1=C(OC([H])([H])[H])C([H])=C([H])C(Cl)=C1[H])C([H])([H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])[C@@]1([H])C([H])([H])C([H])([H])[C@]([H])(O)C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0556" : {
                             "Name" : "Glyburide",
            "Substrate's structure" : "[H]N(C(=O)C1=C(OC([H])([H])[H])C([H])=C([H])C(Cl)=C1[H])C([H])([H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "ZNNLBTZKUZBEKO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0538",
                     "inchikey" : "VFBAJFAMXTVSQA-ROUUACIJSA-N",
                         "name" : "3-trans-Hydroxycyclohexyl glyburide",
                    "structure" : "[H]N(C(=O)C1=C(OC([H])([H])[H])C([H])=C([H])C(Cl)=C1[H])C([H])([H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])[C@@]1([H])C([H])([H])C([H])([H])C([H])([H])[C@]([H])(O)C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0557" : {
                             "Name" : "Glyburide",
            "Substrate's structure" : "[H]N(C(=O)C1=C(OC([H])([H])[H])C([H])=C([H])C(Cl)=C1[H])C([H])([H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "ZNNLBTZKUZBEKO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0539",
                     "inchikey" : "VFBAJFAMXTVSQA-ZWKOTPCHSA-N",
                         "name" : "3-cis-Hydroxycyclohexyl glyburide",
                    "structure" : "[H]N(C(=O)C1=C(OC([H])([H])[H])C([H])=C([H])C(Cl)=C1[H])C([H])([H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])[C@@]1([H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(O)C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0558" : {
                             "Name" : "(-)-bisoprolol",
            "Substrate's structure" : "CC(C)NC[C@@H](COC1=CC=C(C=C1)COCCOC(C)C)O",
                         "InChIKey" : "VHYCDWMUTMEGQY-KRWDZBQOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP3A4",
                       "References" : [
                "Horikiri, Y. (1998); Pharmacokinetics and Metabolism of Bisoprolol Enantiomers in Humans; Journal of Pharmaceutical Sciences; Vol. 87, No. 3"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0540",
                     "inchikey" : "AIGGWEPYIOOYLI-AWEZNQCLSA-N",
                         "name" : "(-)-bisoprolol, O-deisopropyl",
                    "structure" : "CC(C)NC[C@H](O)COC1=CC=C(COCCO)C=C1"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0559" : {
                             "Name" : "(r)-chloroquine, N-desethyl",
            "Substrate's structure" : "[H]N(C1=C2C([H])=C([H])C(Cl)=C([H])C2=NC([H])=C1[H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])NC([H])([H])C([H])([H])[H]",
                         "InChIKey" : "MCYUUUTUAAGOOT-GFCCVEGCSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2D6; CYP3A4; CYP3A5",
                       "References" : [
                "Zanger, U.M. and Schwab, M.; Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation; Pharmacology & Therapeutics 138 (2013) 103���141; PMID:23333322",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0541",
                     "inchikey" : "GYEDIFVVTRKXHP-SNVBAGLBSA-N",
                         "name" : "(r)-chloroquine, N-desethyl",
                    "structure" : "[H]N(C1=C2C([H])=C([H])C(Cl)=C([H])C2=NC([H])=C1[H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])N"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0560" : {
                             "Name" : "(r)-fluoxetine",
            "Substrate's structure" : "[H]N(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]([H])(OC1=C([H])C([H])=C(C([H])=C1[H])C(F)(F)F)C1=C([H])C([H])=C([H])C([H])=C1[H]",
                         "InChIKey" : "RTHCYVBBDHJXIQ-MRXNPFEDSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 (major); CYP2D6; CYP2C19; CYP3A5 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Ring, B.J. et al. (2001); Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine; J Pharmacol Exp Ther. 2001 Jun;297(3):1044-50.",
                "Margolis J.M.; (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes; Drug Metab Dispos. 2000 Oct;28(10):1187-91; PMID: 10997938; Drug Metab Dispos. 2000 Oct;28(10):1187-91."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0542",
                     "inchikey" : "WIQRCHMSJFFONW-OAHLLOKOSA-N",
                         "name" : "(r)-Norfluoxetine",
                    "structure" : "[H]NC([H])([H])C([H])([H])[C@@]([H])(OC1=C([H])C([H])=C(C([H])=C1[H])C(F)(F)F)C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0561" : {
                             "Name" : "(r)-fluoxetine",
            "Substrate's structure" : "[H]N(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]([H])(OC1=C([H])C([H])=C(C([H])=C1[H])C(F)(F)F)C1=C([H])C([H])=C([H])C([H])=C1[H]",
                         "InChIKey" : "RTHCYVBBDHJXIQ-MRXNPFEDSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Ring, B.J. et al. (2001); Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine; J Pharmacol Exp Ther. 2001 Jun;297(3):1044-50.",
                "Margolis J.M.; (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes; Drug Metab Dispos. 2000 Oct;28(10):1187-91; PMID: 10997938; Drug Metab Dispos. 2000 Oct;28(10):1187-91."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0056",
                     "inchikey" : "BAYGVMXZJBFEMB-UHFFFAOYSA-N",
                         "name" : "p-Trifluoromethyl phenol",
                    "structure" : "[H]C1=C([H])C(=C([H])C([H])=C1O)C(F)(F)F"
                },
                {
                     "BTMDB_ID" : "BTMDB0056",
                     "inchikey" : "BAYGVMXZJBFEMB-UHFFFAOYSA-N",
                         "name" : "p-Trifluoromethyl phenol",
                    "structure" : "[H]N(C([H])([H])[H])C([H])([H])CC(=O)C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0562" : {
                             "Name" : "S-Mephenytoin",
            "Substrate's structure" : "CC[C@]1(NC(=O)N(C)C1=O)C1=CC=CC=C1",
                         "InChIKey" : "GMHKMTDVRCWUDX-LBPRGKRZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : " CYP2D6;  CYP2C19;  CYP1A2;  CYP2C18;  CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Koyama, E. et al. (1997); Reappraisal of Human CYP Isoforms Involved in Imipramine N-Demethylation and 2-Hydroxylation: A Study Using Microsomes Obtained from Putative Extensive and Poor Metabolizers of S-Mephenytoin and Eleven Recombinant Human CYPs; Journal of Pharmacology and Experimental Therapeutics; 281 (3) 1199-1210;"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0543",
                     "inchikey" : "OQPLORUDZLXXPD-LBPRGKRZSA-N",
                         "name" : "4��_-Hydroxymephenytoin",
                    "structure" : "CC[C@]1(NC(=O)N(C)C1=O)C1=CC=C(O)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0563" : {
                             "Name" : "S-Mephenytoin",
            "Substrate's structure" : "CC[C@]1(NC(=O)N(C)C1=O)C1=CC=CC=C1",
                         "InChIKey" : "GMHKMTDVRCWUDX-LBPRGKRZSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP2C18; CYP2D6; CYP1A2; CYP3A4; CYP2B6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Koyama, E. et al. (1997); Reappraisal of Human CYP Isoforms Involved in Imipramine N-Demethylation and 2-Hydroxylation: A Study Using Microsomes Obtained from Putative Extensive and Poor Metabolizers of S-Mephenytoin and Eleven Recombinant Human CYPs; Journal of Pharmacology and Experimental Therapeutics; 281 (3) 1199-1210;"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0544",
                     "inchikey" : "UDTWZFJEMMUFLC-NSHDSACASA-N",
                         "name" : "Nirvanol",
                    "structure" : "CC[C@]1(NC(=O)NC1=O)C1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0564" : {
                             "Name" : "(S)-(-)-Mexiletine",
            "Substrate's structure" : "CC1=C(C(=CC=C1)C)OC[C@H](C)N",
                         "InChIKey" : "VLPIATFUUWWMKC-JTQLQIEISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (minor); CYP2D6 (major)",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Zhou, S.F. and Wang, B. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0545",
                     "inchikey" : "YWOSWRCXWBDSRQ-VIFPVBQESA-N",
                         "name" : "(S)-(-)-Mexiletine, p-hydroxyl",
                    "structure" : "C[C@H](N)COC1=C(C)C=C(O)C=C1C"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0565" : {
                             "Name" : "(S)-(-)-Mexiletine",
            "Substrate's structure" : "CC1=C(C(=CC=C1)C)OC[C@H](C)N",
                         "InChIKey" : "VLPIATFUUWWMKC-JTQLQIEISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (minor); CYP2D6 (major)",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Zhou, S.F. and Wang, B. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0546",
                     "inchikey" : "LBHCZYGJQAXJSW-QMMMGPOBSA-N",
                         "name" : "(S)-(-)-Mexiletine, m-hydroxyl",
                    "structure" : "C[C@H](N)COC1=C(C)C=CC(O)=C1C"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0566" : {
                             "Name" : "(S)-(-)-Mexiletine",
            "Substrate's structure" : "CC1=C(C(=CC=C1)C)OC[C@H](C)N",
                         "InChIKey" : "VLPIATFUUWWMKC-JTQLQIEISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (minor); CYP2D6 (major)",
                       "References" : [
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Zhou, S.F. and Wang, B. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 4066-4218; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0547",
                     "inchikey" : "XMJYSMLLWRQQAE-VIFPVBQESA-N",
                         "name" : "(S)-(-)-Mexiletine, 2-OH-hydroxymethyl",
                    "structure" : "C[C@H](N)COC1=C(C)C=CC=C1CO"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0567" : {
                             "Name" : "(S)-(-)-Mexiletine",
            "Substrate's structure" : "CC1=C(C(=CC=C1)C)OC[C@H](C)N",
                         "InChIKey" : "VLPIATFUUWWMKC-JTQLQIEISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2 (major); CYP2B6; CYP2E1",
                       "References" : [
                "Abolfathi, Z. et al. (1995); CYP1A2 is the Major Enzyme Involved in the N-Oxidation of Mexiletine (MEX) in Man. Clin. Pharmacol. Ther.; 57; 221 (OIII- A33)",
                "Labbe, L. et al.; (2003). Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine. Xenobi- otica 33:13���25."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0548",
                     "inchikey" : "ABMUWCMGKRQAIK-JTQLQIEISA-N",
                         "name" : "(S)-(-)-Mexiletine, N-hydroxy",
                    "structure" : "C[C@@H](COC1=C(C)C=CC=C1C)NO"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0568" : {
                             "Name" : "(s)-azelastine",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])C(=O)N(N=C2C([H])([H])C1=C([H])C([H])=C(Cl)C([H])=C1[H])[C@]1([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "MBUVEWMHONZEQD-SFHVURJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2D6; CYP1A2 (minor)",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0549",
                     "inchikey" : "WRYCMIFVXDQIKN-KRWDZBQOSA-N",
                         "name" : "(s)-azelastine, N-desmethyl",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])C(=O)N(N=C2C([H])([H])C1=C([H])C([H])=C(Cl)C([H])=C1[H])[C@]1([H])C([H])([H])C([H])([H])NC([H])([H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0569" : {
                             "Name" : "(s)-bupropion",
            "Substrate's structure" : "[H]N([C@]([H])(C(=O)C1=C([H])C(Cl)=C([H])C([H])=C1[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "SNPPWIUOZRMYNY-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP3A4",
                       "References" : [
                "Chen, Y. et al. (2010); The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19, Xenobiotica, 40:8, 536-546, DOI: 10.3109/00498254.2010.492880"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0550",
                     "inchikey" : "AKOAEVOSDHIVFX-VIFPVBQESA-N",
                         "name" : "(2S)-1-(3-chlorophenyl)-2-[(1-hydroxy-2-methylpropan-2-yl)amino]propan-1-one",
                    "structure" : "[H]N([C@]([H])(C(=O)C1=C([H])C(Cl)=C([H])C([H])=C1[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0570" : {
                             "Name" : "(s)-bupropion",
            "Substrate's structure" : "[H]N([C@]([H])(C(=O)C1=C([H])C(Cl)=C([H])C([H])=C1[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "SNPPWIUOZRMYNY-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Chen, Y. et al. (2010); The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19, Xenobiotica, 40:8, 536-546, DOI: 10.3109/00498254.2010.492880"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0551",
                     "inchikey" : "MYCARDPPKMGEQK-NSHDSACASA-N",
                         "name" : "(2S)-2-(tert-butylamino)-1-(3-chlorophenyl)-3-hydroxypropan-1-one",
                    "structure" : "[H]N([C@]([H])(C(=O)C1=C([H])C(Cl)=C([H])C([H])=C1[H])C([H])([H])O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0571" : {
                             "Name" : "(s)-bupropion",
            "Substrate's structure" : "[H]N([C@]([H])(C(=O)C1=C([H])C(Cl)=C([H])C([H])=C1[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "SNPPWIUOZRMYNY-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6;CYP2C19; CYP2E1",
                       "References" : [
                "Chen, Y. et al. (2010); The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19, Xenobiotica, 40:8, 536-546, DOI: 10.3109/00498254.2010.492880",
                "Faucette, S.R. et al. (2000); Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity. Drug Metab. Dispos. 2000, 28, 1222 ��� 1230."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0552",
                     "inchikey" : "LSZBTGUSYVNVLH-QMMMGPOBSA-N",
                         "name" : "(2S)-2-(tert-butylamino)-1-(3-chloro-4-hydroxyphenyl)propan-1-one",
                    "structure" : "[H]N([C@]([H])(C(=O)C1=C([H])C(Cl)=C(O)C([H])=C1[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0572" : {
                             "Name" : "(s)-bupropion",
            "Substrate's structure" : "[H]N([C@]([H])(C(=O)C1=C([H])C(Cl)=C([H])C([H])=C1[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "SNPPWIUOZRMYNY-VIFPVBQESA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6;CYP2C19; CYP2E1",
                       "References" : [
                "Chen, Y. et al. (2010); The in vitro metabolism of bupropion revisited: concentration dependent involvement of cytochrome P450 2C19, Xenobiotica, 40:8, 536-546, DOI: 10.3109/00498254.2010.492880",
                "Faucette, S.R. et al. (2000); Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity. Drug Metab. Dispos. 2000, 28, 1222 ��� 1230."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0553",
                     "inchikey" : "MKUMNNVIQOBJFK-QMMMGPOBSA-N",
                         "name" : "(2S)-2-(tert-butylamino)-1-(3-chloro-5-hydroxyphenyl)propan-1-one",
                    "structure" : "[H]N([C@]([H])(C(=O)C1=C([H])C(Cl)=C([H])C(O)=C1[H])C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0573" : {
                             "Name" : "1,4-dichlorobenzene",
            "Substrate's structure" : "[H]C1=C([H])C(Cl)=C([H])C([H])=C1Cl",
                         "InChIKey" : "OCJBOOLMMGQPQU-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1 (major)",
                       "References" : [
                "bogaards, JJP et al. (1995); Human Cytochrome P450 Enzyme Selectivities in the Oxidation of Chlorinated Benzenes; Toxicol Appl Pharmacol. 1995 May;132(1):44-52; PMID:7747284",
                "Nedelcheva, V. et al. (1998); Cytochrome P450 catalyzed oxidation of monochlorobenzene, 1,2- and 1,4-dichlorobenzene in rat, mouse, and human liver microsomes; Chemico-Biological Interactions 115 (1998) 53���70"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0554",
                     "inchikey" : "RANCECPPZPIPNO-UHFFFAOYSA-N",
                         "name" : "2,5-dichlorophenol",
                    "structure" : "[H]OC1=C(Cl)C([H])=C([H])C(Cl)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0574" : {
                             "Name" : "1,8-dinitropyrene",
            "Substrate's structure" : "[O-][N+](=O)C1=CC=C2C=CC3=CC=C(C4=CC=C1C2=C34)[N+]([O-])=O",
                         "InChIKey" : "BLYXNIHKOMELAP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1",
                       "References" : [
                "Rendic, S. and Guengerich, F.P. (2012); Contributions of Human Enzymes in Carcinogen Metabolism; Chem Res Toxicol; 25(7): 1316���1383; DOI:10.1021/tx300132k; PMID:22531028"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0555",
                     "inchikey" : "WGVCNGPAJHVJKK-UHFFFAOYSA-N",
                         "name" : "1-amino-8-nitropyrene",
                    "structure" : "NC1=CC=C2C=CC3=CC=C(C4=CC=C1C2=C34)[N+]([O-])=O"
                }
            ],
                    "Reaction Type" : [
                "Reduction"
            ]
        },
        "BIOTID0575" : {
                             "Name" : "1�ې{3�ې[4�ې(3�ېchloro�ې4�ېhydroxyphenyl)piperazin�ې1�ېyl]propyl}�ې3�ېethyl�ې4�ې(2�ېphenoxyethyl)�ې4,5�ېdihydro�ې1H�ې1,2,4�ېtriazol�ې5�ېone",
            "Substrate's structure" : "[H]OC1=C([H])C([H])=C(C([H])=C1Cl)N1C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])N2N=C(N(C2=O)C([H])([H])C([H])([H])OC2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])C([H])([H])[H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "XGIODORTBODPTQ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Bolleddula, J. et al. (2014); Biotransformation and bioactivation reactions of alicyclic amines in drug molecules, Drug Metabolism Reviews, 46:3, 379-419, DOI: 10.3109/03602532.2014.924962."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0556",
                     "inchikey" : "UMYTXCCAWDJHPP-UHFFFAOYSA-N",
                         "name" : "1�ې(3�ېchloro�ې4�ېoxocyclohexa�ې2,5�ېdien�ې1�ېylidene)�ې4�ې{3�ې[3�ېethyl�ې5�ېoxo�ې4�ې(2�ېphenoxyethyl)�ې4,5�ېdihydro�ې1H�ې1,2,4�ېtriazol�ې1�ېyl]propyl}�ې1lambda5�ېpiperazin�ې1�ېylium",
                    "structure" : "[H]C1=C([H])C([H])=C(OC([H])([H])C([H])([H])N2C(=O)N(N=C2C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])N2C([H])([H])C([H])([H])[N+](=C3C([H])=C([H])C(=O)C(Cl)=C3[H])C([H])([H])C2([H])[H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic ring oxidation"
            ]
        },
        "BIOTID0576" : {
                             "Name" : "1�ې{3�ې[4�ې(3�ېchloro�ې4�ېhydroxyphenyl)piperazin�ې1�ېyl]propyl}�ې3�ېethyl�ې4�ې(2�ېphenoxyethyl)�ې4,5�ېdihydro�ې1H�ې1,2,4�ېtriazol�ې5�ېone",
            "Substrate's structure" : "[H]OC1=C([H])C([H])=C(C([H])=C1Cl)N1C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])N2N=C(N(C2=O)C([H])([H])C([H])([H])OC2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])C([H])([H])[H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "XGIODORTBODPTQ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Bolleddula, J. et al. (2014); Biotransformation and bioactivation reactions of alicyclic amines in drug molecules, Drug Metabolism Reviews, 46:3, 379-419, DOI: 10.3109/03602532.2014.924962."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0557",
                     "inchikey" : "XAUKQBXYNIMIMU-VWLOTQADSA-N",
                         "name" : "1�ې{3�ې[4�ې(3�ېchloro�ې1�ېhydroxy�ې4�ېoxocyclohexa�ې2,5�ېdien�ې1�ېyl)piperazin�ې1�ېyl]propyl}�ې3�ېethyl�ې4�ې(2�ېphenoxyethyl)�ې4,5�ېdihydro�ې1H�ې1,2,4�ېtriazol�ې5�ېone",
                    "structure" : "[H]O[C@]1(C([H])=C([H])C(=O)C(Cl)=C1[H])N1C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])N2N=C(N(C2=O)C([H])([H])C([H])([H])OC2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])C([H])([H])[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic ring oxidation"
            ]
        },
        "BIOTID0577" : {
                             "Name" : "1�ې{3�ې[4�ې(3�ېchloro�ې4�ېhydroxyphenyl)piperazin�ې1�ېyl]propyl}�ې3�ېethyl�ې4�ې(2�ېphenoxyethyl)�ې4,5�ېdihydro�ې1H�ې1,2,4�ېtriazol�ې5�ېone",
            "Substrate's structure" : "[H]OC1=C([H])C([H])=C(C([H])=C1Cl)N1C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])N2N=C(N(C2=O)C([H])([H])C([H])([H])OC2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])C([H])([H])[H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "XGIODORTBODPTQ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Bolleddula, J. et al. (2014); Biotransformation and bioactivation reactions of alicyclic amines in drug molecules, Drug Metabolism Reviews, 46:3, 379-419, DOI: 10.3109/03602532.2014.924962."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0558",
                     "inchikey" : "KOPPHSPBFWSOBD-RDGATRHJSA-N",
                         "name" : "1�ې[3�ې(4�ې{3�ېchloro�ې4�ېhydroxy�ې7�ېoxabicyclo[4.1.0]hepta�ې2,4�ېdien�ې1�ېyl}piperazin�ې1�ېyl)propyl]�ې3�ېethyl�ې4�ې(2�ېphenoxyethyl)�ې4,5�ېdihydro�ې1H�ې1,2,4�ېtriazol�ې5�ېone",
                    "structure" : "[H]OC1=C([H])[C@@]2([H])O[C@]2(C([H])=C1Cl)N1C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])N2N=C(N(C2=O)C([H])([H])C([H])([H])OC2=C([H])C([H])=C([H])C([H])=C2[H])C([H])([H])C([H])([H])[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Epoxidation"
            ]
        },
        "BIOTID0578" : {
                             "Name" : "1-aminopyrene",
            "Substrate's structure" : "NC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34",
                         "InChIKey" : "YZVWKHVRBDQPMQ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP3A4",
                       "References" : [
                "Rendic, S. and Guengerich, F.P. (2012); Contributions of Human Enzymes in Carcinogen Metabolism; Chem Res Toxicol; 25(7): 1316���1383; DOI:10.1021/tx300132k; PMID:22531028"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0559",
                     "inchikey" : "LQWUGNODGKKHOP-UHFFFAOYSA-N",
                         "name" : "N-hydroxy-1-aminopyrene",
                    "structure" : "ONC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0579" : {
                             "Name" : "17alpha-Ethinylestradiol",
            "Substrate's structure" : "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3CC[C@@]21C",
                         "InChIKey" : "DQHWEKFXUGLNRV-QPJCZJHGNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4; CYP2C19; CYP1A2",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0560",
                     "inchikey" : "SYRDZWUTDZQTTL-PQLHGUBISA-N",
                         "name" : "2beta-OH-17beta-Ethinylestradiol",
                    "structure" : "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=CC(O)=C(O)C=C3CC[C@@]21C"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0580" : {
                             "Name" : "17alpha-Ethinylestradiol",
            "Substrate's structure" : "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3CC[C@@]21C",
                         "InChIKey" : "DQHWEKFXUGLNRV-QPJCZJHGNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4; CYP2C19; CYP1A2",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0560",
                     "inchikey" : "SYRDZWUTDZQTTL-PQLHGUBISA-N",
                         "name" : "2alpha-OH-17beta-Ethinylestradiol",
                    "structure" : "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=CC(O)=C(O)C=C3CC[C@@]21C"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0581" : {
                             "Name" : "17alpha-Ethinylestradiol",
            "Substrate's structure" : "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3CC[C@@]21C",
                         "InChIKey" : "DQHWEKFXUGLNRV-QPJCZJHGNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0561",
                     "inchikey" : "OFVWXERYXWCPBX-FVJLHALJSA-N",
                         "name" : "4beta-OH-17beta-Ethinylestradiol",
                    "structure" : "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C(O)=C3CC[C@@]21C"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0582" : {
                             "Name" : "17alpha-Ethinylestradiol",
            "Substrate's structure" : "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3CC[C@@]21C",
                         "InChIKey" : "DQHWEKFXUGLNRV-QPJCZJHGNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0561",
                     "inchikey" : "OFVWXERYXWCPBX-FVJLHALJSA-N",
                         "name" : "4alpha-OH-17beta-Ethinylestradiol",
                    "structure" : "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C(O)=C3CC[C@@]21C"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0583" : {
                             "Name" : "17alpha-Ethinylestradiol",
            "Substrate's structure" : "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3CC[C@@]21C",
                         "InChIKey" : "DQHWEKFXUGLNRV-QPJCZJHGNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0562",
                     "inchikey" : "QAPYNJHRINFWAG-YQPXSLGVSA-N",
                         "name" : "6beta-OH-17beta-Ethinylestradiol",
                    "structure" : "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3[C@H](O)C[C@@]21C"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0584" : {
                             "Name" : "17alpha-Ethinylestradiol",
            "Substrate's structure" : "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3CC[C@@]21C",
                         "InChIKey" : "DQHWEKFXUGLNRV-QPJCZJHGNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0563",
                     "inchikey" : "QAPYNJHRINFWAG-SSFAQJFESA-N",
                         "name" : "6alpha-OH-17beta-Ethinylestradiol",
                    "structure" : "[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3[C@@H](O)C[C@@]21C"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0585" : {
                             "Name" : "2,6-Xylidine",
            "Substrate's structure" : "[H]NC1=C(C([H])=C([H])C([H])=C1C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "UFFBMTHBGFGIHF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP2E1",
                       "References" : [
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0564",
                     "inchikey" : "GCWYXRHXGLFVFE-UHFFFAOYSA-N",
                         "name" : "4-hydroxy-2,6-dimethylaniline",
                    "structure" : "[H]NC1=C(C([H])=C(O)C([H])=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0586" : {
                             "Name" : "2,6-Xylidine",
            "Substrate's structure" : "[H]NC1=C(C([H])=C([H])C([H])=C1C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "UFFBMTHBGFGIHF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP2E1",
                       "References" : [
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0565",
                     "inchikey" : "YFVSZHCWKQTSGT-UHFFFAOYSA-N",
                         "name" : "N-(2,6-dimethylphenyl)hydroxylamine",
                    "structure" : "[H]C1=C([H])C(=C(NO)C(=C1[H])C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0587" : {
                             "Name" : "3-Hydroxylidocaine",
            "Substrate's structure" : "[H]N(C(=O)C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])C1=C(C([H])=C([H])C(O)=C1C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "PMGUCIDDSCRAMY-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6; CYP3A4",
                       "References" : [
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0566",
                     "inchikey" : "YITCMQBVWIHTTA-UHFFFAOYSA-N",
                         "name" : "3-Hydroxymonoethyl glycinexylidide",
                    "structure" : "[H]N(C(=O)C([H])([H])NC([H])([H])C([H])([H])[H])C1=C(C([H])=C([H])C(O)=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0588" : {
                             "Name" : "3'-HPPH",
            "Substrate's structure" : "[H]N1C(=O)N([H])C(C1=O)(C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C([H])C(O)=C1[H]",
                         "InChIKey" : "FSPRLRPJSPWQNC-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0567",
                     "inchikey" : "WWEKVOUOQUHVHS-UHFFFAOYNA-N",
                         "name" : "3�۪,4�۪- diHPPH",
                    "structure" : "[H]N1C(=O)N([H])C(C1=O)(C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C(O)C(O)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0589" : {
                             "Name" : "4'-HPPH",
            "Substrate's structure" : "[H]N1C(=O)N([H])C(C1=O)(C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C(O)C([H])=C1[H]",
                         "InChIKey" : "XEEDURHPFVXALT-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0567",
                     "inchikey" : "WWEKVOUOQUHVHS-UHFFFAOYNA-N",
                         "name" : "3�۪,4�۪- diHPPH",
                    "structure" : "[H]N1C(=O)N([H])C(C1=O)(C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C(O)C(O)=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0590" : {
                             "Name" : "4,4'-Dichlorobiphenyl",
            "Substrate's structure" : "ClC1=CC=C(C=C1)C1=CC=C(Cl)C=C1",
                         "InChIKey" : "YTBRNEUEFCNVHC-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0568",
                     "inchikey" : "YIRDONCMEBQOJP-UHFFFAOYSA-N",
                         "name" : "4,4��_-Dichloro-3-biphenylol",
                    "structure" : "OC1=C(Cl)C=CC(=C1)C1=CC=C(Cl)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0591" : {
                             "Name" : "7-Methoxyresorufin",
            "Substrate's structure" : "COC1=CC2=C(C=C1)N=C3C=CC(=O)C=C3O2",
                         "InChIKey" : "KNYYMGDYROYBRE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0097",
                     "inchikey" : "HSSLDCABUXLXKM-UHFFFAOYSA-N",
                         "name" : "Resorufin",
                    "structure" : "OC1=CC2=C(C=C1)N=C1C=CC(=O)C=C1O2"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0592" : {
                             "Name" : "(R)-mianserin, 8-hydroxy",
            "Substrate's structure" : "[H]C1=C([H])C2=C(C([H])=C1[H])[C@@]1([H])N(C3=C(C([H])=C([H])C(O)=C3[H])C2([H])[H])C([H])([H])C([H])([H])N(C([H])([H])[H])C1([H])[H]",
                         "InChIKey" : "IXAPYQICIDTITB-SFHVURJKSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP1A2; CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0569",
                     "inchikey" : "KDLZTAPNHXUVCE-KRWDZBQOSA-N",
                         "name" : "(R)-mianserin, 8-OH-N-desmethyl",
                    "structure" : "[H]N1C([H])([H])C([H])([H])N2C3=C(C([H])=C([H])C(O)=C3[H])C([H])([H])C3=C(C([H])=C([H])C([H])=C3[H])[C@]2([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0593" : {
                             "Name" : "(R)-acenocoumarol",
            "Substrate's structure" : "[H]OC1=C(C(=O)OC2=C([H])C([H])=C([H])C([H])=C12)C([H])(CC(C)=O)C1=C([H])C([H])=C(C([H])=C1[H])[N+]([O-])=O",
                         "InChIKey" : "VABCILAOYCMVPS-OAHLLOKOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP1A2; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0570",
                     "inchikey" : "RXFXXWMNPIVMHP-UHFFFAOYNA-N",
                         "name" : "6-OH-R-acenocoumarol",
                    "structure" : "[H]OC1=C(C(=O)OC2=C(O)C([H])=C([H])C([H])=C12)C([H])(CC(C)=O)C1=C([H])C([H])=C(C([H])=C1[H])[N+]([O-])=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0594" : {
                             "Name" : "(R)-acenocoumarol",
            "Substrate's structure" : "[H]OC1=C(C(=O)OC2=C([H])C([H])=C([H])C([H])=C12)C([H])(CC(C)=O)C1=C([H])C([H])=C(C([H])=C1[H])[N+]([O-])=O",
                         "InChIKey" : "VABCILAOYCMVPS-OAHLLOKOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0571",
                     "inchikey" : "JTCREUDLEYTCAB-UHFFFAOYNA-N",
                         "name" : "7-OH-R-acenocoumarol",
                    "structure" : "[H]OC1=C(C(=O)OC2=C([H])C(O)=C([H])C([H])=C12)C([H])(CC(C)=O)C1=C([H])C([H])=C(C([H])=C1[H])[N+]([O-])=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0595" : {
                             "Name" : "(R)-acenocoumarol",
            "Substrate's structure" : "[H]OC1=C(C(=O)OC2=C([H])C([H])=C([H])C([H])=C12)C([H])(CC(C)=O)C1=C([H])C([H])=C(C([H])=C1[H])[N+]([O-])=O",
                         "InChIKey" : "VABCILAOYCMVPS-OAHLLOKOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3677"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0572",
                     "inchikey" : "SUHPKJKJROTWOQ-UHFFFAOYNA-N",
                         "name" : "8-OH-R-acenocoumarol",
                    "structure" : "[H]OC1=C(C(=O)OC2=C([H])C([H])=C(O)C([H])=C12)C([H])(CC(C)=O)C1=C([H])C([H])=C(C([H])=C1[H])[N+]([O-])=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0596" : {
                             "Name" : "Bromazepam",
            "Substrate's structure" : "BrC1=CC=C2NC(=O)CN=C(C3=CC=CC=N3)C2=C1",
                         "InChIKey" : "VMIYHDSEFNYJSL-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6",
                       "References" : [
                "Bolleddula, J. et al. (2014); Biotransformation and bioactivation reactions of alicyclic amines in drug molecules, Drug Metabolism Reviews, 46:3, 379-419, DOI: 10.3109/03602532.2014.924962."
            ],
                         "Products" : [],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0597" : {
                             "Name" : "6-Aminochrysene",
            "Substrate's structure" : "[H]N([H])C1=C([H])C2=C(C([H])=C([H])C3=C([H])C([H])=C([H])C([H])=C23)C2=C([H])C([H])=C([H])C([H])=C12",
                         "InChIKey" : "KIVUHCNVDWYUNP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1B1; CYP1A2; CYP1A1; CYP2A6; CYP2B6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0573",
                     "inchikey" : "DDEXKYQWZJEPRX-UHFFFAOYSA-N",
                         "name" : "N-Hydroxychrysene",
                    "structure" : "[H]N(O)C1=C([H])C2=C(C([H])=C([H])C3=C([H])C([H])=C([H])C([H])=C23)C2=C([H])C([H])=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0598" : {
                             "Name" : "Aminoflavone",
            "Substrate's structure" : "[H]N([H])C1=C(F)C([H])=C(C([H])=C1[H])C1=C([H])C(=O)C2=C(N([H])[H])C(F)=C(C(F)=C2O1)C([H])([H])[H]",
                         "InChIKey" : "RTUZVPPGTJRELI-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP1A1; CYP2C9; CYP2C19",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0574",
                     "inchikey" : "BUGQDNPBVYMEFE-UHFFFAOYSA-N",
                         "name" : "Aminoflavone, N4'-Hydroxy",
                    "structure" : "[H]N([H])C1=C2C(=O)C([H])=C(OC2=C(F)C(=C1F)C([H])([H])[H])C1=C([H])C(F)=C(N([H])O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0599" : {
                             "Name" : "Aminoflavone",
            "Substrate's structure" : "[H]N([H])C1=C(F)C([H])=C(C([H])=C1[H])C1=C([H])C(=O)C2=C(N([H])[H])C(F)=C(C(F)=C2O1)C([H])([H])[H]",
                         "InChIKey" : "RTUZVPPGTJRELI-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C9; CYP2C19",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0600" : {
                             "Name" : "Aminoflavone",
            "Substrate's structure" : "[H]N([H])C1=C(F)C([H])=C(C([H])=C1[H])C1=C([H])C(=O)C2=C(N([H])[H])C(F)=C(C(F)=C2O1)C([H])([H])[H]",
                         "InChIKey" : "RTUZVPPGTJRELI-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0575",
                     "inchikey" : "HUSFKTRIHYXGPZ-UHFFFAOYSA-N",
                         "name" : "Aminoflavone, C3-hydroxy",
                    "structure" : "[H]N([H])C1=C(F)C([H])=C(C([H])=C1[H])C1=C(O)C(=O)C2=C(N([H])[H])C(F)=C(C(F)=C2O1)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0601" : {
                             "Name" : "Aminoflavone, N4'-Hydroxyl",
            "Substrate's structure" : "[H]N([H])C1=C2C(=O)C([H])=C(OC2=C(F)C(=C1F)C([H])([H])[H])C1=C([H])C(F)=C(N([H])O)C([H])=C1[H]",
                         "InChIKey" : "BUGQDNPBVYMEFE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C9; CYP2C19",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0576",
                     "inchikey" : "GEASYZROZMRJJL-UHFFFAOYSA-N",
                         "name" : "Aminoflavone, N4', N5-dihydroxy",
                    "structure" : "[H]ON([H])C1=C(F)C([H])=C(C([H])=C1[H])C1=C([H])C(=O)C2=C(N([H])O)C(F)=C(C(F)=C2O1)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0602" : {
                             "Name" : "Aminoflavone, N5-Hydroxyl",
            "Substrate's structure" : "[H]N([H])C1=C(F)C([H])=C(C([H])=C1[H])C1=C([H])C(=O)C2=C(N([H])O)C(F)=C(C(F)=C2O1)C([H])([H])[H]",
                         "InChIKey" : "BGZUIZSBNOBPKP-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C9; CYP2C19",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0576",
                     "inchikey" : "GEASYZROZMRJJL-UHFFFAOYSA-N",
                         "name" : "Aminoflavone, N4', N5-dihydroxy",
                    "structure" : "[H]ON([H])C1=C(F)C([H])=C(C([H])=C1[H])C1=C([H])C(=O)C2=C(N([H])O)C(F)=C(C(F)=C2O1)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0603" : {
                             "Name" : "Amphetamine",
            "Substrate's structure" : "[H]N([H])[C@]([H])(C([H])([H])[H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H]",
                         "InChIKey" : "KWTSXDURSIMDCE-SVGMAFHSNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0577",
                     "inchikey" : "GIKNHHRFLCDOEU-UHFFFAOYNA-N",
                         "name" : "4-Hydroxyamphetamine",
                    "structure" : "CC(N)CC1=CC=C(O)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0604" : {
                             "Name" : " Aprindine",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])N(C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])C1([H])C([H])([H])C2=C([H])C([H])=C([H])C([H])=C2C1([H])[H]",
                         "InChIKey" : "NZLBHDRPUJLHCE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259986"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0578",
                     "inchikey" : "LOCYZRRMXVRONA-UHFFFAOYNA-N",
                         "name" : "N-[3-(N,NDiethylamino)propyl]-N-phenyl-2-aminoindan-5-ol",
                    "structure" : "[H]OC1=C([H])C([H])=C2C(=C1[H])C([H])([H])C([H])(N(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0605" : {
                             "Name" : " Aprindine",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])N(C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])C1([H])C([H])([H])C2=C([H])C([H])=C([H])C([H])=C2C1([H])[H]",
                         "InChIKey" : "NZLBHDRPUJLHCE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259987"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0579",
                     "inchikey" : "NDSJVPYEVPNZKX-UHFFFAOYSA-N",
                         "name" : "p-Hydroxyphenylaprindine",
                    "structure" : "[H]OC1=C([H])C([H])=C(C([H])=C1[H])N(C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])C1([H])C([H])([H])C2=C([H])C([H])=C([H])C([H])=C2C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0606" : {
                             "Name" : " Aprindine",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])N(C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H])C1([H])C([H])([H])C2=C([H])C([H])=C([H])C([H])=C2C1([H])[H]",
                         "InChIKey" : "NZLBHDRPUJLHCE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259988"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0580",
                     "inchikey" : "JVKNBCGVGGFZLV-UHFFFAOYSA-N",
                         "name" : "Desethylaprindine",
                    "structure" : "[H]N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])N(C1=C([H])C([H])=C([H])C([H])=C1[H])C1([H])C([H])([H])C2=C([H])C([H])=C([H])C([H])=C2C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0607" : {
                             "Name" : "Butachlor",
            "Substrate's structure" : "[H]C1=C([H])C(=C(N(C(=O)C([H])([H])Cl)C([H])([H])OC([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(=C1[H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "HKPHPIREJKHECO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP3A4",
                       "References" : [
                "Coleman, S. et al.; Comparative metabolism of chloroacetamide herbicides and selected metabolites in human and rat liver microsomes.; Environ Health Perspect. 2000 Dec;108(12):1151-7"
            ],
                         "Products" : [],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0608" : {
                             "Name" : "Butachlor",
            "Substrate's structure" : "[H]C1=C([H])C(=C(N(C(=O)C([H])([H])Cl)C([H])([H])OC([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(=C1[H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "HKPHPIREJKHECO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP3A4",
                       "References" : [
                "Coleman, S. et al.; Comparative metabolism of chloroacetamide herbicides and selected metabolites in human and rat liver microsomes.; Environ Health Perspect. 2000 Dec;108(12):1151-7"
            ],
                         "Products" : [],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0609" : {
                             "Name" : "Buprenorphine",
            "Substrate's structure" : "[H]OC1=C2O[C@]3([H])[C@@]45C2=C(C([H])=C1[H])C([H])([H])[C@@]([H])(N(C([H])([H])C1([H])C([H])([H])C1([H])[H])C([H])([H])C4([H])[H])[C@]51C([H])([H])C([H])([H])[C@@]3(OC([H])([H])[H])[C@]([H])(C1([H])[H])[C@@](O[H])(C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "RMRJXGBAOAMLHD-IHFGGWKQSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C8; CYP2C9; CYP3A5",
                       "References" : [
                "(R) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0581",
                     "inchikey" : "YOYLLRBMGQRFTN-IOMBULRVSA-N",
                         "name" : "Norbuprenorphine",
                    "structure" : "CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1)=C(O)C=C4"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0610" : {
                             "Name" : "(+)-Camphor",
            "Substrate's structure" : "[H]C([H])([H])[C@@]12C(=O)C([H])([H])[C@@]([H])(C([H])([H])C1([H])[H])C2(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "DSSYKIVIOFKYAU-XCBNKYQSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0582",
                     "inchikey" : "MANWHKQXMFYQDY-IKZKJGMZSA-N",
                         "name" : "5-exo-hydroxycamphor",
                    "structure" : "CC1(CO)[C@@H]2CC[C@@]1(C)C(=O)C2"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0611" : {
                             "Name" : "(+)-Camphor",
            "Substrate's structure" : "[H]C([H])([H])[C@@]12C(=O)C([H])([H])[C@@]([H])(C([H])([H])C1([H])[H])C2(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "DSSYKIVIOFKYAU-XCBNKYQSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0583",
                     "inchikey" : "DJQYBVLXBVJHMU-ZRJGNOHYSA-N",
                         "name" : "8-hydroxycamphor",
                    "structure" : "CC1(C)[C@H]2CC(=O)[C@]1(C)CC2O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0612" : {
                             "Name" : "Carbosulfan",
            "Substrate's structure" : "[H]C1=C([H])C2=C(OC(C([H])([H])[H])(C([H])([H])[H])C2([H])[H])C(OC(=O)N(SN(C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])[H])=C1[H]",
                         "InChIKey" : "JLQUFIHWVLZVTJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C19; CYP3A4",
                       "References" : [
                "Abass, K. et al. (2010). Metabolism of carbosulfan II. Human interindividual variability in its in vitro hepatic biotransformation and the identification of the cytochrome P450 isoforms involved. Chem. Biol. Interact., Vol. 185, No. 3, (163-173)."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0584",
                     "inchikey" : "DUEPRVBVGDRKAG-UHFFFAOYSA-N",
                         "name" : "carbofuran",
                    "structure" : "CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2"
                },
                {
                     "BTMDB_ID" : "BTMDB0584",
                     "inchikey" : "DUEPRVBVGDRKAG-UHFFFAOYSA-N",
                         "name" : "carbofuran",
                    "structure" : "CCCCN(S)CCCC"
                }
            ],
                    "Reaction Type" : [
                "Hydrolysis"
            ]
        },
        "BIOTID0613" : {
                             "Name" : "Carbosulfan",
            "Substrate's structure" : "[H]C1=C([H])C2=C(OC(C([H])([H])[H])(C([H])([H])[H])C2([H])[H])C(OC(=O)N(SN(C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])[H])=C1[H]",
                         "InChIKey" : "JLQUFIHWVLZVTJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP2B6; CYP2C19; CYP3A4",
                       "References" : [
                "Abass, K. et al. (2010). Metabolism of carbosulfan II. Human interindividual variability in its in vitro hepatic biotransformation and the identification of the cytochrome P450 isoforms involved. Chem. Biol. Interact., Vol. 185, No. 3, (163-173)."
            ],
                         "Products" : [],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0614" : {
                             "Name" : "Chlorpyrifos-oxon",
            "Substrate's structure" : "[H]C1=C(Cl)C(OP(=O)(OC([H])([H])C([H])([H])[H])OC([H])([H])C([H])([H])[H])=NC(Cl)=C1Cl",
                         "InChIKey" : "OTMOUPHCTWPNSL-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP2B6; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0182",
                     "inchikey" : "WCYYAQFQZQEUEN-UHFFFAOYSA-N",
                         "name" : "3,5,6-Trichloro-2-pyridinol",
                    "structure" : "OC1=NC(Cl)=C(Cl)C=C1Cl"
                },
                {
                     "BTMDB_ID" : "BTMDB0182",
                     "inchikey" : "WCYYAQFQZQEUEN-UHFFFAOYSA-N",
                         "name" : "3,5,6-Trichloro-2-pyridinol",
                    "structure" : "CCOP(O)(=O)OCC"
                }
            ],
                    "Reaction Type" : [
                "Dearylation"
            ]
        },
        "BIOTID0615" : {
                             "Name" : "Citalopram",
            "Substrate's structure" : "[H]C1=C([H])C(C#N)=C([H])C2=C1C(OC2([H])[H])(C1=C([H])C([H])=C(F)C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "WSEQXVZVJXJVFP-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "(R) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0585",
                     "inchikey" : "DIOGFDCEWUUSBQ-UHFFFAOYNA-N",
                         "name" : "Citalopram N-oxide",
                    "structure" : "[H]C1=C([H])C(C#N)=C([H])C2=C1C(OC2([H])[H])(C1=C([H])C([H])=C(F)C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])[N+]([O-])(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0616" : {
                             "Name" : "Citalopram",
            "Substrate's structure" : "[H]C1=C([H])C(C#N)=C([H])C2=C1C(OC2([H])[H])(C1=C([H])C([H])=C(F)C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "WSEQXVZVJXJVFP-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP2C19; CYP3A4",
                       "References" : [
                "(R) Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0586",
                     "inchikey" : "PTJADDMMFYXMMG-UHFFFAOYNA-N",
                         "name" : "N-Desmethylcitalopram",
                    "structure" : "[H]C1=C([H])C(C#N)=C([H])C2=C1C(OC2([H])[H])(C1=C([H])C([H])=C(F)C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0617" : {
                             "Name" : "D-617",
            "Substrate's structure" : "[H]N(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@](C#N)(C1=C([H])C([H])=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H])C([H])(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "WLOBUUJURNEQCL-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0587",
                     "inchikey" : "UCWOSFAANAZHKR-UHFFFAOYNA-N",
                         "name" : "D-620",
                    "structure" : "[H]NCCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0618" : {
                             "Name" : "D-702",
            "Substrate's structure" : "[H]OC1=C([H])C([H])=C(C([H])=C1OC([H])([H])[H])C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])[C@](C#N)(C1=C([H])C([H])=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H])C([H])(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "CAAKRPRWCVWYAO-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0619" : {
                             "Name" : "Deltamethrin",
            "Substrate's structure" : "[H]C(=C(Br)Br)C1([H])C([H])(C(=O)OC([H])(C#N)C2=C([H])C(OC3=C([H])C([H])=C([H])C([H])=C3[H])=C([H])C([H])=C2[H])C1(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "OWZREIFADZCYQD-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C19; CYP3A4; CYP3A5",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0588",
                     "inchikey" : "RLMJIYYRLVNAOJ-UHFFFAOYNA-N",
                         "name" : "4'-OH-deltamethrin",
                    "structure" : "[H]C(=C(Br)Br)C1([H])C([H])(C(=O)OC([H])(C#N)C2=C([H])C(OC3=C([H])C([H])=C(O)C([H])=C3[H])=C([H])C([H])=C2[H])C1(C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0620" : {
                             "Name" : "Dimethoate",
            "Substrate's structure" : "[H]N(C(=O)C([H])([H])SP(=S)(OC([H])([H])[H])OC([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "MCWXGJITAZMZEV-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C9; CYP2C19; CYP3A4",
                       "References" : [
                "Buratti, F.M. and Testai, E. (2007). Evidences for CYP3A4 autoactivation in the desulfuration of dimethoate by the human liver. Toxicology, Vol. 241, No. 1-2, (33-46)."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0589",
                     "inchikey" : "PZXOQEXFMJCDPG-UHFFFAOYSA-N",
                         "name" : "Omethoate",
                    "structure" : "CNC(=O)CSP(=O)(OC)OC"
                }
            ],
                    "Reaction Type" : [
                "Desulfurization"
            ]
        },
        "BIOTID0621" : {
                             "Name" : "Diazoxon",
            "Substrate's structure" : "[H]C1=C(OP(=O)(OC([H])([H])C([H])([H])[H])OC([H])([H])C([H])([H])[H])N=C(N=C1C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "VBLJFQYCTRKKKF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Kappers, W.A. et al.; (2001). Diazinon Is Activated by CYP2C19 in Human Liver. Toxicol. Appl. Pharmacol., Vol. 177, No. 1, (68-76)",
                "Buratti, F.M. et al.; Toxicology and Applied Pharmacology 186 (2003) 143���154."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0227",
                     "inchikey" : "AJPIUNPJBFBUKK-UHFFFAOYSA-N",
                         "name" : "Pyrimidinol",
                    "structure" : "CC(C)C1=NC(O)=CC(C)=N1"
                }
            ],
                    "Reaction Type" : []
        },
        "BIOTID0622" : {
                             "Name" : "Diazoxon",
            "Substrate's structure" : "[H]C1=C(OP(=O)(OC([H])([H])C([H])([H])[H])OC([H])([H])C([H])([H])[H])N=C(N=C1C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "VBLJFQYCTRKKKF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Kappers, W.A. et al.; (2001). Diazinon Is Activated by CYP2C19 in Human Liver. Toxicol. Appl. Pharmacol., Vol. 177, No. 1, (68-76)",
                "Buratti, F.M. et al.; Toxicology and Applied Pharmacology 186 (2003) 143���154."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0183",
                     "inchikey" : "UCQFCFPECQILOL-UHFFFAOYSA-N",
                         "name" : "Diethy phosphate",
                    "structure" : "CCOP(O)(=O)OCC"
                }
            ],
                    "Reaction Type" : [
                "Dearylation"
            ]
        },
        "BIOTID0623" : {
                             "Name" : "Disulfoton",
            "Substrate's structure" : "CCOP(=S)(OCC)SCCSCC",
                         "InChIKey" : "DOFZAZXDOSGAJZ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2B6; CYP2C9; CYP2C18; CYP2C19; CYP2D6; CYP3A4",
                       "References" : [
                "Usmani, K.A.; (2004b). In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily. Drug Metab. Dispos., Vol. 32, No. 3, (333-339)."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0590",
                     "inchikey" : "UPUGLJYNCXXUQV-UHFFFAOYNA-N",
                         "name" : "Disulfoton sulfoxide",
                    "structure" : "CCOP(=S)(OCC)SCCS(=O)CC"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0624" : {
                             "Name" : "Diuron",
            "Substrate's structure" : "[H]N(C(=O)N(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C(Cl)C(Cl)=C1[H]",
                         "InChIKey" : "XMTQQYYKAHVGBJ-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C19; CYP3A4",
                       "References" : [
                "Abass, K. et al. (2007c). Characterization of diuron N-demethylation by mammalian hepatic microsomes and cDNA- expressed human cytochrome P450 enzymes. Drug Metab. Dispos., Vol. 35, No. 9, (1634-1641)."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0591",
                     "inchikey" : "IDQHRQQSSQDLTR-UHFFFAOYSA-N",
                         "name" : "N-demethyldiuron",
                    "structure" : "CNC(=O)NC1=CC=C(Cl)C(Cl)=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0625" : {
                             "Name" : "donepezil",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])N1C([H])([H])C([H])([H])C([H])(C([H])([H])C2([H])C(=O)C3=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C3C2([H])[H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "ADEBPBSSDYVVLD-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9; CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0592",
                     "inchikey" : "DSMISVLYMKJMLP-UHFFFAOYNA-N",
                         "name" : "2�ې[(1�ېbenzylpiperidin�ې4�ېyl)methyl]�ې5�ېhydroxy�ې6�ېmethoxy�ې2,3�ېdihydroinden�ې1�ېone",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])N1C([H])([H])C([H])([H])C([H])(C([H])([H])C2([H])C(=O)C3=C([H])C(OC([H])([H])[H])=C(O)C([H])=C3C2([H])[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0626" : {
                             "Name" : "donepezil",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])N1C([H])([H])C([H])([H])C([H])(C([H])([H])C2([H])C(=O)C3=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C3C2([H])[H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "ADEBPBSSDYVVLD-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0593",
                     "inchikey" : "PGBZORAISITZTF-UHFFFAOYNA-N",
                         "name" : "5,6�ېdimethoxy�ې2�ې(piperidin�ې4�ېylmethyl)�ې2,3�ېdihydroinden�ې1�ېone",
                    "structure" : "[H]C1=C2C(=O)C([H])(C([H])([H])C3([H])C([H])([H])C([H])([H])NC([H])([H])C3([H])[H])C([H])([H])C2=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0627" : {
                             "Name" : "donepezil",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])N1C([H])([H])C([H])([H])C([H])(C([H])([H])C2([H])C(=O)C3=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C3C2([H])[H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "ADEBPBSSDYVVLD-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3677"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0594",
                     "inchikey" : "DJRBBQJREIMIEU-UHFFFAOYNA-N",
                         "name" : "2�ې[(1�ېbenzylpiperidin�ې4�ېyl)methyl]�ې6�ېhydroxy�ې5�ېmethoxy�ې2,3�ېdihydroinden�ې1�ېone",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])N1C([H])([H])C([H])([H])C([H])(C([H])([H])C2([H])C(=O)C3=C([H])C(O)=C(OC([H])([H])[H])C([H])=C3C2([H])[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0628" : {
                             "Name" : "Encainide",
            "Substrate's structure" : "COC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1CCC1CCCCN1C",
                         "InChIKey" : "PJWPNDMDCLXCOM-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0595",
                     "inchikey" : "QLMVRMLCNYDKJN-UHFFFAOYNA-N",
                         "name" : "N-demethylencainide",
                    "structure" : "COC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1CCC1CCCCN1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0629" : {
                             "Name" : "Encainide",
            "Substrate's structure" : "COC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1CCC1CCCCN1C",
                         "InChIKey" : "PJWPNDMDCLXCOM-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0596",
                     "inchikey" : "QMHJFCPHRGVEAF-UHFFFAOYNA-N",
                         "name" : "O-demethylencainide",
                    "structure" : "CN1CCCCC1CCC1=CC=CC=C1NC(=O)C1=CC=C(O)C=C1"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0630" : {
                             "Name" : "Esfenvalerate",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(OC2=C([H])C([H])=C([H])C(=C2[H])C([H])(OC(=O)C([H])(C2=C([H])C([H])=C(Cl)C([H])=C2[H])C([H])(C([H])([H])[H])C([H])([H])[H])C#N)C([H])=C1[H]",
                         "InChIKey" : "NYPJDWWKZLNGGM-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C9; CYP2C19; CYP3A4; CYP3A5",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3677"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0597",
                     "inchikey" : "DGQZGRIBSTXBJK-UHFFFAOYNA-N",
                         "name" : "2'-OH-esfenvalerate",
                    "structure" : "[H]C1=C([H])C(O)=C(OC2=C([H])C([H])=C([H])C(=C2[H])C([H])(OC(=O)C([H])(C2=C([H])C([H])=C(Cl)C([H])=C2[H])C([H])(C([H])([H])[H])C([H])([H])[H])C#N)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0631" : {
                             "Name" : "Esfenvalerate",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(OC2=C([H])C([H])=C([H])C(=C2[H])C([H])(OC(=O)C([H])(C2=C([H])C([H])=C(Cl)C([H])=C2[H])C([H])(C([H])([H])[H])C([H])([H])[H])C#N)C([H])=C1[H]",
                         "InChIKey" : "NYPJDWWKZLNGGM-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C9; CYP2C19; CYP3A4; CYP3A5",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3677"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0598",
                     "inchikey" : "DHTRRTYYQFWHPE-UHFFFAOYNA-N",
                         "name" : "4'-OH-esfenvalerate",
                    "structure" : "[H]C1=C([H])C(=C([H])C(OC2=C([H])C([H])=C(O)C([H])=C2[H])=C1[H])C([H])(OC(=O)C([H])(C1=C([H])C([H])=C(Cl)C([H])=C1[H])C([H])(C([H])([H])[H])C([H])([H])[H])C#N"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0632" : {
                             "Name" : "N-Desmethylclomipramine",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N(C1=C(C([H])=C([H])C(Cl)=C1[H])C([H])([H])C2([H])[H])C([H])([H])C([H])([H])C([H])([H])NC([H])([H])[H]",
                         "InChIKey" : "VPIXQGUBUKFLRF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP3A4; CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0599",
                     "inchikey" : "LHDZEFLZJRLKPT-UHFFFAOYSA-N",
                         "name" : "N-Didesmethylclomipramine",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N(C1=C(C([H])=C([H])C(Cl)=C1[H])C([H])([H])C2([H])[H])C([H])([H])C([H])([H])C([H])([H])N"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0633" : {
                             "Name" : "N-Desmethylclomipramine",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N(C1=C(C([H])=C([H])C(Cl)=C1[H])C([H])([H])C2([H])[H])C([H])([H])C([H])([H])C([H])([H])NC([H])([H])[H]",
                         "InChIKey" : "VPIXQGUBUKFLRF-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0600",
                     "inchikey" : "HURXSDYLRQSNES-UHFFFAOYSA-N",
                         "name" : "8-OH-N-desmethylclomipramine",
                    "structure" : "[H]C1=C([H])C(O)=C2C(=C1[H])N(C1=C(C([H])=C([H])C(Cl)=C1[H])C([H])([H])C2([H])[H])C([H])([H])C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0634" : {
                             "Name" : "N-demethylencainide",
            "Substrate's structure" : "[H]N(C(=O)C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1C([H])([H])C([H])([H])[C@@]1([H])N([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "QLMVRMLCNYDKJN-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0601",
                     "inchikey" : "PAXWCICVMPVYNO-UHFFFAOYNA-N",
                         "name" : "N,O-didemethylencainide",
                    "structure" : "OC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1CCC1CCCCN1"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0635" : {
                             "Name" : "O-demethylencainide",
            "Substrate's structure" : "CN1CCCCC1CCC1=CC=CC=C1NC(=O)C1=CC=C(O)C=C1",
                         "InChIKey" : "QMHJFCPHRGVEAF-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0601",
                     "inchikey" : "PAXWCICVMPVYNO-UHFFFAOYNA-N",
                         "name" : "N,O-didemethylencainide",
                    "structure" : "OC1=CC=C(C=C1)C(=O)NC1=CC=CC=C1CCC1CCCCN1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0636" : {
                             "Name" : "Endosulfan-alpha",
            "Substrate's structure" : "[H]C1([H])O[S@@](=O)OC([H])([H])[C@@]2([H])[C@@]1([H])[C@@]1(Cl)C(Cl)=C(Cl)[C@]2(Cl)C1(Cl)Cl",
                         "InChIKey" : "RDYMFSUJUZBWLH-KUGKFLLMSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19; CYP3A4; CYP3A5; CYP3A7",
                       "References" : [
                "Casabar, R.C.T. (2006). Metabolism of endosulfan- {alpha} by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4. Drug Metab. Dispos., Vol. 34, No. 10, (1779-1785)",
                "Lee, H. 2006). Stereoselective metabolism of endosulfan by human liver microsomes and human cytochrome P450 isoforms. Drug Metab. Dispos., Vol. 34, No. 7, (1090-1095)."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0602",
                     "inchikey" : "AAPVQEMYVNZIOO-GXZSMAFLSA-N",
                         "name" : "Endosulfan sulfate",
                    "structure" : "ClC1=C(Cl)[C@]2(Cl)[C@H]3COS(=O)(=O)OC[C@@H]3[C@@]1(Cl)C2(Cl)Cl"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0637" : {
                             "Name" : "Fenthion",
            "Substrate's structure" : "[H]C1=C(OP(=S)(OC([H])([H])[H])OC([H])([H])[H])C([H])=C(C(SC([H])([H])[H])=C1[H])C([H])([H])[H]",
                         "InChIKey" : "PNVJTZOFSHSLTO-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2B6; CYP2C9; CYP2C19; CYP3A4; CYP3A5",
                       "References" : [
                "Leoni, C. et al. (2008). The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol. Appl. Pharmacol., Vol. 233, No. 2, (343-352)."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0603",
                     "inchikey" : "ZNRZGJAHNMGWQN-UHFFFAOYSA-N",
                         "name" : "Fenthion oxon",
                    "structure" : "COP(=O)(OC)OC1=CC=C(SC)C(C)=C1"
                }
            ],
                    "Reaction Type" : [
                "Desulfurization"
            ]
        },
        "BIOTID0638" : {
                             "Name" : "Flecainide",
            "Substrate's structure" : "[H]N(C(=O)C1=C([H])C(OC([H])([H])C(F)(F)F)=C([H])C([H])=C1OC([H])([H])C(F)(F)F)C([H])([H])[C@@]1([H])N([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "DJBNUMBKLMJRSA-LDGXTIHJNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0604",
                     "inchikey" : "FNWQOVVWANCDDT-UHFFFAOYNA-N",
                         "name" : "2-hydroxy-N-[(piperidin-2-yl)methyl]-5-(2,2,2-trifluoroethoxy)benzamide",
                    "structure" : "OC1=CC=C(OCC(F)(F)F)C=C1C(=O)NCC1CCCCN1"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0639" : {
                             "Name" : "Fluoxetine ",
            "Substrate's structure" : "CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1",
                         "InChIKey" : "RTHCYVBBDHJXIQ-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9 (major); CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0605",
                     "inchikey" : "WIQRCHMSJFFONW-UHFFFAOYNA-N",
                         "name" : "Norfluoxetine",
                    "structure" : "NCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0640" : {
                             "Name" : "Fluoxetine ",
            "Substrate's structure" : "CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1",
                         "InChIKey" : "RTHCYVBBDHJXIQ-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0056",
                     "inchikey" : "BAYGVMXZJBFEMB-UHFFFAOYSA-N",
                         "name" : "p-Trifluoromethylphenol",
                    "structure" : "OC1=CC=C(C=C1)C(F)(F)F"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0641" : {
                             "Name" : "Gavestinel",
            "Substrate's structure" : "[H]OC(=O)C1=C(\\C([H])=C(/[H])C(=O)N([H])C2=C([H])C([H])=C([H])C([H])=C2[H])C2=C(Cl)C([H])=C(Cl)C([H])=C2N1[H]",
                         "InChIKey" : "WZBNEZWCNKUOSM-VOTSOKGWSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0606",
                     "inchikey" : "KAIGNSIVVAINPQ-AATRIKPKSA-N",
                         "name" : "p-OH-gavestinel",
                    "structure" : "[H]OC(=O)C1=C(\\C([H])=C(/[H])C(=O)N([H])C2=C([H])C([H])=C(O)C([H])=C2[H])C2=C(Cl)C([H])=C(Cl)C([H])=C2N1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0642" : {
                             "Name" : "Gliclazide",
            "Substrate's structure" : "[H]N(N1C([H])([H])C2([H])C([H])([H])C([H])([H])C([H])([H])C2([H])C1([H])[H])C(=O)N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[H]",
                         "InChIKey" : "BOVGTQGAOIONJV-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0607",
                     "inchikey" : "JMHDCYDSYHLATB-UHFFFAOYNA-N",
                         "name" : "7-OH-gliclazide",
                    "structure" : "[H]N(N1C([H])([H])C2([H])C([H])([H])C([H])(O)C([H])([H])C2([H])C1([H])[H])C(=O)N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0643" : {
                             "Name" : "Gliclazide",
            "Substrate's structure" : "[H]N(N1C([H])([H])C2([H])C([H])([H])C([H])([H])C([H])([H])C2([H])C1([H])[H])C(=O)N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[H]",
                         "InChIKey" : "BOVGTQGAOIONJV-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0608",
                     "inchikey" : "IHCHVBQHVIUSTM-UHFFFAOYNA-N",
                         "name" : "Methylhydroxygliclazide",
                    "structure" : "[H]N(N1C([H])([H])C2([H])C([H])([H])C([H])([H])C([H])([H])C2([H])C1([H])[H])C(=O)N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0644" : {
                             "Name" : "Gliclazide",
            "Substrate's structure" : "[H]N(N1C([H])([H])C2([H])C([H])([H])C([H])([H])C([H])([H])C2([H])C1([H])[H])C(=O)N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[H]",
                         "InChIKey" : "BOVGTQGAOIONJV-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3677"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0609",
                     "inchikey" : "VUUZEWXIRFGRFE-UHFFFAOYNA-N",
                         "name" : "6-OH-gliclazide",
                    "structure" : "[H]N(N1C([H])([H])C2([H])C([H])([H])C([H])([H])C([H])(O)C2([H])C1([H])[H])C(=O)N([H])S(=O)(=O)C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0645" : {
                             "Name" : "Glimepiride",
            "Substrate's structure" : "CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC2CCC(C)CC2)C1=O",
                         "InChIKey" : "WIGIZIANZCJQQY-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3678"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0610",
                     "inchikey" : "YUNQMQLWOOVHKI-UHFFFAOYSA-N",
                         "name" : "Cyclohexylhydroymethylglimepiride",
                    "structure" : "[H]C1CC(CO)CCC1NC(=O)NS(=O)(=O)C1=CC=C(CCNC(=O)N2CC(C)=C(CC)C2=O)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0646" : {
                             "Name" : "Glipizide",
            "Substrate's structure" : "[H]N(C(=O)C1=NC([H])=C(N=C1[H])C([H])([H])[H])C([H])([H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "ZJJXGWJIGJFDTL-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3679"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0611",
                     "inchikey" : "WPQWQJBFAJEUHS-UHFFFAOYSA-N",
                         "name" : "4-trans-OH-glipizide",
                    "structure" : "[H]N(C(=O)C1=NC([H])=C(N=C1[H])C([H])([H])[H])C([H])([H])C([H])([H])C1=C([H])C([H])=C(C([H])=C1[H])S(=O)(=O)N([H])C(=O)N([H])C1([H])C([H])([H])C([H])([H])C([H])(O)C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0647" : {
                             "Name" : "Hydromorphone",
            "Substrate's structure" : "[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O",
                         "InChIKey" : "WVLOADHCBXTIJK-YNHQPCIGSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9; CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0612",
                     "inchikey" : "SWIRXSKBBSJXGY-UIHHKEIPSA-N",
                         "name" : "Norhydromorphone",
                    "structure" : "[H]OC1=C2O[C@@]3([H])C(=O)C([H])([H])C([H])([H])[C@@]4([H])[C@]5([H])NC([H])([H])C([H])([H])[C@]34C2=C(C([H])=C1[H])C5([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0648" : {
                             "Name" : "R-Ibuprofen",
            "Substrate's structure" : "[H]OC(=O)[C@@]([H])(C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "HEFNNWSXXWATRW-SNVBAGLBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0613",
                     "inchikey" : "HFAIHLSDLUYLQA-QVDQXJPCSA-N",
                         "name" : "R,S-3-Hydroxyibuprofen",
                    "structure" : "[H]C(C)(CO)CC1=CC=C(C=C1)[C@@H](C)C(O)=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0649" : {
                             "Name" : "R-Ibuprofen",
            "Substrate's structure" : "[H]OC(=O)[C@@]([H])(C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "HEFNNWSXXWATRW-SNVBAGLBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0613",
                     "inchikey" : "HFAIHLSDLUYLQA-QVDQXJPCSA-N",
                         "name" : "R,R-3-Hydroxyibuprofen",
                    "structure" : "[H]C(C)(CO)CC1=CC=C(C=C1)[C@@H](C)C(O)=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0650" : {
                             "Name" : "R-Ibuprofen",
            "Substrate's structure" : "[H]OC(=O)[C@@]([H])(C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "HEFNNWSXXWATRW-SNVBAGLBSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3677"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0614",
                     "inchikey" : "UJHKVYPPCJBOSG-SECBINFHSA-N",
                         "name" : "R-2-Hydroxyibuprofen",
                    "structure" : "C[C@@H](C(O)=O)C1=CC=C(CC(C)(C)O)C=C1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0651" : {
                             "Name" : "Lansoprazole",
            "Substrate's structure" : "[H]N1C(=NC2=C([H])C([H])=C([H])C([H])=C12)[S@](=O)C([H])([H])C1=NC(C)=C([H])C(OC([H])([H])C(F)(F)F)=C1C([H])([H])[H]",
                         "InChIKey" : "DQJZOUNZNYHEBV-AREMUKBSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP2C9; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0615",
                     "inchikey" : "GJTJOZQYAJLAKN-HHHXNRCGSA-N",
                         "name" : "Hydroxylansoprazole",
                    "structure" : "[H]N1C(=NC2=C(O)C([H])=C([H])C([H])=C12)[S@](=O)C([H])([H])C1=NC(C)=C([H])C(OC([H])([H])C(F)(F)F)=C1C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0652" : {
                             "Name" : "Lansoprazole",
            "Substrate's structure" : "[H]N1C(=NC2=C([H])C([H])=C([H])C([H])=C12)[S@](=O)C([H])([H])C1=NC(C)=C([H])C(OC([H])([H])C(F)(F)F)=C1C([H])([H])[H]",
                         "InChIKey" : "DQJZOUNZNYHEBV-AREMUKBSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3676"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0616",
                     "inchikey" : "PQOKUEVEGVMXIV-UHFFFAOYSA-N",
                         "name" : "Lansoprazole sulfone",
                    "structure" : "[H]N1C(=NC2=C([H])C([H])=C([H])C([H])=C12)S(=O)(=O)C([H])([H])C1=NC(C)=C([H])C(OC([H])([H])C(F)(F)F)=C1C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0653" : {
                             "Name" : "Imidacloprid",
            "Substrate's structure" : "[H]N(C1=NC([H])([H])C([H])([H])N1C([H])([H])C1=C([H])C([H])=C(Cl)N=C1[H])[N+]([O-])=O",
                         "InChIKey" : "YWTYJOPNNQFBPC-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP2D6; CYP2E1; CYP3A4",
                       "References" : [
                "Schulz-Jander, D.A. and Casida, J.E. (2002). Imidacloprid insecticide metabolism: human cytochrome P450 isozymes differ in selectivity for imidazolidine oxidation versus nitroimine reduction. Toxicol. Lett., Vol. 132, No. 1, (65-70)."
            ],
                         "Products" : [],
                    "Reaction Type" : [
                "Reduction"
            ]
        },
        "BIOTID0654" : {
                             "Name" : "Linoleic acid",
            "Substrate's structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "OYHQOLUKZRVURQ-HZJYTTRNSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0617",
                     "inchikey" : "FBUKMFOXMZRGRB-YFHOEESVNA-N",
                         "name" : "Leukotoxin",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])OC1([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0655" : {
                             "Name" : "Linoleic acid",
            "Substrate's structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "OYHQOLUKZRVURQ-HZJYTTRNSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0618",
                     "inchikey" : "CCPPLLJZDQAOHD-FLIBITNWNA-N",
                         "name" : "Isoleukotoxin",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(\\[H])=C(\\[H])C([H])([H])C1([H])OC1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0656" : {
                             "Name" : "Lithocholic Acid",
            "Substrate's structure" : "[H]OC(=O)C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H]",
                         "InChIKey" : "SMEROWZSTRWXGI-ZQMJQECZNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0619",
                     "inchikey" : "DGABKXLVXPYZII-SIBKNCMHSA-N",
                         "name" : "6�-Hydroxylithocholic acid",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])[C@]([H])(O)[C@]4([H])C([H])([H])[C@]([H])(O[H])C([H])([H])C([H])([H])[C@]4(C([H])([H])[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0657" : {
                             "Name" : "Lumiracoxib",
            "Substrate's structure" : "[H]OC(=O)C([H])([H])C1=C([H])C(=C([H])C([H])=C1N([H])C1=C(Cl)C([H])=C([H])C([H])=C1F)C([H])([H])[H]",
                         "InChIKey" : "KHPKQFYUPIUARC-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0620",
                     "inchikey" : "PREBINJQDJNORC-UHFFFAOYSA-N",
                         "name" : "Lumiracoxib metabolite 1",
                    "structure" : "[H]OC(=O)C([H])([H])C1=C([H])C(=C([H])C([H])=C1N([H])C1=C(Cl)C([H])=C([H])C([H])=C1F)C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0658" : {
                             "Name" : "Lumiracoxib",
            "Substrate's structure" : "[H]OC(=O)C([H])([H])C1=C([H])C(=C([H])C([H])=C1N([H])C1=C(Cl)C([H])=C([H])C([H])=C1F)C([H])([H])[H]",
                         "InChIKey" : "KHPKQFYUPIUARC-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0621",
                     "inchikey" : "LUNFHOZKXHTOLG-UHFFFAOYSA-N",
                         "name" : "Lumiracoxib metabolite 2",
                    "structure" : "[H]OC(=O)C([H])([H])C1=C([H])C(=C([H])C([H])=C1N([H])C1=C(Cl)C([H])=C(O)C([H])=C1F)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0659" : {
                             "Name" : "M7",
            "Substrate's structure" : "[H]N1N=NC(=N1)C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])N1C(=O)C2(N=C1C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])(O)C2([H])[H]",
                         "InChIKey" : "SGLAKMDXJPVHBY-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3675"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0622",
                     "inchikey" : "LIDZWACDVHJFLD-UHFFFAOYNA-N",
                         "name" : "M1",
                    "structure" : "[H]N1N=NC(=N1)C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])N1C(=NC2(C1=O)C([H])([H])C([H])([H])C([H])(O)C2([H])[H])C([H])([H])C([H])([H])C([H])(O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0660" : {
                             "Name" : "Malathion",
            "Substrate's structure" : "[H]C([H])([H])OP(=S)(OC([H])([H])[H])S[C@@]([H])(C(=O)OC([H])([H])C([H])([H])[H])C([H])([H])C(=O)OC([H])([H])C([H])([H])[H]",
                         "InChIKey" : "JXSJBGJIGXNWCI-SVGMAFHSNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2B6; CYP2C19; CYP3A4",
                       "References" : [
                "Buratti, F.M. et al. (2005). Malathion bioactivation in the human liver liver: The contribution of different cytochrome P450 isoform. Drug Metab. Dispos., Vol. 33, No. 3, (295-302)."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0623",
                     "inchikey" : "WSORODGWGUUOBO-UHFFFAOYNA-N",
                         "name" : "Maloxon",
                    "structure" : "CCOC(=O)CC(SP(=O)(OC)OC)C(=O)OCC"
                }
            ],
                    "Reaction Type" : [
                "Desulfurization"
            ]
        },
        "BIOTID0661" : {
                             "Name" : "Mianserine",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N1C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C1([H])C1=C([H])C([H])=C([H])C([H])=C1C2([H])[H]",
                         "InChIKey" : "UEQUQVLFIPOEMF-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6 (major; (major, R���S)); CYP2B6 (R>S); CYP3A4  (S>R) ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0624",
                     "inchikey" : "YTMQIPGEXLWJTN-UHFFFAOYNA-N",
                         "name" : "8-Hydroxymianserin",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])C([H])([H])C1=C([H])C(O)=C([H])C([H])=C1N1C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C21[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0662" : {
                             "Name" : "Mianserine",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N1C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C1([H])C1=C([H])C([H])=C([H])C([H])=C1C2([H])[H]",
                         "InChIKey" : "UEQUQVLFIPOEMF-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6 (R>S); CYP3A4 (R>S); CYP2C19 (R>S); CYP1A2 (R���S)",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0625",
                     "inchikey" : "ZBILSSSEXRZGKS-UHFFFAOYNA-N",
                         "name" : "Desmethylmianserin",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N1C([H])([H])C([H])([H])NC([H])([H])C1([H])C1=C([H])C([H])=C([H])C([H])=C1C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0663" : {
                             "Name" : "Mianserine",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N1C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C1([H])C1=C([H])C([H])=C([H])C([H])=C1C2([H])[H]",
                         "InChIKey" : "UEQUQVLFIPOEMF-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4 (R���S); CYP1A2 (S>R)",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0626",
                     "inchikey" : "VVDXWJOYXVNLLQ-UHFFFAOYNA-N",
                         "name" : "Mianserin N-oxide",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N1C([H])([H])C([H])([H])[N+]([O-])(C([H])([H])[H])C([H])([H])C1([H])C1=C([H])C([H])=C([H])C([H])=C1C2([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0664" : {
                             "Name" : "Mirtazapine",
            "Substrate's structure" : "[H]C1=NC2=C(C([H])=C1[H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1C1([H])N2C([H])([H])C([H])([H])N(C([H])([H])[H])C1([H])[H]",
                         "InChIKey" : "RONZAEMNMFQXRA-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6; CYP3A4",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0627",
                     "inchikey" : "GAFCUVMEBFTFQJ-UHFFFAOYNA-N",
                         "name" : "Mirtazapine N-oxide",
                    "structure" : "[H]C1=NC2=C(C([H])=C1[H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1C1([H])N2C([H])([H])C([H])([H])[N+](C)([O-])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0665" : {
                             "Name" : "Mirtazapine",
            "Substrate's structure" : "[H]C1=NC2=C(C([H])=C1[H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1C1([H])N2C([H])([H])C([H])([H])N(C([H])([H])[H])C1([H])[H]",
                         "InChIKey" : "RONZAEMNMFQXRA-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6; CYP3A4",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0628",
                     "inchikey" : "FGLAMNFOHWVQOH-UHFFFAOYNA-N",
                         "name" : "N-Desmethylmirtazapine",
                    "structure" : "[H]C1=NC2=C(C([H])=C1[H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1C1([H])N2C([H])([H])C([H])([H])NC1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0666" : {
                             "Name" : "Mirtazapine",
            "Substrate's structure" : "[H]C1=NC2=C(C([H])=C1[H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1C1([H])N2C([H])([H])C([H])([H])N(C([H])([H])[H])C1([H])[H]",
                         "InChIKey" : "RONZAEMNMFQXRA-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6; CYP3A4",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0629",
                     "inchikey" : "WKBHWUSDTGYZBT-UHFFFAOYNA-N",
                         "name" : "8-OH-mirtazapine",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])C([H])([H])C1=C(N=C(O)C([H])=C1[H])N1C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C21[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0667" : {
                             "Name" : "(-)-Menthol",
            "Substrate's structure" : "[H]O[C@]1([H])C([H])([H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]1([H])C([H])(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "NOOLISFMXDJSKH-KXUCPTDWSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0630",
                     "inchikey" : "LMXFTMYMHGYJEI-IWSPIJDZSA-N",
                         "name" : "p-Menthane-3,-8-diol",
                    "structure" : "C[C@@H]1CC[C@H]([C@H](O)C1)C(C)(C)O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0668" : {
                             "Name" : "Mestranol",
            "Substrate's structure" : "[H]O[C@@]1(C#C[H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C(C([H])=C([H])C(OC([H])([H])[H])=C4[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H]",
                         "InChIKey" : "IMSSROKUHAOUJS-MJCUULBUSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0631",
                     "inchikey" : "BFPYWIDHMRZLRN-SLHNCBLASA-N",
                         "name" : "Ethinylestradiol",
                    "structure" : "[H]O[C@@]1(C#C[H])C([H])([H])C([H])([H])[C@@]2([H])[C@]3([H])C([H])([H])C([H])([H])C4=C(C([H])=C([H])C(O)=C4[H])[C@@]3([H])C([H])([H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0669" : {
                             "Name" : "Methoxychlor",
            "Substrate's structure" : "[H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C(Cl)(Cl)Cl",
                         "InChIKey" : "IAKOZHOLGAGEJT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C9; CYP2D6; CYP2C19; CYP3A4",
                       "References" : [
                "Hu, Y. and Kupfer, D. (2002); Metabolism of the Endocrine Disruptor Pesticide-Methoxychlor by Human P450s: Pathways Involving a Novel Catechol Metabolite; Drug Metab Dispos. 2002 Sep;30(9):1035-42."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0632",
                     "inchikey" : "BUZUQNXGKRJIJT-UHFFFAOYNA-N",
                         "name" : "Mono-OH-methoxychlor",
                    "structure" : "COC1=CC=C(C=C1)C(C1=CC=C(O)C=C1)C(Cl)(Cl)Cl"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0670" : {
                             "Name" : "Mono-OH-methoxychlor",
            "Substrate's structure" : "[H]OC1=C([H])C([H])=C(C([H])=C1[H])[C@@]([H])(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C(Cl)(Cl)Cl",
                         "InChIKey" : "BUZUQNXGKRJIJT-YQTOOIBONA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2B6; CYP3A4; CYP3A5",
                       "References" : [
                "Hu, Y. and Kupfer, D. (2002); Metabolism of the Endocrine Disruptor Pesticide-Methoxychlor by Human P450s: Pathways Involving a Novel Catechol Metabolite; Drug Metab Dispos. 2002 Sep;30(9):1035-42."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0633",
                     "inchikey" : "CFAVOGVJXCIQLR-UHFFFAOYNA-N",
                         "name" : "Catechol-methoxychlor",
                    "structure" : "COC1=CC=C(C=C1)C(C1=CC(O)=C(O)C=C1)C(Cl)(Cl)Cl"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0671" : {
                             "Name" : "Mono-OH-methoxychlor",
            "Substrate's structure" : "[H]OC1=C([H])C([H])=C(C([H])=C1[H])[C@@]([H])(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C(Cl)(Cl)Cl",
                         "InChIKey" : "BUZUQNXGKRJIJT-YQTOOIBONA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2C8; CYP2C19; CYP2D6",
                       "References" : [
                "Hu, Y. and Kupfer, D. (2002); Metabolism of the Endocrine Disruptor Pesticide-Methoxychlor by Human P450s: Pathways Involving a Novel Catechol Metabolite; Drug Metab Dispos. 2002 Sep;30(9):1035-42."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0634",
                     "inchikey" : "IUGDILGOLSSKNE-UHFFFAOYSA-N",
                         "name" : "Bis-OH-methoxychlor",
                    "structure" : "OC1=CC=C(C=C1)C(C1=CC=C(O)C=C1)C(Cl)(Cl)Cl"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0672" : {
                             "Name" : "Monodemethylated mifepristone",
            "Substrate's structure" : "[H]O[C@@]1(C#CC([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])[C@@]3([H])C(=C4C(=C([H])C(=O)C([H])([H])C4([H])[H])C([H])([H])C3([H])[H])[C@@]([H])(C3=C([H])C([H])=C(NC([H])([H])[H])C([H])=C3[H])C([H])([H])[C@]12C([H])([H])[H]",
                         "InChIKey" : "IBLXOBHABOVXDY-WKWWZUSTSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Khan, K. K. et al. (2002); Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: An evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation; Mol. Pharmacol. 61:495���506",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996017"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0635",
                     "inchikey" : "MIPBCIAEOBOEKD-YEEPMTPTSA-N",
                         "name" : "Didemethylated mifepristone",
                    "structure" : "[H]O[C@@]1(C#CC([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])[C@@]3([H])C(=C4C(=C([H])C(=O)C([H])([H])C4([H])[H])C([H])([H])C3([H])[H])[C@@]([H])(C3=C([H])C([H])=C(N)C([H])=C3[H])C([H])([H])[C@]12C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0673" : {
                             "Name" : "Bis-OH-methoxychlor",
            "Substrate's structure" : "[H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])(C1=C([H])C([H])=C(O[H])C([H])=C1[H])C(Cl)(Cl)Cl",
                         "InChIKey" : "IUGDILGOLSSKNE-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Hu, Y. and Kupfer, D. (2002); Metabolism of the Endocrine Disruptor Pesticide-Methoxychlor by Human P450s: Pathways Involving a Novel Catechol Metabolite; Drug Metab Dispos. 2002 Sep;30(9):1035-42."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0636",
                     "inchikey" : "TUYRXLVIBHDPDA-UHFFFAOYNA-N",
                         "name" : "Tris-OH-methoxychlor",
                    "structure" : "OC1=CC=C(C=C1)C(C1=CC(O)=C(O)C=C1)C(Cl)(Cl)Cl"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0674" : {
                             "Name" : "methadone",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(C(=O)C([H])([H])C([H])([H])[H])(C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])(N(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "USSIQXCVUWKGNF-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP3A4 (major); CYP2B6; CYP2C8; CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0637",
                     "inchikey" : "DDUXMJACVBEYOX-UHFFFAOYNA-N",
                         "name" : "2ethylidene-1,5-dimethyl-3,3-diphenylpyrolidine",
                    "structure" : "CCC1C(C)N(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0675" : {
                             "Name" : "Monoethylglycinexylidide",
            "Substrate's structure" : "[H]N(C(=O)C([H])([H])NC([H])([H])C([H])([H])[H])C1=C(C([H])=C([H])C([H])=C1C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "WRMRXPASUROZGT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6; CYP3A4",
                       "References" : [
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0566",
                     "inchikey" : "YITCMQBVWIHTTA-UHFFFAOYSA-N",
                         "name" : "3-Hydroxymonoethyl glycinexylidide",
                    "structure" : "[H]N(C(=O)C([H])([H])NC([H])([H])C([H])([H])[H])C1=C(C([H])=C([H])C(O)=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0676" : {
                             "Name" : "Monoethylglycinexylidide",
            "Substrate's structure" : "[H]N(C(=O)C([H])([H])NC([H])([H])C([H])([H])[H])C1=C(C([H])=C([H])C([H])=C1C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "WRMRXPASUROZGT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A4",
                       "References" : [
                "Zhou, S-F.; (2016); Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism; Edited by CRC Press; ISBN 9781466597884 - CAT# KE23693"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0638",
                     "inchikey" : "IXYVBZOSGGJWCW-UHFFFAOYSA-N",
                         "name" : "Glycinexylidide",
                    "structure" : "[H]N(C(=O)C([H])([H])N)C1=C(C([H])=C([H])C([H])=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0677" : {
                             "Name" : "N-Desmethyldiphenhydramine",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(OC([H])([H])C([H])([H])NC([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H]",
                         "InChIKey" : "AGSLYHYWLYGAOU-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP1A2; CYP2C9; CYP2C19",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0639",
                     "inchikey" : "NFJFUDGBWGXTHS-UHFFFAOYSA-N",
                         "name" : "N,N-Didesmethyldiphenhydramine",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(OC([H])([H])C([H])([H])N)C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0678" : {
                             "Name" : "N-Desmethylmianserin",
            "Substrate's structure" : "[H]N1C([H])([H])C([H])([H])N2C3=C(C([H])=C([H])C([H])=C3[H])C([H])([H])C3=C(C([H])=C([H])C([H])=C3[H])[C@]2([H])C1([H])[H]",
                         "InChIKey" : "ZBILSSSEXRZGKS-KRWDZBQOSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP1A2; CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0569",
                     "inchikey" : "KDLZTAPNHXUVCE-KRWDZBQOSA-N",
                         "name" : "(R)-mianserin, 8-OH-N-desmethyl",
                    "structure" : "[H]N1C([H])([H])C([H])([H])N2C3=C(C([H])=C([H])C(O)=C3[H])C([H])([H])C3=C(C([H])=C([H])C([H])=C3[H])[C@]2([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0679" : {
                             "Name" : "N-Desmethyltamoxifen",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])([H])[H])\\C1=C([H])C([H])=C(OC([H])([H])C([H])([H])NC([H])([H])[H])C([H])=C1[H]",
                         "InChIKey" : "NYDCDZSEEAUOHN-IZHYLOQSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0640",
                     "inchikey" : "MCJKBWHDNUSJLW-VHXPQNKSSA-N",
                         "name" : "N-Desdimethyltamoxifen",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])([H])[H])\\C1=C([H])C([H])=C(OC([H])([H])C([H])([H])N)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0680" : {
                             "Name" : "N-Desmethyltamoxifen",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])([H])[H])\\C1=C([H])C([H])=C(OC([H])([H])C([H])([H])NC([H])([H])[H])C([H])=C1[H]",
                         "InChIKey" : "NYDCDZSEEAUOHN-IZHYLOQSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0094",
                     "inchikey" : "MHJBZVSGOZTKRH-IZHYLOQSSA-N",
                         "name" : "Endoxifen",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C(O)C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])C([H])([H])NC([H])([H])[H])C([H])=C1[H])\\C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0681" : {
                             "Name" : "N-Desmethyltamoxifen",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])([H])[H])\\C1=C([H])C([H])=C(OC([H])([H])C([H])([H])NC([H])([H])[H])C([H])=C1[H]",
                         "InChIKey" : "NYDCDZSEEAUOHN-IZHYLOQSSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0641",
                     "inchikey" : "GREXPZNIZPCGIV-IZHYLOQSNA-N",
                         "name" : "alpha-OH-N-desmethyltamoxifen",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])(O)C([H])([H])[H])\\C1=C([H])C([H])=C(OC([H])([H])C([H])([H])NC([H])([H])[H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0682" : {
                             "Name" : "N-methyl-3,4methylenedioxyamphetamine ",
            "Substrate's structure" : "[H]N(C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])C1=C([H])C2=C(OC([H])([H])O2)C([H])=C1[H]",
                         "InChIKey" : "SHXWCVYOXRDMCX-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP1A2 ",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0642",
                     "inchikey" : "NTCPGTZTPGFNOM-UHFFFAOYNA-N",
                         "name" : "N-Methyl-3,4dihydroxyamphetamine",
                    "structure" : "[H]N(C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])C1=C([H])C(O)=C(O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Heterocyclic ring fission"
            ]
        },
        "BIOTID0683" : {
                             "Name" : "1-Naphtaldehyde",
            "Substrate's structure" : "[H]C(=O)C1=C([H])C([H])=C([H])C2=C([H])C([H])=C([H])C([H])=C12",
                         "InChIKey" : "SQAINHDHICKHLX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0643",
                     "inchikey" : "PBLNHHSDYFYZNC-UHFFFAOYSA-N",
                         "name" : "1-Nahthalenethanol",
                    "structure" : "[H]OC([H])([H])C1=C([H])C([H])=C([H])C2=C([H])C([H])=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "Reduction"
            ]
        },
        "BIOTID0684" : {
                             "Name" : "1-Naphtaldehyde",
            "Substrate's structure" : "[H]C(=O)C1=C([H])C([H])=C([H])C2=C([H])C([H])=C([H])C([H])=C12",
                         "InChIKey" : "SQAINHDHICKHLX-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0644",
                     "inchikey" : "LNETULKMXZVUST-UHFFFAOYSA-N",
                         "name" : "1-Naphthoic acid",
                    "structure" : "[H]OC(=O)C1=C([H])C([H])=C([H])C2=C([H])C([H])=C([H])C([H])=C12"
                }
            ],
                    "Reaction Type" : [
                "C-oxidation"
            ]
        },
        "BIOTID0685" : {
                             "Name" : "Nateglinide",
            "Substrate's structure" : "[H]OC(=O)C([H])(N([H])C(=O)C1([H])C([H])([H])C([H])([H])C([H])(C([H])([H])C1([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H]",
                         "InChIKey" : "OELFLUMRDSZNSF-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0645",
                     "inchikey" : "GMHTWYIGIMINLF-UHFFFAOYNA-N",
                         "name" : "2�ې{[4�ې(1�ېhydroxypropan�ې2�ېyl)cyclohexyl]formamido}�ې3�ېphenylpropanoic acid",
                    "structure" : "[H]OC(=O)C([H])(N([H])C(=O)C1([H])C([H])([H])C([H])([H])C([H])(C([H])([H])C1([H])[H])C([H])(C([H])([H])[H])C([H])([H])O)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0686" : {
                             "Name" : "Nateglinide",
            "Substrate's structure" : "[H]OC(=O)C([H])(N([H])C(=O)C1([H])C([H])([H])C([H])([H])C([H])(C([H])([H])C1([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H]",
                         "InChIKey" : "OELFLUMRDSZNSF-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0646",
                     "inchikey" : "IUMHIIXPABZGRF-UHFFFAOYNA-N",
                         "name" : "2�ې{[4�ې(2�ېhydroxypropan�ې2�ېyl)cyclohexyl]formamido}�ې3�ېphenylpropanoic acid",
                    "structure" : "[H]OC(=O)C([H])(N([H])C(=O)C1([H])C([H])([H])C([H])([H])C([H])(C([H])([H])C1([H])[H])C(O)(C([H])([H])[H])C([H])([H])[H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0687" : {
                             "Name" : "Nicardipine",
            "Substrate's structure" : "COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1",
                         "InChIKey" : "ZBBHBTPTTSWHBA-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0647",
                     "inchikey" : "ZYQSJVQRWNAWHO-UHFFFAOYNA-N",
                         "name" : "De-benzylated nicardipine",
                    "structure" : "CNCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0688" : {
                             "Name" : "Nicardipine",
            "Substrate's structure" : "COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1",
                         "InChIKey" : "ZBBHBTPTTSWHBA-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C8; CYP2D6; CYP2E1; CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0648",
                     "inchikey" : "GROZWIBBDLLXKU-UHFFFAOYSA-N",
                         "name" : "Dehydronicardipine",
                    "structure" : "COC(=O)C1=C(C2=CC=CC(=C2)[N+]([O-])=O)C(C(=O)OCCN(C)CC2=CC=CC=C2)=C(C)N=C1C"
                }
            ],
                    "Reaction Type" : [
                "Heteroring dehydrogenation"
            ]
        },
        "BIOTID0689" : {
                             "Name" : "Nordoxepin",
            "Substrate's structure" : "[H]\\C(=C1\\C2=C([H])C([H])=C([H])C([H])=C2OC([H])([H])C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])C([H])([H])NC([H])([H])[H]",
                         "InChIKey" : "HVKCEFHNSNZIHO-YBEGLDIGSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Musshoff F. et al. (2010); Pharmacogenetics and forensic toxicology; Forensic Sci Int.; 203, 53-62. doi: doi:10.1016/j.forsciint.2010.07.011"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0649",
                     "inchikey" : "VOSZEQAEJIINHX-GIDUJCDVSA-N",
                         "name" : "2-Hydroxynordoxepin",
                    "structure" : "[H]\\C(=C1\\C2=C([H])C([H])=C([H])C([H])=C2OC([H])([H])C2=C([H])C([H])=C(O)C([H])=C12)C([H])([H])C([H])([H])NC([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0690" : {
                             "Name" : "Norverapamil",
            "Substrate's structure" : "[H]N(C([H])([H])C([H])([H])C1=C([H])C([H])=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H])C([H])([H])C([H])([H])C([H])([H])[C@](C#N)(C1=C([H])C([H])=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H])C([H])(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "UPKQNCPKPOLASS-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4; CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0650",
                     "inchikey" : "OGPWXYNEWNCFSU-UHFFFAOYNA-N",
                         "name" : "D-715 (PR-22)",
                    "structure" : "COC1=CC(CCNCCCC(C#N)(C(C)C)C2=CC=C(OC)C(OC)=C2)=CC=C1O"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0691" : {
                             "Name" : "Norverapamil",
            "Substrate's structure" : "[H]N(C([H])([H])C([H])([H])C1=C([H])C([H])=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H])C([H])([H])C([H])([H])C([H])([H])[C@](C#N)(C1=C([H])C([H])=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H])C([H])(C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "UPKQNCPKPOLASS-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4; CYP2D6",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Tracy, T.S. et al. (1999); Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil; Br J Clin Pharmacol. 1999 May; 47(5): 545���552; doi: 10.1046/j.1365-2125.1999.00923.x",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0587",
                     "inchikey" : "UCWOSFAANAZHKR-UHFFFAOYNA-N",
                         "name" : "D-620",
                    "structure" : "COC1=CC=C(C=C1OC)C(CCCN)(C#N)C(C)C"
                },
                {
                     "BTMDB_ID" : "BTMDB0587",
                     "inchikey" : "UCWOSFAANAZHKR-UHFFFAOYNA-N",
                         "name" : "D-620",
                    "structure" : "COC1=CC=C(CC=O)C=C1OC"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0692" : {
                             "Name" : "omeprazole",
            "Substrate's structure" : "[H]N1C(=NC2=C1C([H])=C([H])C(OC([H])([H])[H])=C2[H])S(=O)C([H])([H])C1=NC([H])=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "SUBDBMMJDZJVOS-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0651",
                     "inchikey" : "IGVYIWUGJPECAJ-UHFFFAOYNA-N",
                         "name" : "3-Hydroxyomeprazole",
                    "structure" : "[H]N1C(=NC2=C1C([H])=C([H])C(OC([H])([H])[H])=C2[H])S(=O)C([H])([H])C1=NC([H])=C(C(OC([H])([H])[H])=C1C([H])([H])O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0693" : {
                             "Name" : "omeprazole",
            "Substrate's structure" : "[H]N1C(=NC2=C1C([H])=C([H])C(OC([H])([H])[H])=C2[H])S(=O)C([H])([H])C1=NC([H])=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "SUBDBMMJDZJVOS-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19; CYP3A4; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0652",
                     "inchikey" : "CMZHQFXXAAIBKE-UHFFFAOYNA-N",
                         "name" : "5-Hydroxyomeprazole",
                    "structure" : "[H]N1C(=NC2=C1C([H])=C([H])C(OC([H])([H])[H])=C2[H])S(=O)C([H])([H])C1=NC([H])=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0694" : {
                             "Name" : "omeprazole",
            "Substrate's structure" : "[H]N1C(=NC2=C1C([H])=C([H])C(OC([H])([H])[H])=C2[H])S(=O)C([H])([H])C1=NC([H])=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "SUBDBMMJDZJVOS-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0653",
                     "inchikey" : "TWXDTVZNDQKCOS-UHFFFAOYNA-N",
                         "name" : "5'-O-Desmethyl omeprazole",
                    "structure" : "[H]N1C(=NC2=C1C([H])=C([H])C(O)=C2[H])S(=O)C([H])([H])C1=NC([H])=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0695" : {
                             "Name" : "omeprazole",
            "Substrate's structure" : "[H]N1C(=NC2=C1C([H])=C([H])C(OC([H])([H])[H])=C2[H])S(=O)C([H])([H])C1=NC([H])=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "SUBDBMMJDZJVOS-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0249",
                     "inchikey" : "IXEQEYRTSRFZEO-UHFFFAOYSA-N",
                         "name" : "Omeprazole sulfone",
                    "structure" : "[H]N1C2=C(N=C1S(=O)(=O)C([H])([H])C1=NC([H])=C(C(OC([H])([H])[H])=C1C([H])([H])[H])C([H])([H])[H])C([H])=C(OC([H])([H])[H])C([H])=C2[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0696" : {
                             "Name" : "Ondansetron",
            "Substrate's structure" : "[H]C1=C([H])N(C(=N1)C([H])([H])[H])C([H])([H])C1([H])C(=O)C2=C(N(C3=C([H])C([H])=C([H])C([H])=C23)C([H])([H])[H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "FELGMEQIXOGIFQ-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2D6; CYP1A2",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0654",
                     "inchikey" : "LMMFEGYKXLPLFC-UHFFFAOYNA-N",
                         "name" : "6-OH-ondansetron",
                    "structure" : "[H]C1=C([H])N(C(=N1)C([H])([H])[H])C([H])([H])C1([H])C(=O)C2=C(N(C3=C([H])C([H])=C(O)C([H])=C23)C([H])([H])[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0697" : {
                             "Name" : "Ondansetron",
            "Substrate's structure" : "[H]C1=C([H])N(C(=N1)C([H])([H])[H])C([H])([H])C1([H])C(=O)C2=C(N(C3=C([H])C([H])=C([H])C([H])=C23)C([H])([H])[H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "FELGMEQIXOGIFQ-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6; CYP3A4",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0655",
                     "inchikey" : "DTJUCZWBHDEFRB-UHFFFAOYNA-N",
                         "name" : "7-OH-ondansetron",
                    "structure" : "[H]C1=C([H])N(C(=N1)C([H])([H])[H])C([H])([H])C1([H])C(=O)C2=C(N(C3=C([H])C(O)=C([H])C([H])=C23)C([H])([H])[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0698" : {
                             "Name" : "Ondansetron",
            "Substrate's structure" : "[H]C1=C([H])N(C(=N1)C([H])([H])[H])C([H])([H])C1([H])C(=O)C2=C(N(C3=C([H])C([H])=C([H])C([H])=C23)C([H])([H])[H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "FELGMEQIXOGIFQ-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6; CYP3A4",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0656",
                     "inchikey" : "XVDKMEPUFIAQFH-UHFFFAOYNA-N",
                         "name" : "8-OH-ondansetron",
                    "structure" : "[H]C1=C([H])N(C(=N1)C([H])([H])[H])C([H])([H])C1([H])C(=O)C2=C(N(C3=C(O)C([H])=C([H])C([H])=C23)C([H])([H])[H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0699" : {
                             "Name" : "Phorate",
            "Substrate's structure" : "[H]C([H])([H])C([H])([H])OP(=S)(OC([H])([H])C([H])([H])[H])SC([H])([H])SC([H])([H])C([H])([H])[H]",
                         "InChIKey" : "BULVZWIRKLYCBC-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A4; CYP2B6; CYP2C9; CYP2C18; CYP2C19; CYP2D6",
                       "References" : [
                "Usmani, K.A.; (2004b). In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily. Drug Metab. Dispos., Vol. 32, No. 3, (333-339)."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0657",
                     "inchikey" : "XRQHTUDGPWMPKX-UHFFFAOYNA-N",
                         "name" : "Phorate sulfoxide",
                    "structure" : "CCOP(=S)(OCC)SCS(=O)CC"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0700" : {
                             "Name" : "Pioglitazone",
            "Substrate's structure" : "[H]N1C(=O)SC([H])(C1=O)C([H])([H])C1=C([H])C([H])=C(OC([H])([H])C([H])([H])C2=NC([H])=C(C([H])=C2[H])C([H])([H])C([H])([H])[H])C([H])=C1[H]",
                         "InChIKey" : "HYAFETHFCAUJAY-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0658",
                     "inchikey" : "OIQJTMMAMWFMQR-UHFFFAOYNA-N",
                         "name" : "2�ې[6�ې(2�ې{4�ې[(2,4�ېdioxo�ې1,3�ېthiazolidin�ې5�ېyl)methyl]phenoxy}ethyl)pyridin�ې3�ېyl]acetic acid",
                    "structure" : "[H]N1C(=O)SC([H])(C1=O)C([H])([H])C1=C([H])C([H])=C(OC([H])([H])C([H])([H])C2=NC([H])=C(C([H])=C2[H])C([H])([H])C(O)=O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-oxidation"
            ]
        },
        "BIOTID0701" : {
                             "Name" : "Pioglitazone",
            "Substrate's structure" : "[H]N1C(=O)SC([H])(C1=O)C([H])([H])C1=C([H])C([H])=C(OC([H])([H])C([H])([H])C2=NC([H])=C(C([H])=C2[H])C([H])([H])C([H])([H])[H])C([H])=C1[H]",
                         "InChIKey" : "HYAFETHFCAUJAY-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0659",
                     "inchikey" : "OXVFDZYQLGRLCD-UHFFFAOYNA-N",
                         "name" : "5�ې[(4�ې{2�ې[5�ې(1�ېhydroxyethyl)pyridin�ې2�ېyl]ethoxy}phenyl)methyl]�ې1,3�ېthiazolidine�ې2,4�ېdione",
                    "structure" : "[H]N1C(=O)SC([H])(C1=O)C([H])([H])C1=C([H])C([H])=C(OC([H])([H])C([H])([H])C2=NC([H])=C(C([H])=C2[H])C([H])(C)O)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0702" : {
                             "Name" : "Pioglitazone",
            "Substrate's structure" : "[H]N1C(=O)SC([H])(C1=O)C([H])([H])C1=C([H])C([H])=C(OC([H])([H])C([H])([H])C2=NC([H])=C(C([H])=C2[H])C([H])([H])C([H])([H])[H])C([H])=C1[H]",
                         "InChIKey" : "HYAFETHFCAUJAY-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0660",
                     "inchikey" : "RMTFRGFLVHAYCI-UHFFFAOYNA-N",
                         "name" : "5�ې({4�ې[2�ې(5�ېethylpyridin�ې2�ېyl)�ې2�ېhydroxyethoxy]phenyl}methyl)�ې1,3�ېthiazolidine�ې2,4�ېdione",
                    "structure" : "[H]N1C(=O)SC([H])(C1=O)C([H])([H])C1=C([H])C([H])=C(OC([H])([H])C([H])(O)C2=NC([H])=C(C([H])=C2[H])C([H])([H])C)C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0703" : {
                             "Name" : "17�_-OH-progesterone",
            "Substrate's structure" : "[H]C1=C2C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@](O)(C(=O)C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C([H])([H])C1=O",
                         "InChIKey" : "DBPWSSGDRRHUNT-CEGNMAFCSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D4; CYP2D6",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0661",
                     "inchikey" : "WHBHBVVOGNECLV-OBQKJFGGSA-N",
                         "name" : "17Beta-21-dihydroxyprogesterone",
                    "structure" : "[H]C1=C2C([H])([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])[C@](O)(C(=O)C([H])([H])O)[C@@]4(C([H])([H])[H])C([H])([H])C([H])([H])[C@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C([H])([H])C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0704" : {
                             "Name" : "Pranidipine",
            "Substrate's structure" : "COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\\C=C\\c1ccccc1",
                         "InChIKey" : "XTFPDGZNWTZCMF-DHZHZOJONA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0662",
                     "inchikey" : "UZYMZRZCYLNXQU-DHZHZOJOSA-N",
                         "name" : "Dehydrogenated pranidipine",
                    "structure" : "COC(=O)C1=C(C)N=C(C)C(C(=O)OC\\C=C\\c2ccccc2)=C1c1cccc(c1)[N+]([O-])=O"
                }
            ],
                    "Reaction Type" : [
                "Heteroring dehydrogenation"
            ]
        },
        "BIOTID0705" : {
                             "Name" : "Pranidipine",
            "Substrate's structure" : "COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\\C=C\\c1ccccc1",
                         "InChIKey" : "XTFPDGZNWTZCMF-DHZHZOJONA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2D6; CYP3A4",
                       "References" : [
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0663",
                     "inchikey" : "QROGIFZRVHSFLM-QHHAFSJGSA-N",
                         "name" : "trans�ې1�ېphenyl�ې1�ېpropene",
                    "structure" : "C\\C=C\\c1ccccc1"
                },
                {
                     "BTMDB_ID" : "BTMDB0663",
                     "inchikey" : "QROGIFZRVHSFLM-QHHAFSJGSA-N",
                         "name" : "trans�ې1�ېphenyl�ې1�ېpropene",
                    "structure" : "COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(O)=O"
                }
            ],
                    "Reaction Type" : []
        },
        "BIOTID0706" : {
                             "Name" : "Propafenone ",
            "Substrate's structure" : "[H]OC([H])(C([H])([H])OC1=C([H])C([H])=C([H])C([H])=C1C(=O)C([H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])N([H])C([H])([H])C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "JWHAUXFOSRPERK-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0664",
                     "inchikey" : "LUTWDNUXHDYZRA-UHFFFAOYNA-N",
                         "name" : "5-Hydroxypropafenone",
                    "structure" : "[H]OC([H])(C([H])([H])OC1=C([H])C([H])=C(O)C([H])=C1C(=O)C([H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])N([H])C([H])([H])C([H])([H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0707" : {
                             "Name" : "Propafenone ",
            "Substrate's structure" : "[H]OC([H])(C([H])([H])OC1=C([H])C([H])=C([H])C([H])=C1C(=O)C([H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])N([H])C([H])([H])C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "JWHAUXFOSRPERK-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A4",
                       "References" : [
                "R1) Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0665",
                     "inchikey" : "HIGKMVIPYOFHBP-UHFFFAOYNA-N",
                         "name" : "N-Despropylpropafenone",
                    "structure" : "[H]NC([H])([H])C([H])(O[H])C([H])([H])OC1=C([H])C([H])=C([H])C([H])=C1C(=O)C([H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0708" : {
                             "Name" : "(+)-limonene",
            "Substrate's structure" : "[H]C([H])=C(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "XMGQYMWWDOXHJM-JTQLQIEISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0011",
                     "inchikey" : "BAVONGHXFVOKBV-UHFFFAOYNA-N",
                         "name" : "Carveol",
                    "structure" : "[H]C([H])=C(C([H])([H])[H])C1([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])(O)C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0709" : {
                             "Name" : "(+)-limonene",
            "Substrate's structure" : "[H]C([H])=C(C([H])([H])[H])[C@@]1([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "XMGQYMWWDOXHJM-JTQLQIEISA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19; CYP3A4",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0666",
                     "inchikey" : "NDTYTMIUWGWIMO-UHFFFAOYNA-N",
                         "name" : "Perillyl alcohol",
                    "structure" : "CC(=C)C1CCC(CO)=CC1"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0710" : {
                             "Name" : "Monodesethylchloroquine",
            "Substrate's structure" : "[H]N(C1=C2C([H])=C([H])C(Cl)=C([H])C2=NC([H])=C1[H])[C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])N([H])C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "MCYUUUTUAAGOOT-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6",
                       "References" : [
                "Zanger, U.M. and Schwab, M.; Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation; Pharmacology & Therapeutics 138 (2013) 103���141; PMID:23333322",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0667",
                     "inchikey" : "GYEDIFVVTRKXHP-UHFFFAOYNA-N",
                         "name" : "N,N-didesethylchloroquinone",
                    "structure" : "CC(CCCN)NC1=C2C=CC(Cl)=CC2=NC=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0711" : {
                             "Name" : "Rofecoxib",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C(C2=C([H])C([H])=C(C([H])=C2[H])S(=O)(=O)C([H])([H])[H])C([H])([H])OC1=O",
                         "InChIKey" : "RZJQGNCSTQAWON-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A4",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0668",
                     "inchikey" : "NCBVUSNBLYMFPP-UHFFFAOYNA-N",
                         "name" : "5-OH-rofecoxib",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C(C2=C([H])C([H])=C(C([H])=C2[H])S(=O)(=O)C([H])([H])[H])C([H])(O)OC1=O"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0712" : {
                             "Name" : " rosiglitazone",
            "Substrate's structure" : "CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1",
                         "InChIKey" : "YASAKCUCGLMORW-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3683"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0669",
                     "inchikey" : "AGQGGZNSVNKGDU-UHFFFAOYNA-N",
                         "name" : "para-hydroxyrosiglitazone",
                    "structure" : "[H]OC1=C([H])C([H])=C(N=C1[H])N(C([H])([H])[H])C([H])([H])C([H])([H])OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C1([H])SC(=O)N([H])C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0713" : {
                             "Name" : " rosiglitazone",
            "Substrate's structure" : "CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1",
                         "InChIKey" : "YASAKCUCGLMORW-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3684"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0670",
                     "inchikey" : "ZJQTVMXUIGXRMR-UHFFFAOYNA-N",
                         "name" : "N-Desmethylrosiglitazone",
                    "structure" : "[H]N(C1=C([H])C([H])=C([H])C([H])=N1)C([H])([H])C([H])([H])OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C1([H])SC(=O)N([H])C1=O"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0714" : {
                             "Name" : " rosiglitazone",
            "Substrate's structure" : "CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1",
                         "InChIKey" : "YASAKCUCGLMORW-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3685"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0671",
                     "inchikey" : "KQXWMUFVDAFGPU-UHFFFAOYNA-N",
                         "name" : "ortho-hydroxyrosiglitazone",
                    "structure" : "[H]OC1=C(N=C([H])C([H])=C1[H])N(C([H])([H])[H])C([H])([H])C([H])([H])OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C1([H])SC(=O)N([H])C1=O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0715" : {
                             "Name" : "Rosuvastatin",
            "Substrate's structure" : "CC(C)C1=C(\\C=C\\[C@H](O)C[C@H](O)CC(O)=O)C(=NC(=N1)N(C)S(C)(=O)=O)C1=CC=C(F)C=C1",
                         "InChIKey" : "BPRHUIZQVSMCRT-RJCHQFKYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9; CYP2C19 ",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3686"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0672",
                     "inchikey" : "DJUKMHIJCDJSIJ-FHQWLQQXSA-N",
                         "name" : "N-Desmethylrosuvastatin",
                    "structure" : "CC(C)C1=C(\\C=C\\[C@H](O)C[C@H](O)CC(O)=O)C(=NC(NS(C)(=O)=O)=N1)C1=CC=C(F)C=C1"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0716" : {
                             "Name" : "Rosuvastatin",
            "Substrate's structure" : "CC(C)C1=C(\\C=C\\[C@H](O)C[C@H](O)CC(O)=O)C(=NC(=N1)N(C)S(C)(=O)=O)C1=CC=C(F)C=C1",
                         "InChIKey" : "BPRHUIZQVSMCRT-RJCHQFKYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3686"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0673",
                     "inchikey" : "MSHRTLJOXFXLIV-MDZDMXLPSA-N",
                         "name" : "Rosuvastatin 5 S-lactone",
                    "structure" : "CC(C)C1=C(\\C=C\\C2=CC(O)=CC(=O)O2)C(=NC(=N1)N(C)S(C)(=O)=O)C1=CC=C(F)C=C1"
                }
            ],
                    "Reaction Type" : [
                "NULL"
            ]
        },
        "BIOTID0717" : {
                             "Name" : "silybin ",
            "Substrate's structure" : "COC1=C(O)C=CC(=C1)[C@H]1OC2=C(O[C@@H]1CO)C=CC(=C2)[C@H]1OC2=CC(O)=CC(O)=C2C(=O)[C@@H]1O",
                         "InChIKey" : "SEBFKMXJBCUCAI-ATASIELBNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C8",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3687"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0674",
                     "inchikey" : "RAWNDNZPLHPBEN-OYYPCOLYSA-N",
                         "name" : "O-demethylated-silybin",
                    "structure" : "[H]OC1=C(O)C=CC(=C1)[C@H]1OC2=C(O[C@@H]1CO)C=CC(=C2)[C@H]1OC2=CC(O)=CC(O)=C2C(=O)[C@@H]1O"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0718" : {
                             "Name" : "Sulfinpyrazone",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])N1N(C(=O)C([H])(C1=O)C([H])([H])C([H])([H])S(=O)C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1[H]",
                         "InChIKey" : "MBGGBVCUIVRRBF-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0675",
                     "inchikey" : "DQUYGWDNTAETLI-UHFFFAOYSA-N",
                         "name" : "Sulfinpyrazone sulfone",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])N1N(C(=O)C([H])(C1=O)C([H])([H])C([H])([H])S(=O)(=O)C1=C([H])C([H])=C([H])C([H])=C1[H])C1=C([H])C([H])=C([H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0719" : {
                             "Name" : "Pyributicarb",
            "Substrate's structure" : "[H]C1=C([H])C(=NC(OC([H])([H])[H])=C1[H])N(C(=S)OC1=C([H])C([H])=C([H])C(=C1[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "VTRWMTJQBQJKQH-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C19",
                       "References" : [
                "Ohkawa, H and Inui, H. (2015); Metabolism of agrochemicals and relatedenvironmental chemicals based on cytochromeP450s in mammals and plants; Pest Manag Sci.; 71: 824���828"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0676",
                     "inchikey" : "NXGVDGXPNJOHIJ-UHFFFAOYSA-N",
                         "name" : "Pyributicarb metabolite 1",
                    "structure" : "CN(C(=S)OC1=CC=CC(=C1)C(C)(C)C)C1=NC(O)=CC=C1"
                }
            ],
                    "Reaction Type" : [
                "O-dealkylation"
            ]
        },
        "BIOTID0720" : {
                             "Name" : "Sulprofos",
            "Substrate's structure" : "[H]C1=C([H])C(SC([H])([H])[H])=C([H])C([H])=C1O[P@](=S)(OC([H])([H])C([H])([H])[H])SC([H])([H])C([H])([H])C([H])([H])[H]",
                         "InChIKey" : "JXHJNEJVUNHLKO-HNNXBMFYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP3A4; CYP2C9; CYP2C18; CYP2C19; CYP2D6",
                       "References" : [
                "Usmani, K.A.; (2004b). In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily. Drug Metab. Dispos., Vol. 32, No. 3, (333-339)."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0677",
                     "inchikey" : "CBVUFUJJOXRACG-UHFFFAOYNA-N",
                         "name" : "Sulprofos sulfoxide",
                    "structure" : "[#6]-[#6]-[#6]-[#16]P(=S)([#8]-[#6]-[#6])[#8]-[#6]-1=[#6]-[#6]=[#6](-[#6]=[#6]-1)S([#6])=O"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0721" : {
                             "Name" : "suprofen",
            "Substrate's structure" : "CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1",
                         "InChIKey" : "MDKGKXOCJGEUJW-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0678",
                     "inchikey" : "BBVYLLCHKPXDCK-UHFFFAOYNA-N",
                         "name" : "Suprofen -sulfoxide",
                    "structure" : "[H]OC(=O)C([H])(C1=C([H])C([H])=C(C([H])=C1[H])C(=O)C1=C([H])C([H])=C([H])S1=O)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0722" : {
                             "Name" : "suprofen",
            "Substrate's structure" : "CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1",
                         "InChIKey" : "MDKGKXOCJGEUJW-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0679",
                     "inchikey" : "SDGBIPHZPNRUFG-UHFFFAOYNA-N",
                         "name" : "Thiophene-4,5-epoxide",
                    "structure" : "[H]OC(=O)C([H])(C1=C([H])C([H])=C(C([H])=C1[H])C(=O)C1=C([H])C2([H])OC2([H])S1)C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Ring epoxidation"
            ]
        },
        "BIOTID0723" : {
                             "Name" : "Tamoxifen N-oxide",
            "Substrate's structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])([H])C([H])([H])[H])\\C1=C([H])C([H])=C(OC([H])([H])C([H])([H])[N+]([O-])(C([H])([H])[H])C([H])([H])[H])C([H])=C1[H]",
                         "InChIKey" : "YAASNACECBQAFW-QPLCGJKRSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP3A4; CYP3A5",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985",
                "Wang and Zhou; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423",
                "Zhou, S.F. (2009); Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance; Clin Pharmacokinet 2009; 48 (11); PMID:19902987",
                "Rendic,S. (2002) Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, 34:1-2, 83-448, DOI: 10.1081/ DMR-120001392; PMID:11996015"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0680",
                     "inchikey" : "UPGHFQMAOIISKB-QPLCGJKRNA-N",
                         "name" : "alpha-OH-tamoxifen N-oxide",
                    "structure" : "[H]C1=C([H])C([H])=C(C([H])=C1[H])C(=C(\\C1=C([H])C([H])=C([H])C([H])=C1[H])C([H])(O)C([H])([H])[H])\\C1=C([H])C([H])=C(OC([H])([H])C([H])([H])[N+]([O-])(C([H])([H])[H])C([H])([H])[H])C([H])=C1[H]"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0724" : {
                             "Name" : "Tegafur",
            "Substrate's structure" : "[H]N1C(=O)N(C([H])=C(F)C1=O)C1([H])OC([H])([H])C([H])([H])C1([H])[H]",
                         "InChIKey" : "WFWLQNSHRPWKFK-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2A6; CYP1A2; CYP2C8",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0681",
                     "inchikey" : "GHASVSINZRGABV-UHFFFAOYSA-N",
                         "name" : "5-Fluorouracil",
                    "structure" : "[H]N1C(=O)NC([H])=C(F)C1=O"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0725" : {
                             "Name" : "Thioridazine",
            "Substrate's structure" : "CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1",
                         "InChIKey" : "KLBQZWRITKRQQV-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2D6; CYP3A4",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0682",
                     "inchikey" : "SLVMESMUVMCQIY-UHFFFAOYNA-N",
                         "name" : "Thioridazine 2-sulfoxide",
                    "structure" : "[H]C1=C([H])C([H])=C2N(C3=C(SC2=C1[H])C([H])=C([H])C(=C3[H])S(=O)C([H])([H])[H])C([H])([H])C([H])([H])C1([H])N(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0726" : {
                             "Name" : "Thioridazine",
            "Substrate's structure" : "CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1",
                         "InChIKey" : "KLBQZWRITKRQQV-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A4",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0683",
                     "inchikey" : "UFDCSHQNNVQXAS-UHFFFAOYNA-N",
                         "name" : "N-desmethylthioridazine",
                    "structure" : "[H]C1=C([H])C([H])=C2N(C3=C(SC2=C1[H])C([H])=C([H])C(SC([H])([H])[H])=C3[H])C([H])([H])C([H])([H])C1([H])NC([H])([H])C([H])([H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "N-dealkylation"
            ]
        },
        "BIOTID0727" : {
                             "Name" : "Thioridazine",
            "Substrate's structure" : "CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1",
                         "InChIKey" : "KLBQZWRITKRQQV-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP3A4",
                       "References" : [
                "Wang and Zhou; Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry, 2009 Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0684",
                     "inchikey" : "XLDFFVBQCMLXIE-UHFFFAOYNA-N",
                         "name" : "Thioridazine 5-sulfoxide",
                    "structure" : "[H]C1=C([H])C([H])=C2C(=C1[H])N(C1=C(C([H])=C([H])C(SC([H])([H])[H])=C1[H])S2=O)C([H])([H])C([H])([H])C1([H])N(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        },
        "BIOTID0728" : {
                             "Name" : "Thymol",
            "Substrate's structure" : "[H]OC1=C([H])C(=C([H])C([H])=C1C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "MGSRCZKZVOBKFT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2A6; CYP2D6",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0685",
                     "inchikey" : "LYUBXLHGANLIMX-UHFFFAOYSA-N",
                         "name" : "p-Cymene-2,3-diol",
                    "structure" : "CC(C)C1=CC=C(C)C(O)=C1O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0729" : {
                             "Name" : "Thymol",
            "Substrate's structure" : "[H]OC1=C([H])C(=C([H])C([H])=C1C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "MGSRCZKZVOBKFT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2A6; CYP2D6",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0686",
                     "inchikey" : "OQIOHYHRGZNZCW-UHFFFAOYSA-N",
                         "name" : "Thymoquinol",
                    "structure" : "CC(C)C1=CC(O)=C(C)C=C1O"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0730" : {
                             "Name" : "Thymol",
            "Substrate's structure" : "[H]OC1=C([H])C(=C([H])C([H])=C1C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "MGSRCZKZVOBKFT-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP2A6; CYP2D6",
                       "References" : [
                "J�_ger, W. and H̦ferl, M.; Metabolism of Terpenoids in Animal Models and Humans (Chapter 9) in Handbook of Essential Oils - Science, Technology, and Applications, Second Edition; Edited by K. Husnu Can Baser and Gerhard Buchbauer; CRC Press 2015; pp. 253���279."
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0687",
                     "inchikey" : "IHWFPRKZRRGTTI-UHFFFAOYSA-N",
                         "name" : "p-Cymen-8-en-3-ol",
                    "structure" : "CC(=C)C1=CC=C(C)C=C1O"
                }
            ],
                    "Reaction Type" : [
                "Dehydrogenation"
            ]
        },
        "BIOTID0731" : {
                             "Name" : "Tizanidine",
            "Substrate's structure" : "[H]N(C1=NC([H])([H])C([H])([H])N1[H])C1=C(Cl)C([H])=C([H])C2=NSN=C12",
                         "InChIKey" : "XFYDIVBRZNQMJC-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0688",
                     "inchikey" : "LURMELDQBVJARZ-UHFFFAOYNA-N",
                         "name" : "2�ې[(5�ېchloro�ې2,1,3�ېbenzothiadiazol�ې4�ېyl)amino]�ې4,5�ېdihydro�ې1H�ېimidazol�ې4�ېol",
                    "structure" : "[H]N(C1=NC([H])(O)C([H])([H])N1[H])C1=C(Cl)C([H])=C([H])C2=NSN=C12"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0732" : {
                             "Name" : "Trichloroethylene",
            "Substrate's structure" : "[H]C(Cl)=C(Cl)Cl",
                         "InChIKey" : "XSTXAVWGXDQKEL-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2E1; CYP1A2; CYP3A4",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0689",
                     "inchikey" : "RNFNDJAIBTYOQL-UHFFFAOYSA-N",
                         "name" : "Chloral hydrate",
                    "structure" : "OC(O)C(Cl)(Cl)Cl"
                }
            ],
                    "Reaction Type" : [
                "Epoxidation"
            ]
        },
        "BIOTID0733" : {
                             "Name" : "TSU-68",
            "Substrate's structure" : "[H]OC(=O)C([H])([H])C([H])([H])C1=C(N([H])C(\\C([H])=C2/C(=O)N([H])C3=C([H])C([H])=C([H])C([H])=C23)=C1C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "NHFDRBXTEDBWCZ-ZROIWOOFSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2; CYP1A1; CYP2C8",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0690",
                     "inchikey" : "APJYZRJDCRLKDI-ZSOIEALJSA-N",
                         "name" : "TSU-68 metabolite 1",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C1=C(N([H])C(\\C([H])=C2/C(=O)N([H])C3=C([H])C([H])=C(O)C([H])=C23)=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0734" : {
                             "Name" : "TSU-68",
            "Substrate's structure" : "[H]OC(=O)C([H])([H])C([H])([H])C1=C(N([H])C(\\C([H])=C2/C(=O)N([H])C3=C([H])C([H])=C([H])C([H])=C23)=C1C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "NHFDRBXTEDBWCZ-ZROIWOOFSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C8",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0691",
                     "inchikey" : "NTSFCHHACMZKEA-JYRVWZFOSA-N",
                         "name" : "TSU-68 metabolite 2",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C1=C(N([H])C(\\C([H])=C2/C(=O)N([H])C3=C(O)C([H])=C([H])C([H])=C23)=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0735" : {
                             "Name" : "TSU-68",
            "Substrate's structure" : "[H]OC(=O)C([H])([H])C([H])([H])C1=C(N([H])C(\\C([H])=C2/C(=O)N([H])C3=C([H])C([H])=C([H])C([H])=C23)=C1C([H])([H])[H])C([H])([H])[H]",
                         "InChIKey" : "NHFDRBXTEDBWCZ-ZROIWOOFSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A1; CYP1A2; CYP2C8",
                       "References" : [
                "Wang, B. and Zhou, S.F. (2009); Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development; Current Medicinal Chemistry; Vol. 16, No. 31; PMID:19754423"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0692",
                     "inchikey" : "YEVBDKUJUCJAMN-ZSOIEALJSA-N",
                         "name" : "TSU-68 metabolite 3",
                    "structure" : "[H]OC(=O)C([H])([H])C([H])([H])C1=C(N([H])C(\\C([H])=C2/C(=O)N([H])C3=C([H])C(O)=C([H])C([H])=C23)=C1C([H])([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Aromatic hydroxylation"
            ]
        },
        "BIOTID0736" : {
                             "Name" : "YM-64227",
            "Substrate's structure" : "CCN1C(=O)N=C(C2CCCCC2)C2=CC=C(CC)N=C12",
                         "InChIKey" : "QFBNONLZWZUQCN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0693",
                     "inchikey" : "MJELJBCAAHPYTL-UHFFFAOYNA-N",
                         "name" : "M-2 (1,3-cis)",
                    "structure" : "CCN1C(=O)N=C(C2CCCC(O)C2)C2=CC=C(CC)N=C12"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0737" : {
                             "Name" : "YM-64227",
            "Substrate's structure" : "CCN1C(=O)N=C(C2CCCCC2)C2=CC=C(CC)N=C12",
                         "InChIKey" : "QFBNONLZWZUQCN-UHFFFAOYSA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP1A2",
                       "References" : [
                "Brown, C.M. et al. (2008); Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates; Drug Metabolism Reviews, 40:1, 1-100, DOI: 10.1080/03602530701836662; PMID:18259985"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0694",
                     "inchikey" : "MJELJBCAAHPYTL-GLGOKHISSA-N",
                         "name" : "M-3 (1,3-trans)",
                    "structure" : "CCN1C(=O)N=C(C2CCC[C@@H](O)C2)C2=CC=C(CC)N=C12"
                }
            ],
                    "Reaction Type" : [
                "Aliphatic hydroxylation"
            ]
        },
        "BIOTID0738" : {
                             "Name" : "Zaltoprofen",
            "Substrate's structure" : "[H]OC(=O)C([H])(C1=C([H])C2=C(SC3=C([H])C([H])=C([H])C([H])=C3C(=O)C2([H])[H])C([H])=C1[H])C([H])([H])[H]",
                         "InChIKey" : "MUXFZBHBYYYLTH-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3682"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0695",
                     "inchikey" : "LKGZEJBRWPSWLF-UHFFFAOYNA-N",
                         "name" : "10-OH-zaltoprofen",
                    "structure" : "[H]OC(=O)C([H])(C1=C([H])C2=C(SC3=C([H])C([H])=C([H])C([H])=C3C([H])(O)C2([H])[H])C([H])=C1[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "Reduction"
            ]
        },
        "BIOTID0739" : {
                             "Name" : "Zaltoprofen",
            "Substrate's structure" : "[H]OC(=O)C([H])(C1=C([H])C2=C(SC3=C([H])C([H])=C([H])C([H])=C3C(=O)C2([H])[H])C([H])=C1[H])C([H])([H])[H]",
                         "InChIKey" : "MUXFZBHBYYYLTH-UHFFFAOYNA-N",
                      "DrugBank ID" : "NULL",
                       "PubChem ID" : "NULL",
                      "Database ID" : "NULL",
                           "Enzyme" : "CYP2C9",
                       "References" : [
                "Zhou, S.F. et al. (2009); Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development; Current Medicinal Chemistry, 2009, 16, 3480-3683"
            ],
                         "Products" : [
                {
                     "BTMDB_ID" : "BTMDB0696",
                     "inchikey" : "BMXFBJRSBWVAIU-UHFFFAOYNA-N",
                         "name" : "Zaltoprofen S-oxide",
                    "structure" : "[H]OC(=O)C([H])(C1=C([H])C2=C(C([H])=C1[H])S(=O)C1=C([H])C([H])=C([H])C([H])=C1C(=O)C2([H])[H])C([H])([H])[H]"
                }
            ],
                    "Reaction Type" : [
                "S-oxidation"
            ]
        }
    }
}